cell_line_id,drug_id,response
SNU-119,selumetinib-BRD-A02303741 (4-1 mol-mol),5.373099730339768
BT 231,3676137,5.434962025277539
TCCSUP,9823820,4.428474658115308
BT 231,4578,4.741281810211192
NUGC-4,10427712,4.515503391405006
SW1353,57519531,1.8144711101250768
NCI-H2087,9826308,0.0396540470680391
ECC10,9825149,0.7569853528162225
T84,216239,2.5733907770228956
RCM-1 [Human rectal adenocarcinoma],3136844,4.175493618298147
SK-MES-1,72376,-2.135789528691142
MHH-ES-1,46191454,-0.3162328206111855
Mino,3062316,-1.6625523975971268
KO52,carboplatin-etoposide (40-17 mol-mol),3.309104191597652
NCI-H1395,54678924,1.3168571915404212
LS411N,6914657,-4.299110458286086
NCI-N87,135440466,2.814988966864087
BT 416,selumetinib-MK-2206 (8-1 mol-mol),2.82861002913055
Mino,24748573,1.4256390123386682
NCI-H2087,BRD-A02303741-navitoclax (2-1 mol-mol),2.7852618547945296
HCC1833,11222830,1.6239658383017697
BT-20,53232,2.567008111515563
KP-N-YN,53392493,2.148012888885383
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023
GA-10,446155,1.210505999893269
YH-13,135440466,3.138970949638139
NCI-H2171,56949517,4.289308734480345
OCI-M1,15953870,3.52877399844703
LP-1,16725315,4.190220794645088
MHH-ES-1,327653,2.792753552455636
BT 231,46215462,1.880784914249253
KMS-12-BM,25062766,1.5143080044468464
GP2d,53392493,1.78931958692176
BT-20,carboplatin-UNC0638 (2-1 mol-mol),4.1356267559386035
NCI-H2171,969516,2.758162928931276
KMS-12-BM,53495165,-2.246082698996139
MHH-CALL-4,BRD-K55473186,4.124929889452614
TCCSUP,erlotinib-PLX-4032 (2-1 mol-mol),3.460916777406278
PE/CA-PJ15,44632017,0.8360374067438779
OCI-M1,25183872,-4.248454279411782
SK-HEP-1,3025986,-0.7748266135658505
RCM-1 [Human rectal adenocarcinoma],9887053,4.376213721678965
EJM,decitabine-navitoclax (2-1 mol-mol),0.2249299573101983
RT-4,16741245,3.9190611982266503
PE/CA-PJ15,carboplatin-UNC0638 (2-1 mol-mol),4.28959354666425
SCC-9,613753,3.4469207135602904
SK-OV-3,4788,6.178998906779571
SNU-119,JQ-1-navitoclax (2-1 mol-mol),0.5509382626965866
NCI-H2087,54613361,-0.2995567449198
SW1353,6623618,2.321226222951656
MHH-ES-1,44490293,4.464804713017693
KO52,11609586,2.913368530947096
T84,107970,1.2920542062005194
PL-21,6610355,3.534973973806784
BICR 31,10427712,4.26091650049326
BT 416,2858523,3.06508928900317
NCI-H2087,3011155,4.439594851993467
KO52,11625818,4.5522450622851105
K-562,44607531,1.5533391017282614
SW1116,72734382,3.6555152633490335
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873
NCI-H1395,241158,4.2689573120798165
NCI-H2122,selumetinib-decitabine (4-1 mol-mol),3.84366899520748
K-562,4788,4.09681667300412
PE/CA-PJ15,374536,3.161408900699119
BT-20,252682,6.80397896188742
PL-21,11964036,-0.5529971627087533
HuNS1,49836020,4.176817793282971
KHM-1B,tretinoin-carboplatin (2-1 mol-mol),2.496287811338483
YH-13,52912189,2.2271959636109693
LP-1,135999136,4.095278648632366
NCI-H2171,2749,1.9442537074322577
IST-Mes1,9935249,3.876611894197404
PE/CA-PJ15,11494412,-0.2051245265419709
YD-8,25154868,4.975027029918458
Mino,54618771,0.6228570132231963
REC-1,5278396,3.353742403077532
KYSE-30,5738263,3.854483161609779
HD-MY-Z,135423438,3.7471437497344713
SK-MES-1,676352,1.5880549984893702
Mino,156414,0.9048152948855052
SK-MES-1,135659046,3.5561232881246805
TCCSUP,4477,1.3083766641686785
KO52,9933475,1.739633318252188
KO52,2742550,3.525067743551677
NCI-H2087,6184667,2.1132316467036345
PE/CA-PJ15,9840324,5.741799311729206
REC-1,44607531,1.7540961612840025
GP2d,241158,3.714880329185931
MHH-ES-1,168313016,4.916028116367523
BT-20,24951314,2.250230282847431
NCI-N87,10113978,2.582247145825502
NMC-G1,12001922,1.7140481956648972
LP-1,24753719,3.6405716630369014
K-562,5738263,2.3545721599917027
GA-10,55508,1.830749636911424
NUGC-4,57519531,1.7755175848042175
BT 231,16722836,1.9952000932002232
NCI-H1395,6252,1.808154322431175
Mino,7251185,0.919792826844553
NCI-H2087,64971,2.131330441370475
GA-10,60700,-3.296690296071132
Calu-1,2126,3.264975704607756
SK-MES-1,16722836,0.8122402550613714
Mino,135398516,1.1230856191144136
NCI-N87,613753,3.043533794547513
BT-20,135875424,4.4451352594965545
ECC10,selumetinib-BRD-A02303741 (4-1 mol-mol),3.380284003905944
LS411N,54613361,3.867376577775082
ECC10,2130404,2.7929637282738873
KHM-1B,4259181,-0.2095303903157825
KMS-12-BM,16065773,1.4565661119909743
BT-20,25126798,4.0684908497837045
SK-MES-1,26596,-0.6489352140411898
SK-MES-1,2130404,3.700954058670964
SK-LU-1,10302451,0.6542414788556885
NCI-H929,11404337,-0.6691193705825791
SK-MES-1,25161177,4.301898877988761
SCC-9,16736978,3.1048488109971664
OCI-M1,71466380,3.868178749473328
T84,BRD9876-MK-1775 (4-1 mol-mol),0.3448739605402798
HD-MY-Z,24772860,-1.8685967663558516
NCI-N87,452548,-1.772451424496647
NCI-N87,44620216,3.650574309449747
SKM-1,selumetinib-UNC0638 (4-1 mol-mol),-0.1462150618543426
SW1353,selumetinib-BRD-A02303741 (4-1 mol-mol),4.684826068868717
ALL-SIL,135411,-0.5620485907345016
KHM-1B,2708,5.139604125220885
BT 231,100016,7.4946101776766385
BT 416,15953870,2.7613678891160314
HD-MY-Z,445643,3.870298948524005
PE/CA-PJ15,676352,1.7969794327090745
T84,4378219,3.51511491389043
KMS-12-BM,135999136,1.7056569950210811
LS411N,10231331,0.2083934704449227
ECC10,446155,1.73383199116674
NMC-G1,10074640,3.451897944451936
SK-OV-3,49766530,0.1985460846164677
NCI-H929,10410894,3.741769756077017
SKM-1,46215462,1.429596205296915
Hs 936.T,124202324,2.4413902131984537
NCI-N87,119182,-3.621619524843969
Mino,148198,-4.997781998015961
Mino,676352,1.5507928548431975
NCI-N87,9967941,2.944195178928737
MHH-ES-1,carboplatin-etoposide (40-17 mol-mol),0.8233073959963574
ECC10,17759555,2.418340244891623
GA-10,25150857,0.4473959861378574
SNU-119,25062766,2.2168629550530663
KYSE-30,11494412,4.405043553296497
PE/CA-PJ15,409805,3.811497133930035
K-562,19582717,3.29667086675107
OCI-M1,54619267,3.794882841201717
L3.3,2746,3.431089753490113
RCM-1 [Human rectal adenocarcinoma],selumetinib-tretinoin (2-1 mol-mol),1.4034944184327462
BT 416,11152667,0.4556152500975832
SK-MES-1,5278396,3.613951435140089
NUGC-4,60700,-0.3787828010708689
MHH-CALL-4,135411,-0.3032175747249798
EJM,241158,2.554123806651753
KMS-12-BM,54626689,3.649325161583167
CFPAC-1,44607531,2.5473166186613496
NCI-H2087,carboplatin-UNC0638 (2-1 mol-mol),2.8541949666497577
KYSE-140,54618771,1.7180424995817132
SK-OV-3,322968,3.987773865251791
KYSE-30,selumetinib-JQ-1 (4-1 mol-mol),3.305713321992504
BT-20,5280436,1.94263053891834
TCCSUP,11167602,2.834914441950803
SK-HEP-1,445091,4.514173662724111
RT-4,54143018,0.4678710422160503
PE/CA-PJ15,71466380,5.688383705062217
MHH-ES-1,44819697,-2.970514746290327
Calu-1,60700,3.9553619226595735
ECC10,57330099,3.681719099714748
Mino,4521392,4.167665849502811
YD-8,carboplatin-etoposide (40-17 mol-mol),3.699189794658081
L3.3,73707398,1.2944525096848456
SNU-119,54618164,3.949548457526877
NMC-G1,1239801,6.108838281591178
KYSE-30,53392493,3.4022018060832955
OCI-M1,24771867,-0.1913251805688479
Hs 936.T,11404337,0.4334403969580954
ALL-SIL,49766530,-2.347000417785464
HCC1833,72193861,1.888833295672956
BICR 31,44607531,1.4420456412349776
SK-MES-1,11656518,1.8471406870387763
GA-10,2742550,2.2253737438129564
BT 416,6918638,-2.563404601621211e-06
NCI-N87,decitabine-navitoclax (2-1 mol-mol),0.6446345774598216
Hs 936.T,doxorubicin-navitoclax (2-1 mol-mol),-0.3116537142886704
NCI-H929,5284373,-1.7427436127229046
SCC-9,3025944,4.376039606027409
SKM-1,tanespimycin-gemcitabine (1-1 mol-mol),-1.8087612580761447
KYSE-140,72376,-2.7026375332792676
SNU-119,46907787,2.5271615138386054
EJM,54619267,3.875367584336116
EJM,5566,2.9848804377366545
PE/CA-PJ15,136227924,2.633948596133963
NCI-H929,60700,-1.1580289283938754
IST-Mes1,9915743,1.0557522455188102
REC-1,44241473,4.8692289567308675
NUGC-4,25183872,0.0810547858281302
RCM-1 [Human rectal adenocarcinoma],sirolimus-bortezomib (250-1 mol-mol),0.4278853760712148
Calu-1,448949,3.35052770396008
BICR 31,135875424,5.0736941678127945
YH-13,1242560,3.390662173618847
PL-21,2828334,5.71437360348155
PE/CA-PJ15,11404337,-2.320439466084731
KYSE-140,9927531,4.387230999589902
KMS-12-BM,208908,1.7484542711618651
PE/CA-PJ15,6450551,3.117610470620624
MHH-ES-1,24785538,-1.7163659231117396
Hs 936.T,navitoclax-gemcitabine (1-1 mol-mol),0.7972109229849328
ECC10,176870,1.7846347778453373
SKM-1,24856436,-0.4445096015127717
RCM-1 [Human rectal adenocarcinoma],6917907,-5.490132832786946
EJM,JQ-1-carboplatin (1-1 mol-mol),0.7172378388996342
YH-13,23635314,-3.92693267445326
HMCB,4521392,4.730786278370015
GP2d,3552672,3.3450198881646633
NCI-H2122,5566,3.0985814576575836
IST-Mes1,135398516,1.9830137838908624
NCI-H1395,24797083,1.421721283570518
T84,44507138,4.393594115802306
SK-LU-1,3465537,3.809052717752696
BT 416,selumetinib-BRD-A02303741 (4-1 mol-mol),3.586228621763195
OCI-M1,6914657,-5.652926408969251
KHM-1B,54618771,-0.6219515555388266
KYSE-30,2749,2.199695924416508
RCM-1 [Human rectal adenocarcinoma],selumetinib-BRD-A02303741 (4-1 mol-mol),2.266377175881345
LS411N,11625818,4.428513603720294
EJM,4917,3.5272313521273415
BT 416,44620216,3.911000321451635
HD-MY-Z,JQ-1-carboplatin (1-1 mol-mol),1.7743689460569436
REC-1,9929138,7.294165808460384
ECC10,44507138,0.6484830287117679
MHH-CALL-4,carboplatin-etoposide (40-17 mol-mol),0.0577485230989008
BT 416,54618164,3.776512207378467
SNU-119,5351362,0.9137342384395012
NCI-H2087,24785538,1.6499389824316073
MHH-ES-1,17755052,0.5729115086023739
KYSE-140,16219061,3.836345309299646
MHH-ES-1,3503,1.3526708879672638
PE/CA-PJ15,51039095,2.8865821807336545
SKM-1,9826308,-1.0931344277451622
KO52,6918837,-5.47001608437254
KYSE-30,24748573,1.6972064238237334
BT 416,5494449,1.3299679298871918
SKM-1,53301938,-5.946970566996532
K-562,1641662,2.591871767435193
REC-1,9868037,0.961521370423606
KMS-12-BM,selumetinib-BRD-A02303741 (4-1 mol-mol),5.565016030045443
L3.3,9907093,5.18450339753338
SK-MES-1,16219061,3.0679445351265486
SKM-1,23725625,3.72033085826658
T84,25154868,4.167067508935747
SK-LU-1,JQ-1-MK-0752 (1-1 mol-mol),1.1803491100109154
PE/CA-PJ15,122327,4.1738841994986
ECC10,11234052,3.5434718288105445
IST-Mes1,10184653,1.5276072056435492
BT-20,54454,3.23597067187905
SK-LU-1,2749,2.128859255115231
T84,5287620,-3.4868053352746053
KYSE-30,erlotinib-PLX-4032 (2-1 mol-mol),3.651662858258946
KO52,selumetinib-JQ-1 (4-1 mol-mol),-1.2096541805376022
SK-LU-1,11214940,4.687594807102932
PE/CA-PJ15,445455,4.385473643575934
LS411N,44589607,3.372730635507476
ECC10,25262965,-2.12831278465422
ALL-SIL,409805,3.511042482554543
EJM,44632017,0.4808977509287103
K-562,11640390,3.4084234644631244
NUGC-4,23725625,5.237206724258877
KO52,9866186,-0.5103275036604222
MHH-ES-1,71680916,4.593171183261021
SK-LU-1,219104,4.227014212873794
NUGC-4,9927531,4.1074548867853045
RCM-1 [Human rectal adenocarcinoma],46926350,-4.0983765968922485
BT 416,10231331,-2.083820485023427
HD-MY-Z,1242560,3.078762349571649
SK-MES-1,9887053,4.31219154209573
SKM-1,168313200,4.186901063511942
K-562,6918878,0.8571724386049573
L3.3,54618164,4.298111449535211
BT 231,alisertib-navitoclax (2-1 mol-mol),-1.2220765646432012
KMS-12-BM,selumetinib-piperlongumine (8-1 mol-mol),2.5465910856240512
SNU-119,374536,-1.8347712072853533
T84,1714884,3.494416346366031
NCI-H2087,1714884,3.7496881874745007
KYSE-30,2733526,3.2727367071654014
SK-MES-1,322968,4.292476335853046
YD-8,46191454,1.6533383090175473
KO52,4788,5.9251451184243455
Hs 936.T,56946209,-2.8270544040413315
MHH-ES-1,26596,-2.3851189142163176
NCI-H2087,156414,0.9461657177021514
KO52,44185566,1.2667683963107288
BT 416,54618795,3.5225885457185044
YH-13,2749,2.5667946574986473
LP-1,11427553,1.91550016033583
LS411N,11964036,1.3999141622104765
KHM-1B,navitoclax-sorafenib (1-1 mol-mol),2.457676578610422
HCC1833,136227924,3.0159379881399895
LP-1,462382,-0.080852444465947
HMCB,10127622,5.814733445969234
NCI-H2087,444795,4.628154500266454
MHH-CALL-4,tanespimycin-bortezomib (250-1 mol-mol),0.3224433500782956
MHH-CALL-4,24856436,-1.7924193943847275
TCCSUP,49867926,4.195310139581862
Mino,135421197,1.5483687621841111
K-562,1566236,1.8179642124055264
NCI-H2171,15547703,3.4091207334536717
T84,135411,0.2084979580325832
CFPAC-1,123631,2.5576408099582397
HD-MY-Z,156414,1.5591920607935952
SKM-1,12003241,-1.1629643414911237
HMCB,439501,-1.1140754693945072
RCM-1 [Human rectal adenocarcinoma],285033,0.1322577754861078
EJM,4477,0.4259147068963801
NCI-H2087,selumetinib-navitoclax (8-1 mol-mol),-2.6047054982366062
MHH-ES-1,31703,-2.6337536773293104
SW1353,selumetinib-JQ-1 (4-1 mol-mol),1.7746405965747805
BT-20,9952709,2.3635424027019214
NUGC-4,4259181,-0.8315529215214057
NCI-H1395,54649381,3.0165140825256884
KYSE-30,9868037,3.995382741587693
EJM,66577038,3.002566519429357
HD-MY-Z,vorinostat-carboplatin (1-1 mol-mol),3.5653381002813083
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976
NCI-H2087,selumetinib-tretinoin (2-1 mol-mol),-4.302062460686344
GA-10,54678924,0.6016757161456794
Mino,9840324,5.439202689619101
MHH-ES-1,16722836,0.5644878748484974
OCI-M1,322968,4.161401099330216
NUGC-4,53232,3.215764034042361
NCI-H929,ISOX-bortezomib (250-1 mol-mol),-0.7959511173514853
BT 231,12003241,-1.271590527231957
NCI-H929,11364421,-2.397738455551311
OCI-M1,15983966,-4.135725805167281
HuNS1,alisertib-navitoclax (2-1 mol-mol),-1.8333095437040037
Mino,11152667,-1.4239628293556983
HCC1833,11178236,-2.3373882517026896
KMS-12-BM,72376,-4.576610051960773
KO52,57519531,1.8439662124610676
K-562,46398810,1.812730009869126
PL-21,tretinoin-navitoclax (4-1 mol-mol),0.6042995911281769
GP2d,5278396,3.658976500902125
REC-1,selumetinib-piperlongumine (8-1 mol-mol),4.826033479915962
TCCSUP,9911830,2.7321009507297727
HD-MY-Z,54596558,5.143369258380379
HD-MY-Z,carboplatin-UNC0638 (2-1 mol-mol),3.5912151503884653
YD-8,11222830,1.0279037219326927
BICR 31,24797083,1.8361324304615187
SW1353,375860,-0.9837699886394528
ECC10,24748573,-0.333348687697125
NCI-N87,serdemetan-SCH-529074 (1-1 mol-mol),1.7996053995650736
GP2d,46174525,4.157062029625254
ECC10,10296883,3.344976615043335
GA-10,navitoclax-PLX-4032 (1-1 mol-mol),2.1651286993636285
OCI-M1,44607531,1.7245883878251764
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945
NCI-N87,15983966,-4.100894125332804
BT-20,24901704,3.1963493556596916
SK-LU-1,UNC0638-navitoclax (1-1 mol-mol),4.8277080945305375
SKM-1,5280436,3.132311342282295
GP2d,6918837,-4.639114547641763
NCI-H2087,15547703,2.3950542550158613
SK-MES-1,54596558,4.13551395305641
GA-10,11404337,-3.9267202398834167
BT 416,11609586,2.774219753162881
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951
KMS-12-BM,44632017,-0.0018812054656874
SK-HEP-1,1242560,3.752923936287399
PE/CA-PJ15,52947716,2.90442121100954
PE/CA-PJ15,3025986,-1.5068920069952254
KMS-12-BM,11167602,1.7675298654448677
SNU-119,216468,1.5589878703095297
BT 231,6505803,0.1418659460842767
RT-4,10302451,0.2321939311866163
NCI-H2171,49867930,3.814749813399888
NCI-H2087,54619267,3.514636212577109
EJM,227681,2.671980927947041
KMS-12-BM,3385,3.988129125134885
Mino,49867930,6.219061286561844
NUGC-4,11175137,2.9171919062647205
BT 416,24821094,2.745443923946207
RT-4,doxorubicin-navitoclax (2-1 mol-mol),-0.4200341898170817
ECC10,119607,3.825644681200177
LS411N,452548,1.178688753001054
Mino,54618305,3.884266825894896
BT 231,568763,1.0361089634192413
SK-MES-1,107970,1.6078502223677542
OCI-M1,11955716,-2.380149477057086
L3.3,5278396,3.196787051990793
ALL-SIL,2749,0.4174204822378836
LP-1,12001922,1.3926156457590702
SKM-1,navitoclax-MST-312 (1-1 mol-mol),0.2103824065609011
YD-8,3815108,3.012285181299406
SNU-119,984333,1.4760065970514793
MHH-ES-1,9868037,2.631225103410452
KMS-12-BM,71304818,1.2685254858454966
GP2d,135875424,3.142612243202518
GP2d,11507802,0.5899382889705932
CFPAC-1,selumetinib-MK-2206 (8-1 mol-mol),4.195030559927768
KMS-12-BM,11497983,2.267788359318396
T84,3825829,3.9385604310519926
BT 416,2708,3.2848788777475755
OCI-M1,100016,6.862784368685653
LP-1,53232,3.2567168262611403
KP-N-YN,11625818,4.285778948003561
HMCB,11152667,-0.8228544828189237
Mino,vorinostat-carboplatin (1-1 mol-mol),1.5152769001725366
EJM,136227924,2.8681258655198367
KHM-1B,3825829,3.6551708099406
TCCSUP,65628,5.421928358435332
NCI-H2087,375860,0.2532519276094911
SK-MES-1,135411,0.4726928284800262
SK-OV-3,11175137,3.182781765506491
CFPAC-1,16038120,1.6593654130461946
NCI-N87,208908,-2.7799590207113014
BT 416,navitoclax-PLX-4032 (1-1 mol-mol),-1.8146959311371849
BT 231,6852167,2.464272024157972
SK-LU-1,3854666,3.216847376167724
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206
KMS-12-BM,49793307,-4.548343844172568
PANC-1,60750,3.339199645789133
Mino,702558,3.3847756452007554
BT 231,51039095,2.769148833687662
RCM-1 [Human rectal adenocarcinoma],46199207,3.748216496798377
BT 231,51037431,3.8591271021277023
EJM,46174525,3.426446737452036
RT-4,9935249,3.446453833049965
HCC1833,44607531,1.486686805552789
HD-MY-Z,2949965,2.619554162155433
OCI-M1,168312962,1.984481540957632
SK-MES-1,9911463,3.432548166775373
Calu-1,969516,4.742619356541895
HD-MY-Z,104842,-6.443066141935426
SK-OV-3,44185566,3.1295797630764266
NCI-H929,135421197,1.062377968485951
KYSE-140,135398516,2.030639298204785
SW1353,2729026,3.1505287571497194
KP-N-YN,6852167,3.160535826824463
TCCSUP,navitoclax-piperlongumine (1-1 mol-mol),2.2323075762929863
HMCB,6918638,0.939566819440244
SW1116,44607531,0.8272222761232554
LP-1,5311281,3.249170725321572
HMCB,11238147,1.8414836223135087
HD-MY-Z,426756,4.240416122867043
HCC1833,crizotinib-PLX-4032 (2-1 mol-mol),2.6175839183816567
SK-MES-1,44632017,1.0141497232839365
HuNS1,23635314,-4.879302880535273
NCI-H2087,5470400,-2.2877168361446993
NCI-N87,124202324,1.1856737577999816
BICR 31,241158,4.31214680273537
KYSE-140,5329102,2.329877477384602
SNU-119,selumetinib-vorinostat (8-1 mol-mol),2.4531148017097726
PL-21,5281672,4.352917560084707
NCI-H2122,53392493,3.723560131897502
NCI-H2087,11178236,-2.844209351530629
PE/CA-PJ15,25154868,5.138759833329878
HD-MY-Z,409805,3.913878546925476
LS411N,54619267,4.196494516067777
BT 231,24180125,2.6727981322820664
T84,46907787,1.7674761870685007
SW1116,selumetinib-MK-2206 (8-1 mol-mol),-0.0547990281207436
SKM-1,4788,4.719822695202535
T84,52947716,2.347600773882255
SW1353,969516,2.590088654134951
NCI-H929,6438330,0.6628289141006722
LP-1,1317464,3.7144293460993625
KMS-12-BM,navitoclax-PLX-4032 (1-1 mol-mol),-0.94714190521785
YH-13,135398516,1.589784182396859
NCI-H929,24772860,-3.485705594224342
YH-13,60700,1.6423447574414731
SNU-119,42642645,1.209873965485747
YD-8,11455910,2.3608003231552717
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286
KP-N-YN,navitoclax-sorafenib (1-1 mol-mol),0.8533910510176919
GP2d,erlotinib-PLX-4032 (2-1 mol-mol),1.7024601551232914
GA-10,1242560,2.2042777046520423
GP2d,216468,0.3291576760345102
SKM-1,50905018,4.354316940379774
MHH-ES-1,2708,2.996158869291761
YD-8,654092,-0.8686607010204063
SK-MES-1,241158,4.574622502408226
TCCSUP,262093,2.756857712955527
NCI-N87,24180719,3.957157119616887
NCI-H929,54639024,4.491044339124744
NCI-N87,72376,-2.7230406051655676
MHH-ES-1,11427553,0.9667304118423208
KYSE-140,11717001,4.391162979738208
BICR 31,24951314,2.26082148142024
NUGC-4,JQ-1-carboplatin (1-1 mol-mol),-0.8477062663812829
K-562,11455910,-0.068399521398108
HD-MY-Z,6914657,-4.81836541876514
MHH-ES-1,753704,4.647380747429485
YH-13,11507802,0.9123185813590028
NCI-H1395,984333,2.1058514684040373
NUGC-4,25126798,3.6698770367720392
BT 231,2749,0.9635960554956892
YH-13,6917907,-5.576575659474619
NCI-H929,49766530,-2.4737600180853385
BICR 31,10385095,1.3759128494100044
SNU-119,decitabine-navitoclax (2-1 mol-mol),1.261288354016859
SNU-119,11178236,-5.208015951508076
RCM-1 [Human rectal adenocarcinoma],49793307,-2.331301981492291
BT 416,24951314,0.984946953516176
RCM-1 [Human rectal adenocarcinoma],462382,0.7838643978728388
SCC-9,11964036,1.807051006133268
OCI-M1,11609586,2.942763797076348
ECC10,24901704,3.1350936276587165
GP2d,55283,2.589152705876464
YD-8,6852167,2.601588502277786
IST-Mes1,docetaxel-tanespimycin (2-1 mol-mol),2.3952937403433685
ECC10,carboplatin-UNC0638 (2-1 mol-mol),2.7949147676551633
PE/CA-PJ15,65628,4.3455180568825025
YH-13,7251185,2.541379459758288
KYSE-140,25195348,3.3066869188499917
NCI-N87,9952709,5.048469263792704
SK-MES-1,6505803,-1.6452904236752195
YH-13,11626560,1.8964713919919112
KHM-1B,docetaxel-tanespimycin (2-1 mol-mol),-6.647221860436541
KYSE-140,1242560,3.387227480944728
BT 231,docetaxel-tanespimycin (2-1 mol-mol),-5.5909552152720865
ECC10,46174525,2.919781421955799
NMC-G1,322968,4.90647964907686
SK-LU-1,135398516,1.833576836263468
SK-MES-1,11719255,3.676134884995896
MHH-ES-1,10385095,1.1490063468144698
NUGC-4,12003241,-1.4802161759010128
KO52,3503,1.43557058273406
SW1353,24785538,1.5725470363238128
KO52,6610355,3.452775078666614
SK-OV-3,49836020,-5.2191550029019025
HMCB,9911463,4.262652850494811
BT 416,9887053,4.191771571129995
CFPAC-1,409805,5.9431710343838136
GP2d,11152667,-1.1349019914223002
ALL-SIL,50905018,3.9646846974495418
SK-MES-1,5281321,-3.198839406923769
NCI-H2087,3503,1.4903801598826718
KYSE-30,5280436,3.332044468623732
HuNS1,24901704,2.079300059782405
TCCSUP,51039095,2.6276542591354723
KYSE-30,17755052,1.710721319044558
SKM-1,25195348,1.6929147684241908
SNU-119,448949,1.6770558610697637
SW1353,9911463,4.226440696401509
EJM,4521392,4.5143467912480055
YD-8,89928392,1.3533989026988826
HD-MY-Z,46191454,1.652968422737008
SK-MES-1,400769,-0.8274303041819775
NCI-N87,3543504,4.249309596150935
T84,24964624,1.10957544943268
SW1116,selumetinib-GDC-0941 (4-1 mol-mol),0.1535490592284351
K-562,409805,3.7514940654800064
KYSE-30,9929138,6.4382239569963255
T84,10322450,3.7674280785024976
ALL-SIL,11626560,-1.2475078800938888
LS411N,46907787,0.8939335106347707
Calu-1,25154868,3.122398982845252
BICR 31,9967941,4.3746614656618865
NCI-H2171,24951314,0.4758147687646419
Mino,49766530,-3.2030154452064696
SCC-9,6184667,3.279451062583292
K-562,71304818,1.450074212827562
KP-N-YN,2945648,2.9332992610721975
NCI-H929,656346,1.0360928512144068
NCI-H2171,11977753,0.3036523614034643
CFPAC-1,219104,5.172631679909356
RCM-1 [Human rectal adenocarcinoma],11707110,-2.81784904286785
RT-4,6918328,0.8848146288984396
SW1353,24951314,1.3382936170741284
PE/CA-PJ15,11640390,3.767424083733669
SK-MES-1,11612883,2.822757664754103
EJM,6918878,1.483002003508878
BT-20,71304818,2.87635058238091
MHH-CALL-4,24771867,-2.8040386715982746
GA-10,5282054,2.1502743382645013
RT-4,3025944,4.0203592479598225
KYSE-30,5311281,2.919423553156246
ECC10,2733526,2.8834513488558344
YD-8,53481919,3.5018247603888404
Calu-1,42642645,1.6117131337640775
NMC-G1,3815108,5.45575599507398
BT 416,selumetinib-JQ-1 (4-1 mol-mol),0.8110934532138555
YD-8,navitoclax-piperlongumine (1-1 mol-mol),2.544833640493428
GA-10,6450551,0.7466330463317521
SW1116,selumetinib-decitabine (4-1 mol-mol),-0.2663799203168696
NUGC-4,219104,3.773792787042205
GP2d,crizotinib-PLX-4032 (2-1 mol-mol),1.1375881611393368
SK-HEP-1,11977753,-1.1270659898133608
HD-MY-Z,24797083,1.323232679541559
KYSE-140,568763,0.8721672626462378
MHH-ES-1,675434,4.019164558571782
K-562,46174525,4.631327159993839
NCI-N87,44632017,1.346248550233927
SKM-1,1750826,-4.975588841995149
SK-MES-1,11364421,0.4399678827530276
LP-1,selumetinib-piperlongumine (8-1 mol-mol),2.79069236393486
MHH-ES-1,322968,3.340315374989695
HD-MY-Z,71680916,4.6008121731180305
SCC-9,168313016,4.940700460648117
Mino,11404337,-2.29299189538819
HuNS1,49793307,-5.318871613738746
SW1116,24856436,0.1778795233563665
NUGC-4,675434,3.626120507390404
YD-8,54613361,3.562533264649823
KYSE-30,24753719,4.589617632068179
KMS-12-BM,2708,2.6805418133728747
ECC10,11222830,0.5363567029511633
BICR 31,6505803,0.2507928346620714
GP2d,44241473,3.7158482344549153
SNU-119,148198,-2.509458516530883
PANC-1,5291,3.697611415578539
OCI-M1,44589607,1.839471322749629
Mino,44491742,3.5991371763887616
PE/CA-PJ15,216468,1.1366663027821788
EJM,49766530,-0.6352274600767028
SK-OV-3,46224516,3.444215787907748
HD-MY-Z,56649450,4.112887883801418
SK-HEP-1,25183872,-0.6604608842788147
BT 416,15983966,1.7730416109502742
PL-21,72376,-3.661100951513363
L3.3,selumetinib-UNC0638 (4-1 mol-mol),5.288673066884017
NCI-H2171,5738263,2.6832104272478188
SW1116,445455,4.160579908204914
K-562,44589607,2.662527895237601
MHH-ES-1,11364421,-4.491992397593235
NCI-H2087,100016,6.366125554898137
TCCSUP,selumetinib-BRD-A02303741 (4-1 mol-mol),5.6777204255641305
NCI-H2087,219104,3.5134246492786256
K-562,9911463,2.5078915917546336
MHH-ES-1,6918837,-4.296019380428325
HMCB,446155,0.6240619426088403
K-562,56963564,-0.0263606087054764
SCC-9,10184653,-0.319006591471168
YD-8,568763,0.5213428887941817
NCI-H929,2841722,4.211619881266404
Hs 936.T,9907093,4.831141970626105
HuNS1,decitabine-carboplatin (1-1 mol-mol),2.117619710025851
L3.3,11404337,0.7171912876466348
KO52,11152667,-1.2056266729151108
NMC-G1,11214940,1.9595182289588209
HD-MY-Z,73707398,1.0247944682443757
NCI-H1395,676352,2.20823720680155
SK-MES-1,carboplatin-etoposide (40-17 mol-mol),1.5392175782700568
NCI-N87,5287620,-2.9994225662437928
MHH-ES-1,44589607,2.849176436880111
NCI-H2087,11427553,3.3995175000604405
KHM-1B,4915,4.394677312814559
SK-MES-1,1750826,0.426922585415155
YD-8,25102847,2.057476964760047
BT 231,5281672,4.741828891456126
CFPAC-1,JQ-1-carboplatin (1-1 mol-mol),2.3512621109850897
HuNS1,vorinostat-navitoclax (4-1 mol-mol),0.7475072900287161
SK-MES-1,25150857,0.8872466833344391
YH-13,24180125,3.319627413046534
KO52,53495165,-2.774880309384125
L3.3,9911463,4.128757247123474
KMS-12-BM,46843906,0.1435996413551739
GP2d,2708,5.0518809004931295
KYSE-140,11178236,-2.7012480686877316
HD-MY-Z,54613361,-2.4481568051754024
MHH-ES-1,11238147,1.5142449472460022
MHH-CALL-4,24951314,0.6040401052527556
Hs 936.T,sirolimus-bortezomib (250-1 mol-mol),1.4470879407729986
KHM-1B,44589607,0.0686191939800993
OCI-M1,9826308,0.7507300508933229
SK-HEP-1,4378219,1.9889575503272792
SNU-119,441298,2.074764290405071
NCI-H2122,10385095,1.3305975818263436
NCI-H2122,6918837,-2.0389931347308523
RCM-1 [Human rectal adenocarcinoma],15953870,5.063824663341904
SK-HEP-1,60700,1.3088528574816594
KO52,9826308,-1.4432821349389238
LP-1,9549297,1.4271475561838294
BT-20,5287969,-1.6870133333556212
Calu-1,3825829,5.5688615901889404
LP-1,44607530,1.0257169540021922
SK-MES-1,3503,2.6708260522496134
SNU-119,46199207,2.9147124779042435
KMS-12-BM,9903786,0.6537757100604409
HuNS1,56963564,-0.2833380091420875
RT-4,71304818,2.636098080172375
Hs 936.T,navitoclax-sorafenib (1-1 mol-mol),5.945842725165147
EJM,SNX-2112-bortezomib (250-1 mol-mol),-3.498117100633706
BT-20,navitoclax-birinapant (1-1 mol-mol),3.1044781633081797
RCM-1 [Human rectal adenocarcinoma],42642645,1.367998127032919
IST-Mes1,2749,1.654199391381554
NCI-H929,11427553,0.419395277417347
HD-MY-Z,9926054,1.8885520747906608
NCI-H929,16038120,-2.3089398873167872
SKM-1,5311281,1.1395980087167572
SK-OV-3,56946209,-2.3996417591607235
SW1353,51039095,2.3712164669581655
TCCSUP,3689413,0.6301346851622357
NCI-H2122,44493528,4.295267332742467
K-562,9840324,5.675524269237515
REC-1,65064,4.890612829121044
NCI-N87,10184653,-5.297353828317573
KP-N-YN,23635314,3.4369056588592595
SCC-9,SNX-2112-bortezomib (250-1 mol-mol),-2.0018823279326776
LP-1,5335621,5.449165339307319
KHM-1B,44137675,2.3063788474236957
BT 416,navitoclax-MST-312 (1-1 mol-mol),0.0779082368636746
K-562,135423438,0.8826240773524879
SKM-1,16720766,-1.9505812671776488
PL-21,42642645,0.164390071210332
KO52,9444,3.771327538481611
LP-1,71466445,2.285503887885024
Mino,navitoclax-gemcitabine (1-1 mol-mol),-5.317459070076536
SK-OV-3,5282054,5.04615494272688
MHH-ES-1,6505803,-0.7832039030153297
EJM,49867930,4.535292738275801
RT-4,carboplatin-etoposide (40-17 mol-mol),3.317167056326169
NCI-H2122,25262965,-1.9662257119355655
LP-1,navitoclax-sorafenib (1-1 mol-mol),1.3892474661690286
MHH-ES-1,3634881,3.2977443997667852
HMCB,3503,1.423228329049259
HMCB,11626560,3.142721320668581
MHH-CALL-4,46907787,-0.722309996072336
SCC-9,9907093,4.490912734248418
NCI-H2087,5281321,-1.8943071982317232
ECC10,53495165,-2.443919104082007
SK-LU-1,navitoclax-MST-312 (1-1 mol-mol),2.105159294604657
NCI-N87,doxorubicin-navitoclax (2-1 mol-mol),-2.375472287210564
GA-10,56973724,1.6349711142652863
NCI-N87,11404337,-0.8803091706648726
GP2d,17755052,0.6569888412264087
NCI-N87,carboplatin-UNC0638 (2-1 mol-mol),3.4159981227624394
SCC-9,9933475,1.8547363245124415
KO52,23582824,1.49303559449636
CFPAC-1,452548,1.7935257338222033
PL-21,SNX-2112-bortezomib (250-1 mol-mol),-3.4842918661566658
PL-21,11455910,0.5383649206422021
SNU-119,44489127,4.960346134562833
NCI-H2122,5470400,-0.0669325383132218
BT 231,doxorubicin-navitoclax (2-1 mol-mol),-0.8698078592776621
BT 231,135875424,2.2081545391597728
HD-MY-Z,JQ-1-UNC0638 (2-1 mol-mol),1.5192486909885528
NCI-N87,72193861,-0.2047514956394879
KP-N-YN,9926054,3.360231389536055
SK-MES-1,carboplatin-UNC0638 (2-1 mol-mol),1.5190091466495863
BT 416,644241,2.228775392817017
L3.3,24901704,4.5240834828138095
LS411N,5470400,-0.4509258648896809
SCC-9,107985,-2.37702169012632
KP-N-YN,10074640,3.553564067886908
KYSE-30,navitoclax-piperlongumine (1-1 mol-mol),2.859037548433753
PE/CA-PJ15,2733526,4.109828603744543
KYSE-30,54626689,4.463155066843435
K-562,3025986,-1.372296763308674
KYSE-140,421610,4.3709218537693975
SW1353,JQ-1-UNC0638 (2-1 mol-mol),1.1715747666155536
MHH-CALL-4,54143018,-0.5591849379388475
SW1116,25150857,2.1563204213652076
SCC-9,216239,3.331867398285969
HMCB,56649450,4.482181356100994
PANC-1,2126,5.7565329349954
PL-21,9903786,1.6725311379491856
MHH-CALL-4,36462,-1.0581366443015845
KHM-1B,10074640,2.3153156166587783
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345
NUGC-4,9887053,1.8010310380365988
KHM-1B,119182,-1.6156103715295518
PE/CA-PJ15,9823820,4.4065530992073
T84,66577038,1.2063862320535308
TCCSUP,156414,2.0603521073886952
HCC1833,piperlongumine-MST-312 (1-1 mol-mol),1.459975766177077
SKM-1,selumetinib-tretinoin (2-1 mol-mol),-3.0324303149575904
BT-20,5311281,2.972577749625739
KYSE-30,sirolimus-bortezomib (250-1 mol-mol),0.2847397172348017
SCC-9,46843906,3.309522412048413
HuNS1,56973724,1.7903469571792825
OCI-M1,11507802,1.0705800658034856
NCI-H2171,46943432,3.4065574915710735
LP-1,135398516,0.6345187090622795
REC-1,2858523,2.1850862642442603
SNU-119,135440466,2.0351079961049905
BICR 31,65628,4.368112552275168
LP-1,44493528,4.0079037689618815
REC-1,5746,3.861776168634442
REC-1,107970,3.403139793728704
SKM-1,selumetinib-piperlongumine (8-1 mol-mol),-0.1043250108144624
KYSE-140,12003241,-0.6057431237522657
OCI-M1,702558,3.6205430403025742
Hs 936.T,10231331,-0.3842903211878899
KO52,702558,3.3833897196407645
KYSE-140,5566,3.0207532657540175
BT-20,6918328,1.0165326047558223
SKM-1,2708,3.277988117116173
L3.3,17755052,1.4516432874311858
BT-20,241158,4.666874417516415
PE/CA-PJ15,12001922,2.3409617701087577
NCI-H2122,24951314,1.4113199644696477
IST-Mes1,4578,4.452023444310014
LS411N,9903786,3.6806866285220017
NCI-H929,4259181,0.6476848617762108
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439
BT 231,tanespimycin-gemcitabine (1-1 mol-mol),1.670938832130248
HCC1833,4788,5.840535463560035
KMS-12-BM,57519531,1.217688684529343
NCI-H1395,5311281,3.3268012915389047
Hs 936.T,9903786,5.166198075920313
YD-8,selumetinib-JQ-1 (4-1 mol-mol),3.141432259202229
NCI-H929,44202524,1.214176399548459
TCCSUP,44589607,3.4904966961167516
OCI-M1,46398810,1.0299086963262554
L3.3,5287620,-1.4617046509205764
GA-10,73707438,3.9716296067063097
MHH-ES-1,156422,3.633671740480899
HD-MY-Z,52947716,2.8651307319261576
SKM-1,15953870,2.3750866132882305
GA-10,3825829,3.574861174929505
GA-10,7326481,2.058901545146402
SW1116,9825149,1.137929652528347
BT 416,9866186,-1.2028219350769669
YD-8,9908783,5.744379377370956
HD-MY-Z,16722836,1.824908989094592
HD-MY-Z,carboplatin-etoposide (40-17 mol-mol),1.6980836492434932
PE/CA-PJ15,439501,-2.069757641280327
GP2d,23635314,-3.8122042421298103
Hs 936.T,12001922,1.824804134649663
LS411N,135984461,5.061110843141604
NCI-H2171,3634881,2.317126021520602
TCCSUP,24753719,4.825833368668945
PE/CA-PJ15,5470400,-0.0617904370996869
LS411N,15983966,2.6804451752833978
SKM-1,46907787,-1.5658410471483666
NCI-H2087,56946209,-4.388435458279711
Mino,54618164,3.08934752103197
OCI-M1,11719255,3.610821584343467
IST-Mes1,25126798,3.982374188902535
BT 231,25262965,-1.2332084401819954
NCI-H2087,11404337,-3.0287738757732585
NUGC-4,3025986,-0.5321539236867503
NCI-N87,11656518,1.4544081811160725
KO52,24964624,2.970521329302971
KMS-12-BM,decitabine-carboplatin (1-1 mol-mol),-3.2192264428924755
KMS-12-BM,11640390,-0.5684033392466148
REC-1,11175137,3.868048003377553
SNU-119,15547703,3.1947959639355834
RCM-1 [Human rectal adenocarcinoma],53392493,3.4798204288234165
SK-OV-3,119607,5.6958068077620405
NCI-N87,446155,3.321702095578996
NCI-H1395,2828334,6.054247002865052
SNU-119,11427553,3.011079133606584
KYSE-30,1750826,-3.1091447598979585
RT-4,400769,-0.8649429705916083
SCC-9,3062316,1.318086870144001
REC-1,24964624,5.51443016806739
PE/CA-PJ15,selumetinib-MK-2206 (8-1 mol-mol),1.4968211304792731
NCI-H2122,5280436,5.032194395244219
NUGC-4,25102847,2.291866460709862
GA-10,9915743,0.398325607555859
NCI-H2171,5311281,0.8399284053106422
Mino,6918638,-1.9893642721575304
Hs 936.T,vorinostat-carboplatin (1-1 mol-mol),3.062887188197798
SW1353,5278396,3.997886692366963
YH-13,11640390,4.546437350580995
LP-1,409805,3.155835706039454
YH-13,24785538,1.1754482929087915
T84,JQ-1-UNC0638 (2-1 mol-mol),1.1622325492897168
SK-MES-1,55283,3.2178425243332085
OCI-M1,9936388,-5.157124392155609
HMCB,25102847,1.6678693363559989
Mino,serdemetan-SCH-529074 (1-1 mol-mol),0.9351346080504732
SNU-119,654092,-3.073300249988697
LP-1,1641662,3.1802750430974993
BT 231,44607530,0.7605443532273843
NCI-H2122,3062316,2.9352231139815
YH-13,selumetinib-GDC-0941 (4-1 mol-mol),2.117878884448022
IST-Mes1,5746,2.704326416379231
ECC10,12003241,-2.873030940363692
ALL-SIL,637858,0.2842777242368783
REC-1,135440466,3.3571915295721526
YH-13,16736978,1.9226883316273975
OCI-M1,16725315,5.157924100424497
SK-OV-3,25262965,0.4953902890441227
KYSE-140,16725315,4.103032685828747
GA-10,445455,3.512526649158284
SCC-9,11364421,-0.952029021799848
NCI-H2171,25102847,1.8897460049958847
PE/CA-PJ15,16720766,1.2705022351166626
ALL-SIL,9936388,-6.364749169872344
BICR 31,9866186,1.254760755448308
KYSE-30,11955716,-1.562878716111176
SCC-9,54454,3.1137155512464596
TCCSUP,carboplatin-etoposide (40-17 mol-mol),3.482858760059233
NCI-H2171,23582824,0.048802245172864
T84,3854666,0.9881989979716492
KO52,52912189,-1.11352091818438
SKM-1,25183872,-3.4899394684902947
MHH-CALL-4,4259181,0.5177558135201623
HMCB,15953870,5.102048815758539
EJM,262093,1.353461350978494
KMS-12-BM,erlotinib-PLX-4032 (2-1 mol-mol),2.242242916875039
RT-4,56963564,2.308736271867476
ALL-SIL,5278396,3.0589186731365814
BT 231,71304818,1.847354010337541
SK-LU-1,446155,3.869092060357629
EJM,51039095,2.802911331082466
GP2d,JQ-1-carboplatin (1-1 mol-mol),1.3751792778879013
NUGC-4,9825149,3.0625303692952044
GA-10,25062766,0.8189963337111302
YH-13,tanespimycin-bortezomib (250-1 mol-mol),-0.5369599682458667
SNU-119,9952709,2.3650460687962997
T84,11612883,3.1644067599298284
K-562,66577038,2.461713560075674
BT 416,erlotinib-PLX-4032 (2-1 mol-mol),2.363144121259058
NCI-H929,136227924,1.899057841083653
YD-8,46224516,2.247250860191912
LP-1,65628,4.349583792779986
KMS-12-BM,73707386,2.349774634710614
SW1353,25150857,2.5000042259697906
NCI-H2122,46398810,3.227171702536067
IST-Mes1,6505803,0.837907313306775
KP-N-YN,72193861,4.027763091708557
HD-MY-Z,44241473,4.531432746353987
SK-HEP-1,11178236,-5.847785565222589
KO52,24180125,3.3572012584638613
BT 416,1242560,3.5198437920313563
NUGC-4,452548,0.6243263035871899
BT 231,25161177,2.8778266292860355
NCI-H2087,6918837,-3.586149494199659
ALL-SIL,25062766,1.575972356073685
HD-MY-Z,11497983,4.570987876144974
K-562,448949,1.070656561881704
SK-LU-1,71304818,2.4889863843459716
NMC-G1,3038522,3.9593296253381034
GA-10,5287969,-3.272268506160015
T84,navitoclax-gemcitabine (1-1 mol-mol),-0.1095707262233473
ECC10,11214940,1.9570823108204007
PL-21,56946209,-4.691303411571373
KYSE-140,445455,5.008698357058935
EJM,11178236,-6.131326848580391
SKM-1,doxorubicin-navitoclax (2-1 mol-mol),-1.9778957551235763
K-562,3503,1.244026999465694
REC-1,3543504,2.61004000705113
NCI-H1395,11364421,1.3628820394407153
GP2d,71680916,4.256936698848473
Hs 936.T,44507138,1.6881754750920912
NCI-H2171,439501,-3.0635131055453924
LP-1,11234052,3.8137130464149775
L3.3,135398744,6.452563021638662
BT 416,9927531,5.009885250018842
SNU-119,644241,2.7771526168962084
HuNS1,vorinostat-carboplatin (1-1 mol-mol),1.7110252151631231
BT 231,44819697,-0.2882260639592227
SW1353,159324,5.365297966496093
GA-10,16722836,0.998397760798424
HMCB,46843906,3.827430396412732
NCI-H2122,6917907,-7.461524314255526
NCI-H1395,123631,3.1178254055309553
RCM-1 [Human rectal adenocarcinoma],4259181,1.1322876173551923
HD-MY-Z,10296883,3.8983586745084033
NCI-N87,11364421,-4.7214998150919065
BT 231,11656518,0.8253260548414221
NCI-H2122,25126798,3.899568471213542
SW1353,36462,4.974473156128621
GP2d,5284373,3.613837640444936
T84,navitoclax-sorafenib (1-1 mol-mol),2.267067840498622
HMCB,6918328,1.0614857704066594
SNU-119,119607,5.736335030874665
K-562,9926054,1.8612748023096723
KO52,5287969,-2.47195117056353
EJM,89928392,0.7789703373466773
RT-4,11234052,4.441535600719637
IST-Mes1,selumetinib-PLX-4032 (8-1 mol-mol),4.413511328522001
KYSE-30,51039095,3.106615134676779
SW1116,2949965,2.5720792413048437
GA-10,11364421,-6.475737382182161
BICR 31,71466380,5.422644788319504
L3.3,89928392,2.03013195184945
PL-21,375860,-0.8908022550999798
KHM-1B,54619267,2.762925132943408
NCI-N87,vorinostat-navitoclax (4-1 mol-mol),0.7685195358482984
NCI-H2171,11964036,0.8555185627034467
KMS-12-BM,5291,3.1050299402444095
LS411N,5329102,2.797825403975713
PL-21,navitoclax-piperlongumine (1-1 mol-mol),1.496860845191714
L3.3,3025986,-0.2391966335119921
HMCB,11178236,-3.675827592873557
BT 416,53392493,1.676849165193777
OCI-M1,49793307,-5.152498867526375
MHH-CALL-4,16741245,4.139507561321884
GA-10,50905018,3.5993820512466796
EJM,UNC0638-navitoclax (1-1 mol-mol),1.2280431327330104
LP-1,25062766,2.3135337722487033
T84,11640390,2.9213197510214366
RCM-1 [Human rectal adenocarcinoma],44202524,4.374181896011121
NCI-H2122,vorinostat-carboplatin (1-1 mol-mol),3.788554065729161
ALL-SIL,159324,0.7144692186053382
GA-10,44491742,3.5610264108230365
MHH-CALL-4,49766530,-1.9452729400457551
HCC1833,24180719,3.7123111048651225
PL-21,71466578,4.406724829669361
KYSE-140,452548,1.577775657519264
LS411N,5282054,4.11513360382112
KYSE-140,5281321,-1.3910773910645289
NCI-H929,25262965,-4.479075794204223
KMS-12-BM,53481919,3.061997154400898
PE/CA-PJ15,3689413,2.6755130574722767
EJM,9956119,3.780866112721705
HuNS1,9549297,1.5758530688858188
MHH-CALL-4,613753,2.3593655615882665
RT-4,9929138,7.578104590024713
NCI-H2087,216345,3.997310189843601
MHH-ES-1,11455910,0.3888631975426587
REC-1,89928392,5.908663272108372
Hs 936.T,17759555,5.505108095494984
BICR 31,15953870,5.115358479555731
HuNS1,71304818,1.617491464738092
L3.3,56946209,-3.919110396505915
KO52,BRD-A02303741-navitoclax (2-1 mol-mol),-1.279248349469784
HuNS1,11234052,3.4118445491485234
MHH-CALL-4,25126798,4.057954357300824
SK-MES-1,10410894,2.204601188956546
SKM-1,5311,0.1549027361916286
NCI-H929,6623618,2.0780887581605714
NUGC-4,16741245,4.519217542144304
T84,3384730,2.071734981305522
T84,969516,2.0698109856184996
SK-MES-1,71680916,5.106865942298323
NUGC-4,72734382,2.576756889027741
MHH-CALL-4,11609586,-1.6264371796669257
ECC10,156414,0.8829858531470315
PL-21,25126798,3.740008534328759
SCC-9,6918837,-2.658799999554452
BT 231,11507802,1.0974082780586245
KHM-1B,erlotinib-PLX-4032 (2-1 mol-mol),2.9494241751240353
NCI-H2087,52912189,0.1168789560200478
BT 416,12003241,-2.2907483254938774
OCI-M1,BRD-A02303741-navitoclax (2-1 mol-mol),1.6572114842844037
BT 416,135440466,0.7066001037417192
NCI-H929,5460769,1.81013287796662
HD-MY-Z,11404337,-0.4126072630667986
ALL-SIL,5460769,0.8731159867521163
NMC-G1,60168763,-4.311123617297494
KP-N-YN,3503,2.227930430253734
NCI-H929,25183872,-2.352025063826196
BT 416,25161177,2.8392960919301378
NCI-H1395,3062316,3.8693774304021433
PE/CA-PJ15,24771867,2.507049112145433
REC-1,5738263,3.8957465012071353
NMC-G1,135440466,3.824852615514313
GA-10,2749,-1.745603659756748
HuNS1,25195348,2.5484719886937515
KHM-1B,72193861,0.3865062028609871
SW1116,10322450,3.761194873514236
NCI-N87,36314,2.766113993056904
EJM,tanespimycin-gemcitabine (1-1 mol-mol),-4.796041108961502
OCI-M1,2746,2.0288899582402165
SW1353,52912189,3.4554213055000664
Calu-1,44507138,6.400489630941352
ECC10,11640390,0.9268568579449604
BT-20,24797083,-0.2484072896727632
KYSE-30,135659046,3.903698290168812
SK-OV-3,10127622,6.3662035368843535
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677
NCI-H2122,4259181,0.8798448055972885
OCI-M1,57519531,1.7049996195594086
NCI-H1395,53232,3.2747143495441433
BT 231,44620216,3.924479857389375
IST-Mes1,36462,4.9786696220654845
LP-1,60700,0.8197076335351922
HD-MY-Z,44491742,3.754375539988437
KYSE-140,126941,-1.9341423066544168
MHH-ES-1,10074640,2.493996619251847
PL-21,navitoclax-birinapant (1-1 mol-mol),0.0309857541865778
Mino,675434,3.83423250538531
IST-Mes1,11717001,4.337000636344965
NCI-H2087,24964624,2.3259129365908646
NCI-H929,vorinostat-carboplatin (1-1 mol-mol),1.7849297289104662
CFPAC-1,6852167,4.928120613967257
NCI-H2087,2749,1.592057689484338
SCC-9,6918638,0.4192666549800527
K-562,3689413,1.0071697658281389
BT 231,969516,2.2770309929553245
BT 416,8515,1.3533271204830115
EJM,11485656,1.52616093441074
PL-21,60750,-2.460937648031708
EJM,4096211,1.0165645953400952
HuNS1,753704,4.229822290375821
PL-21,5311,0.5979390645801402
SK-OV-3,3543504,4.529917197725731
KHM-1B,24856436,-0.1873560944062299
SNU-119,11214940,-0.1259721095383459
TCCSUP,17755052,2.4596977315219504
HMCB,5746,1.3604590054330616
PL-21,9868037,2.018011914645477
KMS-12-BM,11222830,0.3420058811643648
SK-LU-1,carboplatin-UNC0638 (2-1 mol-mol),3.24229388946924
SK-HEP-1,445455,4.37046727572682
SK-HEP-1,7251185,3.0945137710223687
BT 416,262093,2.6479795412008937
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914
KO52,tanespimycin-bortezomib (250-1 mol-mol),1.3473417684314797
PL-21,1242560,3.3436881997598547
KMS-12-BM,44137675,1.9058431411693373
Hs 936.T,JQ-1-MK-0752 (1-1 mol-mol),1.8198782945394296
NCI-H929,322968,-0.4532114476759251
NCI-H1395,10385095,0.8966814857932361
HCC1833,441298,2.1230067255575644
KYSE-140,24951314,1.4742929925100046
HMCB,135875424,3.5183087899290686
KMS-12-BM,4917,2.744184399982424
KYSE-30,4788,5.867259310237582
LS411N,25150857,2.959758413524705
ECC10,46199207,2.7597244786934696
SKM-1,54618771,0.6725959366795358
RT-4,24180125,3.633157370927589
HuNS1,11404337,-3.482184142703688
PL-21,168313047,1.6697596761115918
EJM,selumetinib-decitabine (4-1 mol-mol),1.790992102358079
Mino,selumetinib-BRD-A02303741 (4-1 mol-mol),4.878986734293034
RCM-1 [Human rectal adenocarcinoma],6918878,1.3044693080210874
OCI-M1,alisertib-navitoclax (2-1 mol-mol),-1.9582639971819165
RCM-1 [Human rectal adenocarcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.7027440652786807
SK-MES-1,5287620,-3.789610544856974
PE/CA-PJ15,5311,2.929642766626198
REC-1,9936388,3.0128299108104306
KYSE-30,24797083,1.005952457057914
SW1353,4917,3.0223610395017504
HuNS1,6852167,0.9722710028853416
NCI-H2171,54678924,2.405018759443171
RCM-1 [Human rectal adenocarcinoma],11427553,3.480492721904053
OCI-M1,11625818,4.234351145916479
BT 231,439501,-3.8677572824685913
BICR 31,11977753,-1.0341786941527915
KMS-12-BM,11485656,1.287590694324435
BT 231,11955716,-1.141744294588506
REC-1,54639665,4.455967355102018
Calu-1,4261,4.657058818553146
BT 231,44507138,2.6269002038647615
KYSE-140,10184653,-2.592070821853957
ECC10,89928392,0.091206620435187
ECC10,400769,-1.0817206035017777
KYSE-30,23725625,5.7742652684843945
ALL-SIL,73707398,-0.324762560862376
EJM,72376,-2.674765470406556
TCCSUP,JQ-1-carboplatin (1-1 mol-mol),4.7242319921213225
SK-MES-1,2746,3.092337082097677
OCI-M1,52912189,0.4372120692145379
NCI-N87,156414,-4.435299577962505
SK-MES-1,3465537,2.1833251870865595
NUGC-4,11964036,-0.1174983689394972
BT-20,6918837,-1.8216241140446632
Calu-1,5311,2.642414643730042
YH-13,42642645,0.7428971462414599
TCCSUP,5281321,-1.6830882813028205
KYSE-30,10184653,1.9983109539515471
Hs 936.T,JQ-1-vorinostat (2-1 mol-mol),0.8499323577805267
OCI-M1,9933475,2.991890716743009
REC-1,9911830,2.634781008938807
Mino,9915743,-0.1014414753917248
KYSE-30,54618771,0.4265256767943792
KYSE-30,16659841,4.522667512246524
SNU-119,11640390,2.9384325633103026
HD-MY-Z,15547703,3.2208204876666664
PE/CA-PJ15,4705,2.241412647888812
GA-10,3689413,-4.87834364200375
YH-13,53392493,1.9898975762013085
YH-13,52947716,-5.569011726742263
SW1353,6918328,-0.2532713799742004
KYSE-140,969516,2.795735885993574
HCC1833,168313047,3.354992657816903
SCC-9,5282054,4.577178009511458
NCI-H2122,11485656,1.6231046249934602
SCC-9,52912189,3.371588298050412
MHH-ES-1,6610355,4.753350003235119
NCI-H2087,4096211,1.7459209615691187
NUGC-4,3081361,-0.1778210065378084
PE/CA-PJ15,tanespimycin-bortezomib (250-1 mol-mol),-3.0373663834156943
ECC10,136227331,5.843658104512461
MHH-CALL-4,135398738,3.5544089047789957
MHH-ES-1,11175137,1.8244824335218808
SK-LU-1,selumetinib-navitoclax (8-1 mol-mol),2.0015850092005136
NCI-H929,6918837,-4.507848633334324
Calu-1,12003241,-0.3445186674692038
SNU-119,445643,3.745068929793647
CFPAC-1,24951314,2.9475294333433992
SK-HEP-1,5738263,4.7811273930471065
L3.3,613753,4.077511547969464
HCC1833,54618164,3.937517250635008
Hs 936.T,ISOX-bortezomib (250-1 mol-mol),1.2398225066224586
SK-LU-1,135984461,4.3992720133799725
OCI-M1,3081361,3.358473845244682
NCI-N87,24901704,2.2078626603453664
MHH-ES-1,5460769,-1.13601039501847
BT-20,2871966,5.126957103902694
NCI-H929,10427712,4.4181705669387865
RCM-1 [Human rectal adenocarcinoma],navitoclax-gemcitabine (1-1 mol-mol),1.5505113720092498
ECC10,444795,2.5610873462217687
HCC1833,25154868,4.0734132478318115
KP-N-YN,5278396,4.222394052713633
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315
K-562,44137675,5.346911467461658
LP-1,3854666,0.8576356397095183
TCCSUP,400769,-0.9121100031738296
NCI-N87,216345,3.97830172236079
GP2d,54454,0.3369662158035022
MHH-CALL-4,crizotinib-PLX-4032 (2-1 mol-mol),0.9157063746843188
SKM-1,3038522,3.769689867373741
NCI-H1395,568763,0.9321190773221452
PE/CA-PJ15,5426,4.953040449368789
BICR 31,53232,3.653430995715962
HD-MY-Z,9915743,1.384717362630253
OCI-M1,tanespimycin-gemcitabine (1-1 mol-mol),-2.1595003963158415
PL-21,327653,2.987235766281407
RT-4,135398516,2.327932490402957
PE/CA-PJ15,100016,6.230779358531284
Mino,56963564,0.2052949458099494
HD-MY-Z,24951314,1.3320569304074548
ECC10,16741245,2.111135007406343
Mino,9926054,1.8004792382140618
SK-MES-1,57519531,2.3248544098334927
RCM-1 [Human rectal adenocarcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.9740491797534947
HCC1833,5738263,3.0446173077368357
KO52,11234052,4.403544599113535
LS411N,3062316,3.313525141236135
RT-4,11238147,3.737016422545975
HCC1833,12001922,1.7724795128114657
SCC-9,3038522,1.9571402343301385
TCCSUP,25183872,-1.340391088642973
KP-N-YN,25150857,2.771608397439956
PL-21,25022340,4.041553552018665
RCM-1 [Human rectal adenocarcinoma],3062316,2.514926182355465
HCC1833,navitoclax-birinapant (1-1 mol-mol),-1.3110348140968977
NCI-N87,12003241,-2.470820657410725
NCI-H1395,16722836,3.221617987091192
SW1353,72734382,5.3782387008732035
EJM,3025944,4.146188688594528
Calu-1,3552672,2.0523375601608027
GA-10,11152667,-3.274266411551672
SW1116,11364421,0.9990055379738184
YD-8,3081361,2.3090851828651835
YH-13,24772860,-1.8932225377928673
BT 231,66577038,1.1906091660005256
SK-LU-1,44507138,3.867531130621519
RCM-1 [Human rectal adenocarcinoma],11640390,3.7299689357319257
K-562,44819697,-0.9868024060185686
NCI-N87,46224516,3.4075734240800624
KO52,9956119,3.9050821856051185
KO52,46843906,1.029937825595367
ECC10,56973724,1.9827753072040135
PE/CA-PJ15,25195348,3.4311636975468165
LS411N,24901704,3.828527152917887
YH-13,262093,3.0071094341497826
YD-8,5978,2.5175590604708584
NUGC-4,107970,2.3784134624007436
HCC1833,6252,2.2365461267764384
KMS-12-BM,216239,1.5581321141848137
SK-LU-1,159324,3.7934671922435914
NMC-G1,123631,2.884070601992539
PE/CA-PJ15,56946209,-4.557496180443621
MHH-CALL-4,46943432,0.4587577146987904
EJM,24889392,5.896592144374216
NCI-H2122,135875424,3.891671536757885
SK-HEP-1,2729026,3.094345392685322
KP-N-YN,400769,1.6752259464755976
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549
ECC10,8515,1.9738672443997605
RT-4,6610355,4.842396120436743
REC-1,9825149,3.2738180165412487
KMS-12-BM,5281321,-2.748905186924615
NMC-G1,24964624,3.119470314829418
NUGC-4,46199207,3.3069761354519023
HuNS1,11494412,-0.2614588159632262
OCI-M1,46943432,1.475072626321256
T84,11455910,1.5017947925367456
KHM-1B,5281321,-2.452020874471456
SKM-1,tretinoin-navitoclax (4-1 mol-mol),0.5849402207655147
YD-8,57519531,2.847740049841003
IST-Mes1,17755052,1.8699185860343792
HD-MY-Z,44185566,2.9492403149120285
Mino,9911463,2.4278795242831253
SK-LU-1,135999136,3.760067607406658
BICR 31,6610355,4.797647038745592
IST-Mes1,241158,4.374014389295604
SK-HEP-1,25262965,-1.9202339310426983
GA-10,135398516,-0.1677798711197079
HD-MY-Z,216239,1.853852261121058
ALL-SIL,638278,2.4844738615144797
Calu-1,9549297,2.9571733395842537
NCI-H2087,675434,4.201221945048381
NCI-H2087,11719255,2.121317428445398
OCI-M1,46907787,-0.947970936826993
GA-10,227681,1.818622318585745
PL-21,24772860,-3.4194775314954717
EJM,10184653,1.0173463538393004
KYSE-30,46907787,3.978537949893093
RT-4,46191454,2.354061820255486
KO52,selumetinib-UNC0638 (4-1 mol-mol),-0.866257907363459
Mino,10184653,1.0889410916203577
ECC10,sirolimus-bortezomib (250-1 mol-mol),-0.7952118818560531
NCI-H2087,6918328,-0.6839321435718476
HCC1833,568763,0.1695274390510146
OCI-M1,11427553,1.6666661017277848
RCM-1 [Human rectal adenocarcinoma],168312962,3.7277757368773345
EJM,1242560,2.98578545305507
LP-1,5351362,1.190121791877183
NCI-H1395,375860,1.7808246881173873
NUGC-4,25262965,1.9340482488375608
HuNS1,44486219,3.6888854703768774
YH-13,44566777,0.4820262026960841
SW1116,selumetinib-tretinoin (2-1 mol-mol),-1.1776393312637268
SK-MES-1,60750,-4.638206950313868
LS411N,9911463,4.267700407985282
SKM-1,44493528,3.979629908351757
LS411N,9825149,1.7370452341191267
OCI-M1,2729026,3.1407056879266304
Mino,10077130,1.912343347725037
BT 231,11396600,2.44608853396947
ECC10,45100481,3.9513286420619975
GA-10,6918837,-6.260107554110828
HD-MY-Z,24180125,4.121222391282799
GA-10,44607530,0.9671792655150052
HuNS1,11175137,1.7516221400449143
TCCSUP,66577038,3.1078780517410283
MHH-ES-1,409805,3.617894256902542
EJM,156414,1.801807158025587
NUGC-4,49766530,-0.8370280457407315
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813
KO52,54626689,4.497055456581237
SNU-119,2945648,1.887531870064612
ALL-SIL,168312962,1.491579787235829
MHH-CALL-4,676352,2.2421243982762338
SKM-1,6918736,-4.119160923301796
KYSE-30,44137675,4.317699456921293
NCI-N87,navitoclax-sorafenib (1-1 mol-mol),-0.0367825564296656
SKM-1,5394,3.370864501723167
NCI-N87,26596,-0.8687464208841552
SNU-119,9825149,2.245076319827961
RT-4,25154868,4.28218091835124
SW1116,54618771,-0.9904180488449444
SW1353,6918736,-2.287937280807517
GP2d,4259181,0.2488799202775051
ECC10,9927531,3.415986585333862
Calu-1,136227924,3.5665542391568774
YH-13,89183176,4.032829383808348
SW1353,44607531,1.6292986344132614
BICR 31,24785538,2.8976650742045127
HCC1833,5328940,1.6349618964122374
NCI-H929,36314,1.7139372343272217
NCI-H929,6252,0.9780799453656184
SNU-119,168313047,1.9562265924685545
KYSE-30,445643,3.9642017728414
REC-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.262800070062549
MHH-CALL-4,2945648,0.797995539224445
NCI-N87,selumetinib-navitoclax (8-1 mol-mol),1.647881556522465
HD-MY-Z,16219061,2.6330637317703793
SW1353,9956119,2.961393925403043
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693
REC-1,25126798,6.245895265924279
ALL-SIL,107985,-3.6188373708521495
SK-LU-1,5281321,-0.6605763193357276
BT 231,1566236,1.681485280274636
L3.3,4261,2.1698969963780055
NUGC-4,119607,4.889757463540767
SW1353,11507802,1.765521849012859
HD-MY-Z,3081361,3.2809936230886088
PL-21,25195348,1.1852258901255626
TCCSUP,4917,2.9384011746955467
BICR 31,10127622,3.719060323270891
Calu-1,11178236,-5.082405245764316
GA-10,11507802,0.2785832985089269
Calu-1,5281672,5.351983722914501
TCCSUP,126941,-3.009230192575239
KHM-1B,11222830,0.8303711779930824
NCI-H2171,73707371,5.940029655461802
OCI-M1,11640390,3.6025662132462783
KYSE-30,selumetinib-navitoclax (8-1 mol-mol),0.564278924058352
SKM-1,26596,-4.237929506963809
NCI-H2122,46191454,1.2642944584759752
OCI-M1,9911830,2.240767531955393
L3.3,10113978,3.760524207236511
TCCSUP,25150857,2.738156002354857
SK-HEP-1,10296883,4.4971190241998835
NUGC-4,89928392,1.9577677182367563
LS411N,3854666,3.592971008902542
BT 231,54613361,-2.071450076942706
NCI-H2171,navitoclax-pluripotin (1-1 mol-mol),-1.0064664066659004
EJM,17755052,2.369354031148252
HD-MY-Z,72193861,1.1270281353868274
BT-20,9903786,4.2067479925704925
SNU-119,navitoclax-sorafenib (1-1 mol-mol),2.4601153144436045
ECC10,serdemetan-SCH-529074 (1-1 mol-mol),1.7814018211515827
Calu-1,15983966,2.0875408118034597
IST-Mes1,4096211,2.0722665154973052
GA-10,10077130,1.8814006750211585
YD-8,42611257,3.19679980391278
SK-HEP-1,7326481,2.0213225214426505
TCCSUP,docetaxel-tanespimycin (2-1 mol-mol),-3.3662554716877167
SK-MES-1,136227924,2.193847007439744
L3.3,676352,2.5109454639647373
BT 416,24771867,1.406096437509098
KHM-1B,1716436,3.4645640712789545
KMS-12-BM,65628,3.1283199596989624
NCI-H1395,5287969,-1.6108462512694277
YD-8,9935249,3.870405994417823
KYSE-30,49766530,-1.4671789919373923
HMCB,alisertib-navitoclax (2-1 mol-mol),1.9380444383575808
MHH-ES-1,11222830,1.5868611662397438
BT-20,5113032,4.5093862942903735
ALL-SIL,24951314,0.1921049921473096
NCI-H929,11222830,0.7259966040230217
BT 231,46398810,1.6531513820578414
MHH-CALL-4,44493528,4.165612428769394
EJM,2708,5.071772468532641
KMS-12-BM,6252,-2.6216972044804723
RCM-1 [Human rectal adenocarcinoma],10302451,3.9774689486836383
MHH-CALL-4,tanespimycin-gemcitabine (1-1 mol-mol),-6.515976234359718
BT 231,11485656,1.3713674681165906
KO52,9887053,3.73966963035621
Hs 936.T,16722836,3.759054155090913
KHM-1B,219104,1.6531557302016933
HD-MY-Z,44493528,4.44799186118661
LS411N,11404337,-0.9351547419605356
PE/CA-PJ15,11455910,0.2163871462693647
RT-4,11497983,5.0525297457562335
IST-Mes1,637858,2.1376990366589905
HCC1833,9926054,1.8132192248663452
PL-21,9956119,3.219574282125353
TCCSUP,BRD-K27188169-navitoclax (2-1 mol-mol),3.571342544762983
GA-10,51039095,1.3653272677038777
PL-21,4788,5.302890862248465
BICR 31,5291,3.978522058600436
SK-MES-1,5282054,3.678171191207052
RCM-1 [Human rectal adenocarcinoma],44566777,1.6377443255416146
SK-MES-1,navitoclax-sorafenib (1-1 mol-mol),3.2150146088891733
TCCSUP,25062766,2.2291298825702666
K-562,24951314,0.9405452740645998
RT-4,11964036,3.812081086796839
TCCSUP,637858,2.4470905671949996
PL-21,2749,0.8254866012609257
NCI-H1395,25154868,5.12981371240632
GP2d,6918638,-1.154935446775354
NCI-H929,15983966,1.8742462336946937
TCCSUP,6610216,4.746461050840166
PL-21,10231331,-1.2621716252501856
SK-MES-1,UNC0638-navitoclax (1-1 mol-mol),1.0494999959319211
NCI-H1395,72193861,3.743948008436619
PL-21,613753,3.239203426029031
IST-Mes1,6450551,1.123519877762822
KYSE-140,6917907,-6.144998641160468
NMC-G1,11178236,-2.357731789630781
TCCSUP,10184653,2.1408620170071084
MHH-ES-1,11507802,0.7203132695373792
Mino,24901704,1.8112550019620224
HD-MY-Z,erlotinib-PLX-4032 (2-1 mol-mol),3.711978667011587
OCI-M1,4477,0.6438818752546036
MHH-CALL-4,5311,0.3853238455838984
KMS-12-BM,17755052,-0.7211534532736694
KYSE-30,vorinostat-navitoclax (4-1 mol-mol),2.5237225334051985
OCI-M1,375860,-0.3208113625803119
KYSE-30,53495165,0.2747232541880236
T84,5494449,2.287736748138658
EJM,carboplatin-etoposide (40-17 mol-mol),1.4421874233068297
LP-1,16736978,0.0760242345590648
KMS-12-BM,11977753,-3.492184366851405
NCI-H929,9967941,4.011440111055957
KHM-1B,carboplatin-etoposide (40-17 mol-mol),0.9308702262934592
NCI-H2087,46199207,1.8458802160397367
RT-4,navitoclax-gemcitabine (1-1 mol-mol),-4.248755815605392
NCI-H929,tanespimycin-gemcitabine (1-1 mol-mol),-3.1675537812544516
GA-10,JQ-1-carboplatin (1-1 mol-mol),-0.7456185194400317
YH-13,72376,-1.189178232069283
SNU-119,JQ-1-vorinostat (2-1 mol-mol),3.606308027934859
SW1353,3854666,1.0037118421292317
KYSE-30,BRD9876-MK-1775 (4-1 mol-mol),3.8379953202648616
RT-4,2729026,2.8165603599873306
KHM-1B,JQ-1-navitoclax (2-1 mol-mol),-1.1171420900170967
KP-N-YN,448949,2.918992112013093
IST-Mes1,16659841,2.7339021092282527
KHM-1B,2949965,3.6440598201563423
KMS-12-BM,5702613,3.076262318494198
LS411N,4788,5.997281207159956
MHH-ES-1,5566,2.909543638364716
HCC1833,sirolimus-bortezomib (250-1 mol-mol),1.7413887390149827
Hs 936.T,1716436,2.450119741918197
EJM,24785538,0.370264402749186
TCCSUP,135423438,2.289740320598626
YD-8,5278396,3.5154412560153068
KP-N-YN,24964624,3.5667437811311484
HD-MY-Z,25227462,-0.2708881333267501
NCI-H2171,135440466,1.9220793929810305
NCI-H2122,72376,-2.2643332945295844
NCI-H2171,25262965,-0.9052216234257174
IST-Mes1,135398738,4.689828903809361
ECC10,11317348,1.1814932685062118
K-562,2858523,2.745068324935018
PE/CA-PJ15,5282054,4.554221037529222
SK-MES-1,5351362,0.9470170476408172
EJM,6505803,0.0546883993617254
KMS-12-BM,17759555,4.020532745562922
YD-8,24821094,2.929241602776678
IST-Mes1,16038120,1.0913997834143612
TCCSUP,3385,5.839871573766512
BT-20,42642645,1.1875520352883364
RD-ES,439501,-2.2858768035402623
GA-10,448949,0.2328746422103545
HuNS1,9915743,0.7777068121651658
OCI-M1,54618771,0.2801133336374899
L3.3,12003241,-0.3315333583144895
SNU-119,71304818,1.7575129370546083
PE/CA-PJ15,969516,2.781923448881668
SK-MES-1,66577038,2.203464063680577
PL-21,44589607,2.8613749758989315
HD-MY-Z,11625818,4.235088250485888
NCI-H929,15547703,-0.209100400299692
MHH-CALL-4,151289,1.7059090797586212
PE/CA-PJ15,119182,-1.3122958755203809
T84,6918837,-2.3653874953216767
Hs 936.T,11626560,3.8039359078974297
SK-LU-1,24964624,2.630537843105383
NCI-H2087,navitoclax-piperlongumine (1-1 mol-mol),1.8344698549947869
NCI-H1395,3825829,4.5765318321652355
HMCB,3825829,4.05483266037916
TCCSUP,25262965,-1.8774141116985676
YD-8,5281321,-0.940156182693946
K-562,24180719,3.2747438118023533
LS411N,5281321,2.872375461605106
KMS-12-BM,10127622,5.364692191971256
TCCSUP,100016,6.5110410318476575
NCI-H2087,11626560,1.4187644987656527
HuNS1,56946209,-4.838574171462125
KHM-1B,42642645,-0.1657476945294937
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993
KHM-1B,54613361,-1.0335550774080653
SNU-119,11625818,3.656882116182555
GP2d,selumetinib-MK-2206 (8-1 mol-mol),-0.5811141390315897
KO52,135398516,2.6603419606687564
LS411N,9936388,1.997277136132151
TCCSUP,9926054,2.5470676869748763
MHH-ES-1,46174525,3.479925603130717
SK-MES-1,9926054,1.7676300515090215
OCI-M1,ISOX-bortezomib (250-1 mol-mol),0.0265771012235523
PL-21,9911463,3.159423653145491
T84,54143018,-0.3913740458326385
OCI-M1,5278396,3.4171172840164146
KYSE-140,tanespimycin-gemcitabine (1-1 mol-mol),1.632436576859993
SK-MES-1,selumetinib-UNC0638 (4-1 mol-mol),2.270891461812722
TCCSUP,decitabine-carboplatin (1-1 mol-mol),4.4091116802817325
GP2d,44566777,-0.0571798398709594
NCI-H1395,25150857,3.355605487128081
BT 416,9915743,-0.2022944112216887
KHM-1B,tanespimycin-gemcitabine (1-1 mol-mol),-0.6092153686857478
NCI-H2087,613753,3.0820006281884296
MHH-CALL-4,72376,-4.42777622906987
SW1353,89928392,2.1843128497808895
TCCSUP,5278396,3.4986676958942304
MHH-ES-1,44632017,0.3038443174405593
L3.3,446155,3.865906870912223
BT 416,6184667,3.979110881054798
EJM,6610355,4.327559225261186
SW1116,doxorubicin-navitoclax (2-1 mol-mol),1.021798348357056
OCI-M1,11964036,1.1094637221934505
SCC-9,9927531,5.254709651648818
KYSE-140,navitoclax-sorafenib (1-1 mol-mol),1.6624589204618416
REC-1,11214940,3.3108084395068924
BT 231,9868037,3.3180720809611137
LP-1,119607,3.860426854008545
KMS-12-BM,2113511,4.224689679804032
SCC-9,8515,4.77911141452934
SK-HEP-1,11427553,3.604603983851784
K-562,123631,1.7867714727142892
LP-1,16038120,-1.6934810500215316
HD-MY-Z,tanespimycin-bortezomib (250-1 mol-mol),-0.5200948586273125
BICR 31,6918328,1.2499033439512497
CFPAC-1,52912189,1.5634013303702807
ECC10,3025986,-1.170647016275723
RT-4,176870,3.685175817332376
LS411N,6438330,3.3380693145982816
K-562,262093,3.1056763935044813
EJM,6918736,-2.1636905167867355
Hs 936.T,selumetinib-navitoclax (8-1 mol-mol),0.9122432649096246
NCI-H2087,25062766,1.9256966977375576
RCM-1 [Human rectal adenocarcinoma],60750,2.8463966167693515
Calu-1,56649450,4.387767529391793
SK-MES-1,12001922,1.393136563934824
NCI-H2171,5335621,4.282845813975702
KMS-12-BM,4477,0.337852436385288
KHM-1B,11427553,0.8733560257670158
HMCB,216239,1.7149264696015345
RCM-1 [Human rectal adenocarcinoma],241158,4.470658456064693
BICR 31,46943432,4.176233154169203
SW1353,46199207,3.266620249714702
BICR 31,387447,-3.4745770631768553
Calu-1,10184653,2.5384680842986573
PL-21,9444,3.6640172694067856
NCI-H2087,3825829,3.626836228263037
Calu-1,4917,3.419295735259818
HuNS1,136227924,1.7771734051898846
HMCB,89928392,1.1617926857836482
MHH-CALL-4,2749,0.3151090194221275
CFPAC-1,46907787,2.402933014882264
SK-HEP-1,3025944,4.243935374614092
EJM,24951314,0.9397817217373432
NUGC-4,159324,3.728787065585916
HMCB,9935249,3.1054191675254064
NUGC-4,216468,1.182258881626564
OCI-M1,135875424,3.745039628073017
Mino,4378219,3.5909916747536976
SCC-9,11626560,2.4253223939520976
BT 416,5470400,-2.4453661223588723
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966
IST-Mes1,25022340,4.432743731061051
BT 416,25183872,-1.1537057845023602
NCI-H2171,2729026,2.1337054337121466
GA-10,5460769,2.1295302547958976
NCI-N87,5280436,4.116578666931142
BT-20,56946209,-3.761810483806187
GP2d,24772860,-2.6636147322162427
NMC-G1,46398810,2.555604888828553
PL-21,72734382,3.348328972333976
HD-MY-Z,5329102,1.912063792762742
SKM-1,54678924,0.9652165480263206
NCI-H929,151289,1.2109794778223528
SK-LU-1,24771867,2.357886269602111
KYSE-140,49793307,-2.6566875778953443
SK-OV-3,104842,-0.359869843998673
RCM-1 [Human rectal adenocarcinoma],1641662,3.738448071417011
GA-10,10385095,-0.1867233293810926
RCM-1 [Human rectal adenocarcinoma],409805,6.9502249218901975
KMS-12-BM,54618305,3.825029881117321
SK-MES-1,2828334,5.789248592792015
PE/CA-PJ15,26596,-1.1054075726167758
BT 231,4521392,5.527630016590695
LS411N,135875424,4.300305751936665
BT-20,25262965,0.257574238159106
SCC-9,67291369,5.015060977849177
KMS-12-BM,67156097,-3.200598726498201
NUGC-4,24951314,-0.7381856472319249
LP-1,4096211,1.2893405268569615
KHM-1B,24772860,-4.094705330536473
SNU-119,656346,2.524643522978163
T84,6438330,2.4153287661834617
SK-LU-1,11222830,1.7757056424017457
GP2d,44202524,1.6247749554528643
GA-10,16736978,-0.2046842659541293
NCI-H929,6505803,-1.240454682973536
KP-N-YN,6438330,2.6624704344351104
KO52,675434,4.169961289776668
NCI-H2122,JQ-1-vorinostat (2-1 mol-mol),1.9820932056338667
ALL-SIL,6918878,-0.682122479171039
GP2d,11497983,-0.050951978753368
Hs 936.T,2729026,2.722667895416921
BT-20,11657048,4.5378098522087935
HuNS1,24964624,2.436898446671943
NCI-H2087,51039095,2.5754655348869067
OCI-M1,vorinostat-carboplatin (1-1 mol-mol),1.7212984519707284
SK-MES-1,sirolimus-bortezomib (250-1 mol-mol),0.6700738424680361
KMS-12-BM,12003241,-2.27657533610394
KO52,148124,-8.023122181205325
OCI-M1,3854666,0.1062277305509749
NCI-H2122,20959075,-1.8269772667041615
NCI-H2087,135659046,3.4152304488602727
L3.3,15953870,4.520919895902943
EJM,44487872,4.364141533871357
SK-HEP-1,89928392,1.6602086186634375
NCI-H2171,44462760,3.915746717375186
HMCB,374536,3.816146263296923
EJM,11640390,1.8430526894462032
SNU-119,5978,-4.047164032584213
YD-8,3854666,3.395603852355968
ECC10,5287620,-3.490170349349132
KYSE-30,decitabine-navitoclax (2-1 mol-mol),3.936829594163531
SNU-119,3025944,4.367446555553435
SW1353,452548,1.2400403777119515
HD-MY-Z,89928392,1.6289105953981764
PL-21,4259181,-0.9263969170856944
LS411N,68056272,3.648680202626129
KYSE-140,135421197,1.0055598212916683
YD-8,107985,-2.331165064329628
RCM-1 [Human rectal adenocarcinoma],148198,-3.91492317301152
IST-Mes1,navitoclax-pluripotin (1-1 mol-mol),-0.6633970571557571
KP-N-YN,119607,3.9073924265390336
HMCB,5329102,2.553440838947416
MHH-CALL-4,3634881,1.4532849332820152
HMCB,444795,4.365001038195376
L3.3,969516,2.9670664389679677
HMCB,24180125,3.3063760805557054
KYSE-140,638278,3.6021799412866744
BICR 31,3081361,0.7844567898788304
SW1353,44819697,-0.3901541853324271
RT-4,675434,4.226250873257813
HuNS1,4477,0.7204158906539593
KYSE-30,6852167,3.4266052993567775
HuNS1,3384730,2.905037591853169
KO52,11427553,-1.0437328756331057
SK-HEP-1,11222830,2.864448489509693
BT 231,375860,-0.0580384195874913
GP2d,72734382,4.525559000629422
ECC10,3825829,3.3631877901745626
NCI-H2087,82146,3.2017066371326277
K-562,11719255,4.077642177046201
BT 231,71751553,4.584826391566352
SK-HEP-1,89183176,6.199387598364303
NCI-H2171,168312962,2.801787293375821
L3.3,49850262,4.243504406455669
BT-20,25150857,3.649285693743344
HD-MY-Z,65628,4.144650294210182
KO52,5746,-1.4374461820450624
BICR 31,151289,1.9519908762907336
EJM,selumetinib-PLX-4032 (8-1 mol-mol),4.757753624463101
ECC10,2842253,4.156140438759516
Mino,alisertib-navitoclax (2-1 mol-mol),-3.6624360155074327
GA-10,5470400,3.335396488350569
MHH-CALL-4,25154868,4.637634071419261
BT-20,6252,4.390369391867793
NCI-H1395,5328940,2.584315328897391
PL-21,carboplatin-etoposide (40-17 mol-mol),1.4115305001788885
BT-20,10427712,5.412311370089807
HCC1833,107985,-3.0980572813804352
SK-OV-3,15953870,4.452396287203901
PL-21,46907787,0.2459511356880181
YD-8,10113978,1.4967891530862965
GA-10,navitoclax-gemcitabine (1-1 mol-mol),-5.133393494257321
NCI-N87,navitoclax-pluripotin (1-1 mol-mol),-2.6023370603895337
TCCSUP,16038120,0.8222497592988807
SW1353,67291369,1.2905576872046982
L3.3,navitoclax-sorafenib (1-1 mol-mol),2.85899880302019
ALL-SIL,60750,-4.149254188873004
KMS-12-BM,46191454,-0.8526827535334566
OCI-M1,4521392,4.100194806673698
TCCSUP,11404337,-0.4859326706611666
ECC10,25154868,3.193149514294078
HCC1833,3011155,5.587707385620513
BT 416,53481919,3.772014168593692
NCI-H2087,9884685,1.9812992127779516
BT 231,24797083,0.7348725904483493
Mino,2871966,-0.3004733438104812
KMS-12-BM,6918837,-5.957807567575875
LP-1,15547703,2.5864764437186603
NCI-H929,5311,0.6524822711391439
K-562,4917,1.7461656699737091
BT 416,25150857,1.7144162921906836
REC-1,322968,2.0364678189821865
SCC-9,25105715,3.642638215460893
BICR 31,46215462,1.6669957894505008
SNU-119,44137675,3.0443625578269096
BICR 31,4578,4.306546690441069
SNU-119,navitoclax-piperlongumine (1-1 mol-mol),1.89121393785076
YH-13,16065773,2.7841843870151086
SK-OV-3,72734382,4.397767647147488
GA-10,6918638,-2.7044389235712187
NCI-H929,25062766,1.424722824964366
NCI-H2122,selumetinib-JQ-1 (4-1 mol-mol),1.880665568287093
NUGC-4,5278396,3.2851771807610297
KP-N-YN,4477,1.0896550657036284
NUGC-4,151289,0.9128130386057416
MHH-CALL-4,10427712,3.642678408823805
ECC10,3062316,3.164529630724706
PE/CA-PJ15,54678924,1.6746192512900708
NCI-H1395,24180719,5.770511312321668
SK-LU-1,navitoclax-birinapant (1-1 mol-mol),-0.3966375433721267
NCI-H2171,46926350,-4.867098709680934
HMCB,12003241,-2.4987094510650834
ECC10,36462,0.1453148822762285
SK-OV-3,3062316,0.5292744016150154
SW1353,71304818,3.1163263826159637
SW1353,44489675,5.591553979549204
MHH-ES-1,24772860,-2.9517064275807057
SK-HEP-1,11238147,2.1467729161342524
HD-MY-Z,crizotinib-PLX-4032 (2-1 mol-mol),1.638894863907444
MHH-CALL-4,159324,2.2712057532386254
L3.3,20959075,-2.193253801628986
KMS-12-BM,4788,4.217370600333275
GA-10,10184653,0.7689824910476086
LP-1,JQ-1-vorinostat (2-1 mol-mol),-1.415306896508813
HCC1833,carboplatin-etoposide (40-17 mol-mol),3.9732934833347975
Mino,44486219,3.4156514230359187
BT 416,44507138,3.598487420867471
GP2d,5287969,-1.7884856599277144
SW1353,25126798,3.782636233692823
SNU-119,6852167,1.9740525769719148
Mino,426756,4.371092406144052
BT 416,2749,2.164355247987501
RT-4,656346,1.221442346270773
NCI-H2087,tanespimycin-bortezomib (250-1 mol-mol),-5.178784245038985
NCI-H2087,135421197,1.3607762118240936
MHH-ES-1,6918328,-0.4516796215049732
SK-MES-1,252682,6.380754292339419
LP-1,24964624,-0.4975365243626942
GP2d,9840324,5.218253609119664
SK-OV-3,72193861,3.227068856168802
GP2d,387447,-3.5089212813908555
SCC-9,serdemetan-SCH-529074 (1-1 mol-mol),2.940999186382139
CFPAC-1,136227924,3.3404294087361883
Calu-1,docetaxel-tanespimycin (2-1 mol-mol),2.1903012722048247
IST-Mes1,71304818,2.7451890534908427
YH-13,135411,1.4167541971469908
EJM,24772860,-3.292775584200783
KO52,selumetinib-vorinostat (8-1 mol-mol),-0.9100667251350252
RT-4,6450551,2.2362160436961314
KYSE-140,9907093,4.310956576065174
RCM-1 [Human rectal adenocarcinoma],SNX-2112-bortezomib (250-1 mol-mol),-0.995249621859288
MHH-ES-1,3815108,3.2040420472757924
SCC-9,136227924,3.721677265331546
IST-Mes1,2874250,4.337377448058327
SK-HEP-1,4261,2.0689452694586596
NCI-H929,11609586,2.312289051564489
NMC-G1,56973724,2.993613595979071
ALL-SIL,5282054,2.788902246408387
PE/CA-PJ15,4378219,3.8751704694952753
ALL-SIL,6610216,3.679901693613009
KYSE-30,9884685,1.4164675900937749
SW1353,65064,5.216820278226419
IST-Mes1,salermide-PLX-4032 (12-1 mol-mol),6.709164103992604
YD-8,11609586,3.1428816496644147
SK-MES-1,46907787,1.4035137131204831
T84,11213558,5.384652323894473
NCI-H2087,JQ-1-vorinostat (2-1 mol-mol),-0.2691821837071596
OCI-M1,67156097,-2.629339427819239
NCI-H2122,5328940,2.341536686233132
MHH-CALL-4,navitoclax-birinapant (1-1 mol-mol),-1.507329844590216
KYSE-30,2742550,3.649677885996823
K-562,135984461,3.2548026411837787
NCI-H2171,6252,2.1051572182795
BT 416,89928392,1.6490283746442465
NCI-H2122,11214940,3.1936874685085557
SKM-1,1242560,3.2805801288992296
SK-HEP-1,969516,2.3030983588134917
HCC1833,4261,0.6230518360059483
Mino,71576739,6.461585428611278
IST-Mes1,54613361,2.804102088673467
KHM-1B,JQ-1-vorinostat (2-1 mol-mol),-0.1758433625327752
SCC-9,24180125,3.671852734769843
NMC-G1,969516,4.852729229804009
RCM-1 [Human rectal adenocarcinoma],5311,1.6255593512960202
K-562,387447,-4.172741798582805
KYSE-30,57519531,5.330080790522772
KHM-1B,11485656,1.807132568777105
SK-OV-3,44607530,2.4027946355264507
HCC1833,docetaxel-tanespimycin (2-1 mol-mol),-1.1738225866047556
NCI-H2087,5311281,4.055528731820513
K-562,54143018,0.8143265967368298
YD-8,11167602,2.315498397427602
ECC10,navitoclax-gemcitabine (1-1 mol-mol),-2.781316488443644
BT 416,10184653,1.0880644745767971
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822
PL-21,5351362,2.1415777958830247
NCI-H929,doxorubicin-navitoclax (2-1 mol-mol),-2.4469674599934574
HMCB,10074640,3.711732352742634
HCC1833,9903786,4.187003338939228
Calu-1,44607531,2.355998343429417
KO52,16659841,2.257439927508027
L3.3,16741245,2.275908063521695
MHH-ES-1,387447,-3.882318105798204
GP2d,selumetinib-PLX-4032 (8-1 mol-mol),0.3977474650531843
NMC-G1,3854666,4.917265347218566
K-562,644241,-4.86229706466587
SCC-9,2749,3.600343159035071
EJM,135440466,1.184398396955965
SK-MES-1,176870,2.14045268314154
SK-MES-1,409805,3.68215710914594
ALL-SIL,24889392,1.2675997647257198
OCI-M1,23582824,2.114235638559021
ALL-SIL,54618164,3.625474128679928
LP-1,168312962,-0.2706100426398824
SK-MES-1,71751553,4.12788922702423
SW1116,decitabine-navitoclax (2-1 mol-mol),2.6515889458900244
TCCSUP,crizotinib-PLX-4032 (2-1 mol-mol),1.6984016449467694
BT 416,sirolimus-bortezomib (250-1 mol-mol),0.8644266482137087
L3.3,119607,5.267929584666067
NCI-H929,16725315,0.430149891023638
GA-10,1641662,2.787978814834199
SW1353,16722836,1.1667767430889564
YD-8,8515,3.9380466861306616
NCI-H2087,7251185,3.3725277465887484
NCI-H2087,2126,3.728247344952002
KO52,navitoclax-piperlongumine (1-1 mol-mol),-2.989352719606275
BT 416,carboplatin-UNC0638 (2-1 mol-mol),3.894291927747083
HMCB,285033,-1.7820394591449478
MHH-ES-1,241158,2.9486895199136876
BICR 31,11609586,2.804864928293696
T84,148198,-4.2219788227955855
RT-4,9903786,1.1299984693284726
KMS-12-BM,11175137,1.8406353702051843
NCI-H2087,2858523,2.2441907300378574
NCI-H1395,4788,5.899577984060707
KO52,3384730,2.162623457031388
KP-N-YN,753704,4.764814889948165
RCM-1 [Human rectal adenocarcinoma],5113032,4.670023295767466
OCI-M1,135421197,1.730627187910493
SK-HEP-1,168312962,-1.3309808369359073
GA-10,11977753,-4.9574156039034145
BT 231,piperlongumine-MST-312 (1-1 mol-mol),1.6356177811620207
CFPAC-1,60750,-2.3928943729538927
GP2d,10427712,4.275358879920918
REC-1,24951314,4.225069599426471
GP2d,135398516,3.3908515724128394
BT 231,selumetinib-GDC-0941 (4-1 mol-mol),1.8101702553232384
NCI-H929,31703,-2.722564633295698
SK-LU-1,49766530,-1.2707580776234786
KYSE-30,2871966,1.1085454000281545
PE/CA-PJ15,11214940,4.68728018963696
BT 416,selumetinib-tretinoin (2-1 mol-mol),3.1110042158067643
CFPAC-1,54618164,4.158502253037373
Calu-1,156422,5.016846170986882
BT 231,45100481,4.488075297577812
SCC-9,46926350,-4.135183666473923
GA-10,969516,1.7506908181233245
NCI-H2087,568763,-1.0939633169738774
KO52,16736978,2.222216886070048
SK-HEP-1,135398516,1.8011759760648425
HD-MY-Z,11238147,1.772472221198128
MHH-ES-1,135999136,1.7507962768732164
GP2d,72193861,1.0718752516267895
HuNS1,3552672,3.174474870219477
RCM-1 [Human rectal adenocarcinoma],25195348,3.936962209730735
Hs 936.T,vorinostat-navitoclax (4-1 mol-mol),1.857374133876441
SCC-9,7251185,3.4755501931610486
YD-8,SNX-2112-bortezomib (250-1 mol-mol),-1.2949761873623031
BT-20,vorinostat-carboplatin (1-1 mol-mol),4.032656534211149
IST-Mes1,11507802,2.196367921071978
SCC-9,1716436,3.7585685406918783
KYSE-30,227681,3.9032474457262474
SK-LU-1,25262965,-1.8207327882969349
GP2d,400769,-1.2733871658914886
NCI-N87,159324,0.0331676951949142
BT 231,3552672,1.0850091366023025
HMCB,1750826,1.2340633069907747
ECC10,16722836,0.3199963418829057
PE/CA-PJ15,3465537,1.6564118127840195
MHH-CALL-4,4788,3.958417150432613
HMCB,11214940,4.410091116591445
SK-LU-1,25150857,2.2354047783807567
TCCSUP,5311,0.9056986626797512
IST-Mes1,5281672,4.409062773089972
Mino,753704,3.5464865657469753
KHM-1B,11647372,-0.566073234789779
NCI-N87,1242560,3.6090545678814983
BT 416,UNC0638-navitoclax (1-1 mol-mol),-0.0804251161714488
SCC-9,11222830,1.8600220042192213
PL-21,753704,4.449261254318299
HuNS1,selumetinib-PLX-4032 (8-1 mol-mol),4.09016282328275
CFPAC-1,5328940,1.7515320206784977
NCI-H1395,navitoclax-piperlongumine (1-1 mol-mol),2.9868041104516245
KO52,9823820,4.034259962160193
GA-10,322968,-1.6748970472377194
NCI-H2087,16725315,3.2148990031136324
LP-1,25183872,-2.1254794230535805
Calu-1,11214940,-1.010786475350872
GP2d,462382,1.1582557233002648
HMCB,45279963,3.8576212029181343
BICR 31,4917,3.733916426719056
MHH-ES-1,16741245,3.2440473666382665
REC-1,selumetinib-tretinoin (2-1 mol-mol),6.606807217531799
YH-13,24180719,3.7478543768890136
K-562,49793307,-5.346924391172112
NCI-H2122,676352,2.5917946377653864
NCI-H2087,SNX-2112-bortezomib (250-1 mol-mol),-0.5063094132165172
T84,9549297,1.8614421894369475
Mino,54626689,2.826693695384345
BICR 31,135421197,2.236076370585341
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978
MHH-ES-1,6918878,0.8942123313539464
NCI-H2087,151289,1.6053570877631234
OCI-M1,54678924,2.061774029318974
K-562,136227924,2.737847329779252
KMS-12-BM,carboplatin-etoposide (40-17 mol-mol),0.8739137522045413
GP2d,5328940,0.9756305778294898
BT 416,44819697,-2.452034322142297
SNU-119,11228183,1.025523846387519
RT-4,52947716,0.9303091042236448
HCC1833,54619267,3.840050281233338
KYSE-30,71680916,4.38277454273698
BT 416,2729026,2.370588405546605
SCLC-21H,52947716,3.109561314543001
NCI-H2122,1566236,4.547369215315693
PL-21,446155,3.591955044908648
SNU-119,9927531,4.042335314323924
SK-MES-1,alisertib-navitoclax (2-1 mol-mol),1.218180105716376
NCI-H2087,46174525,3.9469116903316017
SW1116,2733526,2.8851174395534813
GP2d,navitoclax-pluripotin (1-1 mol-mol),-3.162148275953729
HMCB,navitoclax-gemcitabine (1-1 mol-mol),-1.404873290232393
KO52,crizotinib-PLX-4032 (2-1 mol-mol),0.3620509137021238
NCI-H2087,448949,2.0863719642159975
L3.3,1566236,3.261153981033622
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109
SNU-119,89928392,1.8847686882331605
NCI-H929,JQ-1-MK-0752 (1-1 mol-mol),-3.6559725672275394
BT 231,2871966,-0.0780326916631559
SNU-119,5311281,2.891953115435588
KP-N-YN,54619267,4.156870079947878
K-562,16038120,0.8140588279430221
L3.3,1242560,3.353722310779613
ALL-SIL,9866186,-0.4181259896802407
KYSE-30,71466578,5.671735307533785
SKM-1,11214940,2.1069577398563415
SKM-1,227681,3.1077347467323224
RT-4,9926054,1.7601963161522494
LP-1,71680916,4.011068179491315
NUGC-4,selumetinib-GDC-0941 (4-1 mol-mol),-2.271366643531445
LS411N,24785538,0.7817075732213645
YD-8,613753,3.309509462802455
KO52,123631,3.1226138864158903
Hs 936.T,322968,4.748248602330075
KHM-1B,3854666,1.0178761505547558
NUGC-4,36462,2.0627213084673204
PE/CA-PJ15,71751553,4.310591125974167
HMCB,44137675,3.1016831628423542
NCI-H2171,11955716,-2.5749004703466976
YD-8,10427712,4.808988209021756
RCM-1 [Human rectal adenocarcinoma],11222830,1.840895437487006
PANC-1,9887053,3.878433673694437
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922
KO52,54678924,2.3208002144974778
BT-20,445455,5.160655870831624
L3.3,6918736,-1.7247535795274376
LP-1,25262965,-5.8661094720450615
HD-MY-Z,5280436,1.7969789481336869
NCI-N87,navitoclax-piperlongumine (1-1 mol-mol),-1.185093256857405
GA-10,15953870,1.8595203133344016
YD-8,123631,2.5277035528733145
PL-21,6852167,0.788666382413097
KYSE-140,2858523,2.5203362104631686
HCC1833,23725625,4.95074814961913
OCI-M1,17755052,3.805401595172356
GA-10,11626560,0.3584108780408314
NCI-H2171,54619267,3.4799425585632204
PL-21,46943432,1.1872479034734134
BT-20,11317348,4.355561694126074
YH-13,54613361,-0.2526246447247056
L3.3,9935249,4.2075706542966955
BT 231,2842253,6.1602070790049686
NCI-H2171,1750826,-2.946975931831454
NCI-H2171,6918638,-1.5146784294865197
NCI-H2087,439501,-1.341118756842812
ECC10,10074640,2.0890767909580017
SNU-119,16038120,0.2287829434664864
YH-13,2828334,6.017888903931418
KO52,doxorubicin-navitoclax (2-1 mol-mol),-1.6802250262186946
ALL-SIL,71466445,2.2002248480614925
NCI-N87,tanespimycin-bortezomib (250-1 mol-mol),-5.300963645653278
BT 416,11234052,4.373172761306112
SW1353,11404337,0.8555790619059997
KYSE-30,3503,1.4071980069970704
HD-MY-Z,selumetinib-MK-2206 (8-1 mol-mol),2.0648089940731595
RT-4,71466445,5.089577793908251
SNU-119,carboplatin-UNC0638 (2-1 mol-mol),3.434233494695521
SK-LU-1,24772860,0.448488937654672
GP2d,6610216,3.5205675124685025
KMS-12-BM,148198,-2.3401169496211778
SNU-119,25154868,4.579751406552007
ALL-SIL,6918837,-4.772645295536399
SK-LU-1,3025986,-0.4964433261630306
IST-Mes1,11213558,3.9887472477266215
SNU-119,135875424,4.208481763945608
BT-20,9840324,5.395344605534422
HD-MY-Z,2742550,3.521539986674307
NCI-H2087,11228183,0.9522907131215416
T84,11404337,-0.6580973567556256
GA-10,168312962,-1.8483121841826584
T84,erlotinib-PLX-4032 (2-1 mol-mol),2.6993937154683976
SW1353,9903786,3.629285684044714
GA-10,3465537,2.6293508447683376
SNU-119,3503,2.1114931973526425
K-562,6438330,2.2742899368871123
ECC10,654092,0.359825476731589
SCC-9,42642645,1.380036396261508
L3.3,15983966,-2.6250326320128066
NCI-H1395,9933475,2.0762479324148435
KYSE-30,2874250,4.737075724000261
Calu-1,219104,3.7876957165936567
BT-20,salermide-PLX-4032 (12-1 mol-mol),5.234407148642112
RT-4,46398810,2.84559074478432
SKM-1,5278396,2.594174785730779
YD-8,11427553,2.049391717183717
YD-8,selumetinib-GDC-0941 (4-1 mol-mol),2.360092412498975
BT-20,50905018,4.8380099822102505
GA-10,1716436,1.4768172501247965
NCI-H2087,selumetinib-BRD-A02303741 (4-1 mol-mol),-3.5013411432634745
HD-MY-Z,10410894,2.76788898509027
SK-LU-1,613753,3.541592862352877
OCI-M1,decitabine-carboplatin (1-1 mol-mol),-0.9623214774190716
NCI-H2087,9823820,5.514306819195999
YD-8,60700,2.5320757446413222
KO52,984333,-0.7180338735578685
BT-20,644241,2.7102093275988133
NCI-H2122,6918736,-1.8339697342858168
NUGC-4,71466380,3.625979507128067
ECC10,selumetinib-decitabine (4-1 mol-mol),3.239739846523711
LP-1,9903786,3.180613462551036
BT 231,5351362,1.0136890217616688
LP-1,8515,3.897304365418543
NCI-N87,135875424,4.206412745126992
T84,23582824,0.0613396097532627
SK-MES-1,46224516,0.7865574841756734
T84,65628,6.475428256450229
NUGC-4,5282054,4.002547218422391
Calu-1,675434,4.420104871729349
HuNS1,11238147,1.826150406980964
HMCB,25062766,3.4032091718136543
SKM-1,10113978,1.631549527430136
NCI-N87,76446078,4.157863043796239
KO52,6438330,1.0398804577388443
NCI-H1395,119607,5.849828221842235
NCI-N87,5329102,2.120238068250485
RT-4,vorinostat-navitoclax (4-1 mol-mol),0.3971975472076162
GA-10,375860,-0.8493314441415308
PANC-1,56649450,3.41336006773796
KHM-1B,5746,0.0152063150708083
Calu-1,selumetinib-GDC-0941 (4-1 mol-mol),1.845580077173201
IST-Mes1,2828334,6.0384225929755555
REC-1,3676137,5.3966770598151586
SK-HEP-1,8515,5.0523689066797495
YD-8,25183872,-0.0392840886179466
NCI-H2122,135440466,1.820504329041307
YH-13,6450551,2.0238267614967644
NMC-G1,navitoclax-PLX-4032 (1-1 mol-mol),2.7793577969065417
RCM-1 [Human rectal adenocarcinoma],168313200,3.953722308471172
BT 416,53232,1.3637360886531074
SKM-1,11497983,2.969155076814477
LP-1,44632017,0.8569625246232844
YH-13,6610216,4.911134346587397
RT-4,72193861,1.6093035569826073
KO52,613753,2.783890275158845
Hs 936.T,60700,4.486334747016648
KYSE-140,6184667,4.456046366135172
L3.3,vorinostat-navitoclax (4-1 mol-mol),2.138826011171234
KYSE-30,4096211,1.8473940482506177
NCI-H2122,10127622,1.4682728290855964
GA-10,44185566,0.8051764836360304
SK-HEP-1,6918328,0.8938731782790444
EJM,71680916,4.438801841668279
ECC10,9926054,1.849592705301639
K-562,984333,1.160515473081413
KMS-12-BM,46943432,-0.1840385129667849
MHH-ES-1,123631,2.080359463578879
MHH-CALL-4,6918878,0.3808806294186813
PL-21,676352,2.0654762361107046
NCI-H929,984333,-0.3425783149230363
BT 231,23582824,-0.2870757560130124
SK-OV-3,1750826,-0.3132155362058529
KP-N-YN,216239,2.64576772253087
HD-MY-Z,439501,-3.7474534787438714
SK-HEP-1,53232,2.505434368946379
BICR 31,4788,6.181654669045445
NUGC-4,19582717,3.701441692439797
ECC10,selumetinib-tretinoin (2-1 mol-mol),0.3811821369076171
HuNS1,71466445,2.129403545309997
PE/CA-PJ15,salermide-PLX-4032 (12-1 mol-mol),5.176983203845215
SK-LU-1,4705,2.465937162773369
SK-MES-1,5280436,1.812144896936761
NCI-H2087,53481919,3.190777346141547
SW1116,BRD-A02303741-carboplatin (1-1 mol-mol),4.7347948156838955
BICR 31,46926350,-4.294934659479777
SK-HEP-1,24951314,2.4991128927954063
HCC1833,11640390,3.980502144506056
L3.3,8515,4.3523389716154455
SK-LU-1,doxorubicin-navitoclax (2-1 mol-mol),-1.1621439643787228
GP2d,285033,-2.955572967832764
SW1353,60700,1.92536398247873
NCI-H2087,654092,-0.9197833232433122
SK-OV-3,44589607,4.1377534493712265
RT-4,16038120,1.2849695111816888
KMS-12-BM,89183176,3.5435448288108056
KO52,54618164,3.705714044840163
RCM-1 [Human rectal adenocarcinoma],65628,4.3030211924112125
PE/CA-PJ15,400769,-0.9231632206674432
NMC-G1,2841722,4.166409059942429
K-562,6918328,-1.3297822316036851
OCI-M1,11396600,3.110541819968075
SNU-119,24889392,3.5636549899822194
NCI-H2171,9549297,1.2348443580878434
MHH-CALL-4,16722836,0.2039416480584097
MHH-CALL-4,156414,0.8136129124457091
ALL-SIL,46191454,0.8221974593607395
GA-10,2945648,2.0706280126876155
REC-1,54626689,4.088202914478188
HCC1833,11612883,3.0137007241595306
LP-1,1716436,1.8246631876721384
BT-20,9911830,2.435320622289844
SK-MES-1,67156097,-1.311074296597195
SCC-9,4261,1.568262163612179
TCCSUP,5311281,1.9794455257416368
YH-13,36314,4.085888552358508
EJM,135984461,5.02990169097732
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283
NCI-H929,73707398,-1.1294071073635834
SNU-119,selumetinib-MK-2206 (8-1 mol-mol),2.741948442476576
KMS-12-BM,2858523,2.6623892435665337
KYSE-30,selumetinib-vorinostat (8-1 mol-mol),0.7250547393630876
Calu-1,salermide-PLX-4032 (12-1 mol-mol),4.982842631695698
TCCSUP,54686904,5.934830892995649
IST-Mes1,11234052,4.921331368768723
GP2d,2828334,5.984515073621745
LP-1,55283,2.1360767605982436
T84,67156097,-1.7194111634522915
SK-HEP-1,119607,5.888068080296772
GA-10,crizotinib-PLX-4032 (2-1 mol-mol),0.7332666885861185
TCCSUP,25105715,3.142954215629872
SW1353,12001922,1.980156657035459
KHM-1B,136227924,1.9174951940989704
T84,10385095,1.394973696850744
SNU-119,322968,3.936087902128088
RT-4,10127622,3.667218475131435
PL-21,71466445,2.5925493312215053
HD-MY-Z,SNX-2112-bortezomib (250-1 mol-mol),-2.207431849881162
NCI-H929,67156097,-1.392693443988792
SK-OV-3,676352,2.4999853996447423
K-562,2708,5.362475494708341
T84,selumetinib-navitoclax (8-1 mol-mol),0.2711829162499701
ECC10,11213558,4.765436830883506
K-562,10296883,3.719487542859837
T84,10302451,1.5341654621205278
LP-1,2113511,3.59121790785411
BT 416,753704,7.086994634992296
Calu-1,11507802,3.6321774454590217
HCC1833,24901704,3.755392713054315
OCI-M1,24964624,3.12006717647921
ECC10,327653,1.2684206514801013
NCI-H2087,54618771,-0.2190788311634532
GP2d,46199207,3.292456365356619
NCI-H2122,46224516,3.789041227887029
IST-Mes1,16065773,3.0641757349077925
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011
BT-20,7251185,1.9291349328781584
ECC10,2841722,4.505794270239282
SNU-119,36462,1.6001107706429532
GA-10,11625818,2.142782774762562
YH-13,5287969,-1.6680517760665383
NCI-H2122,11175137,3.5115671904906756
PL-21,11175137,1.2009790766987551
KHM-1B,262093,0.9728016968076376
RT-4,5278396,3.4020225081996744
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843
YH-13,11238147,2.49094347137922
NCI-H2087,selumetinib-decitabine (4-1 mol-mol),-2.2179354098787667
LP-1,11494412,0.682179564781432
L3.3,387447,-2.8513357804813553
PE/CA-PJ15,156414,0.0244775870569668
K-562,375860,-0.3542925626582329
NCI-H2087,285033,-2.177404615370771
L3.3,selumetinib-vorinostat (8-1 mol-mol),2.710739742780381
NCI-H929,9915743,0.0759555072139175
NCI-H929,5743,-1.0610868770493211
NCI-H929,375860,-0.8805079289764249
SK-MES-1,4096211,2.277995984679155
MHH-ES-1,10113978,2.560260401925033
KO52,107985,-4.972333164700203
TCCSUP,15953870,3.2845347165405623
ECC10,644241,2.643631790579766
ALL-SIL,104842,-6.679847729141338
BT 231,57330099,4.453394254933213
RCM-1 [Human rectal adenocarcinoma],25227462,1.022239632483553
NCI-H1395,46907787,2.4653160178838354
CFPAC-1,selumetinib-navitoclax (8-1 mol-mol),6.303692463507827
NCI-N87,3025986,-2.1031012904407818
PL-21,5291,3.5927080761203785
ECC10,9444,4.177940303141343
HCC1833,54618305,4.412472871081104
KYSE-30,9935249,3.1154683324094368
SKM-1,969516,2.2754030412406774
MHH-ES-1,5335621,4.775527723780528
MHH-CALL-4,SNX-2112-bortezomib (250-1 mol-mol),-2.3571867413235714
NCI-H2087,46398810,2.081105531046176
NCI-H929,9549297,1.69378915829561
Mino,9956119,1.2124790835608252
T84,49766530,-0.5596671678676561
KYSE-30,4917,3.1616780606306003
TCCSUP,9903786,3.558837088709428
MHH-CALL-4,71466380,3.06135000548556
SCC-9,12001922,2.463166865850559
BT 231,10127622,3.413813945062974
PE/CA-PJ15,tanespimycin-gemcitabine (1-1 mol-mol),-2.5021526295064356
KYSE-30,71729975,1.1746330975815606
NCI-H2122,9907093,3.9987299924196296
REC-1,16065773,3.4063601854764647
L3.3,3503,3.0907711446371
ECC10,151289,0.5574818737537156
KMS-12-BM,151289,-0.2601572179099301
NCI-H2087,135398516,2.4633556873125397
KO52,10074640,3.368382528062951
KYSE-30,44507138,2.8983692883342953
NCI-H1395,9907093,4.0773524584978285
SK-HEP-1,44185566,3.236949395761265
KYSE-30,11178236,-5.270376574864266
SK-LU-1,24821094,3.960201652903153
PE/CA-PJ15,135984461,4.416241968173964
YH-13,5311281,1.1254096591203009
HD-MY-Z,53481919,3.778056625548303
PANC-1,23725625,5.1900671593899075
PANC-1,4788,6.040955641138436
NCI-H2122,11427553,2.9646908784464627
RCM-1 [Human rectal adenocarcinoma],JQ-1-carboplatin (1-1 mol-mol),2.0139488398740637
HD-MY-Z,2729026,3.067112619160507
SNU-119,52947716,2.3236850993344285
YD-8,327653,2.805787909326678
SK-HEP-1,2828334,6.264472809398218
MHH-ES-1,25183872,-0.3769932869618277
NUGC-4,46943432,0.134646197138115
YH-13,2871966,0.9039362697940406
NCI-H929,44819697,-1.4685499411762664
SCC-9,73707398,1.5896934234406246
KO52,1566236,1.4428264325400242
BT 231,72193861,0.0694869722089314
BICR 31,6852167,2.001013365002547
L3.3,60700,-1.0594098724228993
L3.3,46191454,1.113033924578524
NCI-H929,65628,3.950811987229233
LP-1,1566236,1.2090017249909242
NCI-H2122,54619267,3.9351787058184216
Hs 936.T,10385095,1.5324384752571614
PE/CA-PJ15,25161177,5.4130558978250845
SK-LU-1,JQ-1-UNC0638 (2-1 mol-mol),2.0319660183745434
SK-HEP-1,72193861,3.0367238048594603
TCCSUP,doxorubicin-navitoclax (2-1 mol-mol),-1.0692959342225303
SW1116,400769,0.0385944808492462
NCI-H1395,navitoclax-pluripotin (1-1 mol-mol),0.5678965327909137
HMCB,53392493,2.956281764261595
KYSE-30,44819697,-1.6410638053658124
BICR 31,24964624,2.1782924417506235
RCM-1 [Human rectal adenocarcinoma],12003241,-1.4246438063204208
SK-HEP-1,25126798,3.9918710327668503
NCI-H2087,2746,2.6080456190013632
GP2d,73707398,1.3305042715968274
SK-OV-3,5287620,-0.5544150043477152
KO52,71466380,4.947279567827718
HCC1833,navitoclax-pluripotin (1-1 mol-mol),-1.6606204205926025
BT 231,16038120,0.3875963261635954
NCI-N87,107985,-3.2122311985508136
KHM-1B,156414,1.0383008800592366
KP-N-YN,11485656,3.2850291914647345
SCC-9,53392493,3.3396857977581917
K-562,119607,4.708269214175102
HD-MY-Z,15953870,3.40341843750169
RT-4,SNX-2112-bortezomib (250-1 mol-mol),-1.6895298123650488
SKM-1,9903786,0.91314187591027
SK-MES-1,navitoclax-PLX-4032 (1-1 mol-mol),3.3190518754039413
SCC-9,3025986,-0.0492814979551807
EJM,168313200,3.7804211641471097
NCI-H929,135398516,-0.7887215182835613
MHH-CALL-4,49793307,-4.553556883660463
Mino,2746,0.8044795617412364
MHH-CALL-4,44491742,5.077124852247723
TCCSUP,54618305,5.536232511374765
OCI-M1,44566777,3.0671513644592148
YH-13,46926350,-4.088990629945516
EJM,25262965,-4.908290828803979
GA-10,4917,1.81500454050113
LP-1,54143018,1.0845635035157557
K-562,445091,4.14956176193418
MHH-ES-1,107970,2.3247175730314757
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233
MHH-CALL-4,107985,-3.8831394707718294
YD-8,selumetinib-navitoclax (8-1 mol-mol),4.335023783206367
LP-1,JQ-1-carboplatin (1-1 mol-mol),-0.8126599405302602
RT-4,3689413,0.3652230576391069
HCC1833,11656518,4.027069710426819
KHM-1B,ISOX-bortezomib (250-1 mol-mol),-0.0879001565107233
BT 231,navitoclax-piperlongumine (1-1 mol-mol),0.9945561307668396
T84,5113032,5.139142017072603
IST-Mes1,24785538,1.075792459113639
KO52,72193861,-1.1014673459413422
PL-21,36314,2.4214100642911904
PL-21,46174525,3.198579647565115
HuNS1,71751553,4.7444430749787445
KP-N-YN,65064,4.200025768595763
BT-20,107970,2.153530404894493
LP-1,11640390,-0.629286194616334
RT-4,3815108,3.2555557052481
KO52,46191454,1.8283467695557307
BT 416,10296883,4.010101282848487
SK-HEP-1,10427712,4.527720982072863
Hs 936.T,24753719,4.451311160426746
MHH-ES-1,JQ-1-navitoclax (2-1 mol-mol),-0.109215382747667
PE/CA-PJ15,3503,2.508358326972826
BT 231,9967941,3.1837049402851587
SCC-9,24797083,1.144476664186746
KYSE-140,104741,4.31577551179371
YD-8,5328940,1.5878995115689818
LS411N,15953870,3.79326986504028
KMS-12-BM,3543504,3.65561309678176
NUGC-4,136227924,2.1432448607030308
SW1353,11964036,1.179392467612274
SKM-1,9825149,0.9402099583911157
KMS-12-BM,9444,3.443513988010703
NCI-H2122,16722836,2.0724329237670456
RCM-1 [Human rectal adenocarcinoma],46907787,1.929794927586623
KYSE-140,15547703,3.120748127312234
PE/CA-PJ15,216239,2.7008177821497124
LP-1,322968,1.985573452904059
HD-MY-Z,5287620,-2.6336313346412905
L3.3,262093,4.054875705556861
SNU-119,ISOX-bortezomib (250-1 mol-mol),0.3565845670857949
SKM-1,5460769,2.732858525958475
Mino,25227462,-5.636785999770103
PL-21,49850262,3.1780357857267205
GA-10,25183872,-3.1862508612816423
TCCSUP,12001922,1.8065976043630063
BT-20,25102847,1.7864931205619543
LP-1,26596,-1.5638632087078823
HD-MY-Z,10385095,0.804290449533917
ALL-SIL,4096211,-0.2650943934034739
Calu-1,51039095,3.6170133581938657
RCM-1 [Human rectal adenocarcinoma],5329102,2.5793782122473985
MHH-ES-1,25105715,3.1446521523044844
ECC10,10231331,3.4361664003584824
SW1353,11612883,2.7614706098703214
PE/CA-PJ15,11178236,-3.3152218482507867
NCI-H929,selumetinib-piperlongumine (8-1 mol-mol),2.46209131947828
MHH-CALL-4,9868037,2.145138443959549
T84,11647372,-0.6878847411506579
PE/CA-PJ15,9907093,4.416525401831105
ALL-SIL,135421197,0.8278001934093618
TCCSUP,24889392,3.438580211915109
IST-Mes1,11485656,3.5408910362273835
BT 416,4477,-0.2613375977018169
CFPAC-1,57519531,2.306239652682298
CFPAC-1,46199207,3.2544475096730783
NCI-H929,1716436,3.574402272281363
YH-13,448949,1.5692102118953517
ALL-SIL,24772860,-3.38763553354356
NCI-H2122,400769,-0.2598528452854128
GA-10,5284373,1.1753597235264317
SK-LU-1,15983966,1.5138457248972073
KYSE-140,54649381,3.121234531215916
SK-OV-3,53392493,2.9853646548342767
BT 231,151289,0.783350278693398
KYSE-140,3503,1.4567441558085288
YD-8,4705,3.8146154447521146
GP2d,piperlongumine-MST-312 (1-1 mol-mol),1.9512280502663375
NCI-H929,156414,0.5091151756924145
SK-MES-1,135440466,2.124713039759101
KMS-12-BM,15953870,2.0453814346354577
KMS-12-BM,44819697,-0.1317079524994108
GA-10,49867930,4.875257401193379
KYSE-140,36462,3.8546995001877176
HCC1833,1716436,1.3578944478620694
GA-10,136227331,3.9402947188121793
HD-MY-Z,9444,4.341996334786514
K-562,216239,1.6121414929675577
SK-HEP-1,24901704,5.545234809796251
LP-1,5287620,-1.5853989748325072
BICR 31,44137675,3.031084694210408
BICR 31,10184653,-1.3652350776002238
OCI-M1,151289,0.925603021609817
KO52,135411,0.3217608625451301
SCC-9,5311037,3.6943722712183007
MHH-CALL-4,25062766,2.172774403898232
SNU-119,53481919,4.072571105351551
K-562,1242560,3.4884556471232293
BT-20,25105715,3.891192751434957
HD-MY-Z,24964624,3.07176290262241
IST-Mes1,5329102,1.6787488330100182
BT-20,54678924,1.718212256836927
SW1353,4521392,4.431642377833301
OCI-M1,crizotinib-PLX-4032 (2-1 mol-mol),1.1779893343527392
SNU-119,9967941,5.644960862211108
ALL-SIL,52912189,0.8155728349845486
NCI-H2171,227681,1.8296199533038344
BT 231,16741245,4.335557928697965
KO52,31703,-1.3814684432186313
BT 416,17755052,1.037205426415961
SK-OV-3,71304818,3.289226671933847
SKM-1,54618164,3.978394394327194
KHM-1B,68056272,3.2538841376284973
GA-10,216239,1.1853859076889015
T84,219104,3.019358393793213
SK-MES-1,675434,4.38872997722964
BT 416,24785538,-1.1792163963686233
LP-1,9840324,5.616134584843621
EJM,676352,1.4630125029054086
KP-N-YN,374536,2.0150210126698433
KO52,11656518,1.0654338145229658
YH-13,216345,4.472180809621783
OCI-M1,25227462,0.8160763953283124
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169
ECC10,5702613,3.1516482260273544
BT-20,53495165,0.9861058752168644
MHH-ES-1,3385,3.667170103073233
PE/CA-PJ15,5978,-6.95712328026761
NCI-H2087,selumetinib-PLX-4032 (8-1 mol-mol),-3.3659673134645285
SKM-1,4096211,0.188033132168566
BT 416,11222830,0.8649240233492599
PL-21,serdemetan-SCH-529074 (1-1 mol-mol),1.592902396954359
SK-OV-3,4259181,0.9080230343390464
HCC1833,44137675,5.2142940282257015
Calu-1,54618164,4.35336798848697
LP-1,24785538,-2.9087929671393
KHM-1B,60700,-3.1057416609701463
EJM,45279963,3.0633820554062345
PE/CA-PJ15,73707398,0.9467877501744384
OCI-M1,16659841,1.5592371916475896
KYSE-30,5281321,-0.8690429831281447
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526
RT-4,11507802,2.274211340245079
KHM-1B,6610355,4.543219092687797
RT-4,17759555,2.661650836721078
HCC1833,168313016,5.722800305180265
EJM,2746,1.455612839065016
Mino,67291369,0.5092565195098104
SKM-1,11238147,2.2552755658276875
BT-20,44493528,4.336473935891848
ALL-SIL,451668,-1.1904263441284522
CFPAC-1,selumetinib-vorinostat (8-1 mol-mol),3.6214251657468406
LS411N,2945648,3.381909997555915
REC-1,6610355,5.258921054567104
REC-1,piperlongumine-MST-312 (1-1 mol-mol),4.394420056876291
LP-1,135875424,2.677692696582144
RCM-1 [Human rectal adenocarcinoma],675434,4.441344472745021
PL-21,46843906,1.7526806244399489
L3.3,11427553,3.3742390950754984
BT-20,3062316,2.59879524212733
LP-1,444795,7.002761969822617
T84,9967941,3.884672574250886
MHH-ES-1,5311281,0.556161342136925
NCI-H1395,12003241,1.698262392733821
LP-1,54596558,3.977103169265508
LP-1,46907787,-2.0895710134477063
HMCB,selumetinib-PLX-4032 (8-1 mol-mol),4.020315220819304
BT-20,JQ-1-UNC0638 (2-1 mol-mol),4.637152890258517
LS411N,46224516,2.772468105753273
EJM,11213558,2.5134733614994778
KP-N-YN,10127622,4.613905005330127
RCM-1 [Human rectal adenocarcinoma],53232,3.9030972816172262
HuNS1,erlotinib-PLX-4032 (2-1 mol-mol),2.6353509699318773
PE/CA-PJ15,72734382,6.1223876525140914
KMS-12-BM,3689413,-2.359728446736426
ECC10,66577038,3.154814352248027
OCI-M1,89928392,0.9297050227630492
KP-N-YN,navitoclax-gemcitabine (1-1 mol-mol),-0.0487181914327489
KMS-12-BM,16038120,-1.4386618861105946
KYSE-140,navitoclax-MST-312 (1-1 mol-mol),1.7407702668698135
NUGC-4,654092,-0.229711252696206
LS411N,5311281,3.759327828108219
SK-OV-3,51039095,2.3576173335626147
SK-MES-1,25183872,0.7549960166949878
BT-20,5351362,1.1666304005717214
SK-LU-1,25154868,4.554777655311713
HCC1833,11152667,2.1146320609656426
NCI-H2122,2729026,3.0970241743243654
NCI-N87,3854666,1.2679317332294615
ALL-SIL,3038522,2.34327176020718
RCM-1 [Human rectal adenocarcinoma],107985,-2.8907916820196156
KO52,135421197,1.227280721989531
BT 416,54618305,4.383399525094827
KMS-12-BM,24951314,-0.6430805237393931
T84,UNC0638-navitoclax (1-1 mol-mol),2.4353508898299245
OCI-M1,119607,5.755925790313522
KMS-12-BM,3136844,3.1587649853094795
RCM-1 [Human rectal adenocarcinoma],19582717,3.1254677854052333
KO52,3038522,1.8551480195818488
SW1116,alisertib-navitoclax (2-1 mol-mol),2.2992453746229047
SK-MES-1,23725625,4.2499842859618555
NCI-H2087,selumetinib-vorinostat (8-1 mol-mol),-3.329133987399838
LP-1,676352,1.5289987151196012
SNU-119,9926054,2.3608984923700036
PE/CA-PJ15,46926350,-4.278267218938167
ECC10,107985,-2.86450405382575
NCI-H2122,4788,4.943590215750166
Mino,57330099,4.503910071991802
K-562,676352,1.515837042857868
NCI-N87,alisertib-navitoclax (2-1 mol-mol),-1.7331970522410185
YH-13,446155,1.265827677839166
LP-1,3384730,1.9026639619075632
HD-MY-Z,71466578,5.3667867259835305
CFPAC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.378541064438612
LP-1,6610216,3.563963398106019
NCI-H2087,11167602,0.4948017667702105
ECC10,11497983,-3.7321311163314825
REC-1,3552672,3.972703597128775
NCI-H1395,11317348,4.623534055604914
SNU-119,36314,-3.9355379366515586
NCI-H2087,3552672,1.9079313759713632
KMS-12-BM,selumetinib-vorinostat (8-1 mol-mol),2.1031452809096827
TCCSUP,tanespimycin-gemcitabine (1-1 mol-mol),-2.519262130533681
NCI-H929,16115403,-5.6578245507090905
KYSE-140,vorinostat-navitoclax (4-1 mol-mol),1.774135933628816
BT 231,25062766,2.4033358829343476
MHH-CALL-4,5281321,-3.0754179637069474
PL-21,5328940,0.5557767235130725
Calu-1,4788,6.007975648671927
NCI-N87,568763,-0.5346616138078667
Mino,JQ-1-carboplatin (1-1 mol-mol),-0.9180856967211396
IST-Mes1,10127622,4.960728342788448
HD-MY-Z,53232,1.2767218720083144
MHH-CALL-4,71466578,2.330283573842611
PANC-1,123631,3.6125931371073743
NUGC-4,11507802,1.751864205763855
HD-MY-Z,702558,5.211848224690726
KMS-12-BM,156414,0.8404794203086158
SKM-1,9967941,3.3288322621426283
YD-8,10296883,4.26925641885348
BT 416,19582717,4.918701891352299
NUGC-4,JQ-1-navitoclax (2-1 mol-mol),-1.695026332438889
PL-21,26596,-4.324956328818882
PE/CA-PJ15,60750,-4.289743147111487
Mino,44819697,-1.7257207544810818
KP-N-YN,54143018,3.6448573483147886
BT 416,JQ-1-UNC0638 (2-1 mol-mol),-0.1426012267621706
BT-20,49793307,-1.3314896460203238
REC-1,12003241,3.6312404592907614
MHH-CALL-4,123631,3.020095164147361
SK-LU-1,54618164,4.502535850506955
SW1353,docetaxel-tanespimycin (2-1 mol-mol),-0.6584362361455027
CFPAC-1,JQ-1-MK-0752 (1-1 mol-mol),2.278964689718165
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701
NCI-H929,65064,3.1158427845285215
HD-MY-Z,24856436,-0.8736146669923398
SKM-1,selumetinib-PLX-4032 (8-1 mol-mol),-3.711046707808481
EJM,5311,0.5955107958606237
SW1353,3503,3.1041873862790283
NCI-H2122,72734382,5.447146022646347
KHM-1B,16741245,2.621472982126402
NCI-N87,2708,3.9537199090854673
IST-Mes1,11494412,3.57589790392084
KYSE-30,68056272,3.967789324911222
SW1353,navitoclax-gemcitabine (1-1 mol-mol),0.3152100081864818
T84,15547703,3.364806904651125
MHH-CALL-4,56946209,-5.098002539033033
SK-MES-1,439501,-3.0675595474826194
SW1353,53232,4.288309061193608
HMCB,2746,4.319833835287885
K-562,5311281,3.9022564066083967
SKM-1,65064,4.990027609519168
KMS-12-BM,5746,0.0880156660447664
TCCSUP,89183176,6.470181866122735
MHH-ES-1,9936388,-6.403533054534267
LP-1,375860,-0.2769324190070452
T84,9935249,1.8419022966508296
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863
Hs 936.T,123631,2.266462338447285
Mino,5978,-6.408583809412523
BT-20,selumetinib-piperlongumine (8-1 mol-mol),4.830229307785899
L3.3,65064,4.762523259447735
YD-8,4521392,4.941173654959916
LP-1,57519531,2.981389595475153
RCM-1 [Human rectal adenocarcinoma],4917,3.7649934219972727
PANC-1,49793307,-4.650861806333818
KMS-12-BM,421610,2.052297409032463
MHH-CALL-4,107970,1.5226905124680885
T84,54678924,1.7770042023345165
HD-MY-Z,doxorubicin-navitoclax (2-1 mol-mol),-2.0405310639161596
SKM-1,4521392,4.8540748740064705
SW1116,568763,0.5509769931311748
NCI-H2087,65064,3.3375636724299222
NCI-H2171,ISOX-bortezomib (250-1 mol-mol),-0.1667670458768617
ECC10,2858523,2.9782033103804686
RT-4,1750826,-0.6566840301254596
ALL-SIL,52947716,-0.7216046839402591
KYSE-140,6450551,2.874882665468633
HMCB,52912189,1.846008318835607
KO52,6450551,0.7972942512543331
BICR 31,2858523,3.440938149330432
PL-21,24753719,3.7602550214129047
SKM-1,4261,-0.5534245942964136
KMS-12-BM,44507138,1.2526701604401855
HD-MY-Z,327653,3.7321262442272567
T84,26596,-1.9747226822057509
NCI-H2171,168313200,1.615164123973231
LS411N,25062766,1.7796504921777256
EJM,67291369,1.7499501988378825
NMC-G1,JQ-1-navitoclax (2-1 mol-mol),2.6765131148718915
Mino,2708,2.604362376523167
SK-HEP-1,3689413,-2.4602386660304143
PL-21,11977753,-2.3392609083226876
BICR 31,51039095,3.0794813668201546
TCCSUP,10302451,3.6876382718765206
SK-MES-1,68056272,3.718538120033219
TCCSUP,52947716,2.97003679265922
YH-13,46191454,1.7299937465263655
GA-10,168313200,1.62244958697484
T84,5281321,-1.786836461659459
CFPAC-1,2945648,3.3408973787901113
SCC-9,24964624,2.350052808289582
CFPAC-1,3062316,1.5754419200288905
KHM-1B,6623618,1.2635861125154564
NCI-N87,71304818,2.1951958800989133
RT-4,15983966,1.8049995542525132
BICR 31,25126798,3.691910729857057
SK-LU-1,52912189,0.1809003726785632
NUGC-4,JQ-1-vorinostat (2-1 mol-mol),-1.3652131512829382
KMS-12-BM,53245473,5.652555547777156
PL-21,168313200,3.805742072358513
SNU-119,sirolimus-bortezomib (250-1 mol-mol),1.5818216209728622
KYSE-140,17759555,3.0691278189003013
Mino,60700,-3.897810408946044
KYSE-140,3038522,4.184338313552024
SK-LU-1,44819697,1.6559826876672754
NCI-H2122,6610355,4.000146020807975
PL-21,56963564,-0.0008364144024262
TCCSUP,54619267,4.2789999138556425
SCC-9,5746,1.774962232755205
SW1353,24964624,3.034038382701056
KO52,444795,3.710694398794004
OCI-M1,11364421,-5.11159414055149
KYSE-30,6505803,0.8895731520069545
Hs 936.T,107970,2.841992044005918
SK-OV-3,9907093,4.994966956142975
MHH-CALL-4,53495165,-1.3931551063943943
KHM-1B,selumetinib-tretinoin (2-1 mol-mol),1.4198257519630046
KYSE-140,11214940,2.085099383135296
NUGC-4,54618771,0.2838784179231751
KYSE-30,9903786,5.462463083669851
NCI-H2171,9933475,1.8341202855706125
IST-Mes1,tanespimycin-bortezomib (250-1 mol-mol),0.5343992581220592
KYSE-30,126941,-2.751730870337715
BT-20,148124,-6.2975852770754015
GP2d,409805,5.9524352500309545
GA-10,151289,0.2012811235538998
NCI-H1395,51039095,3.804794716936721
K-562,11494412,-0.907204058397288
NCI-H1395,3854666,3.0219534193280637
TCCSUP,25154868,4.544338525999724
HD-MY-Z,9952709,2.894769122426137
T84,4477,1.7011476743899774
BICR 31,12001922,2.662375748901725
LP-1,9911463,2.6220620880442773
GA-10,46191454,-2.0225431159502514
RT-4,5281321,-0.1129489879810674
ECC10,11175137,2.083780770793243
GA-10,71466445,1.994023479253392
KHM-1B,17759555,2.7813398800723914
TCCSUP,11222830,1.4125339406552515
HD-MY-Z,5278396,3.435666898227433
BICR 31,3062316,-1.406162609577698
KHM-1B,44507138,1.4720976685290608
NCI-H2171,16659841,2.989016667138281
HuNS1,navitoclax-MST-312 (1-1 mol-mol),0.6035176538416094
BT 231,9907093,3.3527056362522525
OCI-M1,5329102,1.8236987438326815
SW1353,54143018,-0.2115755950131179
NCI-H2171,107985,-3.896160678794096
NCI-H2171,53495165,-2.473385034422452
HD-MY-Z,24821094,3.673491336124921
K-562,9907093,4.115761716505682
HD-MY-Z,1641662,3.260529362975796
SK-LU-1,23635314,3.545282474676088
T84,navitoclax-birinapant (1-1 mol-mol),2.037326691999281
RCM-1 [Human rectal adenocarcinoma],23725625,5.154585398323981
NUGC-4,637858,2.002597662326331
L3.3,10074640,3.5317966219825414
PL-21,89928392,0.6823667111347278
TCCSUP,421610,3.586976807709893
HD-MY-Z,136227924,3.0737298330446103
NCI-H2171,44493528,3.677120674941258
NCI-H929,11626560,-0.3439403672463312
NMC-G1,4261,3.143987078906949
SCC-9,4096211,2.914802879806832
NMC-G1,navitoclax-piperlongumine (1-1 mol-mol),2.6256522465301906
KO52,piperlongumine-MST-312 (1-1 mol-mol),1.3163609440241515
GA-10,107985,-4.472986688211123
YH-13,JQ-1-navitoclax (2-1 mol-mol),1.7926263588909668
LP-1,46224516,1.0944445035525798
BT-20,65064,5.597234577000038
HMCB,16038120,1.4836068881756783
NUGC-4,2113511,5.577344281883951
REC-1,11427553,3.0944904675195133
ECC10,135875424,2.912404124811061
KYSE-140,11396600,4.836880334492914
OCI-M1,327653,3.224112962070562
HMCB,969516,2.786872605358725
HCC1833,2828334,6.13000881268035
KMS-12-BM,9840324,5.159975426829893
SK-MES-1,6252,-0.1786005188710086
BICR 31,216345,4.54975912567895
RT-4,6852167,2.0895706527990376
T84,16720766,0.7601818109345064
NUGC-4,9911463,3.797597719438973
SW1116,11213558,3.445113299124233
LP-1,52912189,-1.2724536343086947
KHM-1B,46943432,-0.0724756226448156
SK-MES-1,969516,2.704348742276152
KYSE-140,156422,3.64939050969085
Hs 936.T,11178236,-2.696761086675464
HCC1833,46224516,2.3301122602285047
BT 416,9936388,-4.783265609756594
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334
PE/CA-PJ15,176870,3.0085115802075437
T84,4261,2.349063345516416
BT 416,10427712,4.531116499522119
LP-1,3825829,3.7177263710946216
SK-HEP-1,10385095,2.0924930980552148
EJM,9926054,1.7534790705740089
Calu-1,5328940,2.267489151196793
KYSE-30,4477,-0.2483729990035639
BT-20,JQ-1-vorinostat (2-1 mol-mol),2.371036232071858
RT-4,24797083,2.4952556091999347
NCI-H929,54454,1.0391277721640106
KO52,11214940,1.4370538288764154
EJM,tretinoin-navitoclax (4-1 mol-mol),2.7267851224914854
HMCB,5282054,2.5555962503374254
IST-Mes1,11404337,-0.5180157624887997
GP2d,135984461,3.863711386365813
SK-HEP-1,44486219,4.3977685724309215
Hs 936.T,73707398,1.47923152976858
KO52,11317348,-0.6673416896175152
EJM,6852167,1.8935710220557025
Calu-1,71304818,3.3342123090590023
HD-MY-Z,4261,1.3114295374743792
LS411N,46398810,3.253541487295017
SCC-9,1239801,5.7667211168431205
T84,36462,3.2461268076235283
KP-N-YN,tanespimycin-bortezomib (250-1 mol-mol),2.890328599620326
YD-8,piperlongumine-MST-312 (1-1 mol-mol),2.2719488759687385
TCCSUP,15983966,0.2515630787348941
BT-20,49766530,-3.0336116964226076
YD-8,JQ-1-vorinostat (2-1 mol-mol),1.7372019591077774
HuNS1,11955716,-2.723877147043342
OCI-M1,60750,-3.558652255014732
SK-HEP-1,10184653,3.249474772070569
NCI-H2122,15983966,-4.217915103329825
NCI-H929,54618164,3.87455268818749
BT-20,6918638,1.2073069769548774
KO52,216468,2.9064188892685383
KP-N-YN,11427553,2.420138670199018
L3.3,5329102,3.0035184311097245
MHH-CALL-4,vorinostat-navitoclax (4-1 mol-mol),-0.3511784405786974
MHH-CALL-4,5743,-6.711162137466133
K-562,702558,5.364922414830515
BT 231,JQ-1-MK-0752 (1-1 mol-mol),1.53802210324551
IST-Mes1,11175137,3.00105789094782
KHM-1B,selumetinib-piperlongumine (8-1 mol-mol),1.0909589836207738
RT-4,6505803,-1.736360108528808
OCI-M1,25062766,0.9922945743803864
KMS-12-BM,9952709,1.973172777433049
RCM-1 [Human rectal adenocarcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.7783627662163426
SK-MES-1,5460769,2.678686049759102
T84,9929138,6.3577776039121465
SK-HEP-1,24821094,3.809459846332286
MHH-CALL-4,46398810,1.7339189732672913
GA-10,navitoclax-birinapant (1-1 mol-mol),2.111050516439074
BT-20,2729026,3.106511260429172
NCI-H2171,11152667,-0.915095731247344
RT-4,3038522,5.726431253424827
GP2d,ISOX-bortezomib (250-1 mol-mol),0.3563174500447947
TCCSUP,119607,5.1552378410509
SNU-119,5460769,2.8404840787101593
REC-1,1566236,3.018034053127421
IST-Mes1,89928392,1.562289834411229
GA-10,serdemetan-SCH-529074 (1-1 mol-mol),0.9337578082720728
YD-8,serdemetan-SCH-529074 (1-1 mol-mol),2.534681680043658
BT 231,vorinostat-navitoclax (4-1 mol-mol),1.6992938438936256
NUGC-4,44589607,3.040118668071833
NMC-G1,654092,0.9623197548350486
LS411N,54618164,4.167426775220608
KMS-12-BM,vorinostat-navitoclax (4-1 mol-mol),-0.3192913755194076
KYSE-140,15983966,1.6221263259655452
KP-N-YN,doxorubicin-navitoclax (2-1 mol-mol),-1.3302085104299843
L3.3,44607531,2.464561691878258
SKM-1,119182,-3.439658099339246
ECC10,1716436,2.0488728279066852
LP-1,9444,2.380302472846477
SNU-119,25150857,1.966340721822474
NCI-H2087,doxorubicin-navitoclax (2-1 mol-mol),-2.29113131809046
Hs 936.T,selumetinib-vorinostat (8-1 mol-mol),0.3450165973720776
RCM-1 [Human rectal adenocarcinoma],7251185,3.190616991183446
T84,16659841,1.9805652389380883
SCC-9,piperlongumine-MST-312 (1-1 mol-mol),2.236566574852554
Calu-1,100016,7.639038839177244
ALL-SIL,6852167,2.025737624061405
EJM,6918638,-1.326291213724497
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413
NCI-H1395,4705,3.4784735381586183
PE/CA-PJ15,23582824,-0.1031262953747945
LP-1,72376,-2.2524540168215403
RCM-1 [Human rectal adenocarcinoma],5287620,-1.851018785369774
KYSE-140,selumetinib-vorinostat (8-1 mol-mol),3.686519594509002
LS411N,5746,2.615146419652584
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414
NCI-N87,10385095,0.9731458206829144
CFPAC-1,5281321,2.175601302656442
Mino,135440466,1.5309037639218337
RCM-1 [Human rectal adenocarcinoma],10184653,2.2395944761831372
L3.3,11507802,1.6932869737181035
SK-HEP-1,3854666,3.0622551399292264
IST-Mes1,16725315,5.212250641781058
GP2d,26596,-1.9076944219866043
T84,119607,4.21933928758464
GA-10,387447,-5.665927080543195
OCI-M1,44137675,4.09475804170257
PE/CA-PJ15,24772860,-3.9275354144637222
KMS-12-BM,15547703,2.7013494250638614
LP-1,10184653,1.165032194195596
KMS-12-BM,25126798,2.689658126945382
CFPAC-1,carboplatin-etoposide (40-17 mol-mol),4.648261858329131
YH-13,10302451,3.810654470358069
EJM,72199292,1.3006755250597923
SK-LU-1,5329102,2.1098976223426136
HD-MY-Z,6505803,-1.982363986131319
NUGC-4,selumetinib-JQ-1 (4-1 mol-mol),-2.3807316373780716
NCI-H2122,10231331,1.1462222888418094
KYSE-30,168312962,-0.9618538523130268
HCC1833,56946209,-3.232890435095812
NCI-H2087,68056272,5.039816592736941
KHM-1B,135398516,0.0363584972585632
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184
SKM-1,5978,-3.867045594927121
HD-MY-Z,46398810,2.798600642073811
KMS-12-BM,675434,3.718693309292293
OCI-M1,16013152,4.0645728421106755
YH-13,5351362,2.4271787200041066
KMS-12-BM,16720766,-1.5729698680950066
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592
LS411N,44491742,5.693616041532359
GP2d,104842,-2.4757807194242205
BT 231,89928392,0.5140458062217697
SCC-9,285033,-1.0227924755741569
TCCSUP,4788,5.506988938595266
SW1353,42642645,1.0358647954805058
KHM-1B,168313047,1.841337582388115
KP-N-YN,vorinostat-navitoclax (4-1 mol-mol),0.0355946184818721
YH-13,11964036,1.205712988485349
KO52,676352,1.6863796828761293
SK-MES-1,135421197,1.0053632050719472
HD-MY-Z,6918328,0.3987757270076321
HD-MY-Z,5746,0.4247266092564077
HD-MY-Z,2113511,5.734387830960857
BT 231,73707398,1.611870726926167
KO52,6505803,1.22031024799857
NCI-H929,6852167,0.2588908385559714
KHM-1B,54639665,4.391144139421017
SK-HEP-1,5746,3.319924463812582
Hs 936.T,107985,-3.1215732689718028
TCCSUP,49793307,-2.5102688291438557
Hs 936.T,selumetinib-MK-2206 (8-1 mol-mol),0.4443047689467586
TCCSUP,3854666,3.617075113283279
NCI-H2087,11612883,2.1937328214947827
IST-Mes1,selumetinib-MK-2206 (8-1 mol-mol),3.5229121932796423
SK-OV-3,107970,2.5604111984812152
MHH-ES-1,5311,0.4505242405580433
SNU-119,5746,1.4479530054186391
K-562,11175137,2.6421325977097663
GA-10,11640390,2.859078315334937
OCI-M1,135984461,1.8150878916625208
SK-HEP-1,5311,2.3418360503567386
BT-20,71751553,4.468530583756154
MHH-ES-1,44507138,1.5002653811262363
T84,4259181,-0.5082694903070305
IST-Mes1,5566,2.9881744281003373
HCC1833,71304818,2.6937982695836893
YH-13,387447,-4.910282103327875
OCI-M1,439501,-2.6275325883029135
SW1353,135928012,3.769648949542413
ECC10,54618305,3.9917932371163696
ECC10,6450551,0.9149959081084976
HMCB,46199207,3.64794084151039
HD-MY-Z,6438330,1.982104983030448
BT 416,9907093,4.255635349154134
SW1353,26596,-1.2000741302841849
KP-N-YN,72199289,5.448053701160584
GP2d,11228183,-1.3589981198909251
KO52,17755052,4.2754643530208005
GP2d,9907093,3.4873794535747424
NCI-H929,salermide-PLX-4032 (12-1 mol-mol),5.56611074354939
L3.3,51039095,3.7013514518444617
GA-10,71466578,1.7820456926427382
NCI-H2122,5351362,3.0968358343669147
L3.3,241158,3.9670067644952702
OCI-M1,piperlongumine-MST-312 (1-1 mol-mol),0.9538023068290098
YD-8,445643,3.7964641558738688
NUGC-4,44607531,0.2258810197895504
KYSE-140,409805,5.981415467159753
HCC1833,52947716,-6.375652944857306
EJM,56963564,0.0358307292912413
NCI-H2087,452548,-1.5813351913143798
NCI-H2122,selumetinib-BRD-A02303741 (4-1 mol-mol),4.482032862339771
ECC10,11683005,3.5341687720202826
BT 231,16725315,3.17212658675725
SNU-119,11167602,2.3286246928254335
OCI-M1,60700,-1.1960186606085383
REC-1,10296883,4.285765558435674
L3.3,44819697,-3.2466678771673427
IST-Mes1,16720766,0.7299606902549882
OCI-M1,969516,4.117848619310535
SW1353,3025944,4.767246207817844
EJM,46191454,0.9178079006601862
MHH-ES-1,44137675,2.8977058570463705
SKM-1,serdemetan-SCH-529074 (1-1 mol-mol),2.2169498527480664
TCCSUP,107985,-3.010766846655704
YD-8,selumetinib-vorinostat (8-1 mol-mol),2.8906615427618982
K-562,54678924,1.7343444538293111
L3.3,10427712,3.981964931961501
YH-13,6438330,2.6622356468059736
KYSE-140,10113978,3.4455805922643696
T84,637858,0.2956840752422291
KP-N-YN,135999136,4.185097541926131
NCI-H1395,5280436,0.4598531683399105
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067
KO52,selumetinib-MK-2206 (8-1 mol-mol),-0.3185685393152556
KMS-12-BM,3552672,5.9542999196624775
NCI-H2087,44607530,1.5432786619860916
YH-13,107970,3.012104980277858
KYSE-30,19582717,4.56244495971861
KO52,637858,1.0718331271712598
Mino,16065773,1.600157444452853
KYSE-30,44202524,4.849067377806738
ALL-SIL,2841722,3.706104916487932
KO52,387447,-5.494795804144642
Mino,387447,-5.275097956726417
EJM,11717001,5.2726365511414475
BT 416,JQ-1-MK-0752 (1-1 mol-mol),-0.2940770123557343
RT-4,969516,2.145135966433337
LS411N,216345,4.369072592416217
CFPAC-1,5280436,5.6589395235026805
KO52,11175137,1.294092661003282
MHH-CALL-4,322968,-1.3675357910863772
BICR 31,9903786,2.10396775229317
YH-13,462382,1.032048022649818
TCCSUP,71304818,2.998111065090722
HCC1833,3025986,-0.213854231022632
MHH-ES-1,3025944,4.26985509534834
RT-4,navitoclax-PLX-4032 (1-1 mol-mol),-0.362810350442769
ALL-SIL,26596,-3.0181503922951674
NCI-H2087,71466578,5.0530717150952205
KHM-1B,49793307,-3.3171088772826707
KHM-1B,1750826,-3.7148108552334977
HD-MY-Z,23939,4.486226214526259
BT-20,24771867,2.695530760477261
BT-20,24180719,3.806383373160612
BT 416,11175137,1.9078439404146323
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899
K-562,54626689,4.3954029102592145
BT 416,6914657,-5.050347852678551
Mino,53392493,1.860544411834529
SW1353,serdemetan-SCH-529074 (1-1 mol-mol),2.271816342805469
KO52,107970,1.5787465596439585
ECC10,44589607,1.085527981367436
MHH-ES-1,445643,5.758003290700932
RT-4,119607,4.891144020321078
SKM-1,25126798,2.9337562009187192
SK-HEP-1,23582824,1.0257570544783106
ECC10,selumetinib-navitoclax (8-1 mol-mol),-1.014361928212867
Calu-1,57519531,2.670381792634966
SK-HEP-1,11626560,2.7034566874481745
KO52,5284616,3.214737678420765
MHH-ES-1,44185566,1.6805607199657104
IST-Mes1,9840324,6.735519666210419
NCI-N87,54649381,3.6397596564561487
L3.3,568763,0.380782352657369
YD-8,4788,6.071994479446302
NCI-H2087,46224516,1.6564214211970971
Mino,25183872,-2.1035796462294147
SK-MES-1,11647372,0.7179250886591627
SKM-1,387447,-5.418764341651642
NCI-H929,navitoclax-birinapant (1-1 mol-mol),3.0660069376670065
MHH-ES-1,71304818,2.126839649723576
BT-20,11238147,3.6539576691700497
MHH-ES-1,11640390,2.3731815508288
MHH-CALL-4,57519531,1.4335281151736106
EJM,11214940,4.2208595782990965
YD-8,135423438,0.9954856602627224
YD-8,6450551,2.2155909562952685
KYSE-30,51037431,2.5104722777034154
RT-4,1716436,2.9161940059185985
BT-20,16722836,2.8181719243318386
OCI-M1,3025944,3.7911768377352617
REC-1,11404337,-2.3807065169464336
KHM-1B,2874250,4.780971307568023
SK-HEP-1,5281321,-2.075735756673856
K-562,15953870,3.5143251027161613
RT-4,9967941,2.350248504826165
RT-4,25150857,3.012978370734418
TCCSUP,6918878,3.6529452991011766
YD-8,4477,1.1292057160395828
EJM,11955716,-2.8070580374393073
BT-20,72376,-0.2797667351490877
NMC-G1,89928392,3.69101451427952
TCCSUP,11609586,3.3577179942858737
K-562,135440466,2.878154323162211
SK-MES-1,11396600,3.1861183641425823
HCC1833,3503,2.554974262886464
SK-OV-3,168312962,4.003119281373622
MHH-CALL-4,9956119,1.7330624237841754
PE/CA-PJ15,216345,4.449220002696549
GA-10,36462,-2.446264155422686
NCI-H1395,5470400,-0.4743897093415642
BICR 31,1641662,4.3069637553272715
BICR 31,2871966,0.8542621552894032
Mino,54613361,-2.2252179837952664
MHH-CALL-4,49846579,-1.9371771849508952
T84,54596558,4.208547901115818
KMS-12-BM,1242560,1.8091985739591805
BT 416,11404337,-1.6662073764284366
MHH-CALL-4,4261,-0.8412214734864248
HD-MY-Z,11222830,1.3310091712499863
EJM,9884685,0.026997005394607
EJM,navitoclax-birinapant (1-1 mol-mol),0.3808081808829636
NCI-H2171,tanespimycin-bortezomib (250-1 mol-mol),-0.2558464529397277
SK-HEP-1,11175137,3.0126176485486114
KHM-1B,44489367,4.908857615770495
KYSE-30,11167602,2.2363334961957784
SK-MES-1,5311,1.3386811071527778
NCI-H2087,5746,0.6872336596205035
MHH-CALL-4,3825829,4.255364052517795
KO52,11222830,1.115568752483846
RCM-1 [Human rectal adenocarcinoma],24797083,2.1636765251680625
HD-MY-Z,4705,3.2851682687360735
LP-1,23582824,-0.1618675924919506
NCI-N87,24856436,-1.0645338149753525
BICR 31,25161177,4.144120396566418
PL-21,57330099,4.398781834061898
NCI-H2171,JQ-1-MK-0752 (1-1 mol-mol),0.9706610774505884
NCI-H2087,12003241,-2.8362492565909543
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027
BT 416,82146,3.4705995028398022
KP-N-YN,5281672,4.133257686132848
OCI-M1,5287620,-1.407507828099675
GP2d,176870,1.4228449097958775
SW1353,10427712,4.774055147869595
KO52,168312962,3.725113432796697
REC-1,15953870,2.7067445833073407
ECC10,9907093,3.936560173108602
GA-10,24771867,-2.7425401258816104
KHM-1B,119607,4.337560231303076
SNU-119,3062316,-1.081380158367377
ALL-SIL,5280436,2.610850174870569
T84,44491742,3.592181787537852
EJM,65628,4.064740748344536
K-562,60700,0.041873955903415
L3.3,12001922,2.4292832661010557
KHM-1B,2742550,3.1994406451662045
ALL-SIL,2742550,3.1857763586562577
CFPAC-1,49850262,4.38314805475038
HuNS1,10302451,4.039354414327241
MHH-CALL-4,36314,3.082788741104553
HD-MY-Z,50905018,5.100169225014916
KYSE-30,docetaxel-tanespimycin (2-1 mol-mol),-1.1937581077244312
KMS-12-BM,72734382,2.6336747797962445
Calu-1,44819697,3.3286192566105393
HD-MY-Z,446155,0.6634036357559779
NCI-H1395,23582824,0.9688847884522048
NCI-H2122,72193861,1.3515069664409032
Mino,44462760,1.7675264265550543
REC-1,6918289,4.400712248606405
Hs 936.T,3815108,3.6018027704932676
BT 416,3025986,0.2001939081073358
SKM-1,9911830,2.174138233230932
KP-N-YN,9936388,1.912535006220544
IST-Mes1,71466578,4.723128098465521
HuNS1,322968,2.672146001288173
NUGC-4,11178236,-2.1874039261929568
KO52,45279963,2.0128357488117694
MHH-ES-1,11234052,3.4485387219336077
KHM-1B,16720766,-1.5556975858527622
RT-4,selumetinib-JQ-1 (4-1 mol-mol),2.9367807248544233
NCI-H2087,9866186,-0.4556144102615047
RT-4,5351362,2.6254562857357646
RCM-1 [Human rectal adenocarcinoma],448949,2.472966773294446
SW1116,selumetinib-JQ-1 (4-1 mol-mol),-1.5718709944273437
KO52,135659046,3.503950077041595
GA-10,46926350,-6.51404105527081
HD-MY-Z,54619267,4.132338411911898
KYSE-30,2828334,6.300497515944835
KMS-12-BM,107985,-5.423573263916533
NUGC-4,176870,-1.1600668889945602
Mino,168313200,2.290605070302401
NUGC-4,5351362,0.9787971901441254
ECC10,10113978,1.9036236619965383
LS411N,2858523,3.1062955336512603
NCI-H2087,9926054,1.8666936138192145
HD-MY-Z,216345,3.688734104791539
T84,3025986,0.6029906448077772
KYSE-30,219104,4.17719883969505
PL-21,5738263,2.7192823031023825
RT-4,9907093,5.696541057936112
KYSE-30,441298,1.826650393362088
SK-MES-1,72193861,2.036904742058509
PE/CA-PJ15,11626560,2.4485271299143503
ECC10,25195348,3.1463055872166095
RCM-1 [Human rectal adenocarcinoma],15547703,3.173985625992098
KMS-12-BM,9929138,5.078790269314151
TCCSUP,44486219,5.057674735399276
LP-1,tanespimycin-bortezomib (250-1 mol-mol),0.6048283757885538
GP2d,3825829,4.454546832416788
SK-LU-1,9825149,2.1997069838556804
NCI-H2122,2746,3.68558209467045
RT-4,23582824,2.530849045703681
BT 231,6450551,2.336132555682411
ALL-SIL,9843750,4.4328493438561845
Mino,219104,1.9513354332512027
SK-LU-1,16038120,0.6078251143446454
SCLC-21H,6917907,-5.513778631448829
SK-MES-1,60700,-1.0077275040074092
CFPAC-1,135999136,4.179535980060787
BT 416,3385,5.619988464782877
CFPAC-1,3543504,5.535550209246441
GA-10,24964624,-0.5289929756620879
SNU-119,24772860,-1.5346173858714742
KP-N-YN,navitoclax-PLX-4032 (1-1 mol-mol),1.001227532929945
NCI-H1395,8515,4.661084548760473
Mino,9825149,1.504280330631107
NCI-H2122,46199207,3.2058093236107963
Hs 936.T,100016,5.806135174623166
Hs 936.T,375860,0.6750085464565785
RT-4,4096211,1.036713829931397
SK-MES-1,11427553,2.2375012402402255
BT-20,168313200,2.4651891211897734
OCI-M1,23725625,5.4379938384367845
KYSE-140,3543504,4.410973156351761
BT 416,3136844,3.733744252628085
HMCB,107985,-2.41132307847832
HMCB,462382,0.5929109293335464
NCI-N87,crizotinib-PLX-4032 (2-1 mol-mol),2.5035050425609673
BT-20,vorinostat-navitoclax (4-1 mol-mol),2.003122819356521
PE/CA-PJ15,25062766,2.574410153179034
BT 231,5311,3.1751753679830337
NCI-H2122,44185566,2.6435931033499585
KHM-1B,54649381,3.5405814758079117
SW1353,selumetinib-UNC0638 (4-1 mol-mol),4.107061483141426
NMC-G1,11964036,3.0172314129345077
NCI-H2171,navitoclax-birinapant (1-1 mol-mol),-1.0975266283205345
BT 231,11257553,0.9476459380105656
SK-MES-1,16725315,4.705457178880461
REC-1,53232,6.664382272072013
NUGC-4,10302451,-0.3779920067585693
SKM-1,9935249,2.0831236560196147
NMC-G1,2733526,3.505931737572148
KYSE-140,445643,4.445622730454843
GP2d,5291,4.162973385998097
LS411N,168312962,3.224541058203402
NCI-H2087,3854666,1.5016469134351038
BICR 31,46907787,2.190433361645711
REC-1,168312962,1.9726902485289817
BT 416,vorinostat-navitoclax (4-1 mol-mol),-1.4626793360970294
MHH-CALL-4,6450551,1.3719521864217477
SKM-1,3025944,3.5406886531793225
KO52,42642645,-0.8739064396706098
T84,445455,3.5645242137210116
KMS-12-BM,50905018,3.0779303184533076
MHH-CALL-4,11222830,1.5862259732756394
KYSE-30,135440466,1.748443595179905
KHM-1B,46907787,-1.0017805456317357
GA-10,6610216,3.4837383876323975
KYSE-30,6610355,5.758491815801692
OCI-M1,168313016,4.404992087327789
Mino,5329102,1.4500389242117429
NCI-H1395,11494412,4.0372714005300026
KMS-12-BM,11404337,-1.6165924780935808
SK-OV-3,49850262,4.3958011115665006
ECC10,89183176,2.8010409270164605
Calu-1,10074640,3.751039727591352
NMC-G1,11228183,2.7680146061995927
IST-Mes1,5113032,4.841043294054768
MHH-CALL-4,4917,2.968020085230231
KP-N-YN,71576739,4.0152990164208
ALL-SIL,24785538,-0.5874123218373029
Mino,10322450,2.499731281895077
SW1353,alisertib-navitoclax (2-1 mol-mol),2.752205351495262
KHM-1B,1641662,3.357336532713352
Hs 936.T,24856436,-0.4421438224403481
SK-LU-1,vorinostat-navitoclax (4-1 mol-mol),1.3360845880618857
NUGC-4,445643,3.874845477584209
HMCB,11609586,3.5550453810468094
HMCB,5281321,-2.1554910502862046
RT-4,676352,2.39607769576444
SW1353,44137675,3.9091502940178047
GP2d,46215462,1.3156891644107858
T84,selumetinib-GDC-0941 (4-1 mol-mol),-1.055880319299995
GA-10,10322450,2.465288440600798
HCC1833,BRD-K27188169-navitoclax (2-1 mol-mol),0.005806850934129
NCI-H1395,5278396,4.323134607051869
SCC-9,72193861,2.3270498811162508
HCC1833,5282054,3.119006722466991
NCI-H1395,4259181,1.90835331362123
PE/CA-PJ15,322968,4.812819330141393
KMS-12-BM,10427712,2.780946081565878
NUGC-4,36314,-4.659776870275916
YD-8,24856436,0.1714275656823875
Calu-1,25062766,4.17503840113255
MHH-CALL-4,selumetinib-PLX-4032 (8-1 mol-mol),5.493382475083767
CFPAC-1,969516,3.3204451712383825
LP-1,5460769,5.634254198515754
BT 416,676352,2.1269191514499832
GP2d,71304818,1.1179027126994103
OCI-M1,25150857,3.0828095718196877
KYSE-140,24785538,1.399324812952521
BT-20,24856436,0.4431467978015357
RT-4,24772860,-3.0358788359895543
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414
HD-MY-Z,5311281,1.9803579960360136
Calu-1,10302451,5.51693152602978
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024
K-562,285033,-3.792012978388577
Calu-1,9911830,3.594040176900685
T84,16038120,-0.5712205757507545
RCM-1 [Human rectal adenocarcinoma],25262965,2.4523456450078323
EJM,24901704,4.248858299645136
Mino,ISOX-bortezomib (250-1 mol-mol),-0.1024660675942609
KHM-1B,327653,2.4267430839124455
Mino,53232,2.4672323613595477
KMS-12-BM,selumetinib-tretinoin (2-1 mol-mol),1.12843511460163
GA-10,285033,-5.6859708954681265
NCI-H929,3854666,0.9590353539059504
PANC-1,2113511,5.844099980140491
HuNS1,219104,3.445726761765377
T84,568763,-0.4276198615969853
KO52,46174525,3.5997508179953615
NMC-G1,navitoclax-pluripotin (1-1 mol-mol),-0.6789386268374435
BT 416,54765302,1.9464722994832528
SNU-119,54619267,3.4840179257423447
MHH-ES-1,6252,-1.5227991078863676
TCCSUP,168312962,2.9048095339563615
Calu-1,JQ-1-vorinostat (2-1 mol-mol),2.8237027161415735
NUGC-4,46191454,-0.0180654103325609
SK-LU-1,46199207,3.2362478125685707
KHM-1B,135411,-0.0530336141709349
NCI-H1395,6917907,2.884455684924325
KMS-12-BM,159324,-2.1850115101348
YH-13,374536,3.765039330811098
KYSE-140,54619238,5.261492652588975
SK-HEP-1,135875424,4.97106166770821
IST-Mes1,6918638,1.4350648787515894
HCC1833,11455910,1.7776428599570322
RCM-1 [Human rectal adenocarcinoma],100016,6.48277389223573
BICR 31,36462,3.088359748996336
PL-21,11178236,-2.4133101007426507
PL-21,selumetinib-vorinostat (8-1 mol-mol),-0.1981312398958528
BT 231,446155,3.92416274511038
HD-MY-Z,208908,2.1447305102521708
HCC1833,44819697,3.3947058766946543
SK-HEP-1,25227462,1.4628952719758763
NCI-H2087,carboplatin-etoposide (40-17 mol-mol),-0.006562021897114
EJM,57519531,2.975105121216571
KYSE-140,vorinostat-carboplatin (1-1 mol-mol),4.101337840293186
YH-13,10127622,5.098767589051213
SCC-9,135440466,2.439160969941936
GA-10,135659046,2.94673518989487
NMC-G1,11609586,3.293173739768923
BT 231,11964036,1.0298920297542395
BT-20,BRD-K55473186,5.011250741419027
KMS-12-BM,446155,2.3535681188168476
BT 416,10113978,1.5355591286647885
SK-HEP-1,71751553,4.559763777433237
IST-Mes1,tanespimycin-gemcitabine (1-1 mol-mol),1.7121373731851923
HD-MY-Z,selumetinib-BRD-A02303741 (4-1 mol-mol),2.20501426712932
SK-LU-1,65628,4.370272148908934
REC-1,445643,4.336315651295407
GP2d,9911830,1.2685523875748046
K-562,445455,4.202279962055385
T84,445091,4.595079711777154
NCI-H929,5311281,3.339013406601059
LP-1,navitoclax-pluripotin (1-1 mol-mol),-0.011787116249089
TCCSUP,54618164,4.281824636120867
LS411N,135411,0.7383506227122603
BT 231,9884685,-1.167030956523576
SK-OV-3,6918328,0.3966751205296329
GP2d,11178236,-1.3632601319972384
TCCSUP,71680916,5.285506040868583
SK-HEP-1,15547703,3.182423809990023
IST-Mes1,73707398,1.324483483158502
Mino,6438330,0.2946996472314958
BICR 31,42642645,1.5553576315566706
BT 231,25126798,4.168162999601456
PL-21,654092,0.0187981704535481
KYSE-140,5328940,0.1212034813564348
KMS-12-BM,5328940,0.5023752913374658
MHH-CALL-4,1641662,3.6350512886679818
SK-HEP-1,51037431,1.9503987957256583
KO52,2746,2.0900422497447906
SK-HEP-1,6917907,-0.2672796642005143
RCM-1 [Human rectal adenocarcinoma],3689413,0.4564681386605935
KYSE-30,11717001,5.355455787173539
TCCSUP,serdemetan-SCH-529074 (1-1 mol-mol),2.1769637397515997
SKM-1,613753,2.904024053377545
HuNS1,3689413,-2.2730227081216787
GP2d,31703,-0.5372335746386795
BT-20,54618305,4.294432746709741
LP-1,3062316,2.063794367488517
REC-1,676352,3.0460469545928124
HCC1833,10427712,4.170702362223642
KYSE-140,6610355,5.3140460089011405
BT 231,52947716,-7.785739717906248
HD-MY-Z,6610355,3.5977378906939643
SK-MES-1,11964036,0.5943608844756251
OCI-M1,navitoclax-sorafenib (1-1 mol-mol),1.2899887017794949
GA-10,selumetinib-MK-2206 (8-1 mol-mol),1.5337212290507969
KMS-12-BM,selumetinib-GDC-0941 (4-1 mol-mol),1.197952693783939
YD-8,selumetinib-piperlongumine (8-1 mol-mol),4.259135274147536
KMS-12-BM,4259181,-0.5634255522920182
NMC-G1,44819697,-0.5087751000338712
L3.3,5113032,6.1935482945866545
K-562,135875424,2.7247406179323055
PL-21,25150857,1.533349312625599
HCC1833,JQ-1-vorinostat (2-1 mol-mol),1.0943425996330485
EJM,9933475,2.243114584101206
RCM-1 [Human rectal adenocarcinoma],10296883,4.143855024915708
BT 416,5951923,4.413030716944982
PL-21,6918878,0.9714665821060572
KMS-12-BM,374536,-3.694674622373437
NUGC-4,409805,5.054333560474846
BT 416,46224516,2.793427832745812
HD-MY-Z,navitoclax-piperlongumine (1-1 mol-mol),1.7707491170821292
NCI-N87,5281321,-1.2852273423113845
Mino,3503,0.9290014010441238
PL-21,3689413,-0.2817982428361766
HCC1833,5280436,3.872500571501998
BT 231,2945648,1.1439671928728303
NCI-H2087,54686904,3.2986144509914426
KYSE-30,2858523,3.0853645923667914
HD-MY-Z,ISOX-bortezomib (250-1 mol-mol),0.1926530044982022
SK-MES-1,3854666,1.8711540273812308
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982
SKM-1,3384730,1.003819632931897
HD-MY-Z,135440466,3.1802612101109693
KHM-1B,carboplatin-UNC0638 (2-1 mol-mol),1.8078700282440656
BT 416,56973724,2.6021071006925105
NCI-H929,54618771,0.737310556758401
KYSE-140,6918328,1.20024814189824
ALL-SIL,135398738,2.8388897343309214
PE/CA-PJ15,24821094,0.7369223016507568
YH-13,2708,5.143963890139275
MHH-CALL-4,66577038,1.3845184011345664
HD-MY-Z,54618164,4.048037306322694
KYSE-30,439501,-2.11333824600192
LS411N,124202324,2.3656166654970137
OCI-M1,selumetinib-vorinostat (8-1 mol-mol),1.952041230338225
RCM-1 [Human rectal adenocarcinoma],16725315,5.393896472431684
L3.3,54618771,1.1558037208399272
NCI-H929,444795,0.5078215400494521
KYSE-30,107985,-4.08037761036898
KMS-12-BM,11507802,0.0118265671826585
KO52,6918878,1.008757664965314
HMCB,selumetinib-piperlongumine (8-1 mol-mol),4.51678007909172
Calu-1,241158,5.139545731518775
HCC1833,11228183,0.0913370043143008
NCI-N87,9911830,2.159086109533926
KO52,5460769,4.4327211318187745
SK-LU-1,12001922,1.7357890036098025
Hs 936.T,46398810,2.2687937658314636
PL-21,216239,2.756154253438683
NMC-G1,9927531,6.6210082677754984
IST-Mes1,60700,-0.0817355864677207
SKM-1,6505803,-1.0817481083509812
GP2d,2749,1.7637230418953525
NUGC-4,9935249,3.5425573545623847
BT 416,46191454,1.6739736193610226
NCI-H2087,11507802,2.0628337377608275
MHH-ES-1,sirolimus-bortezomib (250-1 mol-mol),0.9882924076413532
CFPAC-1,11485656,2.6116197546865663
T84,2708,5.234104359901674
REC-1,73707386,2.7839275654473243
NCI-H2087,9549297,3.626576284725144
HD-MY-Z,9549297,3.098658498305044
KP-N-YN,10113978,3.557848406383039
PE/CA-PJ15,6438330,2.858510803754111
PE/CA-PJ15,5291,4.05816854700883
K-562,54618771,1.1969173800987956
GA-10,53392493,1.7446103646522404
EJM,44607531,1.4254236431935456
PANC-1,46215462,1.5756033051396938
HMCB,9926054,1.939305093595803
KMS-12-BM,11717001,5.884192823277555
KYSE-30,16725315,4.803583595203047
PE/CA-PJ15,9935249,2.936045396377626
ECC10,11396600,2.3430961684425133
LP-1,5743,-2.948476083344139
PE/CA-PJ15,44237094,3.080316075944741
Calu-1,25102847,3.50709210266847
K-562,5282054,3.5952240521498062
KHM-1B,49850262,2.854623177297442
BT 416,5311281,1.2895128403639355
MHH-CALL-4,654092,0.0029240394584913
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175
SW1353,4096211,4.116911979557087
T84,16065773,1.5682089601652838
BICR 31,49793307,-0.900639036765476
MHH-ES-1,159324,0.9353863537723508
NCI-H1395,2708,5.386847702037966
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046
MHH-CALL-4,10074640,3.471548488234762
SK-OV-3,135398516,2.140261030425796
NMC-G1,navitoclax-sorafenib (1-1 mol-mol),3.1426745466323855
YD-8,60750,-0.3003196445505364
LP-1,36314,4.084363254581501
NCI-N87,selumetinib-vorinostat (8-1 mol-mol),2.348461304209469
TCCSUP,72734382,5.972631043229241
BT 231,selumetinib-vorinostat (8-1 mol-mol),2.946498999717448
CFPAC-1,72193861,3.415019020233483
YD-8,9884685,0.4288602362117117
SKM-1,135421197,1.6359213938027426
PE/CA-PJ15,66577038,3.151084486401523
HD-MY-Z,49867926,3.9832917374966543
NCI-H1395,BRD-A02303741-navitoclax (2-1 mol-mol),5.774765873736903
BT 231,8515,4.035696345547394
HuNS1,53495165,-3.2263458441755812
KYSE-30,73707398,1.0667429400266626
SW1116,176870,0.3324645613200126
OCI-M1,2858523,3.0753270920685374
RT-4,6610216,4.294846652425395
MHH-CALL-4,navitoclax-sorafenib (1-1 mol-mol),-0.3514076243398951
HD-MY-Z,445455,4.316856309386066
LP-1,3689413,0.1149626145640583
Mino,16659841,3.307784180084336
PL-21,11507802,0.1092571454333433
KMS-12-BM,11719255,0.7474259860262262
PE/CA-PJ15,462382,0.9369549231727788
KMS-12-BM,66577038,2.5748125108917312
BT-20,46199207,3.4351304430565426
BT-20,4259181,1.436733914806858
NCI-N87,9444,3.5890718830627923
KO52,selumetinib-decitabine (4-1 mol-mol),-2.793838380317763
T84,9926054,1.9260026490734707
SK-MES-1,46843906,2.1449508384711073
OCI-M1,46199207,3.143246825396657
EJM,9927531,5.060130602494636
SCC-9,176870,2.779248818408345
KHM-1B,vorinostat-navitoclax (4-1 mol-mol),0.9297533405267338
HD-MY-Z,selumetinib-tretinoin (2-1 mol-mol),2.421039227037158
BT 231,10113978,2.8106622809877697
BT 231,3011155,4.4069379954556185
BICR 31,24753719,4.233476426959058
T84,2126,4.910013634017339
SW1353,1242560,3.5510919339275433
MHH-ES-1,11609586,0.2007065874984104
NCI-H2171,9825149,1.181898582623386
YH-13,25062766,1.542076592026761
HMCB,44632017,0.9230813407361356
SK-MES-1,15547703,3.092224528882358
KHM-1B,216345,3.77132854777876
TCCSUP,tretinoin-navitoclax (4-1 mol-mol),3.293954548754522
NCI-H1395,73707398,1.4482642438908118
BT 416,5460769,1.3706696040691966
L3.3,docetaxel-tanespimycin (2-1 mol-mol),-3.9282194992049546
KP-N-YN,11175137,3.919881589125531
GA-10,3038522,1.7220649075744408
SK-MES-1,10127622,2.5721138348981363
Mino,11626560,1.0907516570585627
BT 231,65064,5.215173744607942
NMC-G1,3025944,5.31960001511584
GA-10,3854666,-0.056575285481401
YD-8,73707440,4.452607469919264
Hs 936.T,9935249,4.288072369675604
KYSE-30,6914657,-4.706313364877074
NCI-H929,11485656,1.7872822459041733
NMC-G1,5566,3.0427402443408176
NCI-N87,135398516,0.1780104282584799
OCI-M1,11497983,4.607422281098081
KMS-12-BM,JQ-1-vorinostat (2-1 mol-mol),-2.5260495197970525
GA-10,2733526,3.5784288373936963
LP-1,241158,2.0926541088677055
NCI-H929,46943432,-0.7846111801119194
PL-21,5282054,2.9332553280741704
Calu-1,5566,3.618977863921661
Mino,135398738,1.1644349157405138
REC-1,19582717,5.6127552511190295
SK-MES-1,46199207,2.5911544236825
L3.3,44543605,3.679570515799513
NMC-G1,15983966,2.438471241751301
EJM,5351362,0.5946464682501855
K-562,25183872,-1.1768480549542706
MHH-ES-1,24180125,2.2198565259892775
NCI-N87,36462,0.3600781388020123
LP-1,49793307,-4.773486412680111
SK-HEP-1,42642645,1.5394057036271682
HuNS1,decitabine-navitoclax (2-1 mol-mol),-0.4106439037890702
NUGC-4,3038522,3.906176415758728
ALL-SIL,2828334,5.780519190951295
MHH-ES-1,439501,-2.339727963154972
SKM-1,JQ-1-MK-0752 (1-1 mol-mol),-0.3579798637205856
ECC10,216345,3.6005202922171784
RT-4,25062766,2.555082815499361
HCC1833,6184667,4.960301105731023
MHH-ES-1,24964624,2.1623938234417164
HD-MY-Z,UNC0638-navitoclax (1-1 mol-mol),3.0734625152158688
YD-8,262093,2.4929271706284433
Hs 936.T,6918736,-2.872983631717463
EJM,23939,4.39619028953138
SK-MES-1,54626689,4.736636064579195
NUGC-4,676352,2.250251405323265
YH-13,1750826,-2.081763837802431
ALL-SIL,44507138,0.0905903694215729
SK-HEP-1,3062316,3.432714145613195
KMS-12-BM,136227924,1.841540408480291
KMS-12-BM,54143018,-1.751115897433141
KYSE-30,25150857,3.01800598586933
HCC1833,10231331,4.172766842331065
ECC10,11152667,0.6554196221982307
TCCSUP,6918837,-3.2032955112997623
LS411N,702558,5.325144902608101
BICR 31,53495165,2.344314514368125
NCI-H2122,9903786,2.7991091527294216
ECC10,11427553,1.9245630969431615
SW1116,374536,0.6726467432117932
NCI-H1395,16736978,1.0598222504477564
PL-21,10410894,2.4778526922149244
KP-N-YN,5351362,1.380054829993162
OCI-M1,16038120,1.3792995548491287
LP-1,selumetinib-PLX-4032 (8-1 mol-mol),3.7231035677533018
SCC-9,25150857,2.532575506870741
NCI-H2087,9903786,2.3520196427400717
REC-1,702558,7.790217698913398
BT 231,serdemetan-SCH-529074 (1-1 mol-mol),1.476559552958794
IST-Mes1,25154868,5.0412707783574735
KMS-12-BM,54678924,0.980772180306658
RCM-1 [Human rectal adenocarcinoma],16722836,2.4867038992166783
NCI-H1395,alisertib-navitoclax (2-1 mol-mol),4.525296331369141
MHH-CALL-4,104842,-10.53325219030363
YD-8,650361,3.8896393800715297
L3.3,322968,4.952946424555438
NCI-N87,52947716,-3.473486168283201
LS411N,24856436,0.7977520405714393
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747
TCCSUP,JQ-1-UNC0638 (2-1 mol-mol),6.070182975256097
T84,5280436,3.205428291753749
MHH-ES-1,11214940,-0.0446553770746287
IST-Mes1,carboplatin-etoposide (40-17 mol-mol),4.371414865626411
YD-8,navitoclax-birinapant (1-1 mol-mol),3.490795645603815
MHH-ES-1,16720766,-1.8196202012387803
EJM,46926350,-5.52167397488298
KHM-1B,126941,-4.224902593800319
KMS-12-BM,25102847,2.517658940945127
KO52,9549297,1.130259430761993
LP-1,2742550,1.8998426324012776
PE/CA-PJ15,24180125,3.914289437715523
KYSE-30,11152667,0.7148136552213618
RT-4,5282054,3.801249889065471
SNU-119,49793307,-3.2764253324389268
SCC-9,selumetinib-UNC0638 (4-1 mol-mol),3.717663096766538
SK-MES-1,136227331,4.390258592428933
HuNS1,salermide-PLX-4032 (12-1 mol-mol),4.942625996404829
NUGC-4,44137675,3.715287681165846
IST-Mes1,9911830,1.5716425903239464
MHH-CALL-4,11626560,0.2094475217232335
RT-4,11175137,3.2600224234362796
RCM-1 [Human rectal adenocarcinoma],selumetinib-vorinostat (8-1 mol-mol),2.2938712073349152
KMS-12-BM,6918289,1.1845429294568763
NUGC-4,56946209,-4.0201398535270165
PE/CA-PJ15,9933475,1.484249502746553
RT-4,10231331,3.499380927126235
K-562,65064,5.606410384518605
SW1353,5280436,3.719698456123635
GA-10,BRD-A02303741-carboplatin (1-1 mol-mol),5.401684885813672
SW1353,6852167,2.5995387617408388
KMS-12-BM,3081361,2.7736505977581056
YD-8,44493528,4.2998537557563346
NCI-H2087,salermide-PLX-4032 (12-1 mol-mol),4.966893621961039
NCI-H2122,selumetinib-vorinostat (8-1 mol-mol),2.447368686339531
SK-OV-3,654092,-0.1739817534251795
MHH-ES-1,9444,3.598144664216828
SNU-119,135423438,2.0179604003543288
SW1353,tanespimycin-gemcitabine (1-1 mol-mol),0.5391330912592137
Mino,136227924,1.7493984310197022
IST-Mes1,3081361,1.9096346363157353
OCI-M1,11214940,3.79527528018782
K-562,72376,-2.627875463605781
KMS-12-BM,54618771,-0.8802136937205215
NCI-H929,44259,-0.1109306277503226
LP-1,navitoclax-PLX-4032 (1-1 mol-mol),1.703661995798356
NMC-G1,16038120,1.715245707086582
NCI-H2171,4096211,1.8093642806404184
KO52,6918638,-1.0658834160946808
KO52,53392493,1.8648519897041975
GA-10,54626689,2.543732489563001
HMCB,24901704,3.7054734278526986
HuNS1,53392493,1.6699960604866415
T84,71304818,2.021433972991035
NUGC-4,387447,-3.8888180796870904
NCI-H2171,4259181,0.2390230285316857
Mino,JQ-1-navitoclax (2-1 mol-mol),-2.926836894763339
ECC10,11612883,1.6289137643760343
KO52,219104,1.56489843823841
ALL-SIL,119182,-4.503247338331098
BICR 31,2749,2.2358137088107033
NCI-H2122,71466380,2.6489103620312693
CFPAC-1,216345,4.4809010108654475
LP-1,81146,4.301102479362432
Hs 936.T,5287620,-2.4531523987340167
PL-21,15983966,-6.312562743751777
NCI-H2087,42611257,2.6347213596728265
RCM-1 [Human rectal adenocarcinoma],71751553,4.339346911330044
PE/CA-PJ15,serdemetan-SCH-529074 (1-1 mol-mol),2.869760401874241
KHM-1B,52912189,-0.4693344925919332
LP-1,57330099,4.335619853414482
Calu-1,676352,2.600939984302019
ECC10,54626689,2.3098687462339424
ECC10,54618771,0.89322852305294
ALL-SIL,135398516,1.5622324093538014
KYSE-140,10074640,3.015630940354785
NCI-H2087,3025944,3.795504015130171
REC-1,10127622,4.851193058289671
BT 231,2828334,5.869700584711845
BT 416,148198,-4.446669528218965
Hs 936.T,5282054,4.477602123682538
Mino,46398810,2.164825340893422
KP-N-YN,71751553,4.417015018221096
SNU-119,2733526,3.002199231384174
Calu-1,3634881,4.932555103913829
BT-20,219104,4.214997613246163
K-562,46843906,1.6079735978006011
SK-LU-1,123631,1.9971272923399144
SW1353,9935249,5.005901458565512
IST-Mes1,2746,3.2096433183027604
NCI-H1395,46398810,3.2237740665235495
MHH-CALL-4,3689413,-0.1881082259185382
KO52,100016,6.24417827042609
GA-10,3503,0.7513142130024626
ALL-SIL,54613361,-1.2150310590443698
IST-Mes1,46398810,2.0674819997592406
OCI-M1,53392493,1.909811611437229
KO52,24978538,-3.3415990839313383
IST-Mes1,322968,3.0930404941453933
NCI-H2171,15953870,3.344319567560605
NCI-H2122,11964036,0.9354273243771462
BT 416,9935249,0.9588167986090808
KYSE-30,448949,2.3520144405199654
NCI-N87,11213558,1.0018400483751706
KP-N-YN,24951314,3.085479719554147
SK-MES-1,6450551,2.793295367167699
GP2d,107970,1.8153419418648105
MHH-CALL-4,11152667,-1.953186727917395
HMCB,2749,2.739693517527312
ALL-SIL,5394,4.4345454375843625
KYSE-30,11455910,0.7960710883386756
YD-8,2828334,6.23916264624694
SNU-119,selumetinib-navitoclax (8-1 mol-mol),2.401180921765086
Calu-1,9933475,2.990370285616113
SKM-1,216345,2.58392001557385
Mino,1750826,-4.596687864391328
BT 416,227681,3.888475224888539
KHM-1B,5394,4.374287495449882
Hs 936.T,10427712,4.838531648221245
MHH-CALL-4,44589607,1.2884706228303726
BT 416,24772860,-2.3054453114917073
KMS-12-BM,9907093,3.643463351047445
OCI-M1,451668,0.0731257681938409
KYSE-30,25195348,3.956412024210368
OCI-M1,3825829,4.266885937330685
BT 416,25227462,1.3424058737553806
OCI-M1,24951314,0.5915165948935309
HD-MY-Z,2945648,2.711713090527897
LP-1,54619267,3.3105548704789824
SW1116,54626689,4.825596947242399
RCM-1 [Human rectal adenocarcinoma],selumetinib-decitabine (4-1 mol-mol),3.6407543671140417
SKM-1,2113511,5.805612167808562
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549
SK-HEP-1,24753719,4.401042857593667
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518
SNU-119,SNX-2112-bortezomib (250-1 mol-mol),-2.290476264848759
K-562,53495165,-1.204911447319433
L3.3,44185566,3.1226996854840836
TCCSUP,11152667,-1.0569561728619483
KO52,navitoclax-gemcitabine (1-1 mol-mol),-4.345603571038749
LP-1,31703,0.0093035386388211
NCI-H2171,5978,-3.1305615418900468
ECC10,49793307,-4.507851548612738
REC-1,navitoclax-sorafenib (1-1 mol-mol),2.823908857478378
NCI-H2122,2874250,-2.9977483564493053
NCI-N87,10302451,0.4744399528749561
KO52,104842,-5.71337214933571
SK-OV-3,1641662,4.382504296977698
SNU-119,168312962,2.91418669260086
SW1353,sirolimus-bortezomib (250-1 mol-mol),1.598593802144504
NCI-H929,72376,-2.0403577805803637
ALL-SIL,25262965,-0.0785584741633136
GA-10,4259181,-0.2690364706183594
SKM-1,49793307,-4.429104877934936
SK-MES-1,11609586,1.4731325374643454
REC-1,9908783,5.154056177198126
HuNS1,9840324,7.226115295108759
CFPAC-1,148198,-1.2933950729349923
HuNS1,crizotinib-PLX-4032 (2-1 mol-mol),1.1880392799284432
NCI-N87,11647372,-1.5140697510658656
KHM-1B,16115403,-6.426338372507057
BT 231,702558,5.699595685518614
RT-4,11485656,2.1371904728142
MHH-ES-1,51039095,2.038876495694876
ALL-SIL,1716436,3.0252724323132374
NCI-H1395,42642645,1.8763678628327745
NCI-H2122,6852167,2.6058424993180247
GP2d,5311281,0.9733787998803908
MHH-CALL-4,446155,2.8379041415161113
ECC10,selumetinib-piperlongumine (8-1 mol-mol),2.2838424707504714
NUGC-4,54619267,3.679586750465069
ECC10,73707386,2.488909979454374
ECC10,44202524,0.9904192875763568
MHH-ES-1,46199207,3.036216458869755
BT 231,46907787,1.384655777142133
HD-MY-Z,24785538,1.93795872006902
ECC10,44241473,3.708077266510813
Mino,BRD-A02303741-carboplatin (1-1 mol-mol),6.067201614268015
SK-LU-1,piperlongumine-MST-312 (1-1 mol-mol),2.5754278986100543
SK-HEP-1,56649450,4.110961369423777
BT 416,285033,-1.4764394890628505
GA-10,67156097,-3.01662649778491
Calu-1,107985,-3.5408503665357385
IST-Mes1,10113978,3.525341044523829
HD-MY-Z,10427712,4.234693173367418
HCC1833,3552672,1.9429633139160052
SK-MES-1,6918837,-4.632316245505311
RCM-1 [Human rectal adenocarcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1580465121550203
SW1353,JQ-1-carboplatin (1-1 mol-mol),2.2379049663986437
BT 231,selumetinib-BRD-A02303741 (4-1 mol-mol),4.927656372252654
KO52,11960529,4.1257752289583225
EJM,3634881,2.858173041625091
MHH-CALL-4,89928392,-1.2408308033067648
LS411N,11178236,-2.533537215148808
NCI-H2122,9926054,1.7352659466482192
PL-21,24180719,4.236296326656865
IST-Mes1,24856436,3.396810776549086
NCI-H1395,11178236,-3.24243996776791
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865
MHH-CALL-4,73707398,0.4741930113136588
T84,BRD-A02303741-carboplatin (1-1 mol-mol),4.321263582141219
NCI-H2122,3384730,2.2724093644920815
ALL-SIL,11497983,-4.396279985993102
ECC10,441298,2.1388657863453946
NCI-H929,11455910,1.7265755247991157
HD-MY-Z,11707110,-2.704444287468233
REC-1,6918878,4.654279043966399
BT 416,135984461,1.873658392465374
L3.3,5311,1.4084906886854671
NCI-H2087,9887053,4.243910340069795
YD-8,UNC0638-navitoclax (1-1 mol-mol),2.814214671394628
LS411N,5566,3.1552423609786153
ECC10,24775005,3.5610677818651033
RT-4,44819697,1.9904234220349264
SK-MES-1,SNX-2112-bortezomib (250-1 mol-mol),-1.4777364309325107
SCC-9,24753719,4.411411644196846
LP-1,11719255,3.2854326289101548
GA-10,89183176,2.1310906746311855
YH-13,25154868,5.479535858900875
RCM-1 [Human rectal adenocarcinoma],10427712,4.591789634520137
Hs 936.T,2858523,3.2262547105476416
K-562,67291369,1.5957287334193675
SK-HEP-1,16722836,2.576451725849178
L3.3,16065773,3.089788322580725
HD-MY-Z,9887053,4.281050579490845
SK-MES-1,2742550,3.2236302544154354
BICR 31,5566,3.2898773587253096
L3.3,44491742,6.349276489474054
GA-10,156414,-0.0566742081865969
T84,11257553,0.2692136429767111
KO52,9903786,1.3206822748757847
SK-LU-1,11626560,1.5725093043528875
Mino,66577038,2.530723915783821
EJM,9915743,0.880814312418276
BT 416,6918328,0.1839675684160056
NUGC-4,44202524,1.6372245611584482
SNU-119,selumetinib-PLX-4032 (8-1 mol-mol),3.3924189372513123
CFPAC-1,100016,6.545938487461667
KYSE-30,54618164,4.68504508642832
KYSE-30,2949965,3.0244409995829797
PL-21,107970,1.3819465807660944
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338
OCI-M1,4578,5.01375050842421
L3.3,24785538,3.6784067404983394
REC-1,969516,3.1998096166078915
BT 231,65628,6.2549230990110605
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563
MHH-CALL-4,25150857,1.3047879082093927
PE/CA-PJ15,2113511,6.213528533816965
OCI-M1,5282054,2.909242900126615
LP-1,5284616,-4.186949616873973
NCI-H929,11396600,-1.497885086375298
RT-4,2749,3.2785054841162022
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111
LP-1,44185566,1.1807740594238718
IST-Mes1,10302451,1.9071808976959603
HMCB,54619267,4.162576667162129
BICR 31,44486219,4.3544536670303025
KO52,36314,-6.8423574459706025
EJM,5746,0.8997924429706388
SNU-119,17755052,2.19432063910622
KO52,2858523,3.055649072846991
BT 416,5311,0.6671643206183272
SKM-1,753704,3.832130750350089
GP2d,67156097,-2.2558593331257932
SW1353,7251185,4.419937127850747
KO52,3025944,4.052272043795827
KO52,44489675,3.934012643953168
SKM-1,decitabine-carboplatin (1-1 mol-mol),-0.2461784142024601
REC-1,docetaxel-tanespimycin (2-1 mol-mol),6.128904719375764
KYSE-140,9915743,-1.963321476047282
NUGC-4,BRD-A02303741-navitoclax (2-1 mol-mol),2.1970330808293075
ECC10,11964036,0.8140689690249312
RT-4,36314,1.420570755930605
L3.3,24964624,2.8332468869362115
EJM,selumetinib-MK-2206 (8-1 mol-mol),2.5520093937916144
NUGC-4,71466445,3.986101296043148
CFPAC-1,107970,2.8345957706781544
HCC1833,11964036,2.0088064555908947
SW1116,53495165,-0.8053635066500726
BT 231,44137675,2.8772495475471227
BICR 31,168312962,4.404506435623785
KHM-1B,656346,0.4212696332998811
Mino,11396600,2.601097362695862
CFPAC-1,44137675,4.601211295743961
KO52,44819697,-2.4820963764953707
KYSE-140,44241473,4.686527931868355
HD-MY-Z,10231331,1.3407827449085772
ECC10,445643,2.405666169759834
T84,439501,-3.2363484717371964
SK-LU-1,53392493,3.17211586269663
LS411N,12003241,-0.0946051023392001
GA-10,25195348,1.169589409401368
NCI-H2087,3062316,1.8769767721191235
KHM-1B,11396600,1.492899305921399
KHM-1B,54618305,4.409714485426553
BT 416,9903786,2.244954394725016
K-562,24964624,2.9615918690112717
SNU-119,613753,3.5891543536371184
Mino,JQ-1-UNC0638 (2-1 mol-mol),-1.8530853214277625
GA-10,11485656,1.0334565111558187
NCI-H1395,11404337,2.1973197619817832
YD-8,25126798,3.822441714978281
NCI-H929,selumetinib-UNC0638 (4-1 mol-mol),3.372508515122925
KO52,5311,-0.0281160213778733
ECC10,54619267,3.3776717766770283
RT-4,67156097,-2.3409564010950343
BT 231,26596,-1.8186756145502985
REC-1,44202524,3.930220827110828
KHM-1B,44491742,4.066156285625521
GA-10,5287620,-1.5051774359572945
KMS-12-BM,5113032,5.435585194289586
YH-13,46224516,2.974421814944524
KMS-12-BM,452548,-2.9349157486062736
BT 416,11964036,0.8301256555017142
ALL-SIL,17759555,3.7861470032844418
SCC-9,168312962,1.0708744032070256
NUGC-4,3385,0.6672239395454324
KYSE-140,10427712,4.27267684863262
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841
SW1116,12003241,0.0582707461824652
EJM,4259181,-0.0332233948997356
IST-Mes1,9926054,1.778703370274458
BT 231,53495165,-0.1742631666557167
NCI-H2087,5291,3.3309610429715812
MHH-CALL-4,navitoclax-MST-312 (1-1 mol-mol),-0.8080191951801127
SK-MES-1,702558,5.602048361333647
KMS-12-BM,56973724,1.1510862619514248
SK-HEP-1,25102847,3.375423501622406
REC-1,208908,3.069929195687628
NUGC-4,15547703,2.6752622671284403
KYSE-30,71304818,2.5625980992751587
NCI-H929,19582717,2.600948271168246
KP-N-YN,16722836,1.9425866975092183
SKM-1,10427712,3.615808474028536
NUGC-4,vorinostat-navitoclax (4-1 mol-mol),-0.1915287722357478
LP-1,136227924,2.2350423658008416
RCM-1 [Human rectal adenocarcinoma],JQ-1-navitoclax (2-1 mol-mol),1.3966963569100277
GP2d,24753719,3.999563090079058
PL-21,57519531,1.516777626698265
SK-LU-1,SNX-2112-bortezomib (250-1 mol-mol),0.3119046092894604
MHH-ES-1,52912189,0.6788802712356812
SK-MES-1,46191454,1.6252534962000793
GA-10,6918328,-4.3110015211950525
L3.3,2874250,6.457091097770646
LS411N,60750,3.4958773713368725
HD-MY-Z,3025944,4.103786024140854
PE/CA-PJ15,JQ-1-UNC0638 (2-1 mol-mol),2.4300148232580647
OCI-M1,11977753,-0.1180216671426542
YH-13,5311,2.0479305445727083
SNU-119,10127622,3.9443492007002146
SW1353,11609586,3.403996585996387
SCC-9,53325874,4.533787552290022
SW1353,439501,-2.4341280198681248
OCI-M1,navitoclax-PLX-4032 (1-1 mol-mol),0.989660689460531
NCI-H929,selumetinib-decitabine (4-1 mol-mol),2.969724213776984
NCI-N87,3081361,1.4568926260691408
NCI-H2087,10074640,2.318001635343312
ECC10,9952709,1.9737129964758964
KMS-12-BM,24964624,-0.7604581964304247
SKM-1,72376,-5.080407432720659
HD-MY-Z,1239801,4.445457308357339
GP2d,445455,3.93835572622248
NCI-H929,6610216,4.64058383232424
GA-10,11317348,0.3209049471948358
GA-10,5278396,2.264111515553828
CFPAC-1,60700,-0.4266406730600774
HuNS1,24772860,-3.889022340605094
LP-1,11485656,1.1058923195648849
SK-LU-1,4259181,0.0552405649133211
BT 416,salermide-PLX-4032 (12-1 mol-mol),3.1151150958379947
GA-10,9933475,1.4337389448237616
K-562,46199207,1.8646546122938352
LP-1,6450551,1.5102038696536717
SKM-1,6450551,0.4724418001355981
SK-LU-1,124202324,4.662340386097748
NCI-H1395,11234052,4.314713395827009
KP-N-YN,71680916,4.440722959052433
YD-8,5291,3.66370848447405
SNU-119,3552672,2.2512141905066203
MHH-CALL-4,navitoclax-pluripotin (1-1 mol-mol),-1.686127770142516
IST-Mes1,19582717,4.57770755362997
RCM-1 [Human rectal adenocarcinoma],73707398,2.4695798871265473
SK-LU-1,1750826,-2.7569333330624306
MHH-ES-1,23635314,-3.0780976182540716
KO52,753704,4.242778315458095
PL-21,3081361,2.827030053118396
LP-1,11152667,-1.0091547787337771
RCM-1 [Human rectal adenocarcinoma],66577038,3.167694948675542
SK-LU-1,16736978,2.2244908909999572
GP2d,24901704,2.0409566079375714
NCI-H1395,9911830,2.6279117929683142
RT-4,5460769,0.3645225539442671
Mino,2858523,2.969204475444126
HMCB,54618164,4.179643558652394
PL-21,227681,3.130658788570003
KMS-12-BM,9549297,2.2758198611545035
GP2d,5329102,2.4416072990001223
TCCSUP,159324,3.967918889169363
EJM,6450551,3.4833257379535967
TCCSUP,46907787,2.977323633088547
BT-20,44566777,0.4629043586492611
Hs 936.T,31703,-0.8175291258640845
SK-HEP-1,5460769,6.10306620405049
NCI-N87,52912189,1.61892272115858
BICR 31,11152667,-0.7818812516610519
BT 231,25150857,2.438916563397748
K-562,44241473,4.342180714885996
NUGC-4,serdemetan-SCH-529074 (1-1 mol-mol),1.420721944886137
T84,44566777,1.109354876202711
T84,72376,-3.6903652857643374
BT 231,9840324,6.772243442572783
SCC-9,3854666,1.6335835525169635
NCI-H1395,selumetinib-piperlongumine (8-1 mol-mol),3.796978991433947
TCCSUP,6918289,2.234948683546108
Mino,44137675,2.4793232831617944
SW1116,6852167,3.995945836747335
NUGC-4,124202324,0.5833003772903234
BT 416,445091,4.273914706576626
PL-21,5329102,1.1820016992124556
SK-MES-1,216239,1.8326405103406795
YD-8,9927531,5.007831795650313
SW1116,42642645,0.6467991915782154
EJM,vorinostat-navitoclax (4-1 mol-mol),0.2535752664026445
CFPAC-1,654092,1.0465040814172588
NMC-G1,6852167,3.88532849006431
NCI-N87,46174525,4.699807035348161
PE/CA-PJ15,42642645,1.5086089624743753
BICR 31,9933475,1.7480026685414405
NCI-H929,9926054,0.4409605375156073
HuNS1,984333,0.8600287054885695
HCC1833,5278396,4.07713984384957
NCI-H2087,156422,3.339039245828226
HCC1833,selumetinib-PLX-4032 (8-1 mol-mol),3.226386358214046
Mino,erlotinib-PLX-4032 (2-1 mol-mol),1.582344585689073
HCC1833,44507138,2.633365158939226
IST-Mes1,53392493,1.914417087858707
KO52,439501,-3.705469726802315
KP-N-YN,11214940,1.818616231846812
K-562,24901704,1.0460453676907424
T84,9887053,2.925651375717051
Mino,11964036,0.4024163652138567
BT 231,53232,4.989303060826178
CFPAC-1,25126798,4.715450258269917
BICR 31,11626560,1.5769037831027732
NCI-H929,3136844,3.56413576716979
LP-1,2708,5.18278855176843
SCC-9,89928392,1.8759175792930969
YD-8,2742550,3.780440690417096
Hs 936.T,67291369,2.5103712461974297
BT 416,tanespimycin-gemcitabine (1-1 mol-mol),-2.1049706050799366
HD-MY-Z,24978538,2.525285539661858
K-562,24821094,1.908113699718487
SK-LU-1,135411,1.1287152034241594
BICR 31,4261,2.904745052497421
HMCB,carboplatin-etoposide (40-17 mol-mol),3.2976351954293324
HD-MY-Z,11719255,3.224146783601365
SKM-1,89928392,0.546592586318215
PL-21,2945648,1.9325258224855923
T84,136227924,2.5199027398538707
BT 231,11175137,2.548921638379501
PE/CA-PJ15,136227331,4.888188791536357
REC-1,216345,2.7910779135508967
EJM,445091,4.2359621817187225
SKM-1,11625818,3.916071840286403
L3.3,24856436,2.4877361998822924
SCC-9,tanespimycin-gemcitabine (1-1 mol-mol),-0.581626900680549
GP2d,15983966,-6.801767416396562
IST-Mes1,25150857,2.301198962208278
Mino,2945648,2.259258145223806
TCCSUP,44493528,4.420877523389051
BT 231,10184653,1.5482229308890267
Hs 936.T,11222830,3.881182743910367
SW1353,navitoclax-piperlongumine (1-1 mol-mol),3.2716469612213186
GA-10,3676137,3.39432251116269
TCCSUP,24964624,2.9604589319316985
T84,4521392,3.6129010305666354
HuNS1,3136844,3.9455894296569487
PL-21,4378219,1.9173931358029312
HMCB,10113978,4.0112336544376435
SW1116,2842253,4.59280790478934
CFPAC-1,10127622,5.558104403551794
LS411N,11222830,1.85641131377126
KYSE-30,JQ-1-UNC0638 (2-1 mol-mol),3.4848744488060275
PANC-1,135659046,3.591022095575617
REC-1,374536,2.3703708600058446
SK-MES-1,52947716,2.8925178852296387
REC-1,5328940,3.0740483869601993
SKM-1,1641662,2.105508221547458
ECC10,49766530,-0.6021024707846206
IST-Mes1,11612883,3.500237916670588
ECC10,3136844,3.313352928274663
MHH-CALL-4,24901704,-5.184563649067257
HuNS1,44819697,-1.2874230651207983
BICR 31,6918837,-2.993188010662521
MHH-CALL-4,2828334,5.842943710612946
NCI-N87,selumetinib-decitabine (4-1 mol-mol),3.433626364692319
BT 231,11427553,3.184979553462504
SK-OV-3,168313047,2.892407732266751
KO52,67291369,3.207372114299005
SKM-1,44137675,2.6593794287267127
BT 416,piperlongumine-MST-312 (1-1 mol-mol),1.0432213905439354
BT-20,9884685,0.8317755642556006
HMCB,984333,0.7502928259888776
MHH-ES-1,57519531,1.0530961034275133
PE/CA-PJ15,151289,0.6596724768960354
BT-20,11656518,0.8635283561233805
KO52,448949,1.7278683789034708
YD-8,3038522,3.692005573373659
CFPAC-1,89928392,3.697777181826717
Calu-1,9868037,4.36020250982657
NCI-N87,44507138,1.5580904379761216
Mino,208908,1.695689889994458
MHH-ES-1,9911830,2.233704183464704
PE/CA-PJ15,11964036,1.4785290961040634
MHH-ES-1,637858,1.480038374938484
Hs 936.T,selumetinib-decitabine (4-1 mol-mol),0.71895640768431
Mino,613753,2.5429304044634966
GA-10,9952709,2.0597888949060756
REC-1,56649450,3.786726508072347
BT-20,tretinoin-navitoclax (4-1 mol-mol),3.9697857105779817
IST-Mes1,123631,3.330483874726673
HCC1833,219104,4.045242137230499
NCI-H2087,44819697,-1.0032877232034274
KMS-12-BM,selumetinib-navitoclax (8-1 mol-mol),1.0992303518305886
BICR 31,969516,3.644181632779252
ALL-SIL,171352865,4.1926931777749346
MHH-CALL-4,5311281,1.4129869424286516
LP-1,216468,0.4219402386114366
KMS-12-BM,46215462,1.145613842689034
SW1116,23635314,4.505127279501018
SNU-119,piperlongumine-MST-312 (1-1 mol-mol),1.9759808399995944
HCC1833,17759555,3.265454743433065
HD-MY-Z,54618771,0.9859939173589182
L3.3,6610355,5.020819543145525
NCI-H1395,54618305,4.493399620925908
REC-1,selumetinib-decitabine (4-1 mol-mol),5.032870950205346
IST-Mes1,44632017,4.619480314320218
YD-8,409805,3.827275743082073
BT 231,erlotinib-PLX-4032 (2-1 mol-mol),2.6279872082288644
NCI-H929,11507802,0.9864152558176
HuNS1,11497983,3.6186763694913937
EJM,5287620,-2.617076608456458
KO52,46943432,4.605559929302298
KYSE-30,25105715,3.76895648352755
ALL-SIL,135928012,2.5698772014589992
PE/CA-PJ15,5328940,-0.0830733334700748
NCI-H2087,10231331,-2.7002323257150636
NUGC-4,68056272,3.45893813331669
SK-OV-3,66577038,3.416512813520814
NCI-N87,54618164,3.997308077582706
PE/CA-PJ15,168312962,3.379697023370571
SK-MES-1,56946209,-4.695068833326813
HD-MY-Z,56973724,4.542288288010976
KHM-1B,135440466,-1.206578017984145
GA-10,57519531,1.2611381187754442
NCI-N87,tanespimycin-gemcitabine (1-1 mol-mol),-4.9778446176040845
LP-1,44489675,3.369454985475365
BT 231,decitabine-navitoclax (2-1 mol-mol),1.57399454197302
L3.3,25262965,-0.71498955679679
EJM,216239,1.8380778507015632
PE/CA-PJ15,9825149,3.169297396053598
OCI-M1,10302451,3.881215030976717
PL-21,16741245,3.3086325498377733
OCI-M1,11626560,0.7620738047830702
ALL-SIL,16741245,1.8101156107911176
BT-20,25183872,-0.0899984517502442
KHM-1B,1317464,5.275687871305658
GP2d,24856436,-0.4061896151930643
KMS-12-BM,10322450,2.7501974340219575
PANC-1,409805,5.697873707527969
BT-20,44543605,4.034942093381953
NCI-H1395,navitoclax-birinapant (1-1 mol-mol),3.789667753469327
NCI-H2171,135875424,2.950178944342904
GA-10,100016,3.803284916821312
L3.3,11640390,3.7293417266479905
L3.3,216345,4.451682719982746
PE/CA-PJ15,387447,-4.5457624697994
OCI-M1,6852167,3.793961103000983
MHH-CALL-4,2841722,4.6754983960272725
SW1353,5287620,-2.8139863245495977
NCI-H2087,650361,4.093890124173705
NUGC-4,11167602,1.8627836788845913
HMCB,3689413,1.1423939419443525
MHH-CALL-4,374536,-2.0256098249407795
RT-4,4788,5.796241294754794
PANC-1,5351362,1.8762977311231803
SKM-1,11178236,-3.008392774513597
K-562,54618164,3.946994253297547
KYSE-30,11609586,3.442168032007761
TCCSUP,JQ-1-vorinostat (2-1 mol-mol),1.622320227916817
EJM,11404337,-0.4702991542329423
YD-8,49867926,4.297673709287735
PE/CA-PJ15,24775005,3.768261378939309
NUGC-4,24901704,3.2279643443447883
SKM-1,426756,6.104096040981277
LP-1,25227462,-4.258484402560807
Calu-1,46199207,3.773946700464134
NCI-N87,11427553,2.9770783714757005
Mino,selumetinib-vorinostat (8-1 mol-mol),1.4107779642854583
PANC-1,4917,3.829565373676303
YD-8,44607531,1.5829374298976635
BT-20,selumetinib-vorinostat (8-1 mol-mol),4.571320043409551
NCI-H2087,107985,-3.934436633809772
KHM-1B,5284616,-7.181826614115283
IST-Mes1,25102847,1.8280194065910471
SK-MES-1,23582824,0.6020055463040364
T84,46398810,1.7786535227158675
ALL-SIL,4261,-0.4593745111072439
BT 416,4788,3.7165992100531224
SK-MES-1,selumetinib-tretinoin (2-1 mol-mol),2.5299823350750685
KYSE-30,9825149,2.730587232165161
PL-21,navitoclax-sorafenib (1-1 mol-mol),1.0055191085454354
PE/CA-PJ15,19582717,5.341691439105365
KHM-1B,6852167,0.7581222087853566
IST-Mes1,navitoclax-gemcitabine (1-1 mol-mol),-2.5828122357465144
NCI-H2087,3815108,2.498823187788804
OCI-M1,5287969,-1.6638325422719815
K-562,25262965,-1.232298297425116
NUGC-4,44632017,0.8431212865320641
MHH-CALL-4,25262965,-1.8476723428194215
BT-20,151289,1.4218910334497323
K-562,439501,-2.3563528898814905
BT 416,selumetinib-GDC-0941 (4-1 mol-mol),1.4242599676579912
SW1353,11178236,-5.0033378081728035
SW1353,11364421,-3.0444644665282103
BT 416,16065773,1.357985406882133
K-562,11152667,-1.0937594737206502
TCCSUP,44259,0.3711906611875216
RT-4,11404337,1.401838262846579
NCI-N87,vorinostat-carboplatin (1-1 mol-mol),2.026584102601564
HCC1833,5978,0.5532276851081545
HD-MY-Z,23635314,-2.4418725318458057
NCI-H1395,25126798,4.167853501092747
BT 231,72734382,4.2322845309109525
NCI-H1395,60750,-2.362742731537794
NCI-H2122,23582824,1.3242994215219013
RCM-1 [Human rectal adenocarcinoma],322968,4.629178663880947
SNU-119,24978538,0.7616052232036742
T84,2733526,2.5962296484440905
HMCB,11213558,3.5955546629304997
BT 416,52912189,0.3002273262865359
HuNS1,2828334,5.75800032931554
KYSE-140,123631,-0.7193761496622024
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367
SKM-1,4259181,-0.1122232838107409
SCC-9,25183872,-1.5689686359020558
SNU-119,53232,1.8966224291818248
SW1353,49793307,-0.9704124115945304
KYSE-140,445091,4.546004836857802
EJM,2113511,5.268537886906316
NCI-H2171,5311,-0.0981787470707459
NCI-N87,100016,7.118039999797619
SK-MES-1,11707110,-2.7708433144841944
KO52,erlotinib-PLX-4032 (2-1 mol-mol),3.627940402925763
RCM-1 [Human rectal adenocarcinoma],24821094,4.372062930620609
SKM-1,11175137,1.89374364392194
NCI-H1395,vorinostat-navitoclax (4-1 mol-mol),3.530315000383913
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697
SCC-9,65064,5.356580923551092
PE/CA-PJ15,54619267,4.016762427349269
MHH-CALL-4,selumetinib-UNC0638 (4-1 mol-mol),1.2047158251174324
KYSE-140,JQ-1-navitoclax (2-1 mol-mol),2.411639354190789
NUGC-4,54618164,3.9566801833139063
T84,1317464,3.7056939407255447
GA-10,25102847,1.4727635572639952
YD-8,16725315,5.013629583525294
SK-MES-1,984333,1.4709903961862798
KHM-1B,104842,-4.441757010359471
NCI-H1395,135984461,4.376761136039875
LS411N,16725315,5.1123164266785714
KHM-1B,65064,3.270159834561764
BICR 31,9915743,-0.3251640044425866
EJM,2749,0.9568555282188456
PE/CA-PJ15,50905018,5.401121647936095
GA-10,72193861,-0.8955243893073107
SCC-9,25262965,-0.8228501050995407
HuNS1,2729026,2.0878998091198846
NMC-G1,71466578,-5.719076698641371
NUGC-4,1641662,3.646527010886171
Calu-1,16722836,2.3177472302885733
PL-21,984333,1.7669852536947848
ECC10,2742550,3.033123572020692
KYSE-30,10410894,3.040588500737201
KMS-12-BM,19582717,2.19026036658904
NCI-N87,16720766,-1.168414694473064
YH-13,71466578,4.92268847622802
OCI-M1,72193861,-0.0590825058280721
BT 231,107985,-2.768732072411436
NCI-H929,24856436,1.1628618903895551
SK-HEP-1,44607531,1.6636821475505756
NCI-H2087,6450551,3.476307552225245
GP2d,11955716,-2.614353847098783
ECC10,selumetinib-UNC0638 (4-1 mol-mol),2.548531850322794
NCI-H1395,5746,0.9154814139320177
TCCSUP,selumetinib-JQ-1 (4-1 mol-mol),2.2207378270123725
LS411N,46943432,5.879073426568822
NCI-N87,56963564,-0.4773091963101655
BT 231,44486219,4.544633724020731
K-562,2746,2.4328857060914797
SK-LU-1,25126798,4.050655305233826
SW1116,navitoclax-gemcitabine (1-1 mol-mol),2.0434267209572834
GA-10,445643,3.3798062961308357
RCM-1 [Human rectal adenocarcinoma],selumetinib-navitoclax (8-1 mol-mol),2.9022286191617597
NCI-H2087,10410894,2.5327775159137067
BT-20,676352,1.5953509500596266
REC-1,2841722,5.360306310676448
YH-13,46215462,1.6135517915003736
SK-LU-1,4096211,3.2389869116967867
BT 416,23582824,-0.5868026616971678
GA-10,24772860,-4.246498427391701
NCI-N87,11964036,0.5275056986755973
KHM-1B,107985,-4.92843539421015
SNU-119,selumetinib-tretinoin (2-1 mol-mol),0.2138866552869755
KMS-12-BM,156422,3.026990510346846
LS411N,9911830,3.118029057589745
REC-1,25262965,3.368960294136847
BICR 31,107985,-2.559614665868775
NCI-H2171,UNC0638-navitoclax (1-1 mol-mol),-0.3565063117120224
HCC1833,65064,2.9937446143492776
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872
MHH-ES-1,168313047,1.9255784994194691
SCC-9,9911463,4.4493328300482995
GA-10,1566236,0.5449565889355672
NCI-N87,135999136,4.294797881105147
RT-4,216345,2.153757010037062
NUGC-4,doxorubicin-navitoclax (2-1 mol-mol),-2.245547787190028
SCC-9,2858523,3.190510944053216
KO52,54454,4.035257146285459
SK-LU-1,11178236,-3.0758258747305027
SCC-9,54618771,0.4910288003516506
SNU-119,5281321,-2.123473343303991
REC-1,2126,3.851450658410572
SKM-1,9549297,1.2494873676183296
NCI-H2087,676352,2.064130788852546
SNU-119,5738263,3.822274048298037
YD-8,72193861,2.3860591543368046
PL-21,100016,4.334695208074886
PE/CA-PJ15,10302451,1.647301447843495
BT 416,56649450,2.455029430731379
NCI-H2122,104842,-1.9282043916972529
RT-4,24785538,1.6038296110526935
SCC-9,6610216,4.4695629784882795
MHH-CALL-4,3854666,1.9842302826736613
KHM-1B,4378219,1.8511847617722708
YH-13,54454,3.0632699075103926
ALL-SIL,25150857,1.7729123360103365
MHH-CALL-4,262093,0.5666969129517823
Calu-1,1242560,3.7890151428055407
LP-1,56649450,0.1974651276134106
KYSE-140,25150857,2.9440746971866316
GP2d,44137675,2.0472874992496273
PE/CA-PJ15,11625818,4.212335485082237
KO52,73707398,0.5433059802196046
SK-HEP-1,44819697,-0.1381867301228731
NCI-H929,159324,1.2295170877350825
GA-10,55283,2.711126165152046
PE/CA-PJ15,60700,-1.6744601529140877
LS411N,5351362,1.130738510814583
ALL-SIL,24753719,3.3195109491118635
RT-4,107985,-3.170589180041932
KHM-1B,4788,4.7580664761718054
NCI-H2171,11485656,1.3701169509015756
NUGC-4,448949,2.753978213661019
YD-8,969516,3.325354242438773
TCCSUP,tanespimycin-bortezomib (250-1 mol-mol),-2.003630452657136
BT 231,216345,3.594728608215129
KHM-1B,6918328,-0.972639722757723
SNU-119,49766530,-2.6347810345662785
Hs 936.T,10074640,2.9855950071251605
SKM-1,6918837,-4.5219646789618455
SNU-119,444795,1.2975403527774965
TCCSUP,322968,4.50290577769941
YD-8,6438330,2.2083353285168377
GA-10,11238147,1.260824926543255
KHM-1B,11625818,2.7772036353291725
NCI-H2122,969516,2.9482258019782717
HD-MY-Z,46199207,3.1676052990293817
SK-MES-1,11175137,1.7052824332582148
RT-4,11364421,2.211361780662556
NCI-H2087,17755052,3.909449848792139
MHH-ES-1,9926054,1.555405413320919
Mino,11317348,0.8775503511446432
SK-OV-3,3025944,4.375754256809385
SK-LU-1,9911463,4.212038568288349
SCC-9,15547703,2.91115041464476
SK-LU-1,135875424,4.823970968633346
ECC10,JQ-1-MK-0752 (1-1 mol-mol),0.2046171403185606
NCI-H1395,409805,5.969168563416671
SK-MES-1,8515,3.603504398534682
ALL-SIL,9887053,2.3955838154567703
GP2d,9926054,2.6461987815751096
NCI-N87,241158,3.56045646229574
KHM-1B,969516,2.482442021285449
BT-20,462382,1.0967694688218708
ECC10,16720766,-2.503706625790364
MHH-ES-1,6852167,1.3235332252332372
BICR 31,11222830,2.7999268343872603
GP2d,16722836,1.55283204446231
LP-1,5746,1.7271157709924967
HMCB,71576739,-3.3278802588106955
LS411N,42642645,1.4293896003043414
Calu-1,11152667,1.3026694822022318
Calu-1,16725315,3.2518165565012307
T84,6610355,3.759607363271778
HD-MY-Z,selumetinib-piperlongumine (8-1 mol-mol),2.8425408025583856
BT 416,1716436,3.683600433980017
HMCB,5470400,-3.7060636680278
BT 231,4261,2.0001375590966655
BT 231,25154868,3.3431445160715927
RT-4,54678924,1.2087543441917363
REC-1,49766530,2.1728933829794395
KP-N-YN,56649450,4.032843836691266
EJM,3503,2.0967076650635543
T84,44462760,3.9940200871529856
RT-4,6918736,0.057811102641414
BT 231,2742550,2.753337443391445
SW1353,54618771,0.8265365902772687
Mino,6252,-3.978875801469766
Calu-1,19582717,6.107931129153655
NCI-H929,262093,-0.1267697569252451
ECC10,135999136,4.34093313955728
KYSE-30,10296883,3.7447664313518767
GP2d,salermide-PLX-4032 (12-1 mol-mol),4.943146384427975
GA-10,637858,0.0748434639609226
LP-1,24821094,2.4984536667380266
YD-8,15983966,1.014640671892096
KYSE-30,44589607,3.7926600211246906
GP2d,UNC0638-navitoclax (1-1 mol-mol),-2.07499994680321
BICR 31,56946209,-4.213875977630207
EJM,56649450,2.621369128509505
KYSE-30,1566236,3.7632160201104186
Hs 936.T,44819697,4.866994587469628
MHH-ES-1,serdemetan-SCH-529074 (1-1 mol-mol),1.0409975867112764
SK-MES-1,151289,1.1000923553452364
HMCB,25262965,-1.6581729760544606
GP2d,selumetinib-tretinoin (2-1 mol-mol),-1.9934776534363965
BT 231,11626560,1.8260261727964369
SK-MES-1,4578,4.134653867406266
CFPAC-1,11178236,-2.5765183215400707
BT-20,44589607,3.746257183074089
SKM-1,3815108,3.188772071922917
KYSE-140,serdemetan-SCH-529074 (1-1 mol-mol),2.377749027848133
HMCB,15983966,-4.400200199699085
SK-MES-1,5311037,3.6947175863550017
SK-HEP-1,9907093,4.5474965014619455
KHM-1B,5280436,3.274905702190878
PE/CA-PJ15,6610355,4.832793826513437
NCI-H1395,24951314,2.24574697242026
SNU-119,57330099,4.379346087111643
ECC10,2708,3.267140511882252
Calu-1,vorinostat-carboplatin (1-1 mol-mol),4.505278229428185
NUGC-4,11364421,-3.507549132328967
GA-10,3384730,1.2653665668098937
REC-1,654092,1.1648734902582711
HMCB,136227924,3.0347930044007643
K-562,89183176,3.981701702250952
KYSE-30,9952709,2.9711318810849363
BICR 31,9936388,2.7244047649519074
LP-1,44202524,1.1062906748723706
SK-MES-1,navitoclax-MST-312 (1-1 mol-mol),1.050333382144329
BT 416,JQ-1-vorinostat (2-1 mol-mol),0.5162068845736205
SK-LU-1,322968,4.160216010026596
LS411N,148198,-2.2204558676981576
HD-MY-Z,148124,0.7380672872848864
T84,5978,-2.9829889706863315
EJM,462382,0.2605249998779805
HD-MY-Z,serdemetan-SCH-529074 (1-1 mol-mol),2.3641714573157366
RCM-1 [Human rectal adenocarcinoma],24785538,2.5999055228125254
RT-4,66577038,3.0506588017384635
CFPAC-1,135421197,3.4833112622431357
HD-MY-Z,54596490,4.535330665629844
NCI-H2171,6438330,1.125878118169246
BT-20,25062766,2.0992909947703295
SK-OV-3,10074640,3.759507235638381
TCCSUP,702558,5.6887223150764035
BT-20,9926054,1.9620105743223175
MHH-ES-1,11396600,3.76498087597508
NCI-H929,9868037,2.724281418576466
HCC1833,5329102,1.6308474434047078
KMS-12-BM,753704,4.548989794941243
SKM-1,6610216,3.825535401377457
K-562,71466578,3.85538032532176
NMC-G1,piperlongumine-MST-312 (1-1 mol-mol),3.2041799995482263
YD-8,135440466,0.98060002871852
BT 231,10385095,0.727650114829806
PE/CA-PJ15,6610216,4.602296752882169
OCI-M1,54143018,0.7862055368508435
SW1116,44589607,1.390187051865578
SNU-119,82146,3.4402803249569964
NCI-H2171,10385095,0.5588950968794439
HuNS1,3081361,2.1098987813765615
SK-OV-3,3081361,2.5908903164469317
SK-MES-1,9549297,3.978011117173435
NUGC-4,1750826,-1.0642255739147823
SK-MES-1,24753719,3.7681083522004464
ALL-SIL,11317348,-1.373590167325895
NCI-H2087,5284373,2.694722524137452
ECC10,11717001,4.3488326666601775
T84,53232,1.99757888565544
KHM-1B,3081361,2.464663283347417
CFPAC-1,9911830,2.8943763648289833
KMS-12-BM,24753719,3.8340594609092
SCC-9,4259181,1.940043087837339
NCI-N87,969516,2.8189934287936733
NUGC-4,6918837,-4.5793754670480675
K-562,11427553,0.716330793964625
SW1353,46398810,2.3185736969852475
SW1353,2858523,3.0533217827366177
NUGC-4,23635314,-2.562036099714229
RCM-1 [Human rectal adenocarcinoma],5291,3.9145533177301552
HCC1833,3815108,2.9955265548617835
ALL-SIL,11364421,-5.245070547120315
HD-MY-Z,55283,4.4716843460533955
HuNS1,439501,-3.2381997907918447
ECC10,9911830,2.8495761448668944
BT 416,72376,-2.5733068826951797
Mino,73707398,0.350796804562992
REC-1,16741245,3.3248283023586525
HD-MY-Z,6918837,-2.9645806162307338
HuNS1,11507802,0.9201704235264448
GA-10,135421197,0.1177808721156358
MHH-ES-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.547145403068837
LS411N,19582717,5.192972758226466
NCI-H2087,11317348,4.631867354031117
BT 231,36462,1.8404297564151428
BT 416,5282054,4.112764580591563
KMS-12-BM,20959075,-3.73832330619988
SK-MES-1,15953870,3.5806199424860115
GP2d,56963564,-0.2082017286104099
SK-MES-1,9907093,3.8083070562620662
BT 231,54649381,3.7104884016936106
PE/CA-PJ15,16065773,2.0231988784926123
SK-HEP-1,54618771,0.9570801540222316
CFPAC-1,25154868,5.193114724736923
SK-HEP-1,9444,4.343802313850578
NUGC-4,JQ-1-MK-0752 (1-1 mol-mol),-1.120223897398538
Mino,176870,1.702419593624116
SK-OV-3,11152667,-0.6824217491873509
TCCSUP,445455,5.141683708981469
GP2d,JQ-1-vorinostat (2-1 mol-mol),0.4135452032026371
HMCB,4917,3.7036802766341266
TCCSUP,9840324,5.608027140401768
T84,56963564,-0.2575711843014504
IST-Mes1,24951314,2.196137261882708
Calu-1,24964624,2.475324689176281
NMC-G1,vorinostat-navitoclax (4-1 mol-mol),1.927423667286771
OCI-M1,445643,4.029893965466692
HMCB,135398516,2.391390650545516
KYSE-30,15547703,2.956299932753389
KYSE-140,piperlongumine-MST-312 (1-1 mol-mol),1.6485139527786423
NCI-H2122,5278396,3.702197240666768
PE/CA-PJ15,24753719,4.1461682769332615
YD-8,salermide-PLX-4032 (12-1 mol-mol),5.298830023268121
NCI-H2171,16725315,3.053630151756443
NCI-H1395,104842,-0.629937294678588
LS411N,11364421,-0.88941081068058
PE/CA-PJ15,17755052,1.5124868987767677
SW1116,52912189,-0.2369939390539988
KMS-12-BM,24821094,2.863970661783892
KHM-1B,9825149,-1.748191139364394
MHH-CALL-4,89183176,3.781038263522435
IST-Mes1,49793307,1.120791830462594
SK-OV-3,49793307,0.1269396758315965
NCI-H1395,11222830,1.7032197933937347
BT 416,selumetinib-PLX-4032 (8-1 mol-mol),3.395089951692104
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032
GA-10,107970,0.8863840463858195
BICR 31,44819697,0.4590360698509347
YD-8,135875424,4.059859189077627
KO52,409805,5.182082476499644
ECC10,6252,1.195474537008176
HCC1833,73707438,4.370065311664935
NCI-H1395,11175137,3.230418109330353
Calu-1,400769,-0.5112508599053368
SKM-1,24797083,0.9734913560698324
NCI-N87,56946209,-4.157058230951839
BICR 31,60700,1.4006980690412227
HuNS1,3854666,0.1228986912397878
SKM-1,124202324,1.09229022845767
MHH-CALL-4,60700,-4.413172875056178
SW1353,3062316,-0.1469069080405858
BICR 31,4521392,4.267019749412992
KYSE-140,44819697,3.56455156931497
TCCSUP,24180125,2.590806345958597
NCI-H2122,10074640,3.107910382633133
RT-4,5978,-0.8712015854260087
MHH-CALL-4,25195348,4.168232650509743
MHH-ES-1,3543504,3.8485533765272977
SW1353,5311281,0.7860717573785166
KYSE-30,11234052,4.7207681790228335
MHH-ES-1,72193861,-0.4840667343303496
KMS-12-BM,46224516,1.363965419553059
HCC1833,9868037,3.329588957496932
SKM-1,46174525,2.564354179427139
HuNS1,445643,3.874739643313976
HCC1833,6917907,-5.074728269926679
PE/CA-PJ15,5278396,3.6789098748784808
NCI-H1395,16065773,1.699191956744155
SW1116,51039095,3.4783138882171794
KYSE-140,119607,5.203059545054642
PL-21,11404337,-0.8522775208697388
K-562,11612883,3.292128537791773
KMS-12-BM,selumetinib-UNC0638 (4-1 mol-mol),2.7847421040854603
KMS-12-BM,44185566,1.0129713840485208
BT-20,JQ-1-navitoclax (2-1 mol-mol),3.1479195153526014
KYSE-140,135875424,3.5989722346209927
NCI-H2087,56973724,2.959879748912762
SNU-119,6623618,1.934770207260526
SK-MES-1,24797083,1.392546337211007
NCI-N87,73707398,0.9429301881187698
KYSE-140,54618164,4.2081025861503285
OCI-M1,6917907,-5.615786646504223
PE/CA-PJ15,carboplatin-etoposide (40-17 mol-mol),2.099370260607421
BT 416,7326481,2.4512138340240637
Hs 936.T,6917907,-5.2013666779204195
CFPAC-1,24964624,2.9633325394205747
GA-10,54613361,-0.9808059389939098
RT-4,3385,4.126461688410087
HMCB,54613361,-0.6563978019622596
KYSE-30,44489675,3.633084607879859
L3.3,107985,-3.199791523822717
SNU-119,122327,4.167274545692746
KP-N-YN,7251185,1.1339871994641162
L3.3,11609586,3.8992408569207018
CFPAC-1,4917,3.1341873622678675
NCI-H2171,9915743,0.832341910278816
HD-MY-Z,3384730,2.743250871809845
OCI-M1,24901704,2.1360527448301463
GA-10,3543504,2.1994214854858996
KO52,4261,0.81751905802646
PE/CA-PJ15,119607,5.887802205779473
PL-21,71304818,1.841548376664347
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308
NCI-H929,54618305,4.349731057515986
MHH-CALL-4,piperlongumine-MST-312 (1-1 mol-mol),0.8066861314094598
L3.3,73707438,4.465616964273929
KYSE-30,4261,3.31208600360966
SK-MES-1,11625818,3.1740926457815606
PE/CA-PJ15,44137675,2.851716707756922
SK-MES-1,10427712,4.563682012816465
OCI-M1,16065773,1.723251637926212
T84,carboplatin-etoposide (40-17 mol-mol),6.027997998449588
NMC-G1,409805,5.417486676360457
REC-1,23635314,3.6368440694006585
KYSE-140,6918837,-1.5413314302580934
SKM-1,44607530,1.4032430904738862
NCI-H929,107970,2.2964601738289687
ALL-SIL,216239,1.0502640873271551
KP-N-YN,selumetinib-navitoclax (8-1 mol-mol),1.757016764095776
Mino,71751553,3.961570534496015
T84,25102847,1.699076265951676
IST-Mes1,45279963,3.842534876522704
BT 416,25195348,3.5567746508329603
NUGC-4,104842,-2.096206671430057
MHH-ES-1,66577038,2.8298458900743046
NCI-N87,637858,1.7879892218708664
TCCSUP,969516,3.191540501886845
BICR 31,1750826,0.6511109819152475
LS411N,3025986,-2.0648766502168843
HuNS1,11228183,1.4048972133773316
BICR 31,25227462,0.4256700478941367
Hs 936.T,5329102,1.779724069152289
LP-1,5311,0.4616713084723045
NCI-H929,49836020,2.30560189930029
GP2d,5394,4.130312003647592
HuNS1,selumetinib-tretinoin (2-1 mol-mol),4.37321061545647
NUGC-4,selumetinib-navitoclax (8-1 mol-mol),-2.870087873665254
KO52,44491742,3.2759729423779103
HD-MY-Z,25062766,2.0968435801483576
BT 416,375860,-0.0898603200977126
YD-8,5282054,3.5246749530230996
GA-10,6918736,-0.9824980932552122
KHM-1B,SNX-2112-bortezomib (250-1 mol-mol),-3.421333600529768
ALL-SIL,3025986,-1.187507928097146
GP2d,6505803,-3.22314968715238
KMS-12-BM,navitoclax-MST-312 (1-1 mol-mol),0.0074530885526159
LP-1,446155,1.5907392726868157
SK-LU-1,17759555,2.687775534140947
GP2d,969516,2.4182768919419497
NUGC-4,4261,-0.2199274510854375
ALL-SIL,10113978,1.6173510565910796
PE/CA-PJ15,3038522,3.112992871822826
IST-Mes1,6918878,2.524010054300984
NMC-G1,54454,2.989432719622146
OCI-M1,53232,3.1282924783366832
KYSE-140,2874250,5.180554173856093
BT-20,11717001,4.45820510470287
Calu-1,11455910,4.249423837752583
NCI-H2087,ISOX-bortezomib (250-1 mol-mol),0.3772448246158986
HD-MY-Z,5311,1.656128975354124
NCI-H1395,17755052,2.034281994914555
BT 416,5287620,-4.30910377313395
EJM,168313016,4.883313185195125
K-562,135411,0.731253239019591
GA-10,4521392,3.951415036217473
NCI-H2122,54618771,0.6219971058133998
T84,15983966,-4.54572487381958
KMS-12-BM,46907787,-3.5146066785265746
K-562,3825829,2.9396673791475587
Mino,72199292,2.008218488754736
KMS-12-BM,9826308,-0.4519305046408473
HD-MY-Z,12001922,1.622677629407643
PE/CA-PJ15,135398516,1.9338219503271263
GA-10,11960529,3.5609282076023674
NUGC-4,168313047,2.3341728221649873
BT 231,56946209,-3.0167288688316276
KO52,9915743,1.1549502462375985
MHH-CALL-4,2113511,3.740413108815857
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354
EJM,selumetinib-piperlongumine (8-1 mol-mol),3.077035642814966
SW1116,25154868,4.68855505439891
KHM-1B,9967941,3.052222735088891
REC-1,46398810,4.241593479202957
SK-MES-1,6918638,0.2897648687563215
L3.3,3815108,3.6939531026178
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329
IST-Mes1,3025944,4.475795844293571
NCI-H2087,10302451,3.0804347644462813
KYSE-30,4521392,4.198833275507783
NCI-H1395,44491742,3.9607165302769514
NCI-H2122,31703,0.2447382793154593
TCCSUP,49850262,3.4610282531940615
NCI-N87,3385,5.19418058853999
SNU-119,9903786,3.393165032525661
SKM-1,375860,-0.6747488513339966
SKM-1,53495165,-0.711725561210763
NCI-H2122,11625818,4.334631633893854
OCI-M1,2945648,2.455893577373936
MHH-ES-1,3689413,-2.44734032949193
HMCB,salermide-PLX-4032 (12-1 mol-mol),5.107969579791182
L3.3,23635314,-2.194996881934531
SK-MES-1,445643,3.82730386229053
OCI-M1,selumetinib-GDC-0941 (4-1 mol-mol),2.201687345778046
KYSE-140,3025986,-1.046751867582473
Mino,100016,3.8828597807205023
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467
BT-20,1242560,4.086742497825563
GA-10,71751553,3.203587324288507
T84,241158,3.6074169392609665
ECC10,57519531,1.2441362759524552
PL-21,12003241,-0.83006256212438
T84,104842,-2.1515149568563583
KMS-12-BM,135875424,3.5247186168283453
ECC10,123631,1.6460593642058254
HMCB,15547703,2.756722106244236
NCI-N87,6852167,1.8373876080574163
NCI-H2087,9825149,1.996971864424563
BT 231,navitoclax-gemcitabine (1-1 mol-mol),1.6263064761694177
RT-4,65064,5.007603522761181
NCI-H2122,sirolimus-bortezomib (250-1 mol-mol),1.792709807177603
EJM,7251185,1.248669965280625
NCI-H929,23939,4.224811778291157
TCCSUP,11455910,2.681471740921846
BT 416,72193861,0.135883385061724
LP-1,5282054,2.6464148729118397
IST-Mes1,24964624,2.9505066533460464
BT 416,11626560,1.436224714412949
CFPAC-1,11175137,3.3608989012701724
SKM-1,3634881,1.6208942767524477
K-562,15547703,3.09098547046412
K-562,11625818,4.129982389727392
SCC-9,56649450,2.7319907342568275
BT-20,11427553,3.856908874025523
CFPAC-1,54649381,3.7423940406665728
GA-10,navitoclax-pluripotin (1-1 mol-mol),-3.7210594465542406
SKM-1,44202524,0.4961794817988646
PL-21,135398738,0.7882503081459956
BT 231,4705,1.5996652236036175
NCI-H1395,46191454,1.8704386563260864
Mino,11625818,3.7490369857614914
KMS-12-BM,49850262,1.3155226448331834
TCCSUP,2949965,6.201374753875732
NCI-H1395,9884685,-0.0679636269907438
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667
CFPAC-1,3384730,5.692656174364219
MHH-ES-1,16725315,3.633709829922637
SNU-119,25126798,4.429154191215383
KYSE-30,11612883,3.4813535937049527
RCM-1 [Human rectal adenocarcinoma],56946209,-4.301528027920143
KO52,5282054,2.455165915117943
YD-8,119607,5.2875629658247805
Hs 936.T,11364421,1.5310877661108215
Mino,262093,1.013010854269816
SKM-1,72193861,-0.5325335794598204
NCI-H929,637858,-0.3950607584941885
KHM-1B,2945648,1.137982843837139
YD-8,3676137,3.885314783218408
KO52,11626560,-0.7906152386558187
SK-LU-1,53232,2.8141083803888463
NCI-H2087,3136844,3.748847469849269
MHH-CALL-4,451668,0.0086929213589142
SNU-119,24775005,4.181410107840803
SK-LU-1,400769,0.3813023393174695
KO52,vorinostat-carboplatin (1-1 mol-mol),1.526755959462623
GA-10,9884685,-2.5713880970623397
EJM,24797083,0.92088604751269
REC-1,9887053,4.003103851529854
SK-HEP-1,16741245,3.65273757252914
SK-MES-1,6918736,0.4745771629490999
KO52,decitabine-carboplatin (1-1 mol-mol),3.5937342622341792
NCI-H2087,vorinostat-carboplatin (1-1 mol-mol),2.9324234152860407
SCLC-21H,5978,-7.199198331020883
SK-MES-1,9952709,3.9259024306064
OCI-M1,44202524,1.480584217682982
NCI-H929,navitoclax-piperlongumine (1-1 mol-mol),1.7457744317764834
RT-4,44137675,4.764559708105059
PL-21,24951314,0.59848148124101
MHH-ES-1,613753,3.062779059890945
KYSE-30,135875424,2.992970338382266
LP-1,135411,1.3083387665888602
YD-8,6918736,6.385524567287694
NUGC-4,10385095,2.5267185642809498
MHH-ES-1,6184667,4.309614179580399
T84,327653,3.0918014670068654
BT-20,3634881,3.536755683468339
ECC10,tanespimycin-bortezomib (250-1 mol-mol),1.1222379258321835
T84,5328940,1.1838930148357123
SK-HEP-1,6918638,1.490993863020431
RT-4,crizotinib-PLX-4032 (2-1 mol-mol),2.875224727461572
NCI-N87,984333,0.3233765721021273
YH-13,24901704,3.58648266528955
PE/CA-PJ15,46191454,1.902127423052216
RCM-1 [Human rectal adenocarcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.3016699371514477
RT-4,54619267,4.475901221652596
KMS-12-BM,10410894,1.7534583743773589
GP2d,46191454,3.2765048884506993
YH-13,navitoclax-MST-312 (1-1 mol-mol),0.5038954748118908
SCC-9,4378219,1.9931327421657885
BT-20,9866186,-1.151104658996689
SK-MES-1,387447,-3.6691957408850784
PE/CA-PJ15,9444,4.387009695223505
SK-LU-1,46901937,3.733703625256497
SKM-1,46943432,0.4553858331231263
OCI-M1,426756,4.2375973122978134
MHH-CALL-4,11404337,-1.4992681274735582
RT-4,17755052,3.016553259782671
TCCSUP,BRD-A02303741-navitoclax (2-1 mol-mol),3.413405866150177
OCI-M1,11656518,2.3327955148356807
PE/CA-PJ15,10184653,1.386804330820947
SK-MES-1,6610216,3.4550348226980536
L3.3,10410894,2.582309203973784
BT-20,2874250,4.97525271635718
SK-MES-1,doxorubicin-navitoclax (2-1 mol-mol),-2.6070885804186785
L3.3,3689413,1.7908878640591075
PL-21,135411,-0.0006930098223885
KP-N-YN,3689413,-0.8084843339395943
K-562,15983966,-4.450185495623787
K-562,11609586,2.0906528510972775
GA-10,23635314,-4.757713426982201
ECC10,11507802,0.2635402864424902
NCI-H2087,122327,3.915609352790721
HuNS1,doxorubicin-navitoclax (2-1 mol-mol),-4.383873599547943
PL-21,71680916,4.250969721597006
SKM-1,11964036,0.1293394770460754
RCM-1 [Human rectal adenocarcinoma],selumetinib-JQ-1 (4-1 mol-mol),0.8519093027045113
OCI-M1,135659046,3.73314659306938
L3.3,54649381,4.658116253691046
LP-1,54618771,-0.0349126371834358
NUGC-4,9926054,2.05156938319837
ECC10,vorinostat-navitoclax (4-1 mol-mol),-2.8379246026298226
PE/CA-PJ15,16725315,5.2914205961984235
ECC10,6918328,-2.8070662966028213
BT-20,1641662,3.303235783488545
YH-13,SNX-2112-bortezomib (250-1 mol-mol),-1.3355072923544795
BT-20,24785538,3.2139740785866993
ALL-SIL,54143018,-1.6646130342073118
PL-21,selumetinib-decitabine (4-1 mol-mol),-0.2281985269283565
GA-10,54618305,3.7110732839259257
T84,9903786,2.2055003104833553
NCI-H2122,44632017,3.19159063703341
PE/CA-PJ15,5738263,2.6152875419037898
BT-20,17755052,1.6533989202056023
SNU-119,327653,3.4048649042702364
NCI-H2087,16038120,0.7599269102280005
KMS-12-BM,44241473,4.1211159216828035
PE/CA-PJ15,52912189,3.3034022538106025
SCC-9,carboplatin-etoposide (40-17 mol-mol),3.166154009244092
KO52,16722836,0.8284373841019596
GP2d,11404337,0.3964770765746153
SK-MES-1,119182,-1.476777308892619
SCC-9,568763,0.9120329628896908
BT-20,alisertib-navitoclax (2-1 mol-mol),0.1790530380036566
REC-1,9823820,2.978079708899726
PL-21,docetaxel-tanespimycin (2-1 mol-mol),-7.58386040446555
SKM-1,31703,-4.0248884095114965
SK-LU-1,44589607,3.271193462295671
KO52,24951314,0.169569428706958
GA-10,selumetinib-decitabine (4-1 mol-mol),-2.6754922539688293
REC-1,9803433,3.0512092518172844
SW1353,5281321,-0.9215481550191378
Hs 936.T,452548,0.8610317984960442
SCC-9,66577038,2.999012470787333
HCC1833,11609586,2.4258668626978053
RT-4,4261,2.418492483102545
NCI-H2087,4477,0.7101679613339431
KO52,9825149,1.8631876044655673
Hs 936.T,9936388,-4.507745146359587
GP2d,36314,3.063668265662628
NCI-H2087,208908,2.056372349725563
PE/CA-PJ15,24964624,2.39277886308643
KP-N-YN,selumetinib-MK-2206 (8-1 mol-mol),3.6541486520841144
BICR 31,107970,2.625018410874988
NCI-H2087,6610355,3.811686738696204
NCI-H2087,44632017,2.2517299506627233
KYSE-30,216345,4.550976967570647
GA-10,119607,3.863905689103844
GA-10,6610355,3.4233112238272585
ECC10,54618164,3.9379373119604657
BT 231,123631,1.9730380102731189
NCI-N87,11625818,1.9405356473547937
SCC-9,216345,4.596520649168519
MHH-ES-1,89928392,0.5828953815377608
MHH-ES-1,60700,-3.2857912234267013
K-562,2113511,5.3605896450220785
IST-Mes1,5278396,4.120493778859633
PE/CA-PJ15,126941,-4.198683985585476
SNU-119,3815108,1.8360895016279837
PE/CA-PJ15,44607531,0.9744795313801364
KO52,44462760,2.8997426516295617
SK-HEP-1,54626689,5.252317432323977
NCI-H1395,5329102,2.4714501130754294
IST-Mes1,374536,3.187270781803884
OCI-M1,7326481,3.622976255573157
GP2d,9866186,-0.8543581755617374
NUGC-4,5287620,-2.8284445108764382
REC-1,51039095,5.556234972670518
Hs 936.T,selumetinib-UNC0638 (4-1 mol-mol),1.386931925414555
PL-21,1750826,-3.073929818150953
KO52,375860,-1.0348961069797258
KMS-12-BM,46199207,2.5727127947453585
SK-HEP-1,3385,5.476337571299632
SW1353,5282054,4.284679917201532
EJM,119607,4.869876061461073
IST-Mes1,2858523,3.245314531932087
KYSE-140,65064,4.972426561901897
LP-1,9926054,1.657631549896095
BT 416,11455910,-0.2427833720473563
HCC1833,24978538,-1.1447123215065
NCI-H929,168313047,1.9193676847223529
BT 416,11485656,1.5705982486329817
Mino,637858,0.8453968503614813
OCI-M1,9935249,3.0060343171338624
NCI-H929,168312962,-0.2256493233866316
SKM-1,17759555,3.1390325960457264
PL-21,carboplatin-UNC0638 (2-1 mol-mol),5.421370380356714
YH-13,16725315,3.2502967771135096
NCI-H2087,53232,2.5065699184740695
BT-20,135398516,3.821735735705063
K-562,46215462,1.6076592131491731
Hs 936.T,JQ-1-navitoclax (2-1 mol-mol),0.1551236831189676
MHH-CALL-4,9911463,4.039768304149654
KYSE-140,49766530,-0.5324613674424623
ECC10,439501,-2.678077063421273
NCI-H1395,135875424,3.644181585171065
LS411N,637858,2.7012095970179635
PL-21,148198,-2.77177529672749
YD-8,54454,1.7837031222985251
K-562,4521392,4.220123235241678
OCI-M1,9840324,6.645181952490754
MHH-ES-1,36314,2.4252577419734
HuNS1,25062766,1.5775513137709487
KP-N-YN,2742550,4.250403933342819
PE/CA-PJ15,4259181,0.664963818132981
L3.3,11612883,3.0937227516492767
Calu-1,6450551,3.8205786383410136
EJM,25126798,3.659135720159963
KMS-12-BM,219104,2.1179947044049396
Hs 936.T,5566,3.236958935012896
NUGC-4,11238147,1.383864300583152
OCI-M1,25154868,4.87423256257153
LP-1,9826308,0.3059917687243172
GP2d,11612883,1.660551194552107
YH-13,11625818,3.6537350019321897
SK-HEP-1,11396600,5.84824704867975
K-562,7251185,2.894408284149289
RT-4,9936388,-6.517969541343547
YD-8,66577038,3.168300886602997
NUGC-4,3062316,-1.8486110211648792
K-562,9825149,1.660902694463834
SK-MES-1,11485656,2.7243488930071607
REC-1,656346,5.216170293018418
GP2d,4477,-0.2661838430785525
SK-OV-3,24901704,3.989938255280614
IST-Mes1,44607531,1.530053859314775
KP-N-YN,4259181,2.3669451828988612
K-562,400769,-0.7978860959413716
NCI-N87,72193870,2.948099148236623
Hs 936.T,6918878,1.8534972681438395
SCC-9,10074640,3.673307032160535
LS411N,4477,1.0450277541726452
KHM-1B,5978,-4.717973613430777
PE/CA-PJ15,erlotinib-PLX-4032 (2-1 mol-mol),1.314829540676128
EJM,135421197,1.4211538659692204
SK-MES-1,4521392,4.125367929004717
BT-20,11625818,4.339693672364161
NCI-N87,salermide-PLX-4032 (12-1 mol-mol),5.428528810612746
T84,42642645,0.3072828791348135
KYSE-30,54765302,4.865316580916345
LP-1,9884685,-1.812472682789282
RCM-1 [Human rectal adenocarcinoma],25150857,2.2320644525888165
LP-1,46199207,1.3243802819416213
SCC-9,11485656,3.6663619913543446
KO52,24180719,3.93533100976642
OCI-M1,11175137,3.582926931675541
GP2d,selumetinib-UNC0638 (4-1 mol-mol),0.8058570350297648
SW1353,126941,-2.991476293765946
NCI-N87,4261,0.8200487533079858
L3.3,3025944,4.713949011742796
LP-1,11238147,2.4019654805743462
NCI-H2087,navitoclax-pluripotin (1-1 mol-mol),-2.0053456549238295
NCI-H1395,439501,0.2163751108150007
KHM-1B,5329102,0.5280819798234874
BT-20,10296883,4.2664147255542
GP2d,vorinostat-carboplatin (1-1 mol-mol),2.41624103225782
T84,12001922,1.0984811418501697
KYSE-140,11507802,2.219288774079261
BT 416,6918837,-1.146905318330843
YH-13,89928392,1.3765832739802537
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875
KYSE-30,241158,4.2154926555372
BT-20,53392493,3.5812532110453454
KHM-1B,3503,2.6165416338561633
CFPAC-1,5351362,1.2067899751682063
CFPAC-1,44259,0.7895023753978819
YH-13,49766530,-0.8723369372860722
PE/CA-PJ15,3552672,4.25665482583999
Mino,119182,-4.350200760936349
NCI-N87,3503,2.784967297602414
GP2d,151289,0.6601815691383748
SCC-9,24951314,2.365472705935838
HuNS1,445455,4.404472168888008
NCI-H1395,6610355,4.529724434844308
MHH-ES-1,71466380,3.820746710467522
BT-20,6184667,2.441230772072509
IST-Mes1,136227924,2.313131576565863
KMS-12-BM,54618164,3.5838118675433783
Hs 936.T,285033,-2.086593846553006
LP-1,selumetinib-vorinostat (8-1 mol-mol),2.1103342223953243
KMS-12-BM,4096211,0.0697159534999253
NCI-H2087,11640390,5.067831007264427
IST-Mes1,24821094,3.7341606082149776
SCC-9,carboplatin-UNC0638 (2-1 mol-mol),3.5571818540455413
SK-LU-1,119182,-0.7414705265673658
RCM-1 [Human rectal adenocarcinoma],9911463,4.136675560401034
BT 416,5113032,4.440068860849092
GA-10,73707371,4.727167870834429
BT-20,4705,3.454921322809781
Mino,11455910,-0.3204403040643599
PE/CA-PJ15,49793307,-2.5792921181463617
HD-MY-Z,637858,1.3208525061915146
Mino,24964624,2.588955626460596
Mino,984333,-0.7975164448808868
RCM-1 [Human rectal adenocarcinoma],54618771,0.5185720985561021
EJM,44185566,2.4578466315948013
KO52,3062316,2.7101880307468047
BT-20,navitoclax-pluripotin (1-1 mol-mol),-0.1112193714773921
KHM-1B,3136844,3.849321357179878
BT-20,4917,3.742367438922436
HuNS1,4096211,1.8378662901444287
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314
Calu-1,11719255,3.4707413459218652
LS411N,9926054,1.9376785020428349
SKM-1,3552672,1.0574054456056317
TCCSUP,10074640,2.6482462102155737
GA-10,12003241,-5.009664542431325
RD-ES,alisertib-navitoclax (2-1 mol-mol),-1.283701127097962
BT 416,navitoclax-gemcitabine (1-1 mol-mol),-3.0489706128789575
KMS-12-BM,5284329,2.246794069285595
KO52,11612883,1.73729331381162
MHH-ES-1,54618305,4.636026356107167
MHH-CALL-4,168313047,1.7273086040927563
YD-8,ISOX-bortezomib (250-1 mol-mol),1.1639507987176203
SK-LU-1,crizotinib-PLX-4032 (2-1 mol-mol),1.8039614508246289
SCC-9,11977753,0.680369597029185
LP-1,448949,1.459613733601634
NCI-H2087,3543504,3.561776071746815
OCI-M1,3385,4.936199639270277
SKM-1,136227924,2.5339244468963407
YH-13,44632017,0.8741642499289622
BT 231,44491742,3.9496827176131384
NCI-N87,5282054,3.4882884399441125
CFPAC-1,168312962,2.8502902021316197
BT 231,navitoclax-sorafenib (1-1 mol-mol),1.1792295572203897
SNU-119,136227924,3.0573258202750253
Mino,11609586,0.4763203284393503
SK-MES-1,16720766,0.8992008720877877
KP-N-YN,navitoclax-MST-312 (1-1 mol-mol),0.7158445980315294
HD-MY-Z,11228183,3.031406079986751
SNU-119,176870,1.4867362217138953
BICR 31,11364421,0.6668909809197356
SK-MES-1,49867930,5.597495106336452
Calu-1,6610216,4.821045384716902
TCCSUP,2733526,3.083222005706137
SK-MES-1,285033,-3.003227311242862
YH-13,15983966,-4.17863717198839
NCI-H2087,6438330,1.0400610240456878
GA-10,4261,-1.9424593310620064
BT 231,445643,3.5669441290704573
EJM,24964624,2.1494935456800524
BT 231,selumetinib-decitabine (4-1 mol-mol),4.831366469856365
LP-1,selumetinib-decitabine (4-1 mol-mol),3.7333764399507334
LP-1,2874250,4.669820545537764
SK-MES-1,4477,0.8806989699956372
KYSE-140,57519531,2.2637897230141992
BT 416,107970,2.292868528252604
KYSE-30,12003241,-0.1095696990749684
NCI-H2087,46907787,0.6289755590874684
KO52,46926350,-4.487744142578648
BT 416,selumetinib-navitoclax (8-1 mol-mol),-0.3722886284091833
LP-1,10302451,3.6686554467714574
YD-8,54626689,4.483773401424057
T84,3543504,2.9608152851150784
KHM-1B,25105715,2.694355871197866
Mino,445091,3.8337639981682297
SNU-119,72193861,1.9875714401022249
SK-HEP-1,4788,5.857315027837397
SK-MES-1,vorinostat-carboplatin (1-1 mol-mol),3.272261334257289
SK-MES-1,1239801,4.429527571740844
BT 231,24964624,3.107401580540733
SK-HEP-1,73707398,1.730256970360003
BT 416,46398810,1.7272603046485455
EJM,24856436,-1.4562249201698472
REC-1,6918837,4.296635576829373
GA-10,135928012,0.2112396318699025
YH-13,5978,-2.977787383275712
NMC-G1,6610216,4.832544305447151
MHH-CALL-4,452548,-4.58586088097201
MHH-CALL-4,168313200,3.206527597863312
NCI-N87,73707386,2.4106113659233723
SCC-9,selumetinib-JQ-1 (4-1 mol-mol),2.082538789678548
Calu-1,25227462,2.7914215766130326
NCI-H929,3543504,4.657244806127615
BICR 31,24180719,3.9564262696237096
NCI-H2171,23635314,-3.6505205606038382
SK-OV-3,11964036,1.753508425012185
LP-1,44486219,3.7447837438452183
RD-ES,doxorubicin-navitoclax (2-1 mol-mol),-2.982578059380771
HCC1833,1750826,-0.9896154434110376
HuNS1,navitoclax-gemcitabine (1-1 mol-mol),-5.041619370005064
NCI-H929,11238147,1.9557398811989737
Mino,135875424,2.8874232883749578
KMS-12-BM,51037431,3.9425054893267326
IST-Mes1,9933475,1.3564169932051346
KP-N-YN,navitoclax-pluripotin (1-1 mol-mol),-0.2239459576550763
NUGC-4,selumetinib-decitabine (4-1 mol-mol),-3.3835523965106726
KMS-12-BM,2949965,2.1073962260494348
T84,15953870,2.47809665421024
YD-8,702558,4.53955953938176
GP2d,5351362,1.073278660259
KP-N-YN,5328940,3.43493314058384
SNU-119,24785538,1.16814557127363
PANC-1,15547703,3.1899358121977905
NCI-N87,11222830,1.733835072175261
SW1353,17759555,3.7449922639619495
YD-8,11152667,-1.506864416830652
NCI-H2171,tretinoin-navitoclax (4-1 mol-mol),-0.4442650177645615
SK-MES-1,16065773,2.7838271977186992
YH-13,serdemetan-SCH-529074 (1-1 mol-mol),3.0020411747572098
HuNS1,25102847,2.610475794672579
PL-21,11427553,1.3556154453306826
HMCB,72193861,1.1610146616364858
LP-1,selumetinib-navitoclax (8-1 mol-mol),4.342111489352361
T84,vorinostat-navitoclax (4-1 mol-mol),1.2034200478620851
BT 231,UNC0638-navitoclax (1-1 mol-mol),5.638389329843739
HuNS1,9903786,1.9338093787028072
KYSE-30,9927531,4.7729245028370055
YD-8,17759555,4.675684554869825
HMCB,4578,4.2642752613227435
HD-MY-Z,49766530,-2.787165933045758
KO52,426756,3.509057105571762
YH-13,selumetinib-decitabine (4-1 mol-mol),4.949176752890973
KP-N-YN,tretinoin-navitoclax (4-1 mol-mol),1.357522590610004
SW1116,6918328,0.949973931483892
K-562,252682,6.220409267483573
KYSE-140,2729026,3.0470002368671034
K-562,327653,3.3038748071855175
SCC-9,71304818,2.8421374335972653
NUGC-4,navitoclax-piperlongumine (1-1 mol-mol),1.1084539131715188
BT 231,49766530,0.2532028472914431
SKM-1,5287620,-2.0310276882381633
NCI-N87,6918328,-0.6140119948836108
L3.3,selumetinib-GDC-0941 (4-1 mol-mol),2.633566714315937
NCI-H2087,25150857,1.8835733896772695
SK-LU-1,serdemetan-SCH-529074 (1-1 mol-mol),2.2767784469852432
NCI-H2171,5278396,3.2627520221828115
RT-4,44185566,2.540534847490806
SKM-1,54454,1.9004592108781224
NMC-G1,24779724,4.225220713567242
EJM,11647372,1.0355727686672764
SK-HEP-1,241158,4.116654148222159
SK-MES-1,46926350,-4.205718042329977
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551
PE/CA-PJ15,11647372,1.6267530000250203
Mino,sirolimus-bortezomib (250-1 mol-mol),-0.0680495630332059
SK-MES-1,24964624,2.2296447020776364
NCI-H2122,navitoclax-piperlongumine (1-1 mol-mol),3.5161110427882662
BT 416,151289,0.4993724992596378
KHM-1B,148198,-5.169783546510426
K-562,16741245,3.9224206604880583
HD-MY-Z,docetaxel-tanespimycin (2-1 mol-mol),-6.443786320432872
ECC10,219104,2.4802286692249655
EJM,613753,3.047876123022861
Calu-1,25126798,4.660837350382815
SK-HEP-1,72376,-0.6035227354554765
KYSE-30,44486219,4.990668807448546
NCI-N87,11178236,-2.6087498623354977
Hs 936.T,613753,4.161868601573097
RT-4,168312962,1.4764557241805851
NCI-H1395,vorinostat-carboplatin (1-1 mol-mol),4.5909845476881905
SK-MES-1,2749,1.2500772892058398
Hs 936.T,89928392,2.759794951775686
MHH-CALL-4,409805,3.699144877236461
RCM-1 [Human rectal adenocarcinoma],11625818,4.3229587777026035
SCC-9,tanespimycin-bortezomib (250-1 mol-mol),-0.5584640053775825
KYSE-30,25102847,4.051377480867207
SNU-119,selumetinib-GDC-0941 (4-1 mol-mol),1.3564529496454796
OCI-M1,9549297,2.1328279431117076
GP2d,44491742,5.750365262572418
NCI-H929,selumetinib-vorinostat (8-1 mol-mol),1.6351341952434315
RT-4,3854666,3.7100044962154506
PL-21,44507138,0.6451118780850306
SK-MES-1,selumetinib-vorinostat (8-1 mol-mol),2.706535329304162
YD-8,selumetinib-MK-2206 (8-1 mol-mol),2.9104774003059415
SK-HEP-1,3503,1.99172511033101
NUGC-4,selumetinib-tretinoin (2-1 mol-mol),-0.8467063872756041
BICR 31,11717001,4.942461846011657
IST-Mes1,67291369,1.9412797776758044
BT 231,208908,1.596713590369486
KO52,5280436,1.3391511343144182
SK-HEP-1,322968,4.726859452680793
KO52,54619267,3.343465510835603
MHH-ES-1,151289,0.1383301212391103
SCC-9,11612883,3.4111633177056992
SW1353,124202324,2.199856271603199
BT-20,5566,3.1183665610818663
PE/CA-PJ15,54596558,4.362404185353882
BT 231,10410894,2.1908311783734433
HCC1833,3543504,4.272208369057919
SK-HEP-1,49793307,-1.6219654789172164
BT-20,3552672,2.209265684425471
SK-LU-1,5470400,-1.2875606987443569
ECC10,3385,5.4179290054020495
BT 231,135411,2.441426423284162
SCC-9,44589607,3.476138487776652
CFPAC-1,vorinostat-carboplatin (1-1 mol-mol),4.776732081398986
KYSE-140,107985,-2.0809038336660923
HCC1833,11427553,3.1759969845824876
KMS-12-BM,JQ-1-MK-0752 (1-1 mol-mol),-2.744831923995191
RCM-1 [Human rectal adenocarcinoma],3025944,4.221207920184214
RCM-1 [Human rectal adenocarcinoma],984333,1.0265914359647546
GA-10,11707110,1.8876879159869544
OCI-M1,54618164,3.810802357546973
PL-21,4477,0.7947593381921879
OCI-M1,53495165,-0.907650106434774
NCI-H2087,9952709,2.46229663731706
GP2d,4917,4.118570837914307
HMCB,11955716,-0.0705026992658857
HD-MY-Z,4477,-0.2938268930799214
SNU-119,serdemetan-SCH-529074 (1-1 mol-mol),2.302427714477216
YH-13,4788,5.883867811277833
Calu-1,3689413,-2.465191800637427
KMS-12-BM,46398810,1.728920729166526
IST-Mes1,54618771,0.8929247318821524
NMC-G1,107985,-11.863849928065331
KMS-12-BM,3025944,3.1800470659597284
LP-1,9911830,1.9669881995597704
GP2d,262093,3.014356837300259
NCI-H2171,selumetinib-JQ-1 (4-1 mol-mol),1.3266542460733022
CFPAC-1,17755052,5.015547021508271
ECC10,selumetinib-MK-2206 (8-1 mol-mol),1.723951687795172
KYSE-30,675434,4.396205265662506
NCI-H929,327653,2.3561667456594986
NCI-H2087,11455910,0.3125785540763442
NUGC-4,6918878,-0.576894766558933
KYSE-140,9926054,1.9800704230635255
HD-MY-Z,4259181,0.5589884134551424
TCCSUP,44507138,1.5092098612229228
RCM-1 [Human rectal adenocarcinoma],11364421,0.8746857299268361
IST-Mes1,2113511,6.40207592921409
SNU-119,2708,4.611503362669174
L3.3,navitoclax-gemcitabine (1-1 mol-mol),-4.48479777241671
KP-N-YN,9911463,4.355119869591486
MHH-ES-1,49766530,-2.35946817477404
SK-HEP-1,15983966,0.8278271069258164
HD-MY-Z,25102847,2.7286770075051336
SK-MES-1,3543504,4.717507739648856
MHH-CALL-4,3062316,1.2598372416544776
HuNS1,119182,-3.630036046673292
MHH-CALL-4,serdemetan-SCH-529074 (1-1 mol-mol),-0.6366943858441552
HCC1833,9967941,3.7106222694131743
PE/CA-PJ15,135411,0.500300489214103
PL-21,46191454,0.3517543851238236
OCI-M1,9866186,-0.2288361693855119
K-562,71680916,4.727537128358906
NMC-G1,24978538,2.121136623889162
KMS-12-BM,10074640,2.4619415387123365
REC-1,selumetinib-JQ-1 (4-1 mol-mol),5.213062841516755
SNU-119,12003241,-0.7435067493629696
MHH-ES-1,44543605,5.5945120612511525
GA-10,71304818,1.4385702308529476
BT 416,135875424,2.581275175967605
Hs 936.T,65064,5.127546651030216
KP-N-YN,11178236,-2.220858987157928
SK-LU-1,6852167,4.189762356624802
GP2d,54619267,3.1515829941576334
SK-LU-1,selumetinib-MK-2206 (8-1 mol-mol),6.054097163017744
NUGC-4,6610216,4.097960293460252
NCI-N87,42642645,0.5523493290598761
PL-21,44202524,1.1023710559139328
NCI-H1395,doxorubicin-navitoclax (2-1 mol-mol),0.3327602651018742
HMCB,SNX-2112-bortezomib (250-1 mol-mol),-0.8165650702209287
GP2d,selumetinib-decitabine (4-1 mol-mol),-1.525625343855734
MHH-ES-1,6918736,-4.3132133497575955
T84,1716436,1.840058680235384
BT 231,445455,4.768132256347899
EJM,2828334,5.892634980488002
NUGC-4,15953870,2.7215900423818105
NCI-H1395,7251185,2.615518868498986
K-562,11977753,-1.2336845020581693
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237
MHH-ES-1,216468,0.3677386391454807
MHH-CALL-4,6918328,-2.419476794109877
SK-HEP-1,5329102,2.506246240472525
HD-MY-Z,400769,-1.0656485051768947
NCI-H2171,36314,-6.271125424872196
HMCB,navitoclax-MST-312 (1-1 mol-mol),0.7821438430480089
SK-HEP-1,135421197,3.339831791709741
ECC10,7251185,3.130357646827074
MHH-CALL-4,54619267,4.1928146725263105
IST-Mes1,4259181,1.4706848514509867
Hs 936.T,crizotinib-PLX-4032 (2-1 mol-mol),3.051197886531565
NCI-H1395,9967941,3.3785918920686924
KYSE-140,10231331,3.095458864415077
NMC-G1,16115403,-6.61349522877377
KP-N-YN,selumetinib-GDC-0941 (4-1 mol-mol),4.501272647475443
REC-1,3815108,4.528116845485933
HuNS1,5335621,3.705567454559284
K-562,73707398,1.1020172598138147
YH-13,16659841,3.3586443316598675
RCM-1 [Human rectal adenocarcinoma],135440466,3.6704227989419738
HCC1833,6918837,-4.4830285040744675
BT 416,156422,3.9055365935822968
NCI-H1395,JQ-1-vorinostat (2-1 mol-mol),1.5410924011287808
SW1116,19582717,5.17151511541441
ALL-SIL,11396600,2.960335319566646
BT 416,44589607,2.7667168025248077
NCI-H2122,5281321,-0.8141825751963772
NCI-H929,5282054,1.6993370124309537
BT 231,JQ-1-navitoclax (2-1 mol-mol),0.2608339452750312
ALL-SIL,8515,1.9161675301812888
KO52,5335621,3.91616082408733
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889
NUGC-4,3025944,3.884005820716413
SK-MES-1,44486219,2.9971653856429845
Mino,navitoclax-pluripotin (1-1 mol-mol),-4.005655781523301
SK-MES-1,104842,-3.488536821050202
SK-LU-1,BRD-K27188169-navitoclax (2-1 mol-mol),4.132612583217379
REC-1,24779724,3.0011490046538407
Mino,9911830,1.0503076614334173
SNU-119,16722836,1.1666058390455762
ECC10,3025944,2.872817539681182
T84,11707110,-3.4027383151405055
TCCSUP,46224516,2.7201046077438793
KP-N-YN,135411,0.4776606909582138
NMC-G1,2126,5.5523896384915306
LP-1,3543504,2.5267303724092405
BICR 31,3025944,4.108701914406302
SW1353,11455910,2.4581078683414765
BT 416,16736978,3.5701481499002554
KYSE-30,9956119,4.172160070662993
Mino,36314,-5.843937326950793
Mino,23635314,-4.625478914727077
SCC-9,crizotinib-PLX-4032 (2-1 mol-mol),2.600413424515517
TCCSUP,3825829,3.3137008216702686
MHH-ES-1,73707398,0.6255428046106257
NUGC-4,4521392,3.694096682549442
BT-20,5470400,0.3065164173175672
SW1353,136227924,3.029116785491403
SKM-1,159324,-1.3530804275700197
YH-13,navitoclax-gemcitabine (1-1 mol-mol),-1.557893185204028
KYSE-30,15983966,1.6755507853225002
BT 231,168312962,-0.3558848468638645
SNU-119,9887053,3.651062425326841
ALL-SIL,262093,0.6753795238054565
NCI-H2122,409805,6.0508402213506995
MHH-ES-1,JQ-1-carboplatin (1-1 mol-mol),0.9828156633335828
KMS-12-BM,322968,1.914773928139573
GP2d,11977753,-3.3158223891744867
KMS-12-BM,6610355,3.820739817382138
MHH-ES-1,54619267,4.200595244113585
KMS-12-BM,441298,3.3874000284739028
HuNS1,46926350,-4.494097640967621
SK-HEP-1,4521392,4.36382839215776
GP2d,45279963,3.3591190473002346
PL-21,1641662,2.514971469742373
NCI-H2087,445643,3.7533872399898023
KMS-12-BM,1716436,2.2490231702489956
NCI-H929,24901704,2.6576899414441897
ALL-SIL,46943432,1.7359798293614472
BICR 31,3634881,3.594506321194918
Mino,25102847,1.483514091327799
Calu-1,5470400,2.8945283448227075
RCM-1 [Human rectal adenocarcinoma],2746,2.384271625154073
SK-MES-1,11494412,1.2665104699184024
KMS-12-BM,46174525,2.6859136047743513
BT 416,4096211,0.1429590687605461
SNU-119,44259,0.785845765764312
SKM-1,BRD-A02303741-carboplatin (1-1 mol-mol),3.2500648097928524
GA-10,11167602,1.4173414439490166
NCI-N87,3062316,-1.4174361948917271
YD-8,2733526,3.5062367586766836
KYSE-30,16722836,1.91786191675344
NCI-H1395,54619267,3.786802198247579
PE/CA-PJ15,675434,4.368434014356364
REC-1,46907787,4.0420421547178975
L3.3,36314,2.044128713808568
Calu-1,44566777,-0.183185651570573
SNU-119,6438330,1.1490589890035967
SK-OV-3,12003241,-1.2313805329375749
NCI-H2087,5738263,3.2375483041359185
HD-MY-Z,6918736,-0.0009150083525537
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916
SW1353,10184653,1.84495276288495
L3.3,doxorubicin-navitoclax (2-1 mol-mol),-0.9996417914636118
NCI-H2087,135875424,3.0815246928264575
BT 416,decitabine-carboplatin (1-1 mol-mol),2.993011960239781
SK-HEP-1,11609586,4.257559552037769
MHH-CALL-4,57330099,4.341459109419565
T84,3676137,4.51114616136851
KO52,54618771,1.4631554759036511
ALL-SIL,448949,0.3821166271144734
SNU-119,5702613,2.9838920774559483
MHH-CALL-4,44137675,2.180666176963923
YH-13,4578,5.582049884276352
MHH-CALL-4,BRD-A02303741-carboplatin (1-1 mol-mol),3.759210091714414
MHH-ES-1,24771867,-3.5252517950001097
Calu-1,73707398,1.2133176360224152
KMS-12-BM,JQ-1-carboplatin (1-1 mol-mol),-1.7231272416518306
ECC10,72376,-4.898094599763754
K-562,4259181,-0.7813149193344907
OCI-M1,3384730,2.4129051912283863
SK-MES-1,ISOX-bortezomib (250-1 mol-mol),0.2806116076334115
KO52,16013152,3.657905355539016
TCCSUP,4096211,2.136030263591951
NMC-G1,656346,1.7210564880253068
PE/CA-PJ15,54626689,4.686002745759547
HuNS1,15983966,-4.253426128386734
GP2d,5738263,2.5545734445934336
KP-N-YN,11609586,3.1065788329885557
SKM-1,11640390,1.3825660672186588
Hs 936.T,5278396,4.019581241943352
Calu-1,11234052,5.2023761380682725
SCC-9,24856436,1.519847806890015
NCI-H2087,54618164,3.8851097061175786
SCC-9,123631,1.8109604294388877
MHH-CALL-4,9936388,-7.2015851477673785
Calu-1,carboplatin-etoposide (40-17 mol-mol),3.6017095524974603
RD-ES,12003241,-1.2305184687153958
ECC10,6918878,-1.012115166136148
OCI-M1,25262965,-2.2018428359381588
BICR 31,5460769,3.9433617709959696
NMC-G1,5746,2.2428701274291027
KO52,10410894,3.6577566389370304
RT-4,654092,0.6230468978254379
SKM-1,5335621,3.872375911033952
BT 416,11167602,2.2298904272575686
Calu-1,selumetinib-piperlongumine (8-1 mol-mol),4.417306554892765
NCI-H1395,5284373,3.990100299544354
KYSE-140,5311,1.4435230694964891
MHH-ES-1,selumetinib-JQ-1 (4-1 mol-mol),0.1854105188393836
BT 231,44197249,1.909514175256433
Mino,4259181,-0.1308029844207646
NCI-N87,387447,-5.408237770865747
SCC-9,5566,3.224791432055543
RCM-1 [Human rectal adenocarcinoma],6852167,4.10667945313068
KMS-12-BM,9911830,2.539717819095299
SW1353,piperlongumine-MST-312 (1-1 mol-mol),2.195556608439295
NMC-G1,10302451,5.170100461056351
RCM-1 [Human rectal adenocarcinoma],135411,0.5141731800260497
SK-HEP-1,46191454,1.8876467264614776
MHH-ES-1,135411,0.2720416488721636
PL-21,3025986,-2.4248730658313424
LP-1,11364421,-5.6784964718089785
SNU-119,54143018,0.8882121695154049
ECC10,4261,-0.7226324934896892
GP2d,10074640,3.3438820097841875
NUGC-4,5280436,4.122987547342494
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025
KYSE-140,44489367,4.3269137896614955
KO52,44495899,4.429122430834432
EJM,25154868,4.2554852921408415
HCC1833,15953870,3.819356802324763
BT 416,136227924,3.4255307271180726
ECC10,44493952,3.677485446935018
LP-1,387447,-5.59779100304281
KYSE-30,67156097,5.467176635505784
REC-1,6918328,3.6052842783231993
YD-8,11507802,2.799805869196936
NCI-H1395,65064,5.358143004384587
Mino,6852167,1.220926429953778
SK-OV-3,2729026,2.529477515357917
KMS-12-BM,6184667,2.2804186491767857
PE/CA-PJ15,56649450,2.4864234790550306
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957
Hs 936.T,54618164,4.395374360312425
MHH-CALL-4,11683005,3.307025269294125
OCI-M1,9927531,4.777784518044042
SNU-119,65064,4.58104500437737
HuNS1,docetaxel-tanespimycin (2-1 mol-mol),-7.3701164722967185
ECC10,1641662,3.1910943335711366
SKM-1,9908783,4.725135976054751
OCI-M1,65064,5.540781704358849
HCC1833,JQ-1-navitoclax (2-1 mol-mol),-0.3258650069737906
NCI-H1395,10296883,4.692616973111803
CFPAC-1,44507138,5.2459251976690044
CFPAC-1,11964036,1.6827341572169572
NUGC-4,sirolimus-bortezomib (250-1 mol-mol),-0.7003911185233305
HMCB,107970,2.4632765451158356
BT 231,676352,1.2654935128544424
CFPAC-1,6914657,-4.087399664816676
NCI-H2087,1239801,2.654543086326461
HD-MY-Z,11427553,3.002259599308683
NCI-H2171,54765302,2.983840848305476
PL-21,3543504,4.150027218509285
T84,9866186,-0.0817420780478526
SK-MES-1,2945648,2.5964183520963693
NCI-H929,54613361,-0.2364744908060287
HCC1833,54618771,1.9776792637653005
SW1353,374536,2.4220042537578896
PE/CA-PJ15,decitabine-navitoclax (2-1 mol-mol),3.3125622838929663
PL-21,71466380,4.649060286234952
SCC-9,16720766,1.7269628893506093
L3.3,3384730,1.5710194033023062
KO52,5291,3.753312170095506
SKM-1,219104,2.5131596943012053
Calu-1,5282054,2.562453254686781
OCI-M1,216468,-0.7647762915122314
HD-MY-Z,navitoclax-birinapant (1-1 mol-mol),2.911024328146566
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523
PL-21,241158,4.28297897809028
NUGC-4,400769,-1.065310930555337
KMS-12-BM,2733526,2.511527741006988
GP2d,57330099,4.16071222868741
BT-20,25227462,1.917607440792589
PE/CA-PJ15,9826308,0.508783393758027
HuNS1,5978,-2.98073473381925
BT 416,11977753,-0.1425094010215304
ECC10,11977753,-2.5970381645745566
SK-LU-1,10074640,2.848769446251431
SKM-1,navitoclax-pluripotin (1-1 mol-mol),-0.780320881442614
YH-13,11977753,-2.376684100731715
NCI-H2122,656346,1.1276878733487727
SK-MES-1,1566236,3.8724426148603706
GA-10,11228183,2.8648999879290447
Mino,decitabine-carboplatin (1-1 mol-mol),-0.3688996488925483
L3.3,sirolimus-bortezomib (250-1 mol-mol),2.0691121038567144
KO52,24748573,0.4293193487594113
HCC1833,3689413,0.395553245761409
MHH-CALL-4,5280436,2.308722789616279
KO52,SNX-2112-bortezomib (250-1 mol-mol),-0.6640872675170002
TCCSUP,6505803,-2.3370703799020323
SK-HEP-1,65064,5.472205201006758
GP2d,tretinoin-navitoclax (4-1 mol-mol),4.314431247002535
GP2d,25183872,0.2806895804366852
GA-10,5311,-0.1891717553760856
KYSE-30,168313200,1.925854495062808
YD-8,49850262,3.7509110667991736
SK-HEP-1,676352,1.798347685811885
YH-13,135984461,4.0881390777757245
BT 231,4259181,0.6722298764653775
NCI-H929,4917,2.9629665385410227
RT-4,107970,2.3841738823851255
EJM,71304818,1.7741690400196457
GP2d,23725625,4.0238456012301445
KMS-12-BM,262093,1.1865999929989532
NCI-N87,5311,0.9556802173694716
GA-10,SNX-2112-bortezomib (250-1 mol-mol),-5.461366116815718
ECC10,9823820,2.2890084091726504
T84,53495165,-1.0061580789285147
CFPAC-1,439501,-1.9750103172149232
NCI-H1395,135999136,4.46612092216275
ALL-SIL,71466380,3.7861137397034255
PL-21,3038522,3.483148652537047
HD-MY-Z,11317348,3.903846576107672
L3.3,9911830,2.6705572013337195
PE/CA-PJ15,72376,-1.337193116518152
RT-4,119182,-0.6626417510702334
EJM,1716436,2.8546888693070818
HD-MY-Z,374536,1.289019372407008
T84,73707398,0.224073795276098
RD-ES,5470400,-4.702864105702524
EJM,selumetinib-vorinostat (8-1 mol-mol),1.9565276246961512
OCI-M1,44185566,2.947401421595657
BT-20,3136844,4.330967788293681
SKM-1,JQ-1-carboplatin (1-1 mol-mol),-0.9064446956996236
RT-4,44607531,2.8716913439843803
NCI-H929,9935249,2.217272904882535
YH-13,24856436,1.6547595238479382
NCI-H2171,53232,2.7429596689347875
SNU-119,4259181,-0.8929687482279648
SK-HEP-1,637858,2.866868896175592
PL-21,9825149,-0.0065053613182122
BICR 31,148198,-3.2373882564770513
CFPAC-1,1641662,4.382998942497753
NCI-H2122,tanespimycin-gemcitabine (1-1 mol-mol),1.3056184625160565
SW1353,216345,3.399698703610546
SCC-9,3689413,-0.5284639903905319
NCI-H2087,9911830,2.1008077543098045
KO52,carboplatin-UNC0638 (2-1 mol-mol),3.4121259588832538
GA-10,JQ-1-UNC0638 (2-1 mol-mol),-1.726408829948699
PE/CA-PJ15,2742550,4.3930090361473155
NCI-H929,9927531,5.740923779315927
ECC10,16219061,2.537556603629524
MHH-CALL-4,26596,-1.7349356502662407
PE/CA-PJ15,11396600,3.3444318017760986
RCM-1 [Human rectal adenocarcinoma],46398810,3.3659833177824563
L3.3,1750826,0.7937145951404149
KP-N-YN,11455910,2.456468445716411
KP-N-YN,227681,2.9105913877996565
BICR 31,322968,4.229982613329669
SK-HEP-1,107985,-2.2891993358893856
BICR 31,5281321,1.1837918014475457
SCLC-21H,selumetinib-JQ-1 (4-1 mol-mol),-0.3063993577138266
SK-LU-1,JQ-1-navitoclax (2-1 mol-mol),0.5218437427769349
L3.3,10296883,4.354494828099719
GA-10,72199292,-0.4646539645968595
SKM-1,5329102,1.247777123403785
T84,322968,2.7289103163858197
KMS-12-BM,568763,0.1321382887617515
Calu-1,9935249,4.740703039266813
SK-LU-1,675434,4.928558834362658
LP-1,148198,-3.8284047012705846
RCM-1 [Human rectal adenocarcinoma],JQ-1-UNC0638 (2-1 mol-mol),1.043202454490808
K-562,5281321,0.5422415972342122
T84,11167602,2.5996752416167492
ALL-SIL,60168763,4.204461937910143
KHM-1B,54454,3.744465591598654
KYSE-30,10231331,0.8678234440350742
SK-HEP-1,3384730,4.617019540739567
NMC-G1,erlotinib-PLX-4032 (2-1 mol-mol),2.9635778898524205
BT 416,5281672,5.2749365178514624
SK-MES-1,73707398,1.2846012994899838
EJM,119182,0.4247713532004813
T84,9956119,3.3604767344141093
KO52,24856436,-0.7085491514646743
KMS-12-BM,25195348,1.3906161221402649
KMS-12-BM,11234052,1.039776638758491
CFPAC-1,selumetinib-piperlongumine (8-1 mol-mol),4.99052605610422
NUGC-4,9911830,2.666596193346337
KMS-12-BM,60750,-3.781170987438112
MHH-CALL-4,31703,-4.893749373057055
LP-1,65064,5.244893928267209
T84,11485656,2.016527723529138
LP-1,24180125,3.144388402663548
SK-MES-1,navitoclax-birinapant (1-1 mol-mol),2.92353952606014
Mino,44202524,1.0712152555849994
MHH-ES-1,3025986,-1.5574312905948966
HuNS1,23582824,0.2289322170959503
KHM-1B,11507802,0.7645643199546858
HuNS1,2708,2.9738358315202102
KYSE-140,54619267,3.9840488671156424
HMCB,doxorubicin-navitoclax (2-1 mol-mol),-1.216514285353257
SK-MES-1,54618771,-0.0773843626642112
SNU-119,6610216,4.326307589827554
BT 416,56963564,-1.2380051945230468
OCI-M1,2113511,5.970308768711964
HuNS1,6918638,-1.0677458393848085
NCI-H1395,168312962,2.594728459229535
TCCSUP,1716436,3.07523463483741
PL-21,52947716,-5.198879313228617
NMC-G1,9911463,4.44969477965095
SW1353,24856436,1.046024405686011
ALL-SIL,5281321,-2.461016259028612
KHM-1B,44493528,1.720576936641076
IST-Mes1,JQ-1-navitoclax (2-1 mol-mol),-0.6205173891711487
SW1116,3136844,4.749108435900641
OCI-M1,45279963,3.1194148143310048
LS411N,6610355,5.174673905344729
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829
YD-8,2126,4.624858365561851
BT-20,6610216,4.194352657176605
HuNS1,4917,2.8318322822618063
HuNS1,67156097,-2.791077703408039
BT 231,36314,3.0965255782115975
SK-LU-1,24797083,1.9291309593256705
TCCSUP,9887053,4.648275902812988
IST-Mes1,9825149,1.824146809937508
IST-Mes1,44185566,3.025290337876495
OCI-M1,46926350,-4.328196649183949
LP-1,107970,1.8011925115015095
NCI-H2122,44819697,3.492523481073204
IST-Mes1,3854666,2.0681561223579075
NMC-G1,66577038,3.058935131023225
Mino,71680916,3.571574649488516
IST-Mes1,selumetinib-UNC0638 (4-1 mol-mol),3.472834598034016
NUGC-4,25150857,2.23575881649953
L3.3,439501,-0.248470622878828
NCI-H1395,107970,2.4345825548290265
GP2d,24180719,3.2790512744899023
PL-21,3062316,1.7692806930954557
ECC10,selumetinib-JQ-1 (4-1 mol-mol),0.1905940904726353
NCI-H2087,123631,1.9797977144808867
MHH-CALL-4,9926054,1.817922343737897
HuNS1,tretinoin-carboplatin (2-1 mol-mol),4.285171663090132
KO52,11494412,-1.6308846276697513
SNU-119,17759555,3.1197691897400435
MHH-ES-1,5281672,4.412438197639541
NUGC-4,60750,0.489748876091331
PL-21,11396600,2.4757103369664084
BT 416,11626927,5.940266448781774
BT-20,selumetinib-PLX-4032 (8-1 mol-mol),4.13956486671087
RT-4,159324,1.8094112077356237
SNU-119,16741245,5.112197771644654
YH-13,10427712,4.6201171639095815
KYSE-30,969516,3.833632705011792
NUGC-4,71466578,3.5350103255094893
T84,156414,0.0682461753591611
K-562,25126798,3.746183025237492
PE/CA-PJ15,53481919,3.924471054520181
SK-MES-1,3825829,3.953427903272987
KO52,12003241,-1.0632598943321483
Hs 936.T,24797083,1.3143745339652817
EJM,5282054,2.6284954887881784
BT-20,24964624,2.8332089565181
SK-MES-1,613753,3.125096725801634
ECC10,4096211,0.1544601608979127
KP-N-YN,51039095,3.610750514919402
PL-21,6450551,2.5394365591018455
HMCB,5278396,3.758401391477414
YH-13,119607,5.844423836114236
YD-8,5335621,4.375821722730707
NCI-H2122,serdemetan-SCH-529074 (1-1 mol-mol),2.398174516552481
HD-MY-Z,46843906,3.447026466554496
MHH-ES-1,984333,-2.0563850685920166
SNU-119,11152667,-1.7505046185564503
KO52,374536,-2.868980977087777
PANC-1,11717001,4.387743942011051
MHH-ES-1,656346,0.1939396123587766
RCM-1 [Human rectal adenocarcinoma],2749,1.6658310830765266
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603
GA-10,44566777,-0.9945693101487972
SK-HEP-1,10074640,3.7857764861964935
SK-LU-1,44607531,2.3115463318765213
T84,JQ-1-carboplatin (1-1 mol-mol),2.264364679539306
OCI-M1,selumetinib-MK-2206 (8-1 mol-mol),2.432657464284889
TCCSUP,644241,2.2463977673648823
Mino,11497983,1.0995917005095155
Calu-1,24771867,0.8970625753815772
EJM,selumetinib-GDC-0941 (4-1 mol-mol),1.950719382616822
T84,17755052,-0.9479391097960173
PL-21,53392493,1.8689567686548412
TCCSUP,vorinostat-navitoclax (4-1 mol-mol),0.9791138752454284
NCI-H929,piperlongumine-MST-312 (1-1 mol-mol),3.099725979824717
HD-MY-Z,123631,3.013392566511306
YH-13,9903786,3.849279075978848
NCI-H1395,selumetinib-GDC-0941 (4-1 mol-mol),2.3368578075304463
NCI-H2171,4917,1.7834364774656617
HuNS1,54618164,3.902045461689573
NCI-H2122,5329102,2.9899839429582937
L3.3,3854666,3.761529361474975
ECC10,3634881,2.4788233916045455
PL-21,53232,2.9381787256569467
Calu-1,4259181,1.7629989147872749
NCI-H2087,159324,1.2033860013078608
LS411N,25102847,2.9606059837222767
LP-1,11507802,0.709814361049281
PE/CA-PJ15,11609586,3.1657883491375824
NCI-H1395,JQ-1-carboplatin (1-1 mol-mol),2.36945639284839
BT 416,11427553,1.7229525094965543
SCC-9,JQ-1-carboplatin (1-1 mol-mol),3.612051093214818
HD-MY-Z,11175137,3.2730153794366097
GA-10,5951923,5.484549287295672
KYSE-30,24771867,3.210346701902163
OCI-M1,148198,-4.87600979079706
MHH-ES-1,6623618,1.8396666163891444
CFPAC-1,1242560,3.778072468393604
K-562,73707371,5.645446798773975
NCI-H929,54649381,3.9072363732080535
Mino,15953870,2.630005403588916
ECC10,168313047,1.8532453243446
Hs 936.T,5351362,2.9315229690112607
YH-13,126941,-0.9334172609353208
EJM,10074640,3.565491607836162
IST-Mes1,11152667,-0.1137559634255308
NCI-H929,9911830,2.939236367729051
MHH-ES-1,44197249,3.70244207851584
KO52,46199207,2.692692607294932
NCI-H929,123631,2.2312857610244827
KYSE-30,2945648,1.146819459449515
NCI-H1395,5566,3.555593017937037
NCI-H1395,44566777,1.012205213932494
KO52,3465537,1.4492421646178062
KYSE-30,44491742,4.262990240897069
ALL-SIL,11683005,2.0727325774258794
HD-MY-Z,24180719,3.4052482299900224
Calu-1,5287620,-1.4378758119438004
T84,6610216,3.707288952645697
BT 416,49766530,0.2372877169340128
NCI-H2087,selumetinib-GDC-0941 (4-1 mol-mol),-1.1511446717874352
KYSE-30,2746,4.052809859815596
OCI-M1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.203621790797241
KHM-1B,25062766,1.5737082616521652
SK-LU-1,2729026,2.4446296185956253
SNU-119,409805,3.7561778624984585
SK-HEP-1,6450551,3.663777137244395
GA-10,2708,1.911787871083676
SK-LU-1,168313047,2.0085649202516183
GP2d,selumetinib-navitoclax (8-1 mol-mol),-3.484910799686236
Calu-1,613753,3.1368591594629796
NCI-H929,sirolimus-bortezomib (250-1 mol-mol),-3.8848205267511817
Hs 936.T,46191454,1.7139398343804406
SKM-1,3025986,-2.206806722856398
Mino,4261,-1.5584732563663717
SK-HEP-1,6918878,4.4325993547595655
KYSE-30,71466380,5.522041137096107
GA-10,5291,2.257421221177401
LS411N,44185566,2.59688005994845
BT-20,322968,4.806287203031219
GA-10,54618164,3.873784446701225
NCI-H2122,89183176,2.8792537794251563
SCC-9,5738263,4.330654025732234
SW1116,3081361,1.1972149531991412
OCI-M1,10296883,3.5292915322873255
PL-21,53495165,-0.7846647034406907
SK-MES-1,72199292,0.0099051402151745
NCI-N87,3815108,3.1427265495234513
SK-LU-1,46907787,2.3105401780799917
BICR 31,46174525,4.37434163277974
BT 231,44566777,1.5227843283968532
Mino,89183176,2.200230277226517
BT 231,4477,0.1513876280994911
PE/CA-PJ15,10385095,0.8645470546748426
PE/CA-PJ15,2871966,-1.907957584406415
HuNS1,11626560,0.4978894610370524
SK-LU-1,9967941,3.6285948524934697
PL-21,107985,-4.0458026423659295
TCCSUP,54454,2.1286318992115523
NCI-N87,53232,3.890681715203442
KHM-1B,71680916,4.347689376486287
LP-1,vorinostat-carboplatin (1-1 mol-mol),1.6725135487570435
PL-21,10427712,3.4222667816755266
SKM-1,135398516,2.107945219475692
ECC10,9911463,2.6804416943678917
BT 231,5113032,4.671277876610016
ECC10,448949,1.69576676680303
BT 231,2949965,2.5110208922046513
SNU-119,446155,1.4772127449904695
K-562,2749,1.8349792189296796
YH-13,2746,3.803826628530811
SK-OV-3,16722836,0.9083609759186712
ECC10,675434,3.860769402675527
K-562,2828334,5.968313970587813
Calu-1,24797083,2.505042640710902
Mino,19582717,2.329558498889067
BT-20,11396600,3.3625164921440884
NCI-H929,219104,1.172196270408648
HuNS1,11152667,-1.226453597215441
RT-4,10410894,2.6613455189649913
NCI-N87,3025944,4.18610508240951
L3.3,4096211,2.2417011569185763
SW1353,44589607,4.136615338755029
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642
IST-Mes1,44487872,4.402175961022997
SK-HEP-1,104842,-1.0887000355540395
NCI-H2171,JQ-1-vorinostat (2-1 mol-mol),-0.591426926021434
KYSE-140,19582717,4.893659465603242
LP-1,6917907,-5.861544980882116
MHH-ES-1,60750,-4.493988959844742
SK-OV-3,2858523,3.2787147644650716
NUGC-4,56963564,-0.1792198335371068
YD-8,navitoclax-MST-312 (1-1 mol-mol),1.7163356064773547
YH-13,322968,2.764039711973652
LS411N,10302451,4.220534629483678
Mino,16725315,3.102334229880721
LS411N,6184667,3.0967158778150465
BICR 31,11485656,2.9684140094972387
HMCB,71304818,2.4359376321219046
BICR 31,71576739,4.400142576070014
SW1353,168312962,4.800520591418419
KO52,24821094,2.869182341163551
Hs 936.T,11152667,-0.982911765278613
KYSE-30,52947716,-6.86643945924484
BICR 31,219104,4.339385963743166
PL-21,44632017,0.768381977563246
YD-8,24978538,3.298771682891298
SCC-9,6918878,3.402250236896725
NMC-G1,6505803,2.4700924205747827
NCI-H1395,1566236,2.7287407900944056
BT 416,11507802,1.9829339640508477
NCI-H929,selumetinib-PLX-4032 (8-1 mol-mol),3.606448116077345
RT-4,9911463,3.5197462916355073
KMS-12-BM,6438330,0.9422197844346454
HCC1833,11238147,4.085729500081914
MHH-ES-1,12003241,-1.3957716684214538
LS411N,123631,3.048490743589503
YD-8,doxorubicin-navitoclax (2-1 mol-mol),-0.757010809719607
CFPAC-1,5311,2.663160707171002
SKM-1,216239,2.5216092374481716
YH-13,5284373,3.689481808678744
GP2d,135440466,1.5910972525169933
YD-8,vorinostat-navitoclax (4-1 mol-mol),2.141910659803834
HMCB,676352,1.7835731305737277
KMS-12-BM,navitoclax-piperlongumine (1-1 mol-mol),-0.5668023571576813
NCI-H2087,644241,1.6454264321046088
BT-20,3025944,4.266244561835126
SW1116,10410894,1.6328135710785707
NCI-H2087,72376,-2.5421797666335624
BICR 31,1716436,3.7157300626912617
EJM,67156097,-2.836977847319536
NCI-H929,72734382,3.667669568515042
L3.3,3038522,4.529448646795259
Calu-1,24753719,4.36133444781149
Mino,5282054,2.2264353184224377
IST-Mes1,5328940,2.5729000547912397
BICR 31,208908,2.9880095911503983
SCC-9,4477,0.0462068475019735
BT-20,3825829,4.258781729160101
NUGC-4,135928012,3.892614955295735
LP-1,9803433,4.689328026581546
ECC10,100016,5.627610035010204
SCC-9,9911830,2.3699428367857145
GA-10,16038120,0.5817492414100278
RCM-1 [Human rectal adenocarcinoma],9903786,4.3108216230747685
EJM,6252,2.286416731528207
ECC10,piperlongumine-MST-312 (1-1 mol-mol),1.1260774591672895
SKM-1,3689413,-2.418262014134033
SKM-1,5351362,1.5652480308403496
PL-21,135440466,-0.2713480052305587
ALL-SIL,5746,-1.6673474530311534
BT 231,1750826,-1.4031111199635489
SK-LU-1,9444,4.185494679759212
KYSE-30,11719255,3.5417160191242476
KP-N-YN,702558,7.241446242685368
SK-MES-1,5291,3.474335152826269
SNU-119,4261,2.6486100655772407
BT-20,6438330,2.007125004794655
BT-20,107985,-2.620430033405692
CFPAC-1,11609586,3.428761059683166
EJM,serdemetan-SCH-529074 (1-1 mol-mol),2.152068500257776
MHH-ES-1,11497983,-4.125538181542363
YH-13,3689413,-1.970237829798131
HD-MY-Z,5951923,5.391153622507459
NCI-H1395,11455910,1.7673103520073516
TCCSUP,444795,5.142441230913875
BICR 31,46191454,1.7584497327325264
EJM,4261,0.9185867852984516
HuNS1,16736978,0.0743166811201577
NUGC-4,66577038,3.456624529313481
RT-4,5329102,2.779535568248952
MHH-ES-1,46907787,0.0189081093783337
IST-Mes1,66577038,2.5150906013236423
T84,176870,3.053355164370523
MHH-ES-1,alisertib-navitoclax (2-1 mol-mol),-3.049056572819224
LS411N,135440466,2.8415058675889
EJM,16725315,4.889333996088531
NCI-N87,5566,2.8110881508350567
BT 231,441298,3.0400785513458515
GP2d,tanespimycin-gemcitabine (1-1 mol-mol),-1.8346880793481477
BT 416,66577038,-0.3956840577892757
Calu-1,135875424,4.2506874987837024
Calu-1,JQ-1-navitoclax (2-1 mol-mol),2.2798881283306636
HuNS1,24771867,-2.3585506573330988
GA-10,5311281,0.8462971607258624
PE/CA-PJ15,219104,4.253811608091339
PE/CA-PJ15,4261,3.0667647360084227
SK-LU-1,9866186,0.6823459694534537
NCI-H2087,36462,0.787608907647275
YH-13,4261,1.8145650392112695
BICR 31,16736978,1.5520316002325725
IST-Mes1,1750826,2.0701004204652778
NMC-G1,216345,4.053083631922007
SKM-1,107985,-4.676728901872281
SK-MES-1,2858523,2.945400459701589
ECC10,6918289,-0.3853388448485707
SKM-1,60700,-2.303999469511284
HMCB,6914657,-4.177401359592738
HMCB,3854666,0.4980905922324143
LP-1,89928392,1.1472741166250662
PE/CA-PJ15,vorinostat-carboplatin (1-1 mol-mol),4.177227596511851
KO52,JQ-1-UNC0638 (2-1 mol-mol),0.0630474759486333
SK-LU-1,448949,2.649652860463338
SNU-119,9907093,3.854419311028708
YH-13,11485656,3.672447929172867
REC-1,42611257,4.975411256218309
LS411N,16720766,1.2713952174238143
KMS-12-BM,53392493,1.4932523405392888
NUGC-4,5746,0.1909898303377877
NCI-H1395,2742550,4.633125791317317
PE/CA-PJ15,44486219,4.221629533616514
YD-8,136227924,3.733712180219105
NUGC-4,31703,-2.0073500236582964
SW1353,SNX-2112-bortezomib (250-1 mol-mol),-0.4216646778945483
HD-MY-Z,252682,6.038728890798267
PE/CA-PJ15,6184667,1.987560151741866
ECC10,erlotinib-PLX-4032 (2-1 mol-mol),2.277145705071536
YD-8,9956119,4.565288309306219
BT 231,1641662,3.1147772490578367
GP2d,10184653,-0.9002341682408838
IST-Mes1,6918328,0.8508470020259952
PANC-1,135411,5.06554614706648
YD-8,11647372,1.2851189488565986
T84,57330099,4.251558449389618
EJM,5291,3.786529645155132
SK-HEP-1,25154868,3.1824362497542182
KP-N-YN,selumetinib-BRD-A02303741 (4-1 mol-mol),5.886613370248735
BICR 31,5328940,1.2878315189706533
ECC10,3815108,2.3891709571582616
GA-10,36314,-6.756322560470663
HuNS1,60700,-2.7328870844565087
KP-N-YN,136227924,3.0572578369433376
PL-21,11485656,1.7729113112041155
NCI-N87,5335621,4.88881532131479
NCI-H2122,89928392,4.5814418232897705
OCI-M1,107985,-4.64577499507645
RCM-1 [Human rectal adenocarcinoma],11485656,1.8807064812530925
Calu-1,9908783,5.223050006393556
NCI-N87,11626560,1.9254713694635637
Hs 936.T,969516,2.915689811674282
BT 231,6918837,1.7982873040726883
K-562,11507802,0.4095176942133114
KP-N-YN,9903786,5.5444671223667825
YD-8,44607530,2.028458223492934
HMCB,26596,-1.2966092010554455
NCI-H2087,60700,-2.1071173526496145
RT-4,5281672,5.093859609315912
BT 416,44197249,4.552326885312017
YH-13,3825829,4.007616735103447
SK-LU-1,285033,-0.5217500869297766
Calu-1,89928392,1.866794270035165
HCC1833,3062316,2.9107479335735382
GP2d,65628,4.475000453671442
HD-MY-Z,56963564,0.7246160408494112
NCI-H2087,53301938,-5.970941318247354
TCCSUP,24856436,0.0318600345010346
HCC1833,9907093,5.616080767658905
BICR 31,4705,2.7587837218207194
KYSE-140,73707398,1.695660009720789
HCC1833,46199207,2.4892751921143024
Calu-1,568763,-0.6427120457459795
BT 231,613753,2.9717663600509105
SKM-1,24771867,-3.0651139758567068
SK-MES-1,11228183,2.075180335491279
HD-MY-Z,322968,4.646196899298585
LS411N,65064,5.143309491248943
HD-MY-Z,11485656,2.631776760715326
KP-N-YN,44566777,3.2434262462928447
BT 231,60700,3.1820566460840145
KMS-12-BM,439501,-2.5993845366115016
KMS-12-BM,5566,2.9351867752080887
SW1116,124202324,1.63903378008797
LP-1,16720766,0.5935045352433532
MHH-CALL-4,JQ-1-MK-0752 (1-1 mol-mol),-0.2464089276834694
SW1353,3025986,-0.4602979863973272
OCI-M1,6438330,0.8000243190810598
LS411N,5738263,3.6843208102291127
KMS-12-BM,7326481,2.7761421195772544
HuNS1,selumetinib-vorinostat (8-1 mol-mol),2.3159502101358225
Calu-1,1566236,3.658841194975484
PL-21,4705,2.342779269332656
SW1116,16219061,3.311893029789045
CFPAC-1,9911463,4.23074803596426
GP2d,3689413,0.2049378471192219
BT 416,5738263,4.028547933526076
NMC-G1,24748573,2.263056117516828
GA-10,44819697,-4.371629696400038
SK-LU-1,5328940,2.135141890787423
SW1116,46199207,1.946479167853303
LP-1,49836020,4.554043159133258
SK-LU-1,119607,6.001456965804157
TCCSUP,11626560,1.9975269088878715
RCM-1 [Human rectal adenocarcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.948451755079763
MHH-CALL-4,navitoclax-PLX-4032 (1-1 mol-mol),-0.9689579995698394
KO52,vorinostat-navitoclax (4-1 mol-mol),-2.6787404148123843
SCC-9,23582824,0.351039434592286
SW1116,68056272,3.569491362563028
LP-1,56946209,-7.445314312410024
EJM,42642645,0.830143723901443
PE/CA-PJ15,24856436,-0.9774495657955756
LP-1,51037431,1.4884414714711065
KHM-1B,JQ-1-UNC0638 (2-1 mol-mol),-0.1764853483992549
PE/CA-PJ15,123631,2.5337035997034416
LS411N,60700,1.793788628592944
CFPAC-1,675434,5.342189943967745
Mino,selumetinib-PLX-4032 (8-1 mol-mol),3.9671106010727217
SK-MES-1,23635314,-3.4744985304514193
SNU-119,24748573,1.250225793254589
BT 231,5978,-3.907360667865921
SCC-9,44819697,0.1293575980749295
KO52,16038120,-0.794820665214537
RCM-1 [Human rectal adenocarcinoma],71304818,3.0028368617128485
NCI-N87,216239,2.2423368269273753
NUGC-4,44185566,2.5619399378920913
PANC-1,46191454,2.3629858574520877
NUGC-4,421610,4.150369019906594
SKM-1,71304818,2.6002187783001154
EJM,44493528,4.28788220416213
PE/CA-PJ15,44607530,1.5447595133665166
NCI-H2087,46843906,1.8206074943568136
YH-13,984333,1.552799653388661
NMC-G1,selumetinib-MK-2206 (8-1 mol-mol),3.5106245073036533
LP-1,702558,5.623494141000795
YH-13,56649450,3.222212852506819
RCM-1 [Human rectal adenocarcinoma],439501,-1.003670618583837
RT-4,2708,5.689057420087821
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291
HMCB,168312962,-2.518156127893363
REC-1,10427712,4.273957814608531
EJM,5287969,-2.456057382836623
NCI-H2122,15953870,4.425905668313166
ALL-SIL,2729026,2.163276094007301
SNU-119,3136844,3.853712010646443
IST-Mes1,49867930,4.491137344342606
BT 231,46843906,3.143973287523026
BT 416,446155,3.29168404944883
Calu-1,4578,4.401519180070133
MHH-ES-1,71466578,3.441983476430958
Mino,17755052,0.7577840200703942
PE/CA-PJ15,31703,-2.4270645825749857
NCI-N87,11175137,1.8903805503335804
HuNS1,168313200,3.7440498292509257
MHH-ES-1,5328940,1.470164677883842
Mino,16038120,0.7971993664500123
TCCSUP,19582717,3.018222004156177
K-562,9933475,1.5582186007451084
CFPAC-1,4521392,5.0571376117681766
HMCB,5328940,1.9903033853027137
NUGC-4,16115403,-4.460614242362947
HD-MY-Z,5978,-4.290130103691472
SW1116,66577038,3.382294797712358
YH-13,ISOX-bortezomib (250-1 mol-mol),0.2310542886202235
SCLC-21H,11364421,-7.0325413918932
SNU-119,15953870,2.479349019849552
REC-1,10385095,3.1459726814165205
SK-LU-1,44185566,2.7012780649071733
BT 416,24797083,-0.0551625110651216
YD-8,1566236,1.8146289426775175
SK-LU-1,selumetinib-GDC-0941 (4-1 mol-mol),2.1643494773787224
Hs 936.T,168312962,2.9547044010897
EJM,54143018,0.5914638722228845
GA-10,421610,1.744859868678241
SK-MES-1,49793307,-5.3645229045015865
NCI-H929,5281672,4.191985707125186
ALL-SIL,25195348,0.8279476297727174
OCI-M1,16722836,0.8325562162266944
SCC-9,6917907,-5.592045136043938
KYSE-30,navitoclax-sorafenib (1-1 mol-mol),1.5903427016571647
RCM-1 [Human rectal adenocarcinoma],10074640,3.542423635061651
K-562,7326481,2.6072018104551824
BT-20,445091,4.3301027691215745
BT 231,44185566,1.0546316421769637
KMS-12-BM,644241,2.605305599492216
NCI-H1395,selumetinib-PLX-4032 (8-1 mol-mol),5.142160466217897
CFPAC-1,25150857,2.1209741587136888
ECC10,10322450,3.1238725703849988
SK-MES-1,107985,-3.478483308855868
KHM-1B,46199207,2.2678395325481415
EJM,11222830,0.9008763267177864
KYSE-30,72193861,3.076411493400163
RT-4,135421197,2.4643711937197756
SKM-1,vorinostat-carboplatin (1-1 mol-mol),1.9252377672335388
ALL-SIL,12003241,-5.746631994241774
KYSE-30,216468,3.903733263505704
BT 416,10074640,2.3041544577355424
NCI-N87,11396600,3.282772907192936
GA-10,5284616,-4.651596018185088
K-562,5287620,-0.244838249137823
BT 416,10302451,2.165106846355265
SKM-1,10074640,3.0692754490442975
T84,11175137,2.115426391732061
KMS-12-BM,68056272,2.2091741251856982
Calu-1,107970,2.841948385775343
LP-1,11625818,3.5429993667205566
NCI-H2122,135398516,2.0801085924622957
SK-MES-1,44491742,3.681896184622424
Calu-1,16038120,1.5322636815892898
NCI-N87,409805,4.5069551273823585
SK-OV-3,4096211,3.632564776557465
NCI-N87,135421197,1.227136310912881
YH-13,5328940,2.7108571472659073
YD-8,5746,2.1470622280203693
NUGC-4,5311,-0.2926627497252436
SCC-9,6918328,0.8244293983868239
KO52,5738263,2.2712409628703027
EJM,3543504,5.026142247155409
REC-1,3825829,3.4040065823648877
YD-8,9926054,2.068126295394322
YH-13,24753719,4.493928762122736
KO52,44202524,1.2331460749640877
RD-ES,25195348,0.2831148755084631
YD-8,55283,2.8386191542284007
SK-OV-3,46843906,3.785109660734252
OCI-M1,JQ-1-carboplatin (1-1 mol-mol),0.7435952415619963
EJM,72734382,3.5540919183880733
KMS-12-BM,11364421,-6.458256547246502
ECC10,55283,1.9610238562807851
SKM-1,56963564,-1.6088992179098347
LS411N,25195348,3.7393125277208608
MHH-ES-1,11152667,-1.0440831311792091
NCI-H929,26596,-1.2167182000669836
YD-8,124202324,2.8742041026946596
KHM-1B,613753,3.0054296749373095
YD-8,11485656,2.558902022570011
LP-1,11977753,-4.286738597307926
KP-N-YN,2828334,5.745986755881843
NMC-G1,76446078,4.114622797464651
BT-20,navitoclax-PLX-4032 (1-1 mol-mol),2.871586118596914
Mino,439501,-5.730054140979018
KYSE-30,44607531,1.5857907732500087
Mino,107985,-5.05206384093963
SNU-119,159324,3.0008353242690045
NCI-H929,446155,1.246736711414303
PE/CA-PJ15,16038120,1.6620887407602336
SK-HEP-1,5287969,-1.6185163943497696
SK-HEP-1,9915743,2.4580731883892293
Mino,445455,3.7050877064136207
REC-1,2828334,6.171020558945514
ECC10,44607531,1.12691172739548
SK-OV-3,285033,-0.1977879636486448
HD-MY-Z,10322450,2.950696163732152
BT 416,11364421,1.5910011194512823
KYSE-140,11222830,1.9406779400436716
GP2d,54618164,4.277742817183889
LP-1,44462760,3.5098563848924886
HCC1833,9936388,0.4384818253571875
LP-1,crizotinib-PLX-4032 (2-1 mol-mol),0.9760238921287656
GA-10,24951314,-0.7447554706520183
RCM-1 [Human rectal adenocarcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.6431753699859777
YH-13,285033,-0.9199224136230332
BT 231,9826308,-1.6750260757425828
BT 416,5287969,-1.8202178508340023
RCM-1 [Human rectal adenocarcinoma],selumetinib-UNC0638 (4-1 mol-mol),2.1355082647556127
KMS-12-BM,3825829,2.160644220643388
NCI-H1395,135398516,2.0913666591316216
OCI-M1,5281321,-0.2436508263261703
YD-8,11612883,2.3714565826019247
NCI-H929,25126798,3.7313671343137673
KP-N-YN,11238147,4.109748623135209
KO52,10322450,3.562187913985661
HCC1833,44543605,4.612923731277743
IST-Mes1,327653,2.848745693869025
HD-MY-Z,25105715,3.6261928405997743
REC-1,9840324,7.889263639418533
SCC-9,135398516,3.38372398158662
EJM,navitoclax-MST-312 (1-1 mol-mol),0.9135656796063774
KMS-12-BM,71680916,2.263503265107647
LS411N,66577038,3.114674219164565
HD-MY-Z,2874250,4.538053938802701
HCC1833,carboplatin-UNC0638 (2-1 mol-mol),2.807509476296878
RT-4,16065773,3.1312717151284155
T84,selumetinib-PLX-4032 (8-1 mol-mol),1.8234671814611212
PL-21,9840324,5.400949433078729
SK-MES-1,119607,5.369677831703797
Calu-1,11404337,1.1287217214353569
GA-10,2733487,3.353247046396602
KYSE-140,24772860,-1.7161918630451445
MHH-CALL-4,387447,-5.003000237478102
SK-OV-3,73707386,3.7899266428434233
NUGC-4,613753,2.5401467318559696
RCM-1 [Human rectal adenocarcinoma],3503,2.644951314615224
KP-N-YN,5335621,3.885676762686134
PE/CA-PJ15,56963564,0.3057615147183591
SCC-9,9967941,4.677287493278682
YH-13,4917,3.8244363131273458
BT 231,2733526,2.595012434274407
MHH-ES-1,3136844,5.32653269194897
ECC10,702558,6.702477881377201
KP-N-YN,1716436,1.9811580159156368
K-562,322968,4.0833948777840225
NCI-H2122,5460769,2.4268150631675067
BT 231,3384730,-0.4293417636159527
PE/CA-PJ15,252682,6.5374935724785335
HuNS1,5746,-0.0479083670268534
KYSE-30,11222830,1.7656397327131668
SKM-1,3062316,1.7707772464859106
KHM-1B,11609586,2.3896686488847343
EJM,15547703,3.175300844457044
KP-N-YN,piperlongumine-MST-312 (1-1 mol-mol),1.2105419065772798
SK-MES-1,53481919,3.4267090196948113
SK-HEP-1,409805,5.808157500863876
KP-N-YN,16065773,2.01469339123253
GA-10,3136844,3.529954962395684
KO52,4096211,1.0563203120780016
HuNS1,262093,2.5146440588932397
NCI-N87,44819697,-2.3159908553894932
BT 231,56963564,-0.4890733072784103
BICR 31,24771867,6.325583215176513
YD-8,984333,0.1177037476689329
KO52,9907093,4.4065902785902304
KHM-1B,208908,2.253244414744992
SKM-1,11507802,0.9251203923511582
HuNS1,6918837,-5.127634273735462
NCI-H1395,56649450,3.261892320114533
MHH-ES-1,9967941,2.651964356229795
BICR 31,54618771,0.3365869204450262
KYSE-140,11238147,2.4416751120737437
SK-MES-1,46398810,1.6377670659387842
ECC10,24856436,-0.4628051301707301
RCM-1 [Human rectal adenocarcinoma],44493528,4.389573022277453
HuNS1,1750826,-2.5518373135017196
IST-Mes1,44566777,1.465871694296859
SK-MES-1,6918328,0.1363091952427459
PE/CA-PJ15,46199207,3.270686620801518
SKM-1,322968,1.2808637064656738
GA-10,5335621,2.789001657763211
KO52,11485656,1.6797102251271416
BT 416,9952709,0.9779302899451634
NCI-H929,6914657,-3.822913484179682
OCI-M1,selumetinib-navitoclax (8-1 mol-mol),0.2100060335502565
NCI-N87,24180125,2.059368273959215
NCI-H2122,753704,5.668476615331939
BT 231,327653,3.38465300707193
Mino,9444,3.624046582491275
PL-21,crizotinib-PLX-4032 (2-1 mol-mol),1.4047040338952457
KYSE-140,44185566,2.586521971877553
GP2d,3854666,0.4643191826857844
REC-1,9549297,1.1033414943534166
Calu-1,71729975,3.676587841113591
RT-4,753704,6.379934835187104
KO52,6917907,-6.077503902553056
LP-1,6610355,3.8125244859945
GP2d,49766530,0.1592380212690584
HD-MY-Z,9936388,-7.089387661668647
IST-Mes1,65064,5.185430309398801
NMC-G1,11626560,1.9744552087285
ALL-SIL,57330099,4.126515702027515
TCCSUP,2841722,4.4181775283322
LP-1,51039095,1.4374338323235925
Hs 936.T,selumetinib-BRD-A02303741 (4-1 mol-mol),1.0598371629693188
Hs 936.T,676352,2.614529676161635
HCC1833,5746,1.8779055412891
NCI-H929,11612883,0.7981291863125404
BT 416,44462760,3.8273406561833454
NCI-H1395,31703,-0.5933376727422321
MHH-CALL-4,136227924,1.8406000029443903
HD-MY-Z,3543504,3.36619670574599
REC-1,11656518,-0.6835179208047504
BT-20,568763,0.5190616763024002
HCC1833,11485656,2.071891952669738
SNU-119,5291,3.2986963310167714
Mino,89928392,-0.3907665293577761
Hs 936.T,159324,3.4620555818904473
SNU-119,selumetinib-piperlongumine (8-1 mol-mol),4.5887710430802215
ECC10,262093,1.4663563613449744
KMS-12-BM,serdemetan-SCH-529074 (1-1 mol-mol),1.618935341635423
GP2d,1750826,0.1024615098986996
HMCB,135440466,2.2236465110977988
HCC1833,9927531,4.651328537031639
SK-MES-1,25262965,-3.493687980369939
HMCB,65064,5.473995129472351
NCI-H1395,2729026,3.1697601093173136
EJM,selumetinib-UNC0638 (4-1 mol-mol),4.085374328127957
HMCB,10302451,4.070081150685941
PE/CA-PJ15,selumetinib-vorinostat (8-1 mol-mol),4.124369885528516
L3.3,2708,4.48343396675343
HuNS1,16722836,0.9684642017712062
GA-10,9826308,-1.1991516845279515
EJM,3384730,2.079765680312452
PE/CA-PJ15,11719255,3.5553759448209084
PANC-1,15983966,-4.238151545809434
GP2d,6917907,-5.919478487621494
MHH-ES-1,vorinostat-navitoclax (4-1 mol-mol),0.9369099472043438
OCI-M1,36462,0.2408416750567704
NCI-H929,10231331,2.673485705852421
L3.3,49793307,-1.834464681937742
NMC-G1,5291,3.753085484422811
SK-OV-3,6852167,3.0870556066687076
ALL-SIL,3854666,-1.067048731148745
SCC-9,4705,2.492131143046821
GA-10,676352,1.3695968491821744
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816
SCC-9,168313200,4.072126418899639
REC-1,54619267,3.743801530940776
IST-Mes1,9884685,0.6527999920478087
IST-Mes1,SNX-2112-bortezomib (250-1 mol-mol),1.249422428379272
SK-HEP-1,613753,3.3794099216210203
YH-13,25126798,3.838421818647453
HMCB,54626689,5.696553588626368
BT-20,9823820,4.827750093216814
HD-MY-Z,16720766,0.2959400699854088
IST-Mes1,262093,3.164571948045499
BT 231,46224516,2.839811565474086
SKM-1,11455910,-0.0252675410510007
YD-8,2130404,2.9369369304984994
NCI-H929,6917907,-6.25281779572784
GA-10,24856436,-1.6406397488390518
GP2d,89183176,4.619699223623831
KMS-12-BM,135398738,-0.0456622404629242
SNU-119,5470400,-2.350709459089954
KYSE-140,5746,1.8995481920367356
Calu-1,46907787,5.519405311449107
LP-1,6505803,0.6581900547283019
SK-HEP-1,16736978,1.840110323821058
BT-20,crizotinib-PLX-4032 (2-1 mol-mol),2.483327077923299
IST-Mes1,5282054,4.276236228318484
SK-OV-3,3825829,4.139200001280225
HD-MY-Z,tanespimycin-gemcitabine (1-1 mol-mol),-2.008514678569669
KO52,71751553,4.277873961450632
SK-LU-1,24856436,0.4718063341141958
GP2d,24797083,0.7001070182879497
KHM-1B,753704,4.849440364052096
TCCSUP,44137675,4.277803621948158
PL-21,6918328,-1.7172208759149643
OCI-M1,135999136,1.5304010424247585
SCC-9,148124,-0.9222891029936632
SCC-9,25062766,2.812414712404745
YH-13,JQ-1-carboplatin (1-1 mol-mol),2.725669158848688
LP-1,10296883,3.461993801411865
EJM,19582717,2.2813420198916057
HuNS1,10113978,2.8192618407751997
NUGC-4,441298,2.3127789660824787
PE/CA-PJ15,navitoclax-birinapant (1-1 mol-mol),3.0394243463811947
GA-10,8515,2.077027098708472
NCI-H929,2733487,7.111048494668631
HD-MY-Z,decitabine-navitoclax (2-1 mol-mol),3.2068020156284103
RT-4,1242560,3.444710229960461
KHM-1B,10077130,2.7522927679914764
KHM-1B,375860,-0.460638651136882
ECC10,17755052,0.3308548556784899
SK-HEP-1,46926350,-4.110479335135347
ALL-SIL,11404337,-1.8413362349398936
KYSE-140,2733487,6.376652092069619
SNU-119,3543504,4.346237641095953
SK-HEP-1,568763,1.0235069184223942
GA-10,374536,0.5877741453587988
SW1353,135421197,2.4746920364366813
KYSE-30,SNX-2112-bortezomib (250-1 mol-mol),-2.492596571797035
BT 416,42642645,1.3900431170994498
NMC-G1,3081361,3.0599924907831895
BT 231,JQ-1-UNC0638 (2-1 mol-mol),1.753830985652589
HuNS1,327653,2.9841027206252693
KYSE-30,984333,0.3390157316010456
GP2d,135421197,2.1727622250503607
RCM-1 [Human rectal adenocarcinoma],1716436,2.8487797947795226
YD-8,sirolimus-bortezomib (250-1 mol-mol),1.3877197149953842
GA-10,selumetinib-UNC0638 (4-1 mol-mol),2.4586035796079377
LP-1,2858523,2.3042914911869894
ECC10,107970,2.546230477639249
KP-N-YN,252682,6.403272363263141
NCI-H2087,52947716,2.1720070424371736
TCCSUP,1242560,4.927972037074151
SNU-119,107985,-4.156641254925639
SW1116,44607530,0.7411625024848351
MHH-ES-1,49793307,-3.93547942147797
NCI-H929,6918328,-1.4176016400848788
PL-21,5113032,6.174075139837442
KYSE-140,400769,-0.3341278036120317
RCM-1 [Human rectal adenocarcinoma],7326481,3.471788060157272
BT-20,11152667,0.257803129551301
GP2d,11626560,0.9072355984649664
EJM,46215462,1.2684837092951116
KP-N-YN,selumetinib-piperlongumine (8-1 mol-mol),2.5271853068539007
NCI-H2087,11214940,0.943381318730014
NCI-H929,24785538,-4.700293187910172
BT-20,19582717,5.49233588048388
MHH-CALL-4,docetaxel-tanespimycin (2-1 mol-mol),-8.461196270049415
NUGC-4,44259,0.9295237176631608
SKM-1,6610355,3.573663853963525
KO52,11719255,2.53220812210846
T84,2858523,2.9553548390882396
EJM,52947716,-8.188732553251715
BT-20,71576739,5.146266378732292
YH-13,5738263,3.9080181125060496
K-562,216345,3.9110155346915088
PE/CA-PJ15,6918837,-2.413311422436222
KHM-1B,24951314,0.1876551064877586
KMS-12-BM,UNC0638-navitoclax (1-1 mol-mol),-0.7236362684252565
SKM-1,72734382,3.266871379316779
Calu-1,tanespimycin-bortezomib (250-1 mol-mol),-0.0246421056522193
EJM,11364421,-6.655313631459131
Calu-1,44484893,5.291433468555397
IST-Mes1,25183872,0.0748637978909832
BT 231,44462760,4.224272414163622
HCC1833,17755052,3.990205376393325
SK-LU-1,3038522,3.067154256205729
RT-4,168313047,2.65705548195288
SW1353,25062766,1.8691441322330145
SW1353,carboplatin-UNC0638 (2-1 mol-mol),3.8668738630268953
IST-Mes1,285033,-1.625614851116669
BT 231,selumetinib-JQ-1 (4-1 mol-mol),1.4143353306589224
SK-MES-1,49836020,5.814503877703118
PE/CA-PJ15,4578,4.29753811382301
YD-8,46199207,3.544065292305842
NCI-H1395,216468,5.017239605699041
BT 416,7251185,2.1524887519009734
MHH-CALL-4,135984461,1.796074414413381
KO52,227681,2.1146823151840715
NCI-H2122,24771867,4.015433571715332
GA-10,UNC0638-navitoclax (1-1 mol-mol),1.4796624390436783
ALL-SIL,400769,-0.758162988868875
EJM,44819697,1.6195788474548276
BT-20,2945648,3.018067263813061
Mino,12001922,1.9054218463923691
BICR 31,462382,1.217928478873545
SK-OV-3,135411,1.6318689765112546
NCI-H2122,24964624,2.699462901320687
HMCB,25154868,4.752941970603395
ECC10,11626560,0.861296913464706
LP-1,46398810,2.4479203971751837
GP2d,tanespimycin-bortezomib (250-1 mol-mol),-3.105115465971025
BT 416,6852167,0.3489067839841118
KMS-12-BM,24785538,-2.2279414711107943
HuNS1,44607531,1.273712837092094
RCM-1 [Human rectal adenocarcinoma],136227924,3.314624698864007
GP2d,53325874,4.291105221346407
TCCSUP,selumetinib-UNC0638 (4-1 mol-mol),4.619962365310146
YD-8,5287620,-1.9715121639799928
KHM-1B,44632017,0.9077135445845732
GA-10,16659841,2.588141082821255
GA-10,24753719,1.5492278869101457
BT-20,46398810,3.7639919039681526
NUGC-4,2828334,6.231874917754292
NUGC-4,5328940,-0.6179037511738243
NCI-H2122,44507138,1.735795804155247
TCCSUP,3552672,2.292298404994988
NCI-H2122,448949,2.8254643563622746
EJM,11964036,1.6770560082105996
L3.3,serdemetan-SCH-529074 (1-1 mol-mol),2.4729213733544366
SK-OV-3,11404337,1.4011927232423718
YH-13,44819697,0.6102500342217575
BT 416,9884685,0.6464924018321844
SK-LU-1,60750,-5.077706335585912
K-562,44632017,0.5936262556123562
HuNS1,89928392,1.0969931904769918
NCI-H2171,navitoclax-gemcitabine (1-1 mol-mol),-4.23755685830139
TCCSUP,2858523,3.01661264260951
KMS-12-BM,5278396,2.1546808929463164
SK-LU-1,selumetinib-JQ-1 (4-1 mol-mol),1.493691888542625
NCI-H929,73707386,0.8452841513210776
NCI-H2122,3038522,3.5210187486785576
NCI-H2122,57519531,2.1590885158739295
EJM,decitabine-carboplatin (1-1 mol-mol),2.2378968674639363
EJM,sirolimus-bortezomib (250-1 mol-mol),0.0278018018083393
NCI-H2087,8515,3.0210679259054003
YD-8,71304818,2.9643287808222025
Hs 936.T,5311,1.091145388540678
LP-1,46926350,-4.466735427711426
SCC-9,448949,2.996737074861378
PE/CA-PJ15,53232,2.5776765826269528
KYSE-140,6610216,4.474378770774551
BT 416,24753719,4.37847280119279
NUGC-4,439501,-0.6746997916086527
EJM,24771867,4.483722434089688
KP-N-YN,3634881,2.939734626846214
SK-LU-1,969516,2.65844585416981
YH-13,11494412,0.8602319711686647
ECC10,46224516,1.1201497375778384
SK-OV-3,5328940,3.4311724872159903
RT-4,5328940,2.539742147157725
SCC-9,1641662,3.777884166860496
K-562,9915743,1.457381054045144
Calu-1,54618795,3.587937907350159
OCI-M1,12001922,2.3228381013236223
K-562,46191454,1.7723208241237427
PE/CA-PJ15,25126798,3.7492188324293543
REC-1,24797083,0.9947998320631116
KO52,4477,0.8813587896449887
MHH-ES-1,969516,1.269277131770697
T84,24753719,4.006529455935125
SK-HEP-1,5328940,3.1706915881362097
REC-1,44486219,4.077321087019859
YD-8,5329102,1.6984603402864296
BT 231,6610355,3.676503441981049
KYSE-140,9866186,0.1820510816513951
ALL-SIL,24978538,-2.389127379896269
PL-21,2113511,5.722211235466143
KYSE-30,24779724,4.458734114330223
GA-10,675434,3.5356745968660435
ECC10,71466578,1.6532874264127313
GP2d,16038120,-1.0426786091796605
Calu-1,24901704,5.681126679716808
NCI-H2122,119607,5.299319047200422
GP2d,JQ-1-navitoclax (2-1 mol-mol),-2.022930496235738
RCM-1 [Human rectal adenocarcinoma],44819697,-0.1720631569254475
KO52,60750,-4.433214876259525
HD-MY-Z,11955716,-2.3016799990828707
LP-1,36462,3.92598939536504
Calu-1,44491742,5.4818200754646
GA-10,ISOX-bortezomib (250-1 mol-mol),-0.3148206120911699
NMC-G1,navitoclax-gemcitabine (1-1 mol-mol),0.4858087037779586
NCI-H929,15953870,2.0316293430847594
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486
KYSE-140,446155,2.380025556725525
SK-LU-1,654092,-1.297052349889113
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509
EJM,23582824,0.4180774571431987
KYSE-140,11640390,3.14809626698439
BICR 31,5978,2.6862960741960693
KHM-1B,54619238,4.434806888853119
KHM-1B,89183176,4.960393231670367
SW1116,11647372,1.2865378563296934
MHH-CALL-4,54613361,0.2285616190801155
MHH-ES-1,54618771,0.4734030568205798
KYSE-30,36462,2.847864502569603
SW1353,89183176,4.123075466532357
Calu-1,selumetinib-navitoclax (8-1 mol-mol),2.778646223510058
GP2d,24180125,3.074858377776044
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885
GA-10,selumetinib-JQ-1 (4-1 mol-mol),-0.1687986372090924
SK-LU-1,676352,2.322910270277836
Mino,11647372,2.0622770979241727
OCI-M1,11213558,0.8388740142991292
NCI-H1395,10074640,3.7402432932443137
SK-HEP-1,46907787,5.1061569205326505
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008
SCC-9,2746,3.644005246156997
SK-LU-1,9936388,2.205073285427917
HCC1833,6918328,-0.4034914806012608
HuNS1,135398516,1.4857632144514072
RCM-1 [Human rectal adenocarcinoma],11955716,-2.128476517967918
GA-10,9935249,-0.4353694549259401
NUGC-4,11228183,1.316110847756933
TCCSUP,409805,5.441662511172961
RT-4,3503,2.674693598756191
IST-Mes1,3384730,4.026476803757859
IST-Mes1,168312962,2.5289389848934647
KMS-12-BM,9967941,3.0004287957561875
KP-N-YN,24901704,2.109259896123641
L3.3,57519531,2.574296584662942
GA-10,JQ-1-vorinostat (2-1 mol-mol),-1.1650760368609996
K-562,148198,-4.073315546446919
BT 231,16065773,2.11797154709124
BT 231,54678924,1.6000701573616207
BT 231,24978538,1.0231185350753884
K-562,31703,-1.219746708928784
HD-MY-Z,107985,-4.509019468777268
TCCSUP,5479543,3.29896380845353
GP2d,3025944,3.147540015538868
HCC1833,16038120,1.0868600343862114
SK-MES-1,52912189,2.436554835507857
K-562,135398738,1.706304792848783
NCI-H2122,24797083,0.9662329673666722
KMS-12-BM,6852167,1.232935409292076
BT-20,5738263,4.519202953146549
EJM,151289,0.6472385344760342
PE/CA-PJ15,9911463,4.11474968197752
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824
GA-10,carboplatin-etoposide (40-17 mol-mol),-1.1630906679922108
GA-10,vorinostat-carboplatin (1-1 mol-mol),1.3570247077923203
BT 416,navitoclax-sorafenib (1-1 mol-mol),0.2887263526380953
T84,123631,1.6165826438790305
SK-HEP-1,12003241,-1.7510835313415607
NCI-H929,71304818,2.3374127467417467
KMS-12-BM,1641662,2.032988332793844
PE/CA-PJ15,ISOX-bortezomib (250-1 mol-mol),0.1914462809002973
OCI-M1,753704,2.7515273583684583
NCI-N87,439501,-2.2970478950560715
MHH-CALL-4,selumetinib-MK-2206 (8-1 mol-mol),0.0706125781845115
BT-20,25154868,3.052949437470656
TCCSUP,387447,-4.825347113965475
SNU-119,25195348,3.2417646819599444
EJM,5951923,6.145734491390667
GA-10,6252,-5.497722465410686
RCM-1 [Human rectal adenocarcinoma],9911830,2.5852143987743883
HCC1833,5281321,-0.8212247185054649
KYSE-140,387447,-3.3359687565935534
BICR 31,65064,5.259646525120305
Calu-1,53392493,3.689801449787824
KP-N-YN,selumetinib-decitabine (4-1 mol-mol),4.9706863644210335
SK-HEP-1,107970,2.7276242080982405
NCI-H2171,6918328,-2.9240080597430813
ALL-SIL,54618771,-0.3818526805852408
LP-1,24748573,6.271141125625911
YH-13,56963564,0.220500691161984
KYSE-30,11626560,2.1600894399152
IST-Mes1,5738263,4.045528078129119
SK-MES-1,5746,-0.870099041222338
ALL-SIL,36462,-1.376242093473402
SK-HEP-1,400769,0.2777482831309371
SK-MES-1,73707371,5.7954352649159615
NCI-H1395,1716436,2.423237318066945
YD-8,1716436,3.08383873816405
SK-OV-3,8515,5.143916520422132
NCI-H929,241158,1.4883272197282302
KYSE-140,24901704,4.0115836326370955
IST-Mes1,44607530,1.064599314990069
SCC-9,25126798,4.663845786250664
NCI-H929,23725625,4.820953347318842
NMC-G1,UNC0638-navitoclax (1-1 mol-mol),2.0372459349033716
HMCB,44607531,1.498982144758814
KO52,salermide-PLX-4032 (12-1 mol-mol),5.165396088213933
KMS-12-BM,984333,0.8199562104848779
SW1353,44507138,1.5435913214086072
HuNS1,675434,3.930981650044364
SNU-119,9911830,2.5015276348474424
HuNS1,JQ-1-MK-0752 (1-1 mol-mol),2.076870057609859
KYSE-30,568763,0.9704106301153902
YD-8,44185566,2.6803137078691868
HCC1833,2113511,5.655259753724088
SK-MES-1,selumetinib-BRD-A02303741 (4-1 mol-mol),2.5310781440623344
T84,2749,1.2321718996298616
SK-MES-1,4788,6.082605697619866
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034
NCI-H2122,3025986,-1.0858563149695457
BT 416,2842253,6.132375295328377
KHM-1B,JQ-1-carboplatin (1-1 mol-mol),-0.2133455800101861
Calu-1,2858523,3.1915519917183977
Mino,24951314,-0.3531134794009772
Calu-1,9927531,5.244935764908175
BT-20,11167602,1.9201106442116993
NUGC-4,6505803,-2.369150454841633
EJM,10427712,3.7734158708408585
EJM,387447,-5.475320927013608
Mino,3854666,0.1564706607141011
SK-OV-3,24821094,3.4952627197751744
GP2d,16659841,2.451399138328966
GA-10,11497983,-5.786944225124696
YH-13,613753,3.198655088804402
KO52,51039095,1.8517691823265992
T84,25126798,4.059865033599842
GA-10,613753,0.9389967861859032
SW1116,71304818,2.4767125599161077
MHH-ES-1,1641662,2.7424944981593264
HMCB,44185566,3.1081163889895107
YH-13,5278396,4.665825083326453
MHH-CALL-4,9967941,2.943619844327406
HMCB,selumetinib-GDC-0941 (4-1 mol-mol),1.81562386250498
HMCB,11222830,1.7352561808770213
KYSE-140,51039095,3.4797822876243822
SK-LU-1,selumetinib-piperlongumine (8-1 mol-mol),4.491237205009353
KHM-1B,36462,-0.5615447034427615
REC-1,44137675,4.048277998263935
K-562,462382,0.6666012292356907
BT 416,136227331,3.8203373209104425
ALL-SIL,24901704,-0.1489296834412312
GP2d,53232,1.0818158382559078
K-562,5335621,4.97915810125604
YH-13,12003241,-0.7443010060517422
GA-10,71466380,3.314272234212427
EJM,10026128,6.2528613872855
Mino,11494412,-0.5549437780850603
Mino,23582824,0.1492971367341559
KMS-12-BM,613000,1.9257169552973945
NCI-H2171,6505803,-0.0596794204500112
K-562,25154868,2.7747166739598264
SK-MES-1,4261,1.6566487273653536
SNU-119,decitabine-carboplatin (1-1 mol-mol),5.089069342690692
Calu-1,168312962,4.015484368361019
SW1353,135875424,4.282925625560305
SNU-119,156414,0.2348404717120807
ECC10,doxorubicin-navitoclax (2-1 mol-mol),-2.825901096393697
RT-4,10074640,3.33667314177338
TCCSUP,36462,2.278863397956304
PL-21,216468,2.4554470747810093
T84,selumetinib-UNC0638 (4-1 mol-mol),1.2729976695311669
KYSE-140,9868037,2.3848747025475343
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545
MHH-CALL-4,65064,2.937630066356199
NCI-H2171,SNX-2112-bortezomib (250-1 mol-mol),-3.076194221484089
KHM-1B,5291,3.0747502676954896
HMCB,54618771,0.8772324111806863
PL-21,9887053,4.195389959181903
KYSE-30,9911463,3.831121744516391
OCI-M1,71466445,1.3804412160808055
NCI-H2122,54454,2.331318444581659
NUGC-4,6918736,-1.8477099894468072
KMS-12-BM,26596,-3.7364157309734822
NCI-N87,selumetinib-UNC0638 (4-1 mol-mol),3.172064031081815
HCC1833,675434,4.014293244871498
BT-20,16038120,2.004700968773328
IST-Mes1,46224516,1.3511239581863117
PE/CA-PJ15,5284616,3.1038537418820424
REC-1,67291369,4.7132158410784335
KMS-12-BM,135984461,1.7287315424792562
Calu-1,44462760,6.169055769993314
SK-MES-1,3025944,3.866273066638101
SW1353,72376,-1.6927128564591811
KYSE-140,3815108,3.2147475210926117
YH-13,375860,-0.5335760796053879
TCCSUP,16722836,1.624255919263104
SK-MES-1,3634881,3.4287996468131676
BT 416,16720766,-1.8592771684617897
ECC10,25150857,0.9546937315993352
GP2d,44819697,2.6618357091645497
EJM,vorinostat-carboplatin (1-1 mol-mol),2.441111900525166
KP-N-YN,24978538,1.5410268863605194
BT-20,navitoclax-gemcitabine (1-1 mol-mol),0.5564563293956165
KMS-12-BM,67291369,0.9867493208502254
SK-MES-1,6852167,2.1535089151807796
BT-20,54765302,4.765762572946012
KO52,ISOX-bortezomib (250-1 mol-mol),-0.2750046766745305
EJM,selumetinib-JQ-1 (4-1 mol-mol),1.9175380074632984
MHH-CALL-4,11960529,3.9239713193290138
KYSE-30,5113032,5.243607461564291
NCI-H929,46398810,2.168604614407646
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991
KYSE-140,ISOX-bortezomib (250-1 mol-mol),1.3135516462016776
Mino,11222830,0.964275075802594
Hs 936.T,11427553,3.649276718306068
SK-HEP-1,25150857,3.0587845310763297
SK-LU-1,11152667,-2.9662561957508906
NUGC-4,4096211,1.514839578253823
CFPAC-1,doxorubicin-navitoclax (2-1 mol-mol),0.3948619337920385
KHM-1B,25183872,-1.3979896685185154
NUGC-4,24785538,1.641009370295867
T84,44486219,4.1008211665006185
ALL-SIL,4788,4.920956242868583
KP-N-YN,9911830,1.0744667275955389
NCI-H2087,16722836,0.2038633147097248
GA-10,vorinostat-navitoclax (4-1 mol-mol),0.1837452988438349
KO52,216239,1.4330207183659796
MHH-ES-1,17759555,3.628529667106272
ECC10,24821094,3.0917792832979947
GP2d,vorinostat-navitoclax (4-1 mol-mol),-2.5719651189907315
YH-13,46843906,3.1529849009094604
RCM-1 [Human rectal adenocarcinoma],navitoclax-MST-312 (1-1 mol-mol),1.2670160922961198
NUGC-4,9915743,-4.1416967256258275
EJM,5278396,3.1726685526501357
TCCSUP,25102847,1.617856098484916
KMS-12-BM,123631,1.8519032403273297
PE/CA-PJ15,16722836,2.3675136645426886
NCI-H2087,5328940,1.5306007396833192
BT 416,carboplatin-etoposide (40-17 mol-mol),1.7794058047699564
PL-21,67156097,-2.424176779960811
NUGC-4,10231331,-2.888773769193711
BT 231,156414,0.9770079511825466
BICR 31,2945648,3.0787524499283023
KO52,54618305,4.665930774043992
L3.3,crizotinib-PLX-4032 (2-1 mol-mol),2.765628359334359
NCI-H2122,24785538,0.181609628831692
EJM,15953870,3.026448270110203
TCCSUP,3815108,3.0276070568390208
YD-8,2945648,2.8008863810505873
TCCSUP,445091,4.296569463067844
KO52,7251185,1.4009576735019478
NCI-H2087,16065773,0.7027372360550905
OCI-M1,5284616,3.203980354251189
ALL-SIL,36314,-6.574209880787115
OCI-M1,5311281,3.3079844111039605
HCC1833,52912189,2.689255858444195
KP-N-YN,5746,0.0652388687893603
PL-21,3634881,2.344702387875266
Mino,9826308,-0.261908335215675
TCCSUP,135875424,4.238752084680578
NCI-H2122,5746,2.07515100154515
IST-Mes1,2871966,0.3614602719279896
BT-20,3038522,3.6508670608982
NUGC-4,9823820,3.790212156502799
Calu-1,24785538,2.379547891143732
KP-N-YN,613753,3.33616925751496
SCC-9,71466380,4.753733846444339
T84,11234052,3.8903080142469384
KHM-1B,65628,3.60559222842334
HD-MY-Z,2746,3.1927944542914393
TCCSUP,selumetinib-vorinostat (8-1 mol-mol),2.3847964981208305
NUGC-4,9444,3.8894622480366383
PL-21,126941,-5.133641390216976
BT 231,25102847,2.3025793027676005
SK-LU-1,46843906,3.001722994570029
PE/CA-PJ15,89928392,2.0830072880843407
LP-1,208908,1.2784553511025964
MHH-CALL-4,11427553,1.4086468966794097
HuNS1,24753719,3.3564356231301997
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272
NCI-H2087,2742550,3.773914514591571
RT-4,44589607,2.871102674918077
SW1353,66577038,2.978276859973831
PL-21,5280436,3.162893827524994
PL-21,9915743,0.5916230612831309
NCI-H2171,vorinostat-navitoclax (4-1 mol-mol),-0.1406498808904326
SKM-1,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.9272317692561286
LS411N,3503,3.033347172376105
IST-Mes1,8515,4.272788297141445
HCC1833,387447,-2.8576374016585593
LS411N,322968,4.732979049951269
CFPAC-1,3503,3.715652865343299
ECC10,5329102,1.1436130603127903
SK-HEP-1,54618164,4.274964046269975
BT 416,25262965,1.123951948341381
NCI-H2087,24797083,0.710702537051047
EJM,11494412,-0.937899289743814
K-562,107985,-3.1543528536618175
NCI-H1395,9911463,3.814426972193391
ECC10,9868037,1.7411053203163678
SNU-119,24856436,-0.7380975951321199
SK-MES-1,446155,1.5956707369584642
NUGC-4,51039095,3.2439913202582806
BT 231,5281321,-2.615005478223511
SK-LU-1,selumetinib-vorinostat (8-1 mol-mol),3.1775151004152327
HuNS1,9911830,1.8724721971945
BT 416,docetaxel-tanespimycin (2-1 mol-mol),-3.550390683973519
PANC-1,3825829,4.298668056806913
ALL-SIL,6917907,-6.413711962559719
ECC10,50905018,3.4798802532324715
KO52,9935249,-1.4350246650055785
NCI-H2087,49850262,2.9155688585633723
REC-1,9952709,1.1972813100462671
K-562,753704,4.7227938780788525
LP-1,67156097,-1.593985671542244
LS411N,23635314,4.011909681168236
KYSE-30,148198,-4.331453900167214
IST-Mes1,11626560,1.5280230569409714
TCCSUP,984333,0.6886079351975192
REC-1,46174525,6.333082683836244
LS411N,11640390,3.2208706785393972
GP2d,10410894,1.8105455435792843
HD-MY-Z,24889392,3.275325865053587
Mino,4578,3.980827928195005
OCI-M1,9915743,0.9472890233124052
HMCB,46174525,5.186938834845106
NCI-N87,piperlongumine-MST-312 (1-1 mol-mol),3.209921452990857
SNU-119,156422,3.70265719969244
SCC-9,54596490,5.620994411748341
K-562,168313200,4.769830643466651
HD-MY-Z,6184667,1.7016139360284788
BT 231,6917907,-4.654838950959951
LP-1,100016,3.986438392754067
HD-MY-Z,2871966,0.1968671611799685
SKM-1,123631,1.8909946005603888
HD-MY-Z,53325874,5.342220535934317
GA-10,72376,-4.851128645885253
HMCB,6918837,-1.783371825238031
KO52,11955716,-1.8953160699263083
NUGC-4,54618305,4.338411628407715
NCI-H2171,72193861,0.5955631718249997
ECC10,2733487,6.098826521375279
NCI-N87,25262965,-2.609521679715104
SK-MES-1,2871966,-1.1534282362109316
SK-OV-3,25126798,3.9960730178767
SK-MES-1,19582717,3.321231910760304
BICR 31,5470400,2.045329114611378
BT 416,BRD-K55473186,3.472836361385916
MHH-CALL-4,25105715,4.362381174565311
K-562,241158,3.183928650435804
NMC-G1,6918289,3.683085239257581
SW1353,6918837,-3.126798270137444
KYSE-30,11364421,1.2708704607195105
OCI-M1,73707398,0.9723798314394978
K-562,1750826,1.7671131923879069
NCI-H2087,17759555,2.7131182468145094
GP2d,16065773,-0.6419253912236432
CFPAC-1,selumetinib-UNC0638 (4-1 mol-mol),4.813387349711308
GA-10,24748573,1.1157188776057034
KYSE-30,6918837,-0.7759527113737986
Hs 936.T,6918328,0.000302475993312
NCI-H2122,doxorubicin-navitoclax (2-1 mol-mol),0.6410326105364317
SW1353,44185566,2.622697695184835
NCI-H2171,31703,-2.460746582121975
SK-LU-1,42642645,0.8775390823653701
KP-N-YN,322968,0.8564337119258101
BT-20,9935249,3.213936920036377
NCI-H1395,1750826,-3.702055011401398
HCC1833,24951314,1.1878125719847017
BT-20,439501,-1.326762104121763
HD-MY-Z,25126798,4.053758271063738
L3.3,SNX-2112-bortezomib (250-1 mol-mol),1.42333058116923
IST-Mes1,3552672,2.081532957284865
CFPAC-1,135398516,1.9680871618712263
Mino,54143018,0.7076567343942599
PL-21,3503,1.317657846020735
KO52,navitoclax-birinapant (1-1 mol-mol),-2.4193601330067267
NCI-H2087,11485656,1.6190221901711597
BT 416,24775005,3.510712504326528
BT-20,135411,0.3232772298643774
SCC-9,46174525,4.3512864598075645
SCC-9,5351362,1.6846115382104403
KHM-1B,66577038,2.058186544179473
REC-1,171352865,4.0553194235264565
MHH-CALL-4,15547703,2.791215688355792
LS411N,3384730,4.573317632228089
HD-MY-Z,24771867,3.876330004015234
PE/CA-PJ15,10127622,7.137745593026455
BT 416,107985,-3.986056469995941
HMCB,tanespimycin-bortezomib (250-1 mol-mol),1.0972296557807748
PL-21,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.2651691142170538
LS411N,57330099,4.386912904802011
EJM,3689413,-2.394173462666658
MHH-CALL-4,44185566,1.2423213278505876
CFPAC-1,119607,5.782681476918433
NCI-H2122,selumetinib-PLX-4032 (8-1 mol-mol),4.226719202159174
REC-1,168313047,5.738652550951113
MHH-CALL-4,10302451,3.4549917451264376
CFPAC-1,4788,5.974963871846945
L3.3,44137675,3.3686484205760783
HCC1833,doxorubicin-navitoclax (2-1 mol-mol),-1.5618244827810448
NUGC-4,52947716,-4.935548127872908
NCI-H2122,446155,3.7567026854261822
BT 416,4378219,1.879572994125315
YD-8,168312962,3.8254536486741
NCI-H2087,5329102,1.496553621265363
NUGC-4,9866186,3.0019545940286188
BT 231,3025944,4.323894643334333
KP-N-YN,6252,0.7362669321022957
T84,54626689,4.466094804413681
T84,24901704,2.833647875514428
KHM-1B,67291369,-0.148329679394903
Hs 936.T,439501,-0.3006494435216346
LP-1,42642645,0.4780260401875633
HD-MY-Z,10184653,1.319172449038245
NCI-H2171,6918878,0.0284372668850805
SK-MES-1,decitabine-navitoclax (2-1 mol-mol),3.8775364196295614
NCI-H1395,71680916,4.653034119360089
MHH-CALL-4,3025944,4.291249551145643
KHM-1B,53232,4.4462743832167035
L3.3,123631,2.1308858538649456
HCC1833,66577038,3.4582996639123973
KYSE-140,5280436,3.881516381331721
YH-13,JQ-1-MK-0752 (1-1 mol-mol),1.712752654360266
KO52,613000,2.3498906607917345
BT-20,16065773,1.5799292112926957
KHM-1B,6918837,-4.542516260541086
RCM-1 [Human rectal adenocarcinoma],selumetinib-PLX-4032 (8-1 mol-mol),2.814367803640325
KO52,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.410719813767284
K-562,675434,4.134192231732703
TCCSUP,613753,3.3276324574262595
LS411N,4259181,-1.386635238211632
BT 231,262093,2.1267355779539043
SKM-1,11404337,-1.0204518416697923
L3.3,409805,5.10307456372432
NCI-H929,216239,2.215366899845667
ECC10,tretinoin-carboplatin (2-1 mol-mol),1.5648064958075267
HD-MY-Z,25150857,2.9397305709542336
NCI-N87,5281672,5.2421020595736145
YH-13,11364421,-5.428256768560988
SCC-9,19582717,4.601399638975327
KO52,9967941,3.749170046879557
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573
EJM,36314,-6.683540661368917
BT-20,11626560,3.225950275935103
YH-13,carboplatin-etoposide (40-17 mol-mol),2.297149147603289
KO52,46907787,0.3317813334576328
RCM-1 [Human rectal adenocarcinoma],doxorubicin-navitoclax (2-1 mol-mol),0.7949647024919319
YD-8,122327,5.600297817210885
EJM,16013152,4.173303948908386
TCCSUP,107970,2.506866971737107
T84,11152667,-1.571698746124204
KMS-12-BM,4261,-0.5795047711854386
NCI-H929,5328940,1.4271750635710874
GP2d,6184667,2.6209144371388584
SK-MES-1,89928392,1.5910950872483105
NCI-N87,25126798,3.678424158745535
EJM,10385095,0.7131434808495797
NCI-H2087,4378219,1.8758721744956532
L3.3,151289,1.4499844825237675
KHM-1B,6252,-0.4471831766807136
BICR 31,25154868,5.458998944130281
HuNS1,42642645,0.896475462112374
PL-21,11640390,0.2929164182210664
T84,3025944,4.0086737635943015
YD-8,4261,2.40406466094162
HCC1833,decitabine-navitoclax (2-1 mol-mol),0.6902281696562813
Hs 936.T,25150857,2.547308817592623
SK-OV-3,44607531,1.947967745365508
HuNS1,2945648,2.6549247092052948
SNU-119,3038522,3.3866164987543654
BT 416,24180125,3.4995177261532917
SK-LU-1,52947716,-6.616414912691702
KYSE-140,3081361,0.8245946460769855
MHH-CALL-4,2858523,3.298495833712847
BT 416,56946209,-4.431637728617736
BICR 31,23582824,0.6119811525421108
BT 231,42642645,0.5530706708925721
KYSE-30,3062316,3.3099989140957224
YH-13,11609586,3.847087958422487
ECC10,ISOX-bortezomib (250-1 mol-mol),-0.4407540027695711
YH-13,216239,3.5317850372057875
K-562,135928012,4.4390204871751004
SK-HEP-1,216239,1.5998975447874937
SK-MES-1,11404337,-1.915365805563204
SCC-9,2708,5.420316309291021
SK-LU-1,54619267,4.696393718154956
PE/CA-PJ15,107970,2.9199181042545175
KMS-12-BM,11626560,0.494949626901472
PL-21,24901704,2.300132638715388
GP2d,selumetinib-vorinostat (8-1 mol-mol),0.6453511281872317
KYSE-140,4788,5.176752889720467
NUGC-4,5335621,4.382733161086734
BICR 31,5746,2.9612823230829592
YH-13,1566236,1.6600939078751014
SK-HEP-1,148124,3.734435411699081
PE/CA-PJ15,25102847,1.6675486463652875
KO52,44607530,1.0930355607333748
KYSE-140,6623618,2.3250765212302897
IST-Mes1,11214940,2.2228722379077857
YH-13,9911830,3.324457602349572
T84,11396600,3.8176066701556097
OCI-M1,67291369,0.1664122834739855
T84,tanespimycin-bortezomib (250-1 mol-mol),-1.3994092588399578
T84,9444,3.8801824453951768
YD-8,4096211,2.9365859982689315
NCI-H2122,11152667,-1.4729705548083307
GP2d,219104,2.28936808169178
SCC-9,5113032,4.570528604758655
NCI-H2087,374536,3.0815602143438063
LP-1,10077130,1.84659249728176
ECC10,11656518,-3.0324589202240766
BT-20,3081361,3.694279188223134
Mino,5284329,2.368517389837049
LP-1,9908783,6.464663880364035
GP2d,135411,-1.1735255015444224
L3.3,6918837,-1.6341527445290025
Mino,11427553,0.4102586601648044
NUGC-4,17759555,2.770643719612597
NCI-H2171,5470400,-1.4637445210918176
NUGC-4,11717001,3.163491321526164
SW1353,5746,1.8105017027876624
IST-Mes1,selumetinib-JQ-1 (4-1 mol-mol),0.7556363714344752
HMCB,16725315,3.1918238782276274
KP-N-YN,24753719,5.28590811634551
LS411N,159324,3.2133975478450005
NCI-N87,135411,0.0487965919912929
LP-1,15953870,3.7751814331512374
TCCSUP,71466578,6.231469242081688
YH-13,5282054,3.978961263004533
ECC10,56963564,-1.120982874389056
KO52,2126,4.780292619636026
SK-MES-1,5311281,1.8155139862012863
ECC10,241158,1.496418149137826
SK-HEP-1,2858523,3.173409588420467
Calu-1,3503,2.863271339521392
TCCSUP,5738263,3.424558088510442
YH-13,219104,3.421374487028668
HD-MY-Z,5284373,2.676730239507334
RCM-1 [Human rectal adenocarcinoma],5351362,2.343495237192863
BT-20,docetaxel-tanespimycin (2-1 mol-mol),-2.949758163197872
ECC10,16065773,1.756990462787944
LP-1,selumetinib-UNC0638 (4-1 mol-mol),3.598569631630244
PE/CA-PJ15,2746,3.741230111498992
OCI-M1,2708,3.214265942769868
GP2d,4261,1.0610537032314933
PE/CA-PJ15,5281321,-0.9819012025134504
Hs 936.T,387447,-2.8293562515845303
HD-MY-Z,19582717,4.070144676803784
LS411N,1242560,3.5784744482633526
NUGC-4,9826308,0.5751236933539428
KHM-1B,navitoclax-pluripotin (1-1 mol-mol),-0.8283845367813834
Hs 936.T,24180125,3.7813502708248543
TCCSUP,11656518,3.701677280495769
NUGC-4,44819697,3.4348600181893096
KYSE-140,49850262,4.153315070744595
KO52,selumetinib-tretinoin (2-1 mol-mol),-1.7708890002818076
KMS-12-BM,selumetinib-PLX-4032 (8-1 mol-mol),4.308028949995008
SKM-1,ISOX-bortezomib (250-1 mol-mol),-0.1246400707539527
REC-1,11507802,2.8362664340225336
KP-N-YN,decitabine-carboplatin (1-1 mol-mol),5.119162388965738
HCC1833,135875424,4.246764438360678
EJM,24180125,2.4307327863044215
BICR 31,66577038,3.1838871840280745
LP-1,44137675,2.223248309466022
NCI-N87,9926054,1.7069639615174013
NCI-H1395,5291,4.092601973794721
SK-MES-1,3038522,1.7595539425094844
PL-21,44493528,4.151130838756699
PL-21,selumetinib-UNC0638 (4-1 mol-mol),0.9893975626993124
SW1353,selumetinib-navitoclax (8-1 mol-mol),3.799239761958488
HCC1833,2733487,6.3312937695995135
YD-8,3025986,-0.972358646883598
KHM-1B,9903786,1.5275790345873377
IST-Mes1,5287620,-1.7840398419727848
ECC10,carboplatin-etoposide (40-17 mol-mol),1.0392367142139654
SW1353,11485656,2.8326664945571585
RT-4,262093,3.3301279648450985
ECC10,5284616,-0.6216751840767866
NCI-H929,448949,0.7498835801993375
SNU-119,16720766,2.4248018282214283
YH-13,11175137,1.3907833057777284
ALL-SIL,5328940,-0.9694628184696558
NCI-H2087,2945648,2.5875219223308217
RCM-1 [Human rectal adenocarcinoma],969516,2.888727843593038
ECC10,navitoclax-birinapant (1-1 mol-mol),-3.5515994945424088
L3.3,JQ-1-vorinostat (2-1 mol-mol),2.1502729900256807
SCC-9,selumetinib-decitabine (4-1 mol-mol),6.773727258865908
BT 416,24856436,0.8376916107911017
NCI-N87,327653,3.392428289503534
K-562,52947716,-5.609155633475852
Mino,216345,4.029583591343141
YD-8,10385095,1.4410870728115226
KMS-12-BM,9825149,-0.3079276938801488
HD-MY-Z,tretinoin-navitoclax (4-1 mol-mol),3.9365042015375895
YD-8,3552672,2.336510078255813
BT 231,54619267,3.814646353416104
RT-4,16720766,0.1240040302001555
K-562,446155,2.553560117982406
NCI-H2087,9936388,0.7446762448927194
RT-4,54618771,0.6660630053371256
BT 416,76446078,3.7973677296033985
MHH-ES-1,2729026,2.110594567233672
KYSE-30,44607530,2.546020907094906
BT 416,49867930,4.774057067985877
L3.3,5282054,4.901570069575592
PE/CA-PJ15,3543504,4.175307132679089
Mino,3081361,1.5829486381821456
PL-21,67291369,0.5767887226558264
LP-1,73707398,-0.084919728706542
NUGC-4,navitoclax-sorafenib (1-1 mol-mol),1.7368702982102793
KO52,5281321,-1.995850617560654
HCC1833,selumetinib-GDC-0941 (4-1 mol-mol),1.758331297818262
HCC1833,10302451,4.238662713191706
RCM-1 [Human rectal adenocarcinoma],10231331,1.8254668182041616
NCI-H2087,71304818,2.297325053405267
Calu-1,5743,4.123291215769493
GA-10,2113511,3.0495634516255454
LP-1,6852167,-0.3749906746995474
KHM-1B,44819697,-2.627948052735268
KMS-12-BM,71466380,3.5437906276884696
PL-21,11222830,1.6455328143941927
RT-4,16722836,1.304866960728928
K-562,67156097,-2.769244311294464
ECC10,613753,2.3906569427718325
SK-MES-1,24951314,1.1601588898404858
ECC10,49846579,-1.2719167852373725
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146
NCI-H2122,16038120,0.6885476489619462
K-562,216468,1.7844503846326911
PE/CA-PJ15,11612883,3.8104677239271223
YH-13,53232,2.004863331527642
SNU-119,10184653,0.0248827318699143
GP2d,168312962,-2.908633188761252
SK-LU-1,4788,5.9337305596170005
Hs 936.T,409805,5.094755228809154
L3.3,216239,2.590745343804584
KP-N-YN,10385095,1.8219052928535877
PE/CA-PJ15,56949517,4.259049323571045
SK-LU-1,16065773,1.0228404185914202
NUGC-4,6917907,-5.633454980572077
BT 416,702558,5.184330994828571
GP2d,1716436,0.8160283183138299
NCI-H2171,24821094,2.9775477594317743
NCI-H2087,24978538,1.6332924374636402
NCI-H929,44589607,1.024401977018112
SNU-119,navitoclax-gemcitabine (1-1 mol-mol),1.782334179456962
TCCSUP,241158,3.99107653461265
PE/CA-PJ15,11228183,2.954707650998396
MHH-ES-1,44484440,3.491046763532364
CFPAC-1,9936388,2.1130645315651444
ECC10,24180125,2.9361406436920694
T84,6918638,0.2315605213048026
KYSE-30,10127622,1.6031638387509832
OCI-M1,1474550,4.415420788056462
Calu-1,JQ-1-UNC0638 (2-1 mol-mol),5.348468381568823
RT-4,89928392,1.3155194503405725
PE/CA-PJ15,24889392,3.817168154957895
KHM-1B,159324,1.2436512528819574
BT 416,16219061,2.4071922214319432
KHM-1B,serdemetan-SCH-529074 (1-1 mol-mol),1.1284922177320384
NUGC-4,11427553,3.2801832373646898
SK-MES-1,9956119,3.983604839849025
SK-MES-1,2733526,4.186745528268056
BICR 31,24772860,-2.497965982707089
NUGC-4,52912189,-0.3043141171391114
NUGC-4,126941,-2.084104979182055
NCI-H2087,2729026,1.600072577840739
NMC-G1,selumetinib-navitoclax (8-1 mol-mol),3.9904667984080344
REC-1,3025944,4.955899940581851
NUGC-4,tanespimycin-bortezomib (250-1 mol-mol),-1.8387633895820632
RT-4,60700,0.1864967839530102
KYSE-140,613753,3.3830154954169447
KO52,24772860,-1.0448231719232914
LS411N,56946209,-3.80128700519076
KYSE-30,445091,4.32022803469915
KYSE-30,5470400,-0.3137651359980625
Mino,104842,-6.786846619272012
BICR 31,16720766,0.8786813091838682
Calu-1,11485656,3.860482320905327
KMS-12-BM,selumetinib-decitabine (4-1 mol-mol),-1.3154987364301634
NUGC-4,89183176,2.3949517343251836
GP2d,53495165,0.0427167162963997
KYSE-30,285033,-1.3245320391143411
NCI-H2087,3676137,4.056121190038108
ALL-SIL,31703,-2.84181702758724
NCI-H929,carboplatin-UNC0638 (2-1 mol-mol),2.500876393607731
LP-1,16659841,3.5146801869988087
HuNS1,11609586,0.5169987955493215
HMCB,5287969,-1.832915880429025
BICR 31,6918638,1.4401869695378149
SK-MES-1,24772860,-1.2690024047047594
EJM,5113032,5.279570802403047
K-562,6610216,3.734328570580528
KP-N-YN,9803433,5.284845296108398
NCI-H2087,46943432,0.8121400631384804
MHH-ES-1,navitoclax-piperlongumine (1-1 mol-mol),1.6455860905981017
GP2d,25195348,3.4215542819119102
PL-21,decitabine-navitoclax (2-1 mol-mol),-0.5224540365067872
EJM,54626689,4.594595753018125
SW1353,selumetinib-vorinostat (8-1 mol-mol),2.5043308707131673
EJM,44486219,4.513652355820563
RCM-1 [Human rectal adenocarcinoma],JQ-1-MK-0752 (1-1 mol-mol),2.1464995044057606
SW1353,9907093,6.085004937999375
NCI-H1395,6918837,-1.563832795621605
NCI-H929,selumetinib-tretinoin (2-1 mol-mol),3.262087806301954
BT 416,2742550,2.5913413615570087
SKM-1,23635314,-2.3855466073838913
HD-MY-Z,4096211,1.5023081378935712
T84,5746,1.1668043155773438
BT-20,2113511,5.317508687119132
LS411N,44819697,-0.923326266781905
HD-MY-Z,2749,1.462857775557332
BT 416,135398744,7.827037669937473
T84,216468,0.8436390957950722
HuNS1,11364421,-5.422075735201578
K-562,9549297,1.810271401171294
Calu-1,374536,3.659579318055704
PL-21,54143018,-1.1500291538584946
Calu-1,52947716,3.2497387629928625
HuNS1,168313016,5.986857407824858
PE/CA-PJ15,168313200,2.967546559162406
SK-HEP-1,46843906,3.844316747572769
SKM-1,448949,1.85245067746411
BT-20,216345,4.352984006941567
NCI-H2122,9956119,3.798994967997133
SK-MES-1,navitoclax-piperlongumine (1-1 mol-mol),2.2621519387689815
Calu-1,12001922,2.3923423899296683
SNU-119,11404337,-0.1265251374759644
MHH-ES-1,decitabine-carboplatin (1-1 mol-mol),5.076904449826504
HD-MY-Z,6610216,4.0359125052118685
SK-MES-1,644241,1.6292140413735792
EJM,5738263,3.5762426266629617
REC-1,44607530,5.591472436740001
L3.3,1716436,3.5741303666735633
PE/CA-PJ15,54613361,0.0258798813529389
Hs 936.T,66577038,3.226930536407338
KMS-12-BM,25262965,-2.9423224876958525
SNU-119,135398516,2.000123320648024
IST-Mes1,JQ-1-vorinostat (2-1 mol-mol),0.3770936853030046
LP-1,3385,3.954764521517576
KMS-12-BM,6505803,-0.6027320108546551
BICR 31,25150857,2.3687059872087217
HD-MY-Z,67156097,-1.687853447778736
BICR 31,216239,4.655547148927136
SNU-119,9549297,4.628289370369748
ALL-SIL,11228183,-1.4217334963731665
EJM,5328940,0.8607847045793436
Mino,216239,1.5780248880701924
KO52,10113978,2.712870801438083
SCC-9,6852167,2.7106856908699255
SK-MES-1,docetaxel-tanespimycin (2-1 mol-mol),-3.237914440529625
NCI-H2087,5282054,2.592849063545262
HMCB,carboplatin-UNC0638 (2-1 mol-mol),4.229494663747289
REC-1,44185566,3.2511381919617044
BT-20,12003241,1.693784137841815
LP-1,151289,0.9279604149633623
PL-21,selumetinib-MK-2206 (8-1 mol-mol),-1.6672239428455102
SCC-9,11494412,1.4365999648395638
NCI-H1395,72376,-0.6047916144496074
HD-MY-Z,16659841,4.637043082312436
T84,19582717,5.002795975259344
NCI-N87,24951314,0.3588892807295563
NMC-G1,44185566,2.8417982569691516
HMCB,6917907,-5.7267155149499915
EJM,salermide-PLX-4032 (12-1 mol-mol),5.466360284353834
SKM-1,11626560,0.5030232412556168
BT-20,168312962,0.5872678344701635
TCCSUP,24951314,0.5782862351023664
KMS-12-BM,168313016,3.5287146199889805
BT 416,46907787,1.2743651659496544
MHH-CALL-4,5566,3.0469799060789597
BT 416,3038522,1.9205227474031263
EJM,16720766,0.882880765643151
SW1116,6918289,3.06657670162102
BICR 31,135440466,1.3506373291640237
KO52,44607531,1.055709895972932
RCM-1 [Human rectal adenocarcinoma],262093,3.1357995089449058
TCCSUP,selumetinib-PLX-4032 (8-1 mol-mol),3.752056719076424
K-562,44491742,3.373435641850853
OCI-M1,9926054,1.747333325747777
NCI-N87,54619267,3.778794485594146
SKM-1,44819697,-2.7532924214144727
LP-1,navitoclax-birinapant (1-1 mol-mol),5.217606225254224
MHH-CALL-4,148198,-4.435182205055272
CFPAC-1,sirolimus-bortezomib (250-1 mol-mol),1.733251550284772
PL-21,46199207,2.5052342768056657
YD-8,3062316,-2.7006453915936497
SW1353,151289,2.6582308170560887
PL-21,73707398,0.3528693898804576
NCI-H929,135875424,3.2591057623275006
KMS-12-BM,16219061,2.3730211419345477
NCI-H929,71466445,3.0733288534415233
Mino,135999136,1.739858930997736
BICR 31,2742550,4.742856926113666
KMS-12-BM,11455910,-0.5978210432128618
Mino,44493528,3.6548963085027
OCI-M1,10410894,3.5265519087437687
BT-20,46926350,-4.100078845822285
K-562,4261,1.1039684536741017
KYSE-30,11656518,1.842291362255632
BICR 31,16725315,5.360398456728244
NCI-H2122,19582717,5.2129025327547955
KMS-12-BM,119607,3.6226525677646313
BT 231,9926054,1.8669465776815437
Mino,24978538,1.7640647284403537
KHM-1B,374536,2.314533071976094
TCCSUP,89928392,1.641879388054528
SK-HEP-1,285033,-0.6546577384402199
HMCB,702558,5.238794075302357
SK-OV-3,446155,4.068831864004445
KYSE-30,tanespimycin-gemcitabine (1-1 mol-mol),1.251830231742021
KHM-1B,52947716,-7.453605591404808
NUGC-4,2749,3.19663087562609
RCM-1 [Human rectal adenocarcinoma],ISOX-bortezomib (250-1 mol-mol),0.2714695446270951
YH-13,25150857,2.985150336849829
TCCSUP,11497983,6.1177518304262195
CFPAC-1,2729026,3.1416159588231474
SW1353,54649381,3.9754097874607313
SCLC-21H,56946209,-5.083699504921507
SK-HEP-1,11612883,3.763210558313423
YH-13,11455910,2.765771134789071
KYSE-30,serdemetan-SCH-529074 (1-1 mol-mol),2.38649757278637
NCI-H2171,11238147,2.9150011478889795
HMCB,10184653,1.7690843609902929
KYSE-30,11977753,0.3803732885711897
LP-1,44566777,0.7825219015466653
HMCB,2828334,6.16899162002209
SNU-119,tanespimycin-bortezomib (250-1 mol-mol),0.9832561237476752
TCCSUP,6184667,2.5617640060179823
KP-N-YN,9927531,3.406811023385209
KYSE-140,60700,2.9286620309866143
KO52,3689413,-4.063517257373306
KYSE-30,BRD-A02303741-navitoclax (2-1 mol-mol),3.823832343828407
Calu-1,2733526,3.4116011560677357
K-562,3634881,3.4419902111623473
KO52,11497983,-3.595547093152317
SCC-9,439501,-2.6581193485563737
L3.3,3062316,1.4450663843809155
NCI-H1395,navitoclax-MST-312 (1-1 mol-mol),0.8378237881754972
GP2d,5566,3.2726596692910705
NUGC-4,6610355,4.317156488398992
EJM,49793307,-4.860528919004407
KYSE-140,9823820,4.521860737573389
HD-MY-Z,12003241,-2.342795911905131
Calu-1,24821094,3.9724407334710414
L3.3,5281321,2.3391738882410813
SKM-1,10410894,3.4215303234711065
YH-13,9933475,1.504253268653492
BT 416,67156097,-1.6888419225317588
BICR 31,16722836,0.993439631718574
GA-10,9444,3.1668247223092028
ALL-SIL,16720766,-0.6951675656481376
ALL-SIL,72193861,-0.8088702984298154
NCI-H1395,327653,3.4863341416729847
SK-MES-1,7251185,3.034325287701498
PE/CA-PJ15,448949,2.1767399240328063
BICR 31,11719255,5.311316415457661
KMS-12-BM,57330099,3.2111991420002215
T84,72193861,-0.1419328365438894
KMS-12-BM,3815108,1.5057478423514148
ALL-SIL,15983966,-4.919474478826657
HCC1833,2841722,7.145168821702874
SK-MES-1,9929138,3.12327700271694
BICR 31,9926054,1.721382648019371
SK-HEP-1,4259181,0.3926762831937545
GP2d,5978,-2.5727626949720546
TCCSUP,selumetinib-piperlongumine (8-1 mol-mol),4.721141400278082
HCC1833,selumetinib-UNC0638 (4-1 mol-mol),3.0029761704324955
MHH-CALL-4,selumetinib-vorinostat (8-1 mol-mol),1.0890030142935403
KO52,sirolimus-bortezomib (250-1 mol-mol),0.090002603096776
KHM-1B,alisertib-navitoclax (2-1 mol-mol),-2.308284106027781
YH-13,3025986,-1.231894259194408
Calu-1,3854666,3.7215465603538727
LP-1,2729026,2.210568382658554
NUGC-4,24964624,2.9757010948883593
K-562,613000,2.5009117496842292
NCI-H929,568763,0.1324523108623163
KYSE-140,11175137,2.2257551549001415
L3.3,135440466,3.532632366582018
T84,alisertib-navitoclax (2-1 mol-mol),-2.2789630209597607
SNU-119,15983966,2.01130055779656
HCC1833,10074640,3.311672810620764
TCCSUP,10427712,4.456401436086168
BT 231,6918638,3.0604187031451437
REC-1,9926054,3.5400616992055847
IST-Mes1,44491742,4.903550558956352
SNU-119,51039095,2.8116554470827086
PE/CA-PJ15,4477,0.4659263473677219
NCI-H2171,3025944,4.816182739912449
HD-MY-Z,31703,-1.393335635617352
ALL-SIL,168313016,2.945013463521221
MHH-CALL-4,6438330,0.7720555317272907
SK-MES-1,168313200,1.727184472049229
NCI-H1395,9926054,1.836702615994444
NCI-H1395,54626689,4.483963070109989
Hs 936.T,24964624,2.4396214838479224
PE/CA-PJ15,9956119,4.212049947291104
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623
MHH-CALL-4,doxorubicin-navitoclax (2-1 mol-mol),-3.845004433629427
T84,46843906,2.7521112836734445
CFPAC-1,2828334,6.577734461678012
YD-8,10127622,4.990106068897982
KHM-1B,24901704,2.862700156831434
SCC-9,10296883,4.238304408621306
KHM-1B,124202324,1.1821842907851436
REC-1,4477,3.586856374933584
NUGC-4,72376,-2.5772006814781077
PE/CA-PJ15,445091,4.246266958830633
KYSE-140,3062316,-1.0322404632501094
BICR 31,15983966,1.7355748159582445
MHH-ES-1,65064,3.068332544033923
ECC10,3081361,2.83140185395146
NCI-H2122,3543504,4.3489006699323545
BT-20,73707398,2.7146143235712747
TCCSUP,57330099,4.986462210926318
BT 231,9956119,4.178379846125992
NMC-G1,44489367,4.2984501703001605
YD-8,148198,-3.6074550947406863
NCI-H2122,46907787,2.248014576758407
RCM-1 [Human rectal adenocarcinoma],3552672,4.462538243049003
RCM-1 [Human rectal adenocarcinoma],11609586,3.4054743637312006
GA-10,445091,3.2666492724587557
SNU-119,135411,0.3740085311650424
PL-21,44137675,2.003889769632495
LS411N,5328940,2.1913370268343324
NCI-H929,46191454,-1.4087002661466548
SK-MES-1,54618164,3.771541214581354
KYSE-140,44137675,3.7184605530968065
KHM-1B,11228183,3.292556863347854
Hs 936.T,3689413,1.174689206695868
KMS-12-BM,selumetinib-JQ-1 (4-1 mol-mol),-0.820838989236415
HCC1833,124202324,1.8679152106423855
SNU-119,11175137,3.479199701022153
T84,11626560,1.1345652344134618
SK-MES-1,11955716,-2.466115142046179
PL-21,selumetinib-piperlongumine (8-1 mol-mol),0.8817486190670358
YH-13,9911463,4.412003433189975
SK-OV-3,969516,2.624811361400939
SCC-9,24901704,4.548877009949327
HuNS1,3385,2.010154928237069
CFPAC-1,11228183,3.9385060090529103
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517
KMS-12-BM,navitoclax-gemcitabine (1-1 mol-mol),-3.5560923194390006
ECC10,26596,-3.5060948128404874
LP-1,10385095,1.2298439845363769
IST-Mes1,4788,5.898872389352922
NCI-H2087,11364421,-4.261600003483404
SCC-9,45279963,4.124125049817703
LP-1,10074640,1.7657194000125265
ECC10,46943432,1.1549378530091958
Mino,6914657,-6.321839368914656
PL-21,119607,4.885646424497633
L3.3,25062766,2.9099713416003463
SW1353,241158,3.9499039254187105
KP-N-YN,3062316,2.5343311881212807
SW1353,6914657,-0.8385353546481726
KHM-1B,9936388,-7.3262126051433425
BT 416,6505803,-2.5410330503454173
NCI-H929,51037431,3.389715853394355
NCI-H2171,decitabine-navitoclax (2-1 mol-mol),-1.124671467486642
MHH-CALL-4,ISOX-bortezomib (250-1 mol-mol),0.5659489574796717
LS411N,6623618,2.410312404439064
MHH-CALL-4,72734382,2.3996706426342698
NCI-H2122,SNX-2112-bortezomib (250-1 mol-mol),1.25331336909377
Mino,46926350,-6.0874143472177105
PANC-1,1566236,1.9012203857252232
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075
PL-21,5281321,-1.229248754104069
NCI-H2087,15953870,3.2507904502912743
BT 231,46191454,2.248528460239281
LP-1,11717001,4.247524312046038
SK-MES-1,44137675,3.79543080483213
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761
T84,2729026,1.918430404815631
NCI-H2087,JQ-1-carboplatin (1-1 mol-mol),-1.3930122272626189
TCCSUP,1750826,0.4362415979696089
BT 416,44632017,0.7552247381906405
Mino,9935249,1.3209410835927553
SKM-1,176870,1.6834487076214133
HuNS1,135928012,3.4065980849923103
ALL-SIL,10074640,-0.3353589360570669
SW1353,navitoclax-MST-312 (1-1 mol-mol),1.3128194576470138
TCCSUP,5702613,2.0782660791611045
SCC-9,16065773,3.2014379284662864
BT 231,45279963,3.2637950128536413
GA-10,navitoclax-MST-312 (1-1 mol-mol),0.5546706825319466
T84,7251185,1.065852951625124
SNU-119,alisertib-navitoclax (2-1 mol-mol),-0.0715431732612024
GA-10,11213558,1.3204334809126406
HCC1833,44489367,4.329044594834159
KO52,24771867,-3.917806210376699
GP2d,3101542,5.245957710868802
PL-21,16038120,-1.3970679557202317
REC-1,BRD-K99584050,5.492819834675278
PL-21,374536,2.1392581024511657
SK-HEP-1,49766530,-2.8567737760804324
Calu-1,alisertib-navitoclax (2-1 mol-mol),0.994537892783126
KO52,19582717,4.02566372539437
YH-13,65064,5.536237996349119
HMCB,36462,1.7096647665785494
PE/CA-PJ15,36314,-7.581588008180118
MHH-ES-1,5278396,3.245328527873426
RT-4,71466380,4.899760942476526
SW1353,16038120,0.9760078319269472
KHM-1B,10410894,4.907000133376468
GP2d,navitoclax-sorafenib (1-1 mol-mol),-2.237089513904882
NCI-H2087,11238147,3.3763771967974168
TCCSUP,15547703,4.005095774110686
ECC10,15983966,1.7281938957016854
PE/CA-PJ15,1566236,2.6409505588349353
YH-13,25262965,-2.705880227783202
SK-OV-3,452548,0.7579906967862455
IST-Mes1,54596558,4.6034089904468125
HCC1833,135411,4.072451811658786
OCI-M1,decitabine-navitoclax (2-1 mol-mol),-2.1243887945485125
BICR 31,5287620,-1.513974949921974
Calu-1,216468,5.206769171213586
SCC-9,135421197,2.7056920215811293
SCC-9,219104,4.323236898621614
SK-OV-3,54613361,2.1799599530092597
KYSE-140,135999136,5.49785084344862
NUGC-4,11214940,1.9718150607795817
KP-N-YN,53232,4.601755393955464
L3.3,10385095,1.3503663642800654
MHH-CALL-4,984333,-0.7245015606461234
LP-1,5113032,4.427192045116929
T84,24951314,1.15134065613574
BICR 31,25183872,-0.4870171412848909
BT 231,11612883,2.9794626203224306
SW1116,4096211,3.3002363530872216
PL-21,6610216,4.06640166284154
BT 231,23635314,-0.4018221578518959
OCI-M1,52947716,2.964787776099716
OCI-M1,26596,-2.6046335322938927
PL-21,16736978,0.9078245266807208
LP-1,76446078,4.724451228444263
BT 231,5738263,3.166414845208924
SCC-9,navitoclax-PLX-4032 (1-1 mol-mol),4.098864709147574
SK-HEP-1,53392493,3.66906541895257
SKM-1,5746,0.5128586399928746
BT-20,24821094,3.713357433543465
NCI-H929,5351362,0.2210032032775228
HD-MY-Z,selumetinib-navitoclax (8-1 mol-mol),2.464674390746214
ALL-SIL,5291,-1.9713425457655045
Calu-1,16013152,4.996425837572467
ALL-SIL,6918328,-1.7903684912223865
NCI-H2087,55283,3.3393488667282587
TCCSUP,11364421,-0.436162091200716
SKM-1,168313047,1.823669024693072
MHH-CALL-4,10385095,1.014467804729014
KO52,8515,2.033649946407287
ECC10,676352,2.2469411692953667
KYSE-140,68056272,4.161766057288007
ECC10,24978538,-3.379246763604413
MHH-CALL-4,65628,1.9162335341820356
SKM-1,9868037,0.7505046314280106
GP2d,11625818,3.619219955418842
KMS-12-BM,969516,2.2529798908048244
MHH-ES-1,25126798,3.460367775645627
SK-LU-1,89928392,1.649692121337616
YD-8,135398516,2.8864583978084473
L3.3,erlotinib-PLX-4032 (2-1 mol-mol),3.685667045141098
RCM-1 [Human rectal adenocarcinoma],25183872,-1.7223948932282942
T84,285033,-1.6653741842422254
BT 416,44489675,3.900362822101375
PE/CA-PJ15,5287620,-2.2543660755178827
NCI-H2122,5335621,6.006833012118136
KO52,11238147,3.117687457157308
KP-N-YN,54626689,4.960149402588451
LS411N,12001922,2.0246848718715604
NCI-H2122,11222830,3.023141888287234
NCI-H1395,374536,5.636718886348253
SCC-9,6610355,5.330005746360321
SCC-9,637858,3.7694424070181127
ECC10,11364421,-5.89592709112607
SKM-1,4378219,1.146896788222022
REC-1,17759555,6.872158537406996
GA-10,24821094,-0.4316431272431675
HD-MY-Z,969516,2.957370154982532
Calu-1,16065773,1.234313536503501
L3.3,44202524,1.4046743198353957
BT 231,5328940,1.6487838812327065
YH-13,11955716,-0.8910132220684513
L3.3,16038120,1.9292348544241311
GP2d,16741245,2.511465212861442
NCI-H2122,vorinostat-navitoclax (4-1 mol-mol),2.2166037906528246
NCI-H2171,285033,-3.2427052076981693
MHH-ES-1,9935249,3.1458992380926616
OCI-M1,6610216,4.2941719628539925
MHH-CALL-4,568763,-0.9752412081009332
HMCB,6610216,4.4861904027359145
KHM-1B,9911830,2.660270688725906
K-562,16720766,1.059873963232806
SK-HEP-1,11964036,3.325100881793091
KO52,10296883,3.770873498157397
YH-13,9915743,2.529803461221303
PE/CA-PJ15,9911830,3.3068944538526672
NCI-H2171,42642645,-0.8345775302937554
PL-21,216345,3.5323223975770808
L3.3,285033,-1.389904047242399
TCCSUP,10385095,1.359914637472657
KO52,44493528,4.373207696272561
KYSE-30,44462760,4.1598925494696255
KHM-1B,11213558,1.7651393697887354
BT 416,3465537,2.504203056087228
NCI-H2087,49766530,-1.9829819346209112
NCI-N87,374536,0.3041613365805376
SNU-119,5328940,0.3494705393628248
Calu-1,637858,1.6711749737628838
MHH-CALL-4,25022340,-3.222274321790873
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456
LP-1,4259181,0.3929382473497618
BT 231,carboplatin-UNC0638 (2-1 mol-mol),3.849827727585169
KHM-1B,51037431,2.291600805718332
Mino,5281672,4.71014536336946
YD-8,159324,3.1492291636894416
HD-MY-Z,753704,5.145907515598795
NCI-H1395,9915743,5.704472879097531
KO52,11507802,0.3147818183904139
MHH-CALL-4,15983966,1.448749653606788
KO52,49846579,4.097285176904078
GA-10,11396600,1.0536432572837295
SCC-9,9926054,1.898935947612019
YD-8,11404337,-1.7651477779753342
OCI-M1,4378219,1.9933418249078871
SNU-119,107970,2.4008728686512617
SK-HEP-1,216468,4.223762462623231
YD-8,navitoclax-PLX-4032 (1-1 mol-mol),3.137916156556902
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323
NCI-H2087,54649381,3.78622153080566
NCI-H929,selumetinib-JQ-1 (4-1 mol-mol),-1.4418974567272833
NUGC-4,selumetinib-UNC0638 (4-1 mol-mol),-1.0138769057961463
SNU-119,4096211,1.6502614157208848
SK-MES-1,serdemetan-SCH-529074 (1-1 mol-mol),0.939859217531282
EJM,11455910,0.7170091081693915
Calu-1,9952709,3.454709577440357
SK-LU-1,23582824,1.7927332416718171
SKM-1,24785538,-1.0651885035802942
PL-21,60700,-1.4235045696251467
IST-Mes1,5351362,3.046296530947078
BT-20,123631,3.473850685631007
RT-4,navitoclax-piperlongumine (1-1 mol-mol),1.919426217940122
Mino,24753719,3.6621526674985416
YD-8,46398810,2.5554282020008094
GA-10,11178236,-8.69570620583645
ECC10,3676137,2.755553753735693
KYSE-140,322968,4.184653738881835
LS411N,49836020,4.501659667614969
RT-4,11626560,2.0350958135834656
SKM-1,25150857,2.131946056717962
BT 231,BRD-A02303741-navitoclax (2-1 mol-mol),1.5568540270534312
T84,24821094,2.7007579572742912
BT 231,44607531,0.3540469053779969
RCM-1 [Human rectal adenocarcinoma],docetaxel-tanespimycin (2-1 mol-mol),0.3001853485414289
ECC10,421610,2.5120406780972804
REC-1,6852167,4.364510532165473
GP2d,doxorubicin-navitoclax (2-1 mol-mol),-3.0925234076272914
LP-1,49766530,0.7133399832547254
LP-1,1750826,-1.163993835792072
MHH-ES-1,4917,2.8701808755358074
GA-10,46907787,-1.6483994380715643
PE/CA-PJ15,11238147,1.9368815843555724
LP-1,46843906,0.13819645605411
BT-20,5746,1.5712326096534657
ECC10,3689413,0.143670384150019
EJM,9903786,2.5710642236856818
SNU-119,2113511,5.762989771313452
PL-21,6438330,0.8871055754266769
NCI-H929,JQ-1-carboplatin (1-1 mol-mol),-1.5945452678807737
GA-10,6918878,-0.0384952148884959
T84,JQ-1-navitoclax (2-1 mol-mol),1.1164765875292824
MHH-ES-1,44493528,5.035499242362303
LP-1,6918878,0.994044861292223
KO52,56946209,-4.209607693817565
Calu-1,11955716,3.43617602036544
SKM-1,1716436,1.3420802961199974
NCI-N87,4917,2.911504588829893
YD-8,9903786,2.667696713101927
BT-20,45279963,3.704720862429374
BT 231,44632017,0.7872188651788097
PE/CA-PJ15,9884685,0.3729589706560922
KMS-12-BM,135440466,0.2668313754655885
SCC-9,vorinostat-navitoclax (4-1 mol-mol),1.1894462341904075
GP2d,100016,6.428285689025714
HMCB,445455,4.664999175026341
LP-1,53495165,-1.988905914615412
NCI-H929,638278,2.7948371949110205
BT 416,11656518,1.788076585155938
KYSE-30,selumetinib-BRD-A02303741 (4-1 mol-mol),1.39827641750971
EJM,11507802,0.5924902988751046
HCC1833,9911463,3.7741336364868943
MHH-ES-1,46224516,1.861465320406204
HD-MY-Z,60700,-2.8724122510142016
PE/CA-PJ15,46843906,3.542355715019075
NCI-H2122,25183872,-0.1706456426395564
PE/CA-PJ15,15953870,3.815080099518923
BICR 31,2746,4.041774334142006
BT-20,53245473,3.70521579538694
SK-HEP-1,11364421,3.0648019303900624
LS411N,5311,1.0830647686053458
CFPAC-1,676352,2.9935715443755844
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417
Mino,2749,1.4659801307247888
PL-21,25102847,1.7558332767108282
NCI-H2122,selumetinib-piperlongumine (8-1 mol-mol),4.333311100795728
HD-MY-Z,5281321,-2.257092773260008
ECC10,15953870,2.466320220342026
KHM-1B,10302451,3.4740404834517156
KYSE-140,16038120,1.0885344064584326
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646
ECC10,9967941,1.6070573629057403
MHH-CALL-4,72967,3.718598415166011
ECC10,navitoclax-PLX-4032 (1-1 mol-mol),-2.962061262625355
SKM-1,675434,4.4448031338395655
SK-MES-1,10322450,4.30384017318748
Mino,navitoclax-birinapant (1-1 mol-mol),-3.9613724351931054
REC-1,9444,2.9104997308545264
SCC-9,1750826,-1.358939777918893
HD-MY-Z,9884685,1.0880914261328605
LP-1,serdemetan-SCH-529074 (1-1 mol-mol),1.3221640732269044
SKM-1,36462,-0.9664350566951958
KO52,JQ-1-MK-0752 (1-1 mol-mol),1.137098893083227
BT-20,51037431,2.9102593993595547
MHH-ES-1,65628,3.443367883229779
HD-MY-Z,613753,3.0975503045534247
SK-HEP-1,1750826,-4.478019715406424
MHH-CALL-4,5746,-2.851093637427717
BICR 31,135398516,1.997761003126595
KYSE-30,3081361,3.6276578745198913
BT 416,208908,1.683094008732445
SW1353,446155,3.171137843459326
NCI-H1395,3689413,-2.5246792207692073
HCC1833,76446078,4.238919706292637
SW1116,54678924,2.014242841274849
KP-N-YN,6610216,5.097327149655238
RT-4,148198,-0.8360848986797086
KO52,44566777,-0.2336377473007494
K-562,148124,-7.41486725283878
SKM-1,23939,4.408683246884893
BT 231,675434,3.4479777489994805
EJM,11228183,2.3693057708406005
IST-Mes1,3825829,6.080187468224706
NCI-H1395,53392493,1.9985896329089852
SCC-9,46191454,1.8170261878735936
Calu-1,5280436,3.8593182514613256
NCI-H2087,6918736,-1.6920445853675006
PE/CA-PJ15,36462,-0.1372192920508844
MHH-CALL-4,1242560,3.244705335605847
NCI-H1395,11626560,2.322318216024447
BT-20,4378219,4.276971805341904
BT 231,241158,3.4112394985232517
CFPAC-1,crizotinib-PLX-4032 (2-1 mol-mol),2.317475147771365
SKM-1,2729026,2.7681439157014753
L3.3,11485656,2.040790548836277
SCC-9,25195348,3.9019221273063858
HMCB,docetaxel-tanespimycin (2-1 mol-mol),-7.206922464155887
NCI-N87,JQ-1-navitoclax (2-1 mol-mol),0.0624511044953225
KYSE-140,2828334,6.488287865752542
MHH-ES-1,54613361,-1.6269503122128068
T84,6852167,2.3607700783512686
NUGC-4,216239,1.9847720233092447
IST-Mes1,387447,-3.626604128124616
GA-10,erlotinib-PLX-4032 (2-1 mol-mol),2.4522101898245374
MHH-CALL-4,selumetinib-GDC-0941 (4-1 mol-mol),0.3640668336330579
NCI-H2087,135411,0.426798075107719
YD-8,421610,4.166965318185822
RT-4,1641662,3.4681958034174647
RT-4,24964624,3.0687805889747977
NCI-H929,20959075,-3.1953287844218417
LP-1,42611257,1.2768990148964705
SKM-1,11960529,3.62763439473286
KO52,16725315,3.1980251151125705
SK-MES-1,9927531,5.425786603716899
RCM-1 [Human rectal adenocarcinoma],71576739,4.46778033750866
BT 416,400769,-1.0617810888477526
HMCB,219104,4.272733205803313
TCCSUP,57519531,2.9959744097146803
KO52,navitoclax-sorafenib (1-1 mol-mol),-1.8167289238614717
GA-10,46398810,1.7485896905364493
BT 416,25126798,3.870023513987056
KYSE-30,374536,1.9121137284030565
EJM,89183176,3.310519408856309
NCI-N87,51039095,3.189774410902983
YD-8,10302451,2.519210773741685
GA-10,54765302,2.8033111445871386
MHH-CALL-4,10127622,2.863155069538288
SK-LU-1,10410894,2.884082843020363
PL-21,50905018,4.359170782480627
PE/CA-PJ15,16013152,4.170385211383189
KMS-12-BM,JQ-1-navitoclax (2-1 mol-mol),-3.0294043604496363
NUGC-4,11640390,3.108061487048684
NCI-H2087,2113511,5.619212128743077
NCI-H2087,2841722,3.8657968561683864
YD-8,135999136,6.481795126986557
KMS-12-BM,25105715,2.85606918803758
NUGC-4,carboplatin-UNC0638 (2-1 mol-mol),3.1393349880416004
RCM-1 [Human rectal adenocarcinoma],51037431,4.999864104870178
TCCSUP,selumetinib-navitoclax (8-1 mol-mol),2.911223328987063
Mino,216468,3.1376537260490367
ECC10,445091,3.187618159845471
PL-21,sirolimus-bortezomib (250-1 mol-mol),-0.8951196231855002
MHH-ES-1,11626560,-0.0321595802112307
MHH-ES-1,2113511,5.588225434364416
Mino,16722836,0.7296299535363473
OCI-M1,252682,7.699627038813359
Mino,piperlongumine-MST-312 (1-1 mol-mol),0.9195115610138276
ECC10,227681,3.1299200761973363
MHH-CALL-4,6505803,0.4342437692072871
EJM,16736978,1.1744995972918135
NCI-N87,54613361,-1.4178620324204825
SW1116,9935249,3.7478471232466464
PE/CA-PJ15,selumetinib-piperlongumine (8-1 mol-mol),4.644191554187911
MHH-CALL-4,6852167,1.516764811863356
NCI-H2122,654092,0.5156399977478747
SCC-9,navitoclax-gemcitabine (1-1 mol-mol),1.7873613384947808
SCC-9,984333,1.3591962563360305
K-562,8515,4.039482215632923
NCI-N87,3038522,3.5877635056945443
KHM-1B,702558,3.340125476799818
OCI-M1,selumetinib-tretinoin (2-1 mol-mol),2.6991429175712796
NUGC-4,2729026,2.660880232135923
SK-MES-1,46174525,3.7815716629081497
OCI-M1,135398516,2.2923496181537115
NCI-H929,9444,4.093260386369905
HuNS1,1566236,1.8236827924794037
KP-N-YN,1566236,2.0598398462410215
NCI-H2087,89928392,0.6593555886417739
KO52,11404337,0.1772123930911338
K-562,11238147,1.4367734907149323
Calu-1,387447,-4.037106995788473
KYSE-140,44259,1.5581457096381508
SW1116,JQ-1-MK-0752 (1-1 mol-mol),-0.6001255913717273
SW1116,navitoclax-piperlongumine (1-1 mol-mol),2.239630432937819
Hs 936.T,71466578,6.454837916773772
LP-1,445643,3.847982010915363
GP2d,carboplatin-etoposide (40-17 mol-mol),1.596484957645531
NCI-H2087,42642645,0.4197072186190315
KYSE-140,44487330,3.7235857458146104
MHH-CALL-4,5329102,1.545961191214315
IST-Mes1,navitoclax-piperlongumine (1-1 mol-mol),2.2991023643561115
KYSE-140,11234052,5.559499917284501
PE/CA-PJ15,23635314,-3.571358850473721
KYSE-140,24753719,4.654807821882373
MHH-CALL-4,439501,-2.5308829551991168
HD-MY-Z,44566777,0.1952916495619108
BT 416,24748573,0.7595979045196809
RT-4,6252,2.4296681174551664
YD-8,11497983,4.407361911086299
PE/CA-PJ15,46907787,3.628617033804344
Mino,52912189,-1.259006145969778
HMCB,44819697,-1.3294210375282771
PE/CA-PJ15,11507802,0.9199677226332336
NCI-H2087,53392493,1.7802501299220403
NCI-H929,24180719,3.664799403319753
HD-MY-Z,64971,1.839685123427126
NMC-G1,10184653,3.3683385146882796
SW1353,49766530,-0.8162034464098388
SK-HEP-1,3136844,5.506062707172487
MHH-ES-1,262093,2.803376777339923
SK-MES-1,123631,1.7438308652764742
MHH-ES-1,2858523,2.8386842669176184
ECC10,9915743,-1.3646312579395177
SK-HEP-1,44137675,4.549525792934436
BT 416,46843906,3.0430383139640935
K-562,2874250,4.395305106833161
KP-N-YN,16659841,3.971990184018257
MHH-ES-1,selumetinib-MK-2206 (8-1 mol-mol),3.342440577062064
Calu-1,1716436,1.9874335474801637
K-562,46926350,-4.162486097405079
OCI-M1,2874250,4.354669116357719
HCC1833,9444,2.218205242583616
ECC10,9887053,3.130226708389206
LP-1,5280436,-0.1145967200333474
YD-8,126941,-2.1622153409475593
NCI-H929,1750826,-3.89812639428639
CFPAC-1,322968,4.860033088573461
T84,9907093,3.651052350520635
SW1116,46398810,1.9738343649367471
KMS-12-BM,2841722,2.937327067206498
K-562,11396600,3.7562155275673415
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205
PL-21,135999136,3.272294699588802
ECC10,135423438,0.2657741812126756
HD-MY-Z,71751553,4.240197659195247
HuNS1,11719255,3.32211864779385
HuNS1,JQ-1-carboplatin (1-1 mol-mol),1.1759253044065412
KYSE-140,selumetinib-JQ-1 (4-1 mol-mol),2.3172835703962686
BT 416,46943432,1.605055872741302
KYSE-30,24951314,1.6168739647811514
HD-MY-Z,135411,-0.4374721649112024
KMS-12-BM,126941,-5.220907783111232
ECC10,6610355,3.618109040421801
KMS-12-BM,52947716,-7.113059308361459
BT-20,135659046,3.529178166961368
ALL-SIL,23725625,2.2136327630148736
RCM-1 [Human rectal adenocarcinoma],44462760,4.900478491796212
HD-MY-Z,selumetinib-vorinostat (8-1 mol-mol),2.8123718664727773
RCM-1 [Human rectal adenocarcinoma],135398744,7.791771320405332
KYSE-140,89928392,0.8037365501999809
KP-N-YN,2746,2.243582059323954
EJM,126941,1.4597619440351868
KO52,71304818,3.049404193562579
NUGC-4,5738263,3.1217732692070324
SK-MES-1,208908,1.7861308740371968
KO52,25183872,-2.4696387093627807
L3.3,2749,2.0470310524130717
PE/CA-PJ15,4096211,1.866846334114683
RCM-1 [Human rectal adenocarcinoma],5281321,1.2119883175444373
HMCB,11494412,1.1725416400884527
KYSE-140,3689413,0.0626395685413909
T84,375860,-1.0611721246965713
ALL-SIL,49836020,-3.56746653346715
SW1353,656346,1.5374652279670054
HMCB,148198,-4.3449695976370055
ECC10,68056272,2.801454052606153
K-562,56946209,-4.819463057676977
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299
HCC1833,638278,3.6269501854165935
ECC10,24951314,-0.278484714419479
MHH-CALL-4,6623618,1.6681236272351632
L3.3,ISOX-bortezomib (250-1 mol-mol),1.440349868344241
LS411N,6917907,-5.419583860239815
NUGC-4,5566,2.723978100764212
OCI-M1,6918638,-0.7125786973139969
SNU-119,9868037,3.103417825493656
SK-LU-1,navitoclax-piperlongumine (1-1 mol-mol),2.196372747875973
TCCSUP,11427553,2.2113489694115054
KYSE-140,124202324,3.024555177585928
IST-Mes1,11609586,2.670649923207088
HCC1833,126941,-2.7032882978028776
NCI-N87,11507802,1.464328650743575
GP2d,51037431,0.7333525912292733
BT-20,3025986,-0.7965443232671996
PE/CA-PJ15,135440466,2.775498035074722
SK-MES-1,44202524,1.8372512543484552
BT-20,56649450,1.7900778362662668
NCI-H2122,9911830,3.1197421381222212
YH-13,24821094,3.938816405741356
HD-MY-Z,1716436,3.437361454800368
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199
HMCB,3025986,0.04435044447406
HD-MY-Z,6918878,3.564787070557489
NCI-H2087,6505803,-0.9340345564408612
HMCB,9887053,4.4985851609275995
BT-20,23582824,-1.1548076481204337
NCI-H2122,135421197,1.54063176818906
MHH-ES-1,25262965,-2.2825716741608795
CFPAC-1,49766530,5.350694813461272
OCI-M1,11222830,1.390743357187512
LP-1,16722836,1.2341749554893668
KYSE-30,46215462,1.7464580305211177
Hs 936.T,selumetinib-GDC-0941 (4-1 mol-mol),0.993603643141318
SK-HEP-1,6918837,-2.2229066751457345
BICR 31,9911463,4.617619725588035
MHH-ES-1,654092,-1.087777817113658
NCI-H2087,2842253,3.8700675161958378
NCI-N87,656346,-0.0410900008101642
K-562,208908,1.7214906675478436
HMCB,66577038,3.152546562192711
SKM-1,71466380,3.1609741047778965
PL-21,51037431,4.655316894342883
HCC1833,10385095,1.4425301929083445
HD-MY-Z,4917,3.4262186814169424
NUGC-4,6252,1.9231935717795656
SNU-119,241158,3.4983662079339295
KMS-12-BM,11427553,1.3856549566874048
L3.3,124202324,3.558321901620073
HuNS1,2871966,-1.9089856626622876
T84,carboplatin-UNC0638 (2-1 mol-mol),3.562540088899775
KYSE-140,11656518,-0.1514467772465637
EJM,5281321,-4.177995468364573
YH-13,selumetinib-BRD-A02303741 (4-1 mol-mol),4.816369737179264
ECC10,5479543,0.8081850323216316
KMS-12-BM,124202324,0.0272958362457217
GA-10,65628,2.41107724577683
NCI-H929,89928392,-0.45860298805955
SNU-119,5280436,3.876478127021692
YH-13,168312962,3.022410497071698
OCI-M1,2126,3.988541178358481
SK-MES-1,24775005,3.4795085392301224
PL-21,3384730,0.4809897647806781
PE/CA-PJ15,7326481,2.629394046938682
NCI-H1395,selumetinib-vorinostat (8-1 mol-mol),2.147255996625455
LS411N,16722836,1.825979837410603
BT 231,10302451,3.095881087225805
ECC10,1242560,1.7934905355327109
ECC10,445455,2.628237721555578
NCI-H1395,piperlongumine-MST-312 (1-1 mol-mol),1.204552153931692
SK-LU-1,51037431,1.891020928057262
REC-1,73707438,4.744631332095545
GP2d,11222830,1.56122568627804
SKM-1,10127622,-2.6973341706863567
IST-Mes1,219104,4.071310239310072
RCM-1 [Human rectal adenocarcinoma],60700,-0.2980706312028528
NUGC-4,46907787,-1.879898884008335
NCI-H2087,5278396,3.0782543194546608
HD-MY-Z,selumetinib-GDC-0941 (4-1 mol-mol),1.012079708603172
SW1353,44632017,2.4733795728315706
ALL-SIL,10127622,5.469150259822909
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313
GA-10,11214940,-1.326019554454879
ECC10,285033,-2.0959187628459808
KP-N-YN,11964036,3.091289192242047
LS411N,36314,3.823716751686664
L3.3,25154868,5.156852655599311
MHH-CALL-4,46224516,1.1772377768185278
NCI-H1395,tanespimycin-gemcitabine (1-1 mol-mol),4.210954263258385
TCCSUP,448949,2.8809822031870778
NCI-H1395,JQ-1-UNC0638 (2-1 mol-mol),2.0863626902926065
BT 416,613753,3.1350720294830885
HMCB,16722836,1.8505640461629969
GA-10,5329102,1.1436317048481708
NCI-N87,11238147,1.7339284670687316
ALL-SIL,44185566,1.0410692737439569
MHH-CALL-4,5282054,2.5353700825227583
GA-10,decitabine-carboplatin (1-1 mol-mol),-3.277850924744521
NCI-H2122,5978,0.68458858713772
NCI-H2122,44202524,1.8337590700104576
SCC-9,375860,0.1694000381305893
OCI-M1,31703,-1.501592824849557
SK-HEP-1,5281672,4.68841423543723
MHH-CALL-4,1566236,1.2228321668732802
OCI-M1,56963564,-0.0751019675578404
MHH-ES-1,54649381,3.4472293740768247
YH-13,10231331,5.93947704147761
MHH-ES-1,10427712,3.6942259937962625
KHM-1B,11167602,5.170482443949449
NCI-H929,11640390,-3.3259312039438216
SK-LU-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.1752036402953365
NCI-H2087,25154868,4.462178060683741
HD-MY-Z,JQ-1-navitoclax (2-1 mol-mol),1.086715750494607
Mino,selumetinib-MK-2206 (8-1 mol-mol),2.9443567582650565
KMS-12-BM,carboplatin-UNC0638 (2-1 mol-mol),1.757378560571638
REC-1,54143018,3.927414869926896
MHH-ES-1,126941,-4.143044647540317
MHH-ES-1,107985,-3.8860683176627098
BT 416,176870,2.578398015644675
BICR 31,24821094,2.272776200428542
SK-LU-1,9903786,1.4733207164642357
SCC-9,54619267,4.260733417129102
L3.3,2729026,3.1026966432102863
ALL-SIL,24180125,1.6553840753953686
SNU-119,BRD-K27188169-navitoclax (2-1 mol-mol),3.038273734124671
YH-13,5287620,-2.012457236382429
HMCB,11485656,2.0030375268355116
K-562,6918638,0.0740833242167517
GP2d,JQ-1-MK-0752 (1-1 mol-mol),2.8679091690847573
NMC-G1,2708,6.453873517728225
Hs 936.T,tanespimycin-gemcitabine (1-1 mol-mol),0.2984220050256087
NCI-H2171,11364421,-5.769988570724398
SNU-119,11656518,-1.0487494422596892
NCI-H2122,4477,1.070498058301407
KHM-1B,246676,1.870399937828377
RCM-1 [Human rectal adenocarcinoma],6918328,0.3348856135951876
NCI-H1395,6918638,1.485308761584704
SCC-9,15953870,4.1491811794097995
BT 416,crizotinib-PLX-4032 (2-1 mol-mol),1.5184117085725763
Mino,5284373,1.2001528174039091
BT-20,selumetinib-MK-2206 (8-1 mol-mol),3.4555327434580976
LP-1,ISOX-bortezomib (250-1 mol-mol),0.1914555050471775
HCC1833,24964624,2.7839692766039095
YD-8,11626560,1.5530364177818132
Mino,568763,-0.6526051531445236
NCI-N87,6505803,-6.101345662019038
NCI-H929,119607,5.121308216855954
HD-MY-Z,241158,3.745964403533247
HuNS1,serdemetan-SCH-529074 (1-1 mol-mol),0.852579646558465
Hs 936.T,46224516,1.429107593729198
SK-HEP-1,54454,2.662573207119838
HMCB,3025944,4.29007552344394
NCI-H2122,navitoclax-gemcitabine (1-1 mol-mol),2.472446028164442
YH-13,44589607,3.382953504149869
L3.3,53392493,3.3534830778032045
PL-21,16720766,-2.262728868297287
HCC1833,15983966,2.85898627834211
SK-OV-3,2708,5.531711784720637
L3.3,vorinostat-carboplatin (1-1 mol-mol),3.49555187429186
EJM,3062316,1.2217642247890057
BT 231,12001922,1.144949639789655
KYSE-140,selumetinib-GDC-0941 (4-1 mol-mol),1.940040050969728
T84,9911830,2.4807327035496662
LS411N,73707398,1.3643081745247092
Mino,carboplatin-etoposide (40-17 mol-mol),0.3240192692777656
ECC10,4705,2.6842412149864012
SCC-9,11707110,2.5707994933885736
KO52,16065773,1.718324313076395
NCI-H929,3815108,2.046773234087797
ALL-SIL,644241,-6.056766449232899
MHH-CALL-4,54678924,1.6229631080250602
NCI-H929,25195348,3.383350427765997
SW1353,135984461,3.620259529955406
IST-Mes1,24180125,3.710624760267412
NMC-G1,568763,2.9310265649963867
NCI-H929,9825149,-1.6436750133006153
SNU-119,11485656,2.5966291939022192
ECC10,2126,3.433483583372589
KHM-1B,3062316,-0.287496267646507
NCI-H1395,44137675,3.7508448726513737
T84,navitoclax-pluripotin (1-1 mol-mol),-0.1633148007080243
SK-LU-1,11213558,2.0146451652077286
BT 416,969516,2.5413771829826524
BT-20,54618164,4.2305342335962175
NUGC-4,selumetinib-vorinostat (8-1 mol-mol),-1.0651550460583663
MHH-CALL-4,6917907,-8.185635440206596
OCI-M1,10385095,0.871946369037786
IST-Mes1,24797083,1.4429650511590184
ALL-SIL,9929138,4.286241964174987
YD-8,9823820,4.576416589140342
MHH-CALL-4,16038120,0.2329743936237141
RCM-1 [Human rectal adenocarcinoma],selumetinib-MK-2206 (8-1 mol-mol),1.8238867716534872
BT 231,44589607,2.029786796315878
YH-13,3634881,3.1869210851626075
KO52,5113032,4.556788931704779
PANC-1,24856436,1.3059594080123096
SW1116,1750826,-1.5935318567470695
RCM-1 [Human rectal adenocarcinoma],400769,-1.066885564414268
KHM-1B,selumetinib-navitoclax (8-1 mol-mol),1.5654531920852657
OCI-M1,6450551,3.0584588669256147
KHM-1B,151289,0.8227956110380268
GP2d,10302451,0.1765662972629052
MHH-ES-1,9915743,1.9071670198037491
T84,6918736,-2.4323708714713175
HD-MY-Z,16038120,1.936201770827732
YD-8,12003241,-1.7142863629727714
MHH-ES-1,135875424,3.469224275097477
KYSE-30,136227924,3.298083829392356
MHH-ES-1,44202524,0.9266752633016666
RCM-1 [Human rectal adenocarcinoma],25102847,3.88391486543544
NCI-H2171,navitoclax-sorafenib (1-1 mol-mol),0.0359030592746101
REC-1,9927531,3.800278065681949
PL-21,11625818,2.68945163779208
LS411N,9967941,4.95978669187673
KYSE-30,54678924,1.9052608055889393
YD-8,24772860,-1.4663739289558224
NCI-H2087,216468,3.5603873166026587
LP-1,selumetinib-JQ-1 (4-1 mol-mol),-0.0299849732495822
HCC1833,452548,1.2368006744751732
SW1116,erlotinib-PLX-4032 (2-1 mol-mol),1.6239744026736935
GA-10,selumetinib-PLX-4032 (8-1 mol-mol),4.343011259356776
KO52,9911463,3.5355164060453004
Hs 936.T,3038522,4.225843069582516
BT 416,12001922,1.667963405341588
NCI-H2087,24753719,4.17997265759222
BT 231,4378219,1.1996674528146534
LS411N,3815108,3.549037613932863
ECC10,375860,-0.309694131426854
MHH-ES-1,5329102,1.2136134887225511
NCI-H2087,136227331,3.603331893484652
ECC10,25126798,4.120986026096772
LP-1,71304818,1.0855478257866398
KYSE-30,42611257,3.571232825317866
MHH-ES-1,208908,2.3060086211739015
PE/CA-PJ15,5394,5.238681648406455
NCI-N87,1750826,1.3506728687975464
SCC-9,462382,0.912003027061621
SNU-119,erlotinib-PLX-4032 (2-1 mol-mol),0.7167448472722272
BT 231,5284616,1.9452196102745216
GA-10,5281672,1.9114762253218625
MHH-ES-1,71466445,3.4244975863031755
NCI-H929,11625818,1.510489676264857
PE/CA-PJ15,1239801,3.8964030609370446
KP-N-YN,9866186,3.380511072680034
HCC1833,322968,3.8579542183855033
TCCSUP,104842,-1.1313342296159858
BT 416,11178236,-5.592943198217986
TCCSUP,445643,3.731151770896645
KMS-12-BM,3503,1.8657686630799155
SNU-119,5329102,1.9834591388005431
CFPAC-1,3689413,3.8323467943354337
GA-10,753704,2.5889023664252107
YD-8,24785538,0.9876350008475095
RT-4,11640390,3.689473360751719
HCC1833,selumetinib-JQ-1 (4-1 mol-mol),2.357049659281798
KYSE-30,navitoclax-birinapant (1-1 mol-mol),3.115966946147392
HD-MY-Z,44607530,2.2486729354669435
OCI-M1,erlotinib-PLX-4032 (2-1 mol-mol),3.35214854470989
BT 416,51039095,2.268699303756154
MHH-ES-1,148198,-5.108564856367707
HD-MY-Z,44137675,4.197912651663419
K-562,5311,0.9288629076778604
KHM-1B,31703,-2.376235984768286
REC-1,10074640,4.06593247218381
PE/CA-PJ15,4917,3.7625286971373457
OCI-M1,107970,2.5617440742117794
KYSE-140,31703,-0.1428902938199202
SNU-119,navitoclax-birinapant (1-1 mol-mol),1.664402595144999
SCC-9,vorinostat-carboplatin (1-1 mol-mol),4.0549639225779615
BT 231,984333,1.3802175680857889
PL-21,doxorubicin-navitoclax (2-1 mol-mol),-1.170190083784472
Mino,10427712,3.590995303616826
Hs 936.T,11625818,4.613678666641992
T84,24772860,-2.2321870957335044
SK-HEP-1,12001922,2.448252559355595
NCI-H2087,5311,0.6497900722127591
T84,44589607,2.1241505671090133
KYSE-30,5278396,3.5783477761007885
MHH-ES-1,23725625,0.9674399396135404
SK-MES-1,25154868,4.6477725186368675
PE/CA-PJ15,crizotinib-PLX-4032 (2-1 mol-mol),2.2605390959198113
EJM,25161177,4.274116422039874
PL-21,136227924,2.3397761554923413
SNU-119,151289,0.6680539907323628
SNU-119,11396600,3.5657342992920547
Calu-1,7326481,2.7572120653572068
BT 231,374536,3.025650998981233
KHM-1B,55283,0.1410687049284859
BT 416,44491742,4.3969888889672415
PE/CA-PJ15,JQ-1-vorinostat (2-1 mol-mol),0.8852221304814516
Mino,135398744,6.764750512167438
CFPAC-1,navitoclax-gemcitabine (1-1 mol-mol),-1.2465327619734463
Mino,5335621,3.5171379236679328
SK-MES-1,selumetinib-MK-2206 (8-1 mol-mol),1.4191547002674645
HD-MY-Z,126941,-4.325106202655554
PL-21,123631,2.17096420085253
NUGC-4,11404337,-1.0911037435760411
KYSE-140,44507138,1.8791452329240197
NCI-H2087,9911463,3.2205698375383935
IST-Mes1,72193861,3.6955595837075137
ECC10,5311281,0.6631430664066448
HuNS1,135999136,1.7858791194050956
L3.3,6852167,2.807934515358382
EJM,426756,4.346205416348047
SK-MES-1,11455910,0.6501278721551685
OCI-M1,400769,-0.9261577177668004
MHH-ES-1,54454,2.086290173109921
KHM-1B,2729026,0.9110795955585352
KHM-1B,11626560,-0.6143155119678699
NCI-H929,100016,3.8135603062591
Mino,UNC0638-navitoclax (1-1 mol-mol),-2.2285256214754647
NCI-H1395,2858523,3.2706223313658445
IST-Mes1,24901704,2.6411672165981965
EJM,31703,-1.6176826113818792
EJM,44491742,4.208016925641279
HD-MY-Z,6918638,0.9232072898358828
KYSE-140,tanespimycin-bortezomib (250-1 mol-mol),1.07256809549566
SK-LU-1,44241473,4.4527088326385345
KO52,24901704,1.8747752688503028
Hs 936.T,44607531,3.300505524275658
LP-1,2945648,1.6795140670746027
KYSE-30,vorinostat-carboplatin (1-1 mol-mol),4.498943875890233
REC-1,selumetinib-PLX-4032 (8-1 mol-mol),5.072809874857802
HD-MY-Z,piperlongumine-MST-312 (1-1 mol-mol),1.1951699378818414
T84,135421197,1.1926800486380174
KHM-1B,67156097,-2.0770884732643493
KP-N-YN,15953870,1.7539818153514606
PE/CA-PJ15,2828334,6.208466277594022
K-562,16736978,2.075477087199636
TCCSUP,72193861,1.75237754953521
Mino,25105715,3.062355034521067
REC-1,serdemetan-SCH-529074 (1-1 mol-mol),2.6925549668992197
NCI-H2171,53392493,1.8740494203136608
GP2d,25102847,1.8273114591900137
NCI-H929,44489675,3.656307412577015
KO52,11167602,0.9021081553845208
SW1353,216468,5.051653676502347
EJM,46943432,3.619668904272789
SNU-119,5287620,-2.0634192053301623
EJM,doxorubicin-navitoclax (2-1 mol-mol),-1.6863315158060843
ECC10,216239,1.729849338251906
NUGC-4,5978,-2.557934200814578
SK-MES-1,3384730,2.8261184101271355
BT 416,6450551,2.1117138883617304
KO52,15547703,3.0734769425929236
NCI-H929,216345,1.9065836273896417
KHM-1B,2828334,5.467256536463017
SK-MES-1,5978,-1.387614949060934
SKM-1,9866186,0.3816129775524117
OCI-M1,44491742,3.801673396413645
LP-1,11964036,0.2248390298069791
MHH-ES-1,4261,1.0158984407469278
RCM-1 [Human rectal adenocarcinoma],5282054,4.302238331478781
GP2d,docetaxel-tanespimycin (2-1 mol-mol),-7.246902567479293
BT 231,11238147,3.25397322060028
PE/CA-PJ15,44507138,2.9434296092809595
TCCSUP,135421197,2.510598154952076
HMCB,151289,0.8924062734288687
K-562,45279963,2.402740503794971
Hs 936.T,6918837,-3.199459511291056
BT-20,104842,-2.000695763736974
SK-MES-1,17755052,0.8875358500224465
GA-10,5738263,1.8298834978388911
TCCSUP,5280436,3.7871287976810097
T84,tanespimycin-gemcitabine (1-1 mol-mol),-1.430800286432113
OCI-M1,387447,-5.720282808963336
TCCSUP,3081361,3.015590001754395
IST-Mes1,72376,0.3576615812024088
NUGC-4,67291369,-0.3233340422538147
NCI-H2122,42642645,1.7218128407798157
KYSE-140,11609586,3.349857712367051
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026
HMCB,644241,4.490422282614611
SKM-1,decitabine-navitoclax (2-1 mol-mol),-1.0300252512758497
Mino,6184667,0.8884232010285161
NCI-H1395,4917,3.698580311776931
OCI-M1,9956119,1.8015891228906045
HD-MY-Z,52912189,1.9339074936884368
NUGC-4,135421197,0.9656923984345016
SK-OV-3,5566,3.179406871626594
GA-10,2858523,2.840473156216859
TCCSUP,5291,3.685939275525437
NCI-H929,24964624,-4.598319176525677
OCI-M1,10322450,4.213723369205614
Calu-1,16659841,5.95055951588689
Calu-1,4705,3.5470871536142563
GP2d,2871966,0.4294937581986642
SNU-119,6184667,2.2923669732173093
K-562,44202524,1.302888790519651
ECC10,decitabine-navitoclax (2-1 mol-mol),-3.2064741163872523
KYSE-140,5351362,1.050939174306309
NCI-H929,24753719,4.216810454357832
L3.3,9840324,5.709572906398099
SK-HEP-1,2708,5.260013220141412
HD-MY-Z,navitoclax-sorafenib (1-1 mol-mol),1.805626022303975
Hs 936.T,4788,5.84730757334635
T84,25105715,2.6103543827489224
LP-1,navitoclax-MST-312 (1-1 mol-mol),1.15079978115194
YD-8,9866186,2.735650020983901
Hs 936.T,71466445,3.3475399187974384
L3.3,9866186,0.5756442482063215
NCI-H1395,navitoclax-gemcitabine (1-1 mol-mol),2.205005883298022
ALL-SIL,446155,2.369103686447931
SNU-119,123631,0.6885393078398833
PL-21,3025944,3.626705829841474
KYSE-140,3825829,2.9293009002814183
SK-LU-1,24901704,3.0128433206998575
IST-Mes1,selumetinib-decitabine (4-1 mol-mol),6.500937496154089
K-562,24753719,4.107201496626299
NCI-H2171,55508,1.786136919471965
PANC-1,46843906,1.687884361582426
PL-21,6505803,-0.5329499578695445
NCI-H2122,selumetinib-navitoclax (8-1 mol-mol),2.36899721935362
NCI-N87,11152667,-0.2953714197447944
ALL-SIL,387447,-4.904935645240703
EJM,2733487,6.457690507426682
CFPAC-1,24772860,-1.883570704311996
KYSE-30,100016,6.190453384433256
HCC1833,16720766,0.9548027367016008
TCCSUP,53232,2.5556633861706453
KHM-1B,638278,3.418404486503754
HuNS1,23725625,4.280452744640978
K-562,89928392,1.1726799483120014
YH-13,19582717,5.382815759701368
KYSE-140,2841722,5.217133832633594
REC-1,salermide-PLX-4032 (12-1 mol-mol),4.957710312224808
GA-10,25262965,-5.214461636164843
LP-1,984333,1.1817244601013994
SK-MES-1,vorinostat-navitoclax (4-1 mol-mol),1.0218759100171186
TCCSUP,3025944,4.64601572000857
PANC-1,6450551,3.244005315313389
RCM-1 [Human rectal adenocarcinoma],72734382,4.304323658475911
BICR 31,3025986,-1.7152493432112506
KO52,56649450,4.374413775432872
SW1353,3543504,5.605284159044157
OCI-M1,doxorubicin-navitoclax (2-1 mol-mol),-1.631441486974251
SCC-9,16725315,5.212889946477865
SW1353,15983966,-3.375048324857177
ECC10,16736978,1.053115330363814
SCC-9,11404337,-1.771041191231111
SKM-1,71466578,1.8721097081856155
TCCSUP,9444,3.681679510708516
BICR 31,4259181,2.3774772051226685
OCI-M1,tretinoin-navitoclax (4-1 mol-mol),0.938616357661672
IST-Mes1,selumetinib-GDC-0941 (4-1 mol-mol),2.032921854049634
LS411N,52912189,2.124177170278397
YD-8,53392493,2.3611593558483066
YD-8,25195348,5.853643444602765
ECC10,409805,3.5176729125359123
KP-N-YN,6610355,7.138179879835894
SCC-9,241158,3.962823581088113
TCCSUP,216468,4.422415170962146
NCI-H2087,53495165,-0.7989033173716167
MHH-CALL-4,11977753,-1.0774367967080116
HCC1833,25062766,2.414842232090632
SK-HEP-1,9911463,4.3683168964450125
HMCB,119607,5.35343199280946
BT 416,6918878,3.1827229049107864
HD-MY-Z,54454,0.6562062664300234
PE/CA-PJ15,11175137,2.227719156737245
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296
HD-MY-Z,44819697,-1.7707303704123445
PL-21,selumetinib-tretinoin (2-1 mol-mol),-1.3306677061944836
GP2d,637858,1.5344934743402423
YD-8,JQ-1-navitoclax (2-1 mol-mol),3.0006612821736978
YH-13,71751553,4.865573337264169
LP-1,3025944,3.830405986582179
NUGC-4,26596,-1.113746804335536
TCCSUP,44607531,1.6121278568791757
NCI-H2171,10302451,3.986494326049399
GA-10,10296883,2.032033381288912
SK-OV-3,1323703,3.751791158325908
NCI-H2087,5351362,1.0236591235476205
PE/CA-PJ15,navitoclax-piperlongumine (1-1 mol-mol),4.044139806704131
T84,6436223,-5.36186149358706
REC-1,9911463,3.153332853315619
NMC-G1,448949,3.2822422417835497
PL-21,44241473,4.839124245542347
LP-1,219104,1.7681244042369455
SNU-119,4378219,1.466515976267717
RCM-1 [Human rectal adenocarcinoma],89928392,1.6489632684947326
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264
IST-Mes1,10074640,3.5425729050518053
LS411N,1716436,3.6051806229528394
YH-13,10296883,4.196539709790054
SKM-1,53232,2.0648261510736576
BT-20,60700,0.7211419464061065
SKM-1,3136844,3.4979321802253356
BT 231,25227462,1.0248438263873367
TCCSUP,4261,0.2387476158798516
NCI-H2087,4705,3.3747422843456185
SNU-119,24779724,4.340610631668066
SNU-119,11364421,1.6270559776007496
KHM-1B,60750,-3.330865145118168
MHH-ES-1,135421197,0.9821303635644922
SKM-1,168312962,0.8747361111835986
Mino,selumetinib-piperlongumine (8-1 mol-mol),2.4695673161697593
HCC1833,4378219,1.832290560559543
RT-4,24856436,1.1504694171178176
TCCSUP,2749,2.6496774688336004
NCI-H2087,serdemetan-SCH-529074 (1-1 mol-mol),1.9353239004298557
SNU-119,54626689,4.267759657725626
TCCSUP,136227924,3.28330337763218
HMCB,25183872,-1.6540878742670562
SK-OV-3,11485656,3.3782074628341894
BICR 31,168313200,4.293337148285007
SKM-1,navitoclax-piperlongumine (1-1 mol-mol),0.8307338644583981
OCI-M1,carboplatin-UNC0638 (2-1 mol-mol),4.042552606162654
GA-10,702558,2.622021937059571
KO52,4521392,4.342251998569949
PE/CA-PJ15,selumetinib-JQ-1 (4-1 mol-mol),2.840123680248533
KYSE-30,11657048,4.153776200402227
TCCSUP,24772860,-2.3994622500716503
SK-HEP-1,6914657,-2.911576812343612
NCI-H2087,11222830,0.2797010174182365
MHH-CALL-4,selumetinib-navitoclax (8-1 mol-mol),0.0536776376563911
HuNS1,9887053,3.2166937440729897
KYSE-30,5329102,2.782269554109563
EJM,25183872,-1.9531773899114209
HD-MY-Z,135659046,3.544790983777307
BT 231,46926350,-3.728380335496617
KO52,3081361,3.265083976806624
BT 231,selumetinib-piperlongumine (8-1 mol-mol),3.547649746778795
SK-LU-1,sirolimus-bortezomib (250-1 mol-mol),1.1916216925923933
NCI-H1395,400769,0.1156241429574924
ALL-SIL,6252,-2.462384672511242
REC-1,136227924,3.1866861789415855
NCI-H2171,56946209,-6.55665845628197
ECC10,16038120,-0.3756167097534768
YD-8,56973724,2.610030858184056
NCI-H2087,67156097,-1.5598883586166017
KHM-1B,123631,2.5623362967553858
NCI-N87,136227924,3.040461203265333
NCI-N87,3634881,3.127468365851455
KMS-12-BM,7251185,3.495873339291499
T84,2871966,-0.784418257536695
SK-HEP-1,11234052,4.66363668535284
SNU-119,637858,2.7399101747630867
NCI-H2087,10385095,1.015430791106066
PE/CA-PJ15,5351362,1.0110502710399616
SW1116,17755052,6.3985859318096585
NCI-H2087,36314,1.7460020192731696
SK-MES-1,44819697,0.0466827040943047
TCCSUP,navitoclax-gemcitabine (1-1 mol-mol),0.0412224800820071
SK-LU-1,24785538,1.1199228968876354
GA-10,24978538,2.2436663179589633
NMC-G1,54618771,1.359129875373881
NCI-H2087,49867926,3.328294776746476
HD-MY-Z,135398516,1.283091191038153
BICR 31,104842,-0.0442586507462943
NMC-G1,9825149,2.5635418987784497
SNU-119,23725625,6.436017901271369
T84,44819697,-0.5044697573740384
HuNS1,selumetinib-JQ-1 (4-1 mol-mol),0.1641694525405924
MHH-ES-1,navitoclax-MST-312 (1-1 mol-mol),1.373421335558893
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103
ALL-SIL,24771867,-3.516684419884963
IST-Mes1,9911463,4.127098730346426
NCI-H2171,6184667,1.4164127707768046
LS411N,11485656,1.6093796612349578
KO52,2733526,4.161479785187153
IST-Mes1,alisertib-navitoclax (2-1 mol-mol),2.2852376454563896
BT-20,SNX-2112-bortezomib (250-1 mol-mol),1.7191176717576229
NCI-H2122,16065773,3.1410854146561884
SNU-119,5566,3.0036278847764923
YH-13,327653,3.132127686900927
K-562,10410894,3.650757753763785
YH-13,9866186,1.6052834410324497
NCI-H2171,JQ-1-UNC0638 (2-1 mol-mol),0.4857053438992066
KP-N-YN,24797083,1.846617900701236
SK-OV-3,159324,5.082712026660022
LP-1,6918638,-1.2002393899697523
NCI-H2087,119182,-1.2128371988706157
NCI-H2122,24772860,-2.6241487308525526
Hs 936.T,9444,4.339305334624905
NCI-H2122,23635314,-2.358255247139381
T84,9884685,0.0950503112207011
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802
BT 416,53495165,2.4533238975516363
BICR 31,10074640,3.67367044204876
KHM-1B,72376,-2.838745131270772
HMCB,JQ-1-UNC0638 (2-1 mol-mol),1.877058831391371
BT 231,54618164,4.074270092547043
SNU-119,11497983,3.6896133673877207
NUGC-4,322968,3.155278982211526
PL-21,4261,1.1789145141445527
YD-8,10074640,2.718644140629287
SK-HEP-1,71466578,6.341226391578653
BT 416,11612883,1.4996166517232887
HCC1833,3634881,3.532186071490396
GA-10,JQ-1-MK-0752 (1-1 mol-mol),-0.3088093323835186
SK-OV-3,637858,3.830307013284548
NCI-H2087,24771867,2.194969943963046
BICR 31,11178236,-3.7191700347439176
MHH-CALL-4,5291,3.6797871777122704
SK-MES-1,56949517,4.127961652782748
BT-20,10322450,4.517270992352955
KO52,1750826,-4.467141679047344
HuNS1,17755052,4.168348281902864
KO52,60700,-2.426926956892104
RCM-1 [Human rectal adenocarcinoma],9866186,0.0174318535432376
TCCSUP,navitoclax-MST-312 (1-1 mol-mol),1.0715632013876748
BT 416,71304818,2.6142221940660884
CFPAC-1,11152667,-0.7440904943214312
BICR 31,176870,3.2718013899021607
NCI-H929,71466578,2.486095138204317
BT 231,15953870,3.368838744296408
YD-8,25150857,2.3631685028134544
KHM-1B,tanespimycin-bortezomib (250-1 mol-mol),-0.3010055650508828
Hs 936.T,262093,3.786495505346027
KHM-1B,selumetinib-vorinostat (8-1 mol-mol),0.6358742405488887
GA-10,11647372,-0.1580520575265443
BT-20,9933475,2.951988585393166
GA-10,1750826,-5.4993660444881725
KYSE-30,54143018,4.096728204019495
HD-MY-Z,216468,3.768988179066153
GP2d,11609586,3.788002254682708
ALL-SIL,65064,2.797289094590348
NCI-H2122,11178236,-0.6406035424000264
BT 231,3025986,-0.400270845305179
PL-21,135421197,1.4240798978799187
Calu-1,navitoclax-birinapant (1-1 mol-mol),1.920209256203076
SK-OV-3,24951314,1.413681041410239
PE/CA-PJ15,25150857,2.430682281615116
Hs 936.T,serdemetan-SCH-529074 (1-1 mol-mol),2.340013125129546
SCC-9,46199207,3.715699147831311
Calu-1,54596490,4.459626115799054
ECC10,24771867,-2.5080909522055785
NCI-H2087,6252,2.2360663449018663
TCCSUP,9549297,3.547573054741186
KO52,46398810,1.739829044633002
NCI-H929,11178236,-4.166985560553255
SKM-1,3825829,2.28297195030611
GP2d,11238147,1.4947916042076903
HuNS1,5329102,1.6443015470006734
SK-LU-1,135440466,1.994011772550191
HuNS1,11427553,2.2678943336993234
T84,5479543,1.1411183270257743
SW1353,11213558,3.702008158325542
LS411N,4261,1.591263829932159
RCM-1 [Human rectal adenocarcinoma],9915743,2.171200504833566
LP-1,9825149,-0.5214449016823868
NCI-H2087,11234052,3.6495316815461543
NCI-H2171,serdemetan-SCH-529074 (1-1 mol-mol),1.0572285020282108
GA-10,5328940,0.0730055265155979
PE/CA-PJ15,9926054,1.7631963091393454
ECC10,25105715,3.2774327613163488
Mino,462382,0.2986283576908556
BICR 31,676352,2.5344425849235472
LP-1,135398738,4.741458430193643
NCI-N87,4788,6.175336883845895
BT 416,24180719,3.1133029562660353
HMCB,6505803,-1.40903466994972
GA-10,168313016,4.160019409093505
KO52,2871966,-1.083117753240993
TCCSUP,54649381,3.810492846864681
TCCSUP,11396600,4.109332889227832
NUGC-4,42642645,0.2656700210226594
KMS-12-BM,3038522,3.0774694723408036
K-562,16725315,4.409558206085648
BICR 31,72376,-0.802396523967939
L3.3,753704,5.0689754221003875
ECC10,42611257,2.58854252156509
EJM,11175137,3.135182491748147
KMS-12-BM,6918736,-1.7905560703377923
KO52,44632017,0.0907134536946377
GP2d,navitoclax-PLX-4032 (1-1 mol-mol),-3.180687475277044
KMS-12-BM,135398516,0.3252714266903287
Mino,navitoclax-sorafenib (1-1 mol-mol),-2.8547610519419098
PE/CA-PJ15,BRD-A02303741-navitoclax (2-1 mol-mol),3.651114903292107
SKM-1,42642645,1.502866726077564
NCI-H2122,16741245,3.5287910754439578
PE/CA-PJ15,6852167,2.545538398770599
KYSE-30,JQ-1-vorinostat (2-1 mol-mol),1.665945092191552
OCI-M1,119182,-3.265162994850406
T84,24889392,1.8406334421326935
NCI-H929,5329102,0.3399377983022085
PL-21,4096211,0.3185050053549665
KMS-12-BM,54613361,-2.0656544481167085
KP-N-YN,46901937,3.5807540905671096
OCI-M1,46215462,1.6169100546264998
NCI-H2171,docetaxel-tanespimycin (2-1 mol-mol),-7.650275881256593
BICR 31,3552672,2.13577451695998
EJM,6917907,-6.067792190523033
BICR 31,11404337,-0.6318210319309021
HCC1833,navitoclax-gemcitabine (1-1 mol-mol),-0.6423243914143653
SK-HEP-1,60750,5.759979022694095
PE/CA-PJ15,53301938,6.132050382123197
BT-20,piperlongumine-MST-312 (1-1 mol-mol),1.4645296142406754
HMCB,17755052,3.106416097908083
HMCB,51037431,1.7476286222602764
K-562,54596558,4.166105900128149
SKM-1,409805,3.7093603817382337
SNU-119,3384730,4.617278289213739
NCI-H929,676352,1.778414026340849
NCI-H2122,439501,-2.460326379579743
KO52,54143018,0.4285373524333706
BT 416,25105715,3.666218343203304
OCI-M1,1750826,-0.3629653323298832
CFPAC-1,44819697,-0.5846434286623752
NCI-H2171,25183872,-2.065345244597309
SNU-119,10074640,2.593103189576663
NCI-H2087,25126798,3.7787828825461154
EJM,11612883,2.7547358243223368
LP-1,9907093,3.4004171934293272
HuNS1,375860,-0.6184479016387657
HD-MY-Z,5328940,1.058560587155326
Calu-1,44607530,2.9531303603694083
YD-8,64971,4.450912685829993
NMC-G1,445643,4.405363805879493
IST-Mes1,5311281,1.4883568311904505
HMCB,49793307,0.2477875655449162
BT-20,5284616,3.486815373795057
HCC1833,navitoclax-sorafenib (1-1 mol-mol),0.5523388361779701
LP-1,5328940,1.63720076100311
SK-HEP-1,57519531,4.12625544642691
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328
MHH-CALL-4,selumetinib-decitabine (4-1 mol-mol),-0.0338000608259668
NCI-H2122,387447,-3.461359838367798
NCI-H929,119182,-0.7271204435080775
Hs 936.T,216345,4.491432525254447
HD-MY-Z,135999136,4.336889602343054
EJM,49836020,4.362565190709962
NCI-H929,9936388,-5.492803140929198
SK-MES-1,216345,3.825178063374615
KHM-1B,6450551,1.2159742345507
GP2d,25227462,1.7518082926517873
KMS-12-BM,54619267,2.4046016005161315
Mino,31703,-3.4550388642767804
Calu-1,5738263,4.348103851187664
CFPAC-1,5746,0.2884319404953815
ECC10,49850262,2.1681764418472333
SW1353,5460769,4.513460705614206
HD-MY-Z,53495165,-1.4046760320308695
NCI-H2171,5287620,-0.0573950216422359
PL-21,54618771,-1.4027013448904684
ALL-SIL,89928392,-0.8842785165403505
LP-1,135421197,1.2171511840038625
BICR 31,446155,3.004688823756655
NCI-H1395,135411,0.822890110332085
GA-10,10074640,2.165750347110596
RCM-1 [Human rectal adenocarcinoma],11964036,2.7270949198537195
LS411N,11152667,-0.1489697958567156
SKM-1,25262965,-1.3150053661970005
CFPAC-1,44589607,3.692725122607437
YH-13,carboplatin-UNC0638 (2-1 mol-mol),3.6332761748484255
MHH-CALL-4,JQ-1-carboplatin (1-1 mol-mol),-0.223161875024046
SNU-119,3825829,3.624299392396196
IST-Mes1,piperlongumine-MST-312 (1-1 mol-mol),2.506000344733661
GA-10,5311037,3.9129836479476654
RCM-1 [Human rectal adenocarcinoma],46191454,2.186617263372051
PL-21,3385,3.8994286577020207
MHH-CALL-4,5460769,0.3846301145612474
LS411N,15547703,3.407600768992332
BT 231,3689413,-1.816097223149399
KO52,5470400,-0.2484424992521816
Mino,6610216,4.52250684011298
REC-1,135398738,2.0417076153382316
Mino,67156097,-3.095827549462798
EJM,53245473,3.7165309146021417
ECC10,25102847,2.3439667658173557
OCI-M1,serdemetan-SCH-529074 (1-1 mol-mol),2.2859431859887667
ECC10,54454,2.207206966445826
KYSE-140,1641662,2.9048078476237635
ALL-SIL,25183872,-1.1896517316661384
LP-1,navitoclax-piperlongumine (1-1 mol-mol),0.9968577257159515
NCI-H2087,1750826,-5.037141147792019
YD-8,9907093,4.458824128138645
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742
IST-Mes1,vorinostat-navitoclax (4-1 mol-mol),2.4210379040593972
SK-HEP-1,44566777,0.1035402456781041
T84,5738263,2.579595870242099
L3.3,44589607,3.517286764473911
Calu-1,135984461,1.7273977102248494
YH-13,tanespimycin-gemcitabine (1-1 mol-mol),0.5639208789602934
KMS-12-BM,375860,-0.7808796284755947
SCC-9,salermide-PLX-4032 (12-1 mol-mol),5.953204050581384
HMCB,1242560,3.0802534848210947
TCCSUP,46398810,2.9354899983931433
KMS-12-BM,135928012,2.4606603364640995
KO52,3825829,1.880917675310284
ECC10,452548,-2.2827843419334797
BT-20,10127622,6.365687415754272
KO52,55508,2.226115215062858
HuNS1,9866186,-0.0743750297069717
KO52,2874250,4.969283597945665
MHH-CALL-4,444795,3.2572985338765084
Mino,44498493,4.4262129486717585
T84,24797083,1.212462549644711
KYSE-140,5743,4.3326680057138365
SNU-119,9936388,-1.2994148300283177
HD-MY-Z,441298,2.484887669219378
SK-MES-1,50905018,4.7349444799510865
MHH-ES-1,638278,3.0400150800040997
HCC1833,1242560,4.801698603214809
SK-MES-1,44607530,0.6066080464329566
YD-8,6610355,5.07814691981883
YD-8,navitoclax-sorafenib (1-1 mol-mol),2.877352629511259
NCI-H1395,3634881,3.864261643428736
ALL-SIL,53245473,2.8781179496967666
IST-Mes1,11955716,-2.3343063309165095
PL-21,9967941,3.768232418261226
ALL-SIL,135984461,1.7193250250744925
NCI-N87,6914657,-3.795056001746233
REC-1,5329102,4.264549452194595
KHM-1B,navitoclax-MST-312 (1-1 mol-mol),1.4754840901416553
EJM,11977753,-2.8981828943560255
HD-MY-Z,selumetinib-PLX-4032 (8-1 mol-mol),2.5188430235159807
NCI-N87,5460769,3.352422042402732
GA-10,doxorubicin-navitoclax (2-1 mol-mol),-3.8200371662123622
EJM,25150857,1.0881005690844914
NMC-G1,71304818,3.338937474480211
PE/CA-PJ15,8515,2.421663775633471
CFPAC-1,6438394,3.818576384874022
Calu-1,11427553,3.4847031284635497
BT 416,65628,3.396680033098099
NUGC-4,135440466,2.0917756040203845
Mino,44607531,0.0871259315343507
IST-Mes1,10296883,4.238957650390159
SK-HEP-1,462382,1.018219313736715
LP-1,1242560,2.0562137238232667
HMCB,51039095,2.359958278264178
NUGC-4,156414,-3.830513888497556
BT 231,selumetinib-MK-2206 (8-1 mol-mol),2.863856190767052
LS411N,387447,-3.952629374311597
RCM-1 [Human rectal adenocarcinoma],2871966,0.2370033726564668
SK-MES-1,54143018,0.8053658871453037
SKM-1,9907093,3.8598781273482983
SNU-119,44489367,5.127022911687477
CFPAC-1,11640390,3.686024444562123
LS411N,24951314,1.1768436480242177
Hs 936.T,753704,5.008807553432126
OCI-M1,2828334,5.760123892722639
PE/CA-PJ15,375860,-0.3600146700827705
KP-N-YN,53495165,2.1999495269155855
LS411N,107970,2.4864618038552724
GP2d,107985,-4.252296994603502
NCI-H2171,60700,-0.3771090207819011
NMC-G1,selumetinib-PLX-4032 (8-1 mol-mol),4.507608168716115
BICR 31,7251185,3.1852875333924415
NCI-N87,16115403,-3.919428944380448
IST-Mes1,49836020,4.276541253138442
NCI-N87,11609586,1.5678533381622328
YH-13,9884685,0.7618617096747208
LP-1,5278396,3.550906530722312
SK-OV-3,46199207,3.479599233509405
KYSE-30,9926054,2.699990284064641
L3.3,2858523,3.1166554672991604
OCI-M1,637858,1.0895726887378772
BT 231,11364421,-5.652972875269212
SW1116,9952709,3.0555178772435796
ECC10,67291369,-0.1785393911747309
REC-1,11640390,2.967274756453034
LP-1,66577038,2.0737702371108253
Calu-1,BRD-K55473186,3.8107379981504943
MHH-CALL-4,11175137,1.4357289695448192
SCC-9,navitoclax-pluripotin (1-1 mol-mol),-0.0123473768643266
K-562,24785538,3.0712560410264436
HuNS1,107985,-4.251008653839981
IST-Mes1,44589607,3.0309009389458605
NCI-N87,5746,-2.0970985848352837
SK-HEP-1,136227924,3.6301481247272287
GA-10,piperlongumine-MST-312 (1-1 mol-mol),0.2056543663633318
BT 416,44137675,3.067487252962228
PL-21,9935249,2.29170119673888
SKM-1,selumetinib-JQ-1 (4-1 mol-mol),-3.5716961442559496
RT-4,124202324,3.016060322906711
RCM-1 [Human rectal adenocarcinoma],2729026,3.1482483825414698
HCC1833,2729026,2.8692697578003155
PL-21,navitoclax-MST-312 (1-1 mol-mol),0.9956018024503206
Hs 936.T,44589607,3.9627128398747944
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146
T84,49793307,-3.5466713587827776
HD-MY-Z,148198,-4.870979577806884
PE/CA-PJ15,72193861,0.6686129421450179
RCM-1 [Human rectal adenocarcinoma],10385095,1.0940876839597544
KP-N-YN,ISOX-bortezomib (250-1 mol-mol),2.4346945714759256
MHH-CALL-4,51037431,3.3765638007990533
HCC1833,serdemetan-SCH-529074 (1-1 mol-mol),2.321407112688312
BICR 31,9884685,0.303781088019613
TCCSUP,11178236,-5.158668289111837
BT 231,9911463,2.979244544193708
NCI-H929,124202324,1.4595728205494207
NCI-H2122,15547703,3.3284485518409292
BT-20,9907093,4.482353035614215
SK-OV-3,15983966,-3.6834707194333927
ALL-SIL,15953870,2.429039509996585
HCC1833,168312962,1.4493297536210965
HCC1833,439501,-1.5774129771640248
NCI-H1395,24821094,3.771001667275143
SK-MES-1,7326481,3.242341499365085
NCI-H929,439501,-2.3111413664478513
KMS-12-BM,451668,-4.0111672438300126
NCI-H2122,123631,2.013204826337397
CFPAC-1,SNX-2112-bortezomib (250-1 mol-mol),-0.1465951399298486
SK-MES-1,126941,-4.297651469911801
NUGC-4,374536,-1.4010934911416792
HMCB,44202524,1.5502685423041775
Mino,11167602,5.227056331573394
MHH-CALL-4,9884685,-0.3839194515587534
RCM-1 [Human rectal adenocarcinoma],219104,4.304261518356908
KMS-12-BM,11214940,1.3088229833339329
NUGC-4,72193861,0.0745379833008085
KMS-12-BM,3634881,2.6463615699611807
IST-Mes1,JQ-1-carboplatin (1-1 mol-mol),0.3758398512274805
NUGC-4,11152667,-1.113957335382959
KMS-12-BM,11152667,-2.0033121328533054
KP-N-YN,67291369,5.767503306680568
SK-MES-1,10074640,2.6885406749266747
MHH-CALL-4,3503,2.6674239722808344
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392
SW1353,5566,3.0536041965125262
LS411N,5278396,4.113687735714835
T84,135423438,1.8548659324700536
NCI-H1395,107985,-3.679096931387758
T84,54613361,-0.6895033894689686
KYSE-140,168313047,2.912280434568869
KP-N-YN,crizotinib-PLX-4032 (2-1 mol-mol),2.5278116595226465
SCC-9,446155,1.3937663931747788
NCI-H1395,54618771,3.4411900765558125
NCI-H929,44491742,4.424394304638718
ECC10,5311,-0.5391653426531108
Calu-1,5746,3.1675562421482755
NCI-H1395,11964036,2.245588880269689
IST-Mes1,25262965,-0.2533063216587133
TCCSUP,3062316,1.2176043198217033
TCCSUP,6917907,-5.896507975955653
ECC10,126941,-2.0565807869799984
YH-13,9907093,4.406851873711971
KMS-12-BM,44607531,1.4229825608705295
NCI-H2171,9927531,3.1501077196413783
KYSE-140,25262965,-1.0796227247710146
CFPAC-1,4259181,0.9556133546094158
MHH-CALL-4,119182,-7.32140199759678
Mino,5470400,4.059299624232549
SNU-119,4477,-0.101957157099522
MHH-ES-1,5351362,0.7175893067960571
SW1116,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.3819919735240309
OCI-M1,44486219,4.260456223815449
BT 416,2126,4.053607583895218
NCI-H1395,44185566,2.9760824770163756
SKM-1,73707398,0.3700517012219515
NCI-H1395,11717001,5.001255257039283
RT-4,25183872,-1.211160463214132
SK-LU-1,46224516,1.5801968643017252
NCI-H1395,44493528,4.373197971838804
YD-8,11214940,1.0637832201595108
SK-MES-1,56973724,3.343486132860641
NCI-H2171,26596,-1.7584148860978708
SCC-9,25102847,2.571358625043281
BT 416,serdemetan-SCH-529074 (1-1 mol-mol),2.1501109971341825
KYSE-30,54618795,3.3963973769138955
SK-MES-1,16038120,0.6136939305158159
KO52,5278396,3.3505834178575964
ALL-SIL,10410894,2.969142576372873
YD-8,6918837,-2.6695996874336605
NCI-N87,sirolimus-bortezomib (250-1 mol-mol),-1.2024587113239409
SK-LU-1,docetaxel-tanespimycin (2-1 mol-mol),1.515446519979469
RT-4,73707398,0.8448009736616658
EJM,44462760,3.937355169319973
BT 416,selumetinib-UNC0638 (4-1 mol-mol),3.592444882866076
KO52,23725625,4.165793696925613
SK-OV-3,11609586,4.251063762376387
ECC10,4259181,0.1069108144174364
K-562,10127622,4.587499993681003
TCCSUP,JQ-1-navitoclax (2-1 mol-mol),2.4798341578974568
LP-1,9967941,3.7526843850325338
GA-10,327653,1.367223510616167
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125
EJM,46398810,2.702595853434399
SNU-119,doxorubicin-navitoclax (2-1 mol-mol),-1.1544106992080023
BT 416,54649381,4.305934242917029
SW1353,46907787,-0.2143520062248116
TCCSUP,31703,-0.5078441003760595
TCCSUP,selumetinib-MK-2206 (8-1 mol-mol),3.0080662514608845
NCI-H2122,322968,4.853617315511748
K-562,36462,1.3855340321895664
ECC10,156422,3.092788312951001
NCI-H929,24180125,2.4641763284453795
SK-MES-1,9936388,1.0310687201713455
BT-20,16659841,4.929721857286775
GA-10,9911463,2.3483289589885135
T84,753704,4.360093650278708
K-562,6917907,-5.621792844351372
SCC-9,6505803,-0.8932206272709824
NCI-N87,25150857,2.476373943211786
SW1116,446155,4.031620533219179
GA-10,126941,-4.444918577132315
T84,10113978,3.319876276942283
NCI-H2122,56963564,0.590767834098633
GA-10,selumetinib-BRD-A02303741 (4-1 mol-mol),4.834591707871012
SK-MES-1,122327,4.312886409683709
EJM,11625818,4.5052460488071935
SK-MES-1,2708,5.649304428959478
ECC10,969516,2.4595504203231062
MHH-ES-1,5281321,-1.074773930789223
Mino,16736978,1.267358435560582
BT 416,6438330,1.6824321740722263
PE/CA-PJ15,5287969,-2.03511955746643
NCI-H929,tretinoin-navitoclax (4-1 mol-mol),-0.4664155813684951
HuNS1,4578,4.222976899798567
Hs 936.T,51039095,2.610954786898879
MHH-CALL-4,11964036,-0.3274580449773066
RCM-1 [Human rectal adenocarcinoma],148124,4.246203808599277
T84,10231331,0.9685449870961756
NUGC-4,6623618,2.4056986504012934
LP-1,4521392,3.717675963496476
SCC-9,selumetinib-PLX-4032 (8-1 mol-mol),4.645114234652884
RCM-1 [Human rectal adenocarcinoma],5566,3.137413738775102
SCC-9,10385095,1.4052834583911455
ECC10,salermide-PLX-4032 (12-1 mol-mol),4.625814520744236
NMC-G1,serdemetan-SCH-529074 (1-1 mol-mol),-3.888066908581302
T84,selumetinib-JQ-1 (4-1 mol-mol),0.2360248997526779
SKM-1,SNX-2112-bortezomib (250-1 mol-mol),-3.517071278236208
Mino,44543605,5.040908133155415
GP2d,2746,2.2157786787544023
PL-21,285033,-2.748813182669898
HD-MY-Z,168313200,2.256800856387925
REC-1,24748573,5.040628139289987
GP2d,5746,1.1210970086753331
K-562,23635314,-4.3400265171433725
MHH-CALL-4,60750,-4.732500629418417
TCCSUP,216345,4.067577836181339
HCC1833,25150857,2.331110522979455
NUGC-4,24772860,-1.20224776097102
PL-21,selumetinib-JQ-1 (4-1 mol-mol),-2.2255955274462287
NCI-H1395,9444,4.051341414153912
L3.3,148198,-4.142602322676729
BT 231,2708,5.0363775155854915
KYSE-140,2113511,5.328435067613911
NCI-H929,148198,-3.717368743483661
SK-MES-1,24785538,1.233349048005183
ECC10,56649450,0.6517165523976975
ECC10,3038522,3.2127254483675487
SK-OV-3,24856436,1.946601057004947
TCCSUP,124202324,2.3353692726600173
GA-10,25105715,3.054983739244498
BT 231,107970,1.486990449957834
KYSE-140,4521392,4.208126021246943
KHM-1B,3634881,2.028654365237279
PL-21,17759555,3.783325275031781
MHH-CALL-4,44507138,-1.342532048521566
PANC-1,36314,-8.308411093751157
YD-8,168313047,2.079031997957418
Calu-1,piperlongumine-MST-312 (1-1 mol-mol),2.522753716905326
IST-Mes1,5978,0.1624820602578698
MHH-ES-1,9825149,0.3906144827676981
BT 416,51037431,5.033591417187237
ECC10,6918736,-1.6332585307345706
OCI-M1,24772860,-2.497308212893185
T84,doxorubicin-navitoclax (2-1 mol-mol),0.0548911672498773
KHM-1B,11497983,-3.4105993127539698
KYSE-140,327653,3.149359454040081
HCC1833,72734382,4.0429255728781825
GP2d,3025986,0.0314390635324485
HCC1833,42642645,0.6311898861195337
NCI-H1395,57519531,3.1803418993490715
EJM,12001922,1.7275636633087754
MHH-ES-1,119182,-2.0150843861499164
ALL-SIL,3081361,0.1962192778787347
NUGC-4,9967941,3.457858534628441
CFPAC-1,66577038,3.207998292081203
BT 231,3854666,-0.8969243562437486
KYSE-140,46199207,3.0328895565607996
SK-MES-1,9915743,0.4302153441445988
Hs 936.T,52912189,0.7984895634835069
KMS-12-BM,100016,3.5545657198194873
KYSE-30,24821094,3.706073011343286
SNU-119,10302451,1.573205462567535
NCI-H2122,5291,3.4326643746241916
EJM,9825149,1.9985799603893497
NCI-H929,8515,3.198792100225454
K-562,2871966,0.96376622724181
BICR 31,6914657,-2.1990076047646703
KYSE-30,11404337,-1.4511722042502642
GA-10,24180719,3.6610141975018937
HuNS1,5287620,-1.1833277017435369
SW1353,25183872,-0.1372449657245743
KO52,3634881,3.08346578487488
MHH-CALL-4,5328940,1.2095902594900405
ALL-SIL,2858523,2.9846374491002376
BT 416,439501,-5.114778373309692
TCCSUP,5460769,3.7572024912117103
SK-MES-1,53232,2.1756968830672205
HD-MY-Z,72376,-2.626651912417286
ECC10,6918837,-5.406607195401294
TCCSUP,6623618,2.4538006710515186
NCI-H2087,409805,3.9409208481005864
HCC1833,46398810,2.5616927192881724
KO52,126941,-4.363414933437974
SNU-119,JQ-1-MK-0752 (1-1 mol-mol),1.0166640461128336
GP2d,46843906,3.285164780134436
NCI-H929,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497346861051973
MHH-CALL-4,135928012,3.5215147296897493
HD-MY-Z,54143018,1.0418113167764758
HD-MY-Z,11717001,4.133608553486538
KHM-1B,24180125,1.7183751461282626
KP-N-YN,262093,1.320292146111092
Hs 936.T,89183176,4.7711042575226505
SW1353,vorinostat-navitoclax (4-1 mol-mol),1.3274767508500394
SK-OV-3,3854666,3.321518045263264
SK-OV-3,60700,0.4435128165358443
LP-1,16065773,2.103631293395606
HD-MY-Z,46926350,-5.98174981199225
SKM-1,241158,1.623725861036911
SK-MES-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4427487573604268
GA-10,15547703,2.35722304746948
SK-HEP-1,984333,0.8474815446030621
NCI-H1395,serdemetan-SCH-529074 (1-1 mol-mol),2.764228376704601
NUGC-4,10074640,3.252830654163063
PE/CA-PJ15,9903786,2.2611792207171484
HD-MY-Z,2858523,3.0090496163701728
K-562,52912189,0.5484446218637569
HMCB,44462760,4.190588820303925
REC-1,4917,3.1721395367741088
NCI-N87,9866186,-0.0362526715344146
PE/CA-PJ15,2708,4.901414773558016
TCCSUP,3038522,3.5335989350872716
HD-MY-Z,11455910,0.2534017769980389
K-562,10113978,1.9599198523990544
HCC1833,11175137,3.0744160579845925
PE/CA-PJ15,426756,4.910865073915536
NCI-H2171,52947716,1.4567314464455066
RT-4,2828334,5.9208370423124554
SW1353,104842,0.2221757125063704
LP-1,3025986,-1.6764146298443352
KHM-1B,24785538,-3.445065947322119
BICR 31,46398810,2.284799792972812
MHH-CALL-4,285033,-4.540898133628689
HD-MY-Z,11494412,0.5861901428023402
T84,3101542,4.270036127962095
NCI-H2122,16736978,1.4328447154146338
BT-20,5278396,3.675086900115576
MHH-ES-1,9826308,0.0039189158781244
RT-4,24821094,3.143156783053102
TCCSUP,441298,2.479401374858522
SNU-119,2742550,2.8976089932934883
MHH-ES-1,53232,2.5979530091937164
OCI-M1,19582717,3.1662039669557585
CFPAC-1,42642645,1.8117399529317957
YD-8,3825829,4.049048632362995
PL-21,54618164,3.670173179687308
KO52,3025986,-1.0982287315100452
NCI-H2171,24772860,-3.209318985857815
OCI-M1,216239,2.620781401148316
GA-10,89928392,-1.3639805441298196
MHH-ES-1,54143018,-1.304387964889927
NCI-H2087,sirolimus-bortezomib (250-1 mol-mol),0.3308566581243162
KP-N-YN,12001922,2.2461644398319303
HD-MY-Z,119607,4.963730258425136
Mino,selumetinib-tretinoin (2-1 mol-mol),1.7342003651381972
GP2d,44486219,5.182572566200072
NCI-H929,5566,2.7784584402230266
Calu-1,25183872,-0.629815897191941
K-562,3384730,2.2830550335302555
YH-13,crizotinib-PLX-4032 (2-1 mol-mol),1.6930776874276643
K-562,25062766,2.5223735702376753
L3.3,119182,-1.782056546640076
BT-20,81146,4.428806108186928
IST-Mes1,107970,2.9610434925705773
Hs 936.T,17755052,4.209940447010396
NMC-G1,54626689,4.889759047851804
IST-Mes1,navitoclax-MST-312 (1-1 mol-mol),2.625426297409908
KHM-1B,3025986,-1.4274880637865957
EJM,24821094,3.662751413369248
KHM-1B,6918289,1.9648890084430677
KO52,selumetinib-piperlongumine (8-1 mol-mol),-0.5207684143564267
Calu-1,6918328,0.9217666679708892
SKM-1,3543504,4.073022036864239
KP-N-YN,5738263,4.515186536108677
NCI-H2171,11625818,4.794880990749841
MHH-CALL-4,11507802,1.119099355194517
T84,56946209,-4.207972790316417
YD-8,73707398,1.1339237170250962
RT-4,3081361,2.257643054417338
LP-1,44543605,3.2714531539394596
YD-8,11364421,1.2930032708337824
EJM,409805,3.072892420926549
YD-8,11640390,3.0697082624281093
T84,71729975,0.6789587118033428
T84,100016,6.649554415164183
OCI-M1,126941,-4.250254479715047
SK-HEP-1,135999136,5.290710201924687
BT-20,44137675,1.5709438408524368
T84,148124,-4.089534404816918
YD-8,400769,-0.3423435574112426
NCI-H2171,11178236,-6.134942659978268
SCC-9,2113511,6.3303497429476625
IST-Mes1,46199207,3.629760005921771
NCI-H2087,9915743,0.7035169318123878
RT-4,25102847,1.6194464271831264
NCI-H929,serdemetan-SCH-529074 (1-1 mol-mol),2.524144751229143
RCM-1 [Human rectal adenocarcinoma],168313016,4.590367789402496
BT 231,11609586,2.8386132576771548
BT 416,BRD9876-MK-1775 (4-1 mol-mol),2.031359815193756
YH-13,9926054,1.834128888426512
SK-MES-1,24889392,3.690459849117352
YH-13,11427553,1.71791693691315
LS411N,126941,-2.790198017582557
NCI-H2087,54626689,2.8786913158978664
SCC-9,969516,2.533129063350548
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038
KMS-12-BM,11396600,1.1666466615999174
K-562,53232,2.317344808959498
BT-20,11647372,1.6458440932804528
PE/CA-PJ15,navitoclax-gemcitabine (1-1 mol-mol),-2.7969832915442487
SCC-9,46224516,2.803045033456012
NCI-H2087,135440466,1.0882976449377957
KO52,1716436,3.4089505729900615
SW1353,36314,1.5843756485045453
GA-10,4788,5.001122731665861
KMS-12-BM,36462,-0.0282673998252453
BT 231,9803433,3.874869742331583
LP-1,53392493,1.810477774181603
GP2d,4096211,1.0061169302781643
EJM,2945648,1.6647438664441567
HuNS1,46907787,1.7038689762215966
PL-21,4521392,4.632626602024878
REC-1,selumetinib-GDC-0941 (4-1 mol-mol),5.111180510517744
NMC-G1,16722836,2.051393659135164
SK-LU-1,11455910,1.7364253174007704
PL-21,208908,2.4943346553695807
BT 231,17755052,0.1174554749728617
PE/CA-PJ15,3634881,3.545664118415659
KYSE-30,46843906,4.636934854116622
KP-N-YN,42642645,1.6698991874885412
GP2d,7251185,1.683287147880166
OCI-M1,54613361,-0.2538315966729767
SK-MES-1,24180125,2.8011061593725244
Calu-1,227681,3.9298424075568903
LP-1,5978,-2.981137394202246
KP-N-YN,45279963,3.692806780719619
REC-1,24901704,2.3633064511897315
RCM-1 [Human rectal adenocarcinoma],6610216,4.434175859871968
NCI-H2122,6918328,0.3077998080991951
T84,53325874,4.364468663004157
SNU-119,5284616,1.0337608354309102
ALL-SIL,3384730,0.9130815120154347
IST-Mes1,135421197,1.925463420817299
MHH-CALL-4,426756,3.497695322755457
NUGC-4,54649381,3.636011655069359
Calu-1,5494449,3.818714700108803
NCI-H2171,46907787,0.7633638606493435
BT 416,11494412,-1.7443510359170835
SKM-1,10302451,3.713731670018531
GA-10,135440466,2.330317785662083
SNU-119,3634881,2.8282944940557484
SK-MES-1,selumetinib-JQ-1 (4-1 mol-mol),1.35020527717367
CFPAC-1,vorinostat-navitoclax (4-1 mol-mol),4.202204311043948
BT 416,1750826,-0.7191040031245952
NCI-H2122,285033,-0.6956779622203398
PL-21,66577038,3.0258337435207614
GA-10,24889392,5.40094566414582
YH-13,57519531,2.0380151734661185
KO52,135440466,2.642581102340019
HCC1833,71466578,4.294023523475679
NCI-H2087,1641662,3.04619920424605
YH-13,11404337,1.1602704800571209
NUGC-4,11625818,3.6616907835697026
GP2d,12001922,1.4485741159981689
OCI-M1,6252,0.0512154214970954
SKM-1,11612883,1.510436976347248
Mino,441298,2.9453116748883312
OCI-M1,72734382,3.791864915215404
RT-4,104842,-2.837554052237836
KO52,216345,3.536975928684328
OCI-M1,5951923,4.151661943127663
KHM-1B,5311,0.4270442632867264
SK-LU-1,51039095,1.6606724407493176
KMS-12-BM,piperlongumine-MST-312 (1-1 mol-mol),1.2051347484874666
SK-MES-1,navitoclax-pluripotin (1-1 mol-mol),-0.5580420277661856
SCC-9,36462,2.4622585602605493
MHH-ES-1,56963564,-0.8635563708078701
YD-8,25062766,2.0362931594826055
YD-8,107970,2.31722941739338
K-562,23582824,1.4169931108164455
SNU-119,24771867,2.6075976586492624
MHH-ES-1,11485656,2.0026914663439648
KP-N-YN,4578,4.339899078428926
RCM-1 [Human rectal adenocarcinoma],5460769,3.958915694045798
NCI-H2087,54678924,1.599050703969796
KMS-12-BM,11612883,1.8629511117266817
Hs 936.T,2708,6.739726031918015
NCI-H2171,445455,3.811797523558628
KYSE-30,5566,3.1564488571873532
SK-MES-1,selumetinib-piperlongumine (8-1 mol-mol),3.0714550615570606
NCI-H2087,421610,3.00063308623991
RT-4,6918837,-1.3567481481628696
CFPAC-1,613753,5.123556932478041
GA-10,6505803,-0.6934451176376895
MHH-ES-1,UNC0638-navitoclax (1-1 mol-mol),4.348872164293784
NCI-H929,23635314,-2.487103154782492
BT 416,navitoclax-birinapant (1-1 mol-mol),-1.261240036302287
Calu-1,11175137,3.6206802543970458
BT-20,66577038,4.652922110389285
GA-10,135411,-0.6139581022042082
PL-21,31703,-1.4851937674691715
HD-MY-Z,17755052,2.5636965516326757
HD-MY-Z,9907093,4.172623598614277
NCI-H1395,4378219,4.7590684323615635
CFPAC-1,24901704,3.761457103330124
BT-20,11404337,0.6443596092093807
Hs 936.T,6610355,4.72808025698268
CFPAC-1,4261,3.1516584429759824
SKM-1,11222830,1.186229333087779
SCLC-21H,25150857,0.8488448147847597
SK-MES-1,erlotinib-PLX-4032 (2-1 mol-mol),2.7803046634927213
SCC-9,25227462,0.3695734481821194
NMC-G1,11364421,2.394825867824391
ECC10,44632017,0.5205553300367022
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882
NCI-H2087,24856436,0.5125413697017576
NCI-H2087,168313016,4.712660554948847
HD-MY-Z,10127622,2.6663313551064216
BT 231,SNX-2112-bortezomib (250-1 mol-mol),-1.3655489858390828
BT 416,156414,1.0194631441188509
REC-1,3689413,1.860618150322578
Calu-1,BRD-A02303741-navitoclax (2-1 mol-mol),3.0500205903673794
GA-10,11494412,-0.8165208112665053
HD-MY-Z,11640390,3.0905481332293516
BT 416,24964624,2.4948260508137365
NCI-H2171,72376,-3.3432588050758296
REC-1,71304818,3.5702343060949744
EJM,46843906,2.2065096868149294
K-562,10302451,0.1323934402367818
KHM-1B,doxorubicin-navitoclax (2-1 mol-mol),-2.1386947262651907
YH-13,24951314,1.6254044283291555
MHH-ES-1,72376,-3.070904666155192
SW1353,107970,3.000498774882463
REC-1,73707398,3.9738319614180666
GP2d,60750,1.0111307714218225
CFPAC-1,12003241,-0.6323170147703681
KYSE-30,selumetinib-UNC0638 (4-1 mol-mol),4.67114914714676
K-562,11364421,-5.792707438494169
IST-Mes1,doxorubicin-navitoclax (2-1 mol-mol),-0.5203692654605504
KO52,54765302,5.5636252834337565
LS411N,72376,-2.6969507034435236
REC-1,1750826,2.208787286180855
NCI-H929,11683005,1.6623595675282548
MHH-ES-1,49836020,5.438630069429388
Calu-1,5281321,-2.149779190299563
K-562,126941,-4.461586339574126
LP-1,54613361,-0.2641195709399391
IST-Mes1,135999136,4.360333625305844
Mino,5311281,1.2497600850318282
T84,46199207,2.6723811432768017
NCI-H2087,124202324,1.9786049368771377
HD-MY-Z,11977753,-2.0508960122158864
GA-10,25227462,-6.975375181698785
ECC10,55508,1.2056837977044108
EJM,9911830,2.3498846254734267
YH-13,439501,-2.216859157731525
HD-MY-Z,66577038,3.0516014667647635
HuNS1,60750,-5.281302492088451
K-562,44566777,1.311822236929868
T84,25150857,1.7764346764017462
BT 416,9825149,1.350494163080029
BICR 31,5351362,2.0722735669158876
OCI-M1,tretinoin-carboplatin (2-1 mol-mol),4.195055620893781
NCI-H2122,613753,3.4686668096065465
SW1353,400769,-0.4269260166547402
KYSE-30,156414,3.85489578456772
KYSE-140,23725625,5.435521516152373
KHM-1B,23725625,4.172132187038291
LP-1,selumetinib-tretinoin (2-1 mol-mol),6.137032561372268
HCC1833,3038522,4.139457484525096
TCCSUP,654092,0.20661025220839
KMS-12-BM,4521392,3.943968483954013
SK-LU-1,navitoclax-pluripotin (1-1 mol-mol),-1.2767045565220965
BT 416,71466380,3.813823467221408
EJM,6438330,1.051199955575325
MHH-ES-1,6450551,0.4270898216004571
BT-20,448949,1.9290586864163883
SKM-1,11396600,2.556560537938587
KMS-12-BM,11238147,0.8062576818407409
BT 231,navitoclax-birinapant (1-1 mol-mol),0.9636063692056038
HD-MY-Z,6917907,-5.741451618598553
GA-10,24901704,1.828860874587917
PL-21,445455,5.154951027873406
HMCB,vorinostat-navitoclax (4-1 mol-mol),1.320679048022774
SKM-1,54143018,-1.6863423462272775
YH-13,3062316,-1.0789668620002044
SNU-119,navitoclax-pluripotin (1-1 mol-mol),-1.1228674398646514
SK-OV-3,9911830,2.8997016876614863
NCI-H2171,25227462,0.3993487036849301
NCI-N87,54143018,-0.5822633828546482
GA-10,53232,1.877368162448222
IST-Mes1,6918837,-3.247555275823077
RCM-1 [Human rectal adenocarcinoma],9967941,4.297033846683125
KYSE-30,6610216,4.130988054246519
GP2d,3503,0.918043150063566
NCI-N87,16722836,0.5704530263405226
GP2d,46907787,2.1457899624672296
RT-4,selumetinib-BRD-A02303741 (4-1 mol-mol),4.18220229095385
GA-10,4705,2.180825520695711
NMC-G1,439501,-2.0387411188020024
NCI-H1395,3025944,4.281266699042143
SCC-9,16038120,1.877705535955449
T84,selumetinib-piperlongumine (8-1 mol-mol),1.0202597649879572
K-562,374536,0.780579010414565
BT-20,54618771,4.093139907883374
NCI-N87,tretinoin-navitoclax (4-1 mol-mol),0.6005709555160592
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491
BT 416,71751553,3.5669452232202317
NCI-N87,168312962,2.346349065468924
PE/CA-PJ15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1113612810066529
SKM-1,selumetinib-vorinostat (8-1 mol-mol),-1.297292884672553
Hs 936.T,168313047,4.115752201025836
HuNS1,26596,-3.648585672469648
RCM-1 [Human rectal adenocarcinoma],72193861,4.277039631190645
BT-20,erlotinib-PLX-4032 (2-1 mol-mol),3.0751464883095747
T84,24785538,0.2951820875207128
T84,54649381,2.840070311411164
BT 416,54613361,-2.355592302009248
SK-MES-1,6610355,4.430872030052232
KYSE-30,46398810,2.901932619843963
KYSE-30,11396600,3.6948052468539654
TCCSUP,2126,3.8917278062770566
LP-1,BRD-K55473186,5.759568388003796
HCC1833,36462,3.6976539288717927
BT-20,2828334,5.952276977386491
NCI-N87,119607,4.916125105909822
PE/CA-PJ15,10296883,4.07189179930938
T84,11625818,4.082423513141669
HMCB,11612883,2.765209617636502
MHH-ES-1,135398516,0.6208661825302467
NCI-H2087,969516,1.8818120021331957
PE/CA-PJ15,9866186,-0.0637155066173063
REC-1,11485656,4.187438515257482
BT-20,100016,6.680150665921765
REC-1,46215462,6.2160192270590855
K-562,26596,-3.6076758496321832
NCI-H1395,46843906,3.1516076694809994
YD-8,42642645,0.5447742050526033
GP2d,9903786,1.6186361299968774
NCI-N87,654092,-0.6954721735465327
HuNS1,23939,4.329976531828187
OCI-M1,136227924,3.580987744477365
HD-MY-Z,JQ-1-MK-0752 (1-1 mol-mol),1.9057840617943969
NCI-H2087,44185566,1.5893631476547
Calu-1,16219061,1.3462867645117316
ALL-SIL,25102847,-0.1309610459144975
YH-13,46398810,3.0158285746499645
KYSE-30,5328940,1.6005779988636477
EJM,11234052,4.536788140349876
ALL-SIL,11485656,1.390704841990788
NCI-H929,16722836,-0.2091076703747729
Hs 936.T,9956119,4.529594588317555
KYSE-30,446155,1.8147989261701905
RCM-1 [Human rectal adenocarcinoma],327653,3.480028492466642
SK-LU-1,carboplatin-etoposide (40-17 mol-mol),2.0495118516393407
KO52,alisertib-navitoclax (2-1 mol-mol),-3.629170972120534
NCI-H929,11647372,-2.313105757149245
SW1353,vorinostat-carboplatin (1-1 mol-mol),3.0270928389441147
EJM,448949,1.6009250790915848
KHM-1B,10427712,2.4564060072092486
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651
BT 416,alisertib-navitoclax (2-1 mol-mol),-3.475944601215413
LS411N,400769,-0.3072623933562745
KP-N-YN,46398810,3.790445684764038
NMC-G1,168312962,4.558987239414895
GA-10,24180125,1.046455253129036
SK-OV-3,25183872,-0.070614613180641
HMCB,53495165,0.9664452371473048
KO52,2113511,5.296200545877212
SW1353,676352,3.018826636787295
CFPAC-1,67156097,4.372904047513201
PE/CA-PJ15,3384730,5.08056647864703
T84,sirolimus-bortezomib (250-1 mol-mol),0.444201231826254
KHM-1B,6184667,4.636571439855277
SNU-119,49850262,4.203409740866064
KYSE-140,sirolimus-bortezomib (250-1 mol-mol),2.1276089770363265
LS411N,6852167,3.3651093558735035
SW1116,2874250,4.203693908258186
RCM-1 [Human rectal adenocarcinoma],637858,2.624063294513633
HD-MY-Z,54765302,4.151581906518417
KHM-1B,5328940,1.2346884816807109
K-562,613753,3.252228295501032
T84,44137675,2.6159408103724044
HMCB,135421197,2.011360494635396
Mino,446155,1.9882483674298612
PL-21,16065773,1.8950029471247811
KYSE-30,4259181,0.866671634934387
KHM-1B,11234052,4.09724714531712
NCI-H929,36462,0.845260564861955
NCI-H2171,4261,0.9024779156039784
MHH-CALL-4,24772860,-3.3697493416071223
BICR 31,2729026,2.966794528433677
HD-MY-Z,10172275,4.87752776320299
NCI-H2087,navitoclax-MST-312 (1-1 mol-mol),0.9992682602307488
HMCB,9915743,1.6080279846600372
HuNS1,44566777,1.2263237234335649
GA-10,54618771,-2.458628793316373
KYSE-30,2708,5.2345843532917335
HD-MY-Z,23582824,0.9782904959561042
ALL-SIL,56963564,-1.2928564241979046
LP-1,72199292,0.0792041659544974
EJM,ISOX-bortezomib (250-1 mol-mol),0.254764569122289
NCI-H2122,8515,3.1724007167677297
NCI-H2087,3634881,2.6981912616400106
NCI-H2087,16741245,5.760406783406361
BT 231,25183872,-1.5553581634712852
EJM,969516,2.0507913702378886
NCI-N87,57519531,1.4365599080949227
KHM-1B,676352,1.5366481423958254
LS411N,10385095,1.4098978051841675
BT 416,36314,-7.685630329174363
SK-LU-1,selumetinib-UNC0638 (4-1 mol-mol),2.5062921446905664
KYSE-30,6918638,1.557418868446986
L3.3,piperlongumine-MST-312 (1-1 mol-mol),2.794540893097308
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697
OCI-M1,3136844,3.8568484304541992
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617
PE/CA-PJ15,54765302,4.797362382600232
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972
MHH-CALL-4,2746,0.6611792988086074
YD-8,54618164,4.2297332581599525
NCI-H1395,448949,2.6579762505133915
YH-13,3854666,0.9588236597385832
RCM-1 [Human rectal adenocarcinoma],31703,0.9691163018023546
ECC10,49867926,3.081272498733672
NCI-H2122,crizotinib-PLX-4032 (2-1 mol-mol),2.6930888403931865
HCC1833,49850262,3.0458335415274953
MHH-CALL-4,selumetinib-BRD-A02303741 (4-1 mol-mol),3.337205797443014
GA-10,119182,-4.706200936601203
NCI-H2087,104842,-6.286461602936631
PE/CA-PJ15,9927531,4.562949408871821
NCI-H2171,3552672,1.63504499488054
LP-1,44487872,5.2384234330551385
SCC-9,11178236,-3.8920346249942264
BT 231,53393127,3.729984471399415
MHH-CALL-4,15953870,2.9134788493888735
LP-1,5281321,-3.512764255474446
YH-13,9967941,5.158466300514708
KMS-12-BM,6918878,0.6296559584919736
HD-MY-Z,11152667,-1.450671407688362
MHH-CALL-4,6914657,-5.015228480625604
T84,44484893,4.749329758039
KP-N-YN,BRD-A02303741-navitoclax (2-1 mol-mol),0.6259033624013883
RCM-1 [Human rectal adenocarcinoma],51039095,3.29886736232205
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991
K-562,3038522,1.918387146447148
TCCSUP,3136844,3.997105269832927
YD-8,82146,4.39228659038304
PL-21,44489675,3.708685882039919
PE/CA-PJ15,JQ-1-navitoclax (2-1 mol-mol),1.969066619122252
BT 416,119182,1.0798321665174369
L3.3,5978,-0.2603821575839845
PL-21,11719255,3.5708865498573
MHH-CALL-4,5278396,3.6101054443229135
BT-20,3465537,4.429607875792749
HD-MY-Z,2130404,3.2203619894470803
ECC10,11455910,0.1106794798283132
KO52,navitoclax-PLX-4032 (1-1 mol-mol),-2.6384653458181
NCI-H929,72193861,0.6140343557798097
NCI-N87,168313047,2.984513904409232
KYSE-30,tanespimycin-bortezomib (250-1 mol-mol),0.3165609096596899
OCI-M1,1716436,2.642109277761982
LP-1,46215462,1.4214902422168545
L3.3,107970,2.7957953106701305
KMS-12-BM,73707398,0.3620923628880652
ECC10,4477,0.996777596833446
KP-N-YN,6917907,-3.3211001704233447
LP-1,71466578,2.026914853712418
HMCB,31703,-0.0757887186951435
NMC-G1,400769,0.3238445729122744
KMS-12-BM,24772860,-3.763334552284853
BT 231,JQ-1-vorinostat (2-1 mol-mol),2.270844957283103
ALL-SIL,11222830,0.8263932665864424
GP2d,25062766,1.1697640995404
PE/CA-PJ15,6252,2.755233482446364
ECC10,9929138,5.792605196564901
CFPAC-1,ISOX-bortezomib (250-1 mol-mol),1.0746784252941868
Calu-1,11640390,4.517017854435578
PE/CA-PJ15,285033,-2.5479033681234258
EJM,5329102,1.5761634875262642
K-562,135999136,3.657737204061429
SW1116,644241,1.8306415261059923
PL-21,JQ-1-carboplatin (1-1 mol-mol),-0.1767086466705203
SK-MES-1,piperlongumine-MST-312 (1-1 mol-mol),1.9336696757635152
LS411N,89928392,2.6081309937571655
LS411N,216239,2.6090534487015953
RCM-1 [Human rectal adenocarcinoma],6918638,-0.5937755297048425
KHM-1B,54143018,-0.2893377484312812
K-562,451668,2.928523807666895
KHM-1B,387447,-5.058175638788416
YH-13,6914657,-1.321976768912636
LP-1,72193861,0.9837143374096636
SKM-1,16065773,1.0791751756996522
KO52,49793307,-2.661951064063904
HD-MY-Z,sirolimus-bortezomib (250-1 mol-mol),0.1628834192986952
L3.3,11455910,1.84757483649511
YH-13,doxorubicin-navitoclax (2-1 mol-mol),-1.2809581142975497
TCCSUP,9866186,0.3225667435686323
YH-13,136227924,2.93381240838723
T84,54619267,3.7729660672092207
Mino,6918837,-5.570643171214475
NCI-H1395,11625818,4.225783797548463
KO52,66577038,3.1415883423480655
KHM-1B,11238147,1.9683528585931505
PE/CA-PJ15,navitoclax-PLX-4032 (1-1 mol-mol),3.171250916995731
Mino,2729026,2.549193377947816
MHH-ES-1,11960529,2.838399641890641
OCI-M1,448949,1.137211280648195
ECC10,656346,0.610845114322663
SK-MES-1,5284616,3.059043317353381
IST-Mes1,5311,2.113640627204962
MHH-ES-1,11625818,3.726120650283121
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397
BT-20,441298,3.478644405426396
PL-21,selumetinib-navitoclax (8-1 mol-mol),-0.0346629019172803
PE/CA-PJ15,5746,0.107893092080109
KHM-1B,24964624,-1.4057417627664983
SKM-1,637858,0.6023395164344832
YH-13,73707398,1.2587835012572517
NCI-H929,4477,0.4411881433632111
OCI-M1,4259181,0.123787677516806
K-562,72734382,4.39493075447737
BT 416,2871966,0.8669786136854574
Calu-1,11626560,2.8316550930434787
SK-MES-1,11977753,-2.763924853150869
ALL-SIL,136227924,2.439460537978413
BT 416,9823820,3.59066849797476
L3.3,400769,-0.1977482396353321
CFPAC-1,10427712,4.438879494569552
NCI-H2171,9907093,4.086146580877247
SK-LU-1,3689413,-0.1029638587908799
SCC-9,11507802,1.3688807961315366
HMCB,72376,-0.5022720815558697
L3.3,selumetinib-JQ-1 (4-1 mol-mol),7.047753882053292
TCCSUP,1641662,4.954300722612746
PL-21,72193861,0.2053753349846083
KYSE-30,676352,2.3827950662159636
SCC-9,54618164,4.4493976732458576
L3.3,159324,3.32597872906173
BT 231,15547703,2.6648625624757543
ECC10,124202324,0.8036371832340868
T84,51039095,2.621431193095968
YD-8,24797083,1.7826041410647693
LS411N,119607,5.818355117504778
NCI-H929,2749,1.0943201778081362
GA-10,3081361,1.379491189491014
HMCB,24821094,3.404555238372124
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147
BT 416,984333,0.7060497741092493
YH-13,vorinostat-carboplatin (1-1 mol-mol),4.1657170851740855
YD-8,25105715,3.325556248276192
KYSE-30,6438330,1.4132498738811117
ECC10,24797083,0.9948102709423676
Hs 936.T,carboplatin-etoposide (40-17 mol-mol),4.028739496578446
KHM-1B,navitoclax-birinapant (1-1 mol-mol),2.2294776266179057
NUGC-4,10127622,-4.655377792691628
NCI-N87,9825149,1.7110175659097178
T84,9911463,2.866030218571942
KMS-12-BM,5394,3.997526892316944
ECC10,46398810,1.6652385095636764
BT-20,11228183,4.518636987406234
LP-1,12003241,-0.1215623944522291
REC-1,9903786,4.191167368609226
RT-4,tanespimycin-bortezomib (250-1 mol-mol),-1.2603421044397636
GA-10,6852167,0.8612474487872448
PE/CA-PJ15,25105715,3.675314900908473
GP2d,selumetinib-GDC-0941 (4-1 mol-mol),-1.1591880613582235
KO52,4705,3.2027960620979576
EJM,2729026,3.2130088601508247
L3.3,168312962,-1.2002539688883909
KYSE-140,11404337,-0.0921040105213257
OCI-M1,16736978,1.5055221195968145
YD-8,11317348,1.928861961863856
HD-MY-Z,11657048,4.272310166945613
NCI-H2122,216345,1.7503289803472466
NUGC-4,navitoclax-pluripotin (1-1 mol-mol),-1.5956657639458791
NCI-H2087,10184653,1.4190444573187029
BT 231,9549297,1.58576854552308
SNU-119,421610,2.8611579206364315
CFPAC-1,46191454,2.617796626433225
YH-13,11222830,1.7805573322131083
MHH-ES-1,44486219,4.3509369096591115
ECC10,10427712,3.6711010724397832
KMS-12-BM,10113978,1.9839556331980863
NCI-H929,50905018,3.952577942902894
SCC-9,5328940,1.568072217369216
KMS-12-BM,676352,1.9185611453511533
KYSE-30,16065773,2.586208272505411
HD-MY-Z,16065773,1.7388838605110115
HCC1833,selumetinib-navitoclax (8-1 mol-mol),-0.7132995946050604
HMCB,5566,3.160933533240533
PE/CA-PJ15,24797083,1.5613893197381916
SCC-9,31703,-1.2436349312067534
KP-N-YN,31703,-0.2686179338979448
SKM-1,19582717,2.678138329760968
KYSE-140,25154868,4.925919444048201
CFPAC-1,1750826,2.2846443904677667
BICR 31,10113978,4.990782635230478
LP-1,24772860,-2.4443835432782963
MHH-CALL-4,17759555,4.628973774778277
OCI-M1,2871966,0.6766929224044762
SKM-1,451668,-2.063833274943064
YH-13,11214940,1.756237854396178
SK-HEP-1,5280436,-0.1709015599208282
NMC-G1,5328940,2.722341075975072
L3.3,carboplatin-etoposide (40-17 mol-mol),2.812808375332559
KYSE-30,322968,4.8100921553776566
LS411N,5280436,4.183720769167266
K-562,219104,3.3686951285077273
GP2d,11640390,3.0839763059565057
Calu-1,46398810,3.14600124994183
KHM-1B,9926054,1.3720275885206477
HCC1833,vorinostat-navitoclax (4-1 mol-mol),-0.0161649440880726
TCCSUP,16725315,3.821087103273168
YD-8,387447,-3.9759575932823377
SNU-119,49867926,4.1413838407199375
L3.3,53232,3.8050949011624806
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324
SNU-119,400769,-0.9034553072694146
MHH-ES-1,20959075,-4.029995163334884
HMCB,46191454,1.8598325801790512
NUGC-4,selumetinib-PLX-4032 (8-1 mol-mol),-2.3831728635682956
L3.3,11234052,5.199825372855332
SK-MES-1,3025986,-1.1704446036913156
HD-MY-Z,11364421,-3.4388319921861674
MHH-CALL-4,11625818,3.3709734596629484
SCC-9,54596558,4.378159430294897
NUGC-4,73707386,4.27548765999553
YH-13,676352,1.7621508381493205
BT-20,doxorubicin-navitoclax (2-1 mol-mol),-0.5389846822824581
YH-13,2113511,5.759844147331347
OCI-M1,selumetinib-PLX-4032 (8-1 mol-mol),4.533413997188595
KHM-1B,3815108,2.9895861179131704
YD-8,46843906,4.015586038915998
NCI-H2087,25195348,3.192035276128475
SW1353,6918878,1.0541631026362632
YH-13,4521392,4.421044887945657
LS411N,3689413,2.701640891749041
BT 416,9911830,2.72024665816752
HCC1833,12003241,-0.598038454038546
KYSE-140,5470400,-1.5207352673973349
MHH-ES-1,56946209,-4.60887069243713
EJM,73707398,0.7642029358076543
IST-Mes1,12003241,-1.7187710036837192
HD-MY-Z,54618305,3.941215880627945
OCI-M1,1641662,3.0652587796133814
ALL-SIL,969516,2.19071597716798
KP-N-YN,3854666,3.696443980357986
BICR 31,136227924,2.8140968842668923
NCI-H1395,selumetinib-JQ-1 (4-1 mol-mol),2.8235760807369177
SKM-1,11485656,1.846158462004935
SK-MES-1,9825149,1.595463037755338
LP-1,123631,1.5887215669818997
KO52,446155,3.831951232060963
OCI-M1,navitoclax-birinapant (1-1 mol-mol),0.9186743075662698
NCI-H1395,216345,3.4712022210886824
GA-10,262093,-0.1751219833238948
NMC-G1,8515,3.7052773234568224
NCI-H2122,135398744,6.485849720689022
HMCB,6438330,1.909471735352977
HD-MY-Z,7326481,2.8029780272113656
KMS-12-BM,24978538,-1.4319691213923784
HuNS1,7326481,3.0072324529505248
OCI-M1,25105715,3.838850014150905
NCI-H2171,4477,0.0540600744484099
BT-20,72199289,4.513177041132638
OCI-M1,5566,3.218225834696146
GA-10,123631,1.3569723526596411
KYSE-30,5311,2.139810280352377
KHM-1B,crizotinib-PLX-4032 (2-1 mol-mol),0.397018981574428
KMS-12-BM,1750826,-5.31704186496798
RCM-1 [Human rectal adenocarcinoma],49766530,0.9963320873999868
KP-N-YN,9933475,1.8862293067647795
PE/CA-PJ15,5460769,-0.4178373813349113
ECC10,9840324,4.999784472137203
TCCSUP,5335621,5.467256858897498
HCC1833,60700,0.4372866440159454
SK-HEP-1,9936388,2.725726666175631
KYSE-30,119607,5.570863365059782
LP-1,439501,-3.639573627473922
MHH-CALL-4,9887053,1.5551059592614176
LP-1,6914657,-3.7360959945133576
NCI-H1395,72199292,3.1887982930787575
KYSE-30,7326481,2.9499238919316366
MHH-CALL-4,10296883,2.742921338749494
CFPAC-1,11364421,1.9859677301382892
ALL-SIL,66577038,2.592918053791083
KO52,25150857,1.2754464236425893
T84,navitoclax-piperlongumine (1-1 mol-mol),0.9575689953066564
BT 416,5351362,1.1373283537339538
PL-21,tanespimycin-gemcitabine (1-1 mol-mol),-1.1037382477448645
PE/CA-PJ15,10074640,3.294429044375617
KO52,24785538,-0.0334605587751474
MHH-CALL-4,100016,6.461754156645112
NCI-H1395,135421197,1.2810683988074232
KYSE-140,11612883,2.849546916719797
YH-13,5113032,4.871050749600929
NCI-N87,46398810,2.1002609832839187
BT 231,11178236,-5.272107320950198
SKM-1,654092,-1.7907532685480716
ECC10,2749,0.7896340870785507
HD-MY-Z,445091,4.392744920374866
YD-8,46215462,1.7489393153094872
BT 416,16659841,3.5379885475078563
MHH-CALL-4,2708,1.3963127799025794
NUGC-4,9936388,-5.886331938622264
NCI-H2087,2130404,3.3730425877513017
SNU-119,navitoclax-MST-312 (1-1 mol-mol),1.0798653444132074
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876
ALL-SIL,11234052,3.5011978223530926
SKM-1,46843906,1.3113663495190937
NCI-N87,6917907,-5.514556019160177
KHM-1B,12001922,1.027456865676835
SK-OV-3,6917907,1.1533351492785058
TCCSUP,675434,5.391055260540043
LP-1,JQ-1-MK-0752 (1-1 mol-mol),-1.0625330801199804
ECC10,9903786,0.6869958735378703
Mino,11612883,1.124666050414393
T84,24779724,4.300698841519802
SK-HEP-1,374536,4.396616434658188
SKM-1,46199207,3.0713623583857257
EJM,JQ-1-MK-0752 (1-1 mol-mol),0.8699252378567319
SKM-1,11427553,1.4023933333008194
YD-8,2749,4.008728292988675
SNU-119,11234052,4.141539950400205
BT-20,2733526,4.148019166614495
GP2d,71466380,4.530252115911121
SCC-9,60700,0.6764265945588348
IST-Mes1,71751553,5.350652566949457
MHH-ES-1,11404337,-1.1882712301989995
PL-21,451668,1.221328602519376
CFPAC-1,selumetinib-JQ-1 (4-1 mol-mol),1.2285601106700188
BT 416,31703,-0.9038411869846444
KO52,67156097,-3.4687606598121143
ALL-SIL,5978,-4.2912860791141725
GA-10,navitoclax-sorafenib (1-1 mol-mol),1.2870593027921478
SNU-119,568763,0.0507231945137797
SW1353,56946209,-2.2730678573632717
LS411N,49850262,4.021647044836445
RCM-1 [Human rectal adenocarcinoma],5746,1.2509488539194744
LS411N,17755052,2.4732315703899226
Mino,9933475,1.4897788599448063
BT 231,23725625,5.4531092056693105
SK-MES-1,6914657,-3.322740957316983
SNU-119,3676137,3.8101807796539298
NCI-H2171,24785538,-0.9958553447114444
KHM-1B,44486219,3.979705310962138
SNU-119,3025986,-1.122362641201654
HMCB,448949,2.7592399466934516
KMS-12-BM,44486219,2.8899607356045443
PANC-1,26596,-1.3824156046290312
BT 231,2746,2.74381286555369
HD-MY-Z,135984461,4.3982026911884455
OCI-M1,1242560,3.3023606618856656
HD-MY-Z,11626560,2.006192654953824
RCM-1 [Human rectal adenocarcinoma],11152667,-0.80003376539758
OCI-M1,12003241,0.3090538594406519
RCM-1 [Human rectal adenocarcinoma],135421197,1.2784797904555276
IST-Mes1,3634881,3.096696127840678
PANC-1,9823820,5.42865822243418
SKM-1,44632017,0.051151225180369
SW1116,24797083,1.0967394866263165
PL-21,10302451,3.830293265507133
BT-20,49867930,5.411827469230055
HMCB,42642645,1.005103914323319
KHM-1B,5460769,1.8331932839616616
PL-21,5978,-3.624413796006843
GP2d,327653,2.337916149275068
NCI-H929,135398738,4.7642664235998815
BT 231,71729975,0.8289046061054816
BT 416,11707110,-1.4834104363370215
NCI-H1395,navitoclax-PLX-4032 (1-1 mol-mol),3.577675870608842
NCI-N87,49850262,3.22497182450996
SKM-1,54613361,-1.1301405501278758
KYSE-140,25183872,1.3300880818448015
SNU-119,9877608,5.864690809801913
EJM,11626560,1.3808062425150147
ECC10,5281321,-2.7067608630689604
NCI-N87,20959075,-3.4539866912118784
OCI-M1,219104,2.141589958568093
NCI-N87,44589607,2.3758044537421026
NCI-H2122,4521392,4.139533376580659
ECC10,1750826,-1.301999947098889
OCI-M1,11494412,-0.1293133865918841
REC-1,9956119,4.047976940960665
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577
BT 416,2733526,2.7956894403427985
BT 231,3038522,1.5792586852803552
T84,44632017,0.7334288448956815
K-562,151289,0.3703020531314545
HMCB,1566236,1.7394312384979265
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715
HCC1833,3384730,3.4749172887325184
SK-MES-1,6184667,3.5501890684779425
BT 416,selumetinib-decitabine (4-1 mol-mol),2.746239446439249
HD-MY-Z,375860,-0.2550299270549113
TCCSUP,navitoclax-pluripotin (1-1 mol-mol),-0.7480541514950738
KYSE-140,208908,-0.0115979470824505
KMS-12-BM,387447,-5.588552036556516
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556
GA-10,11609586,1.226349475622928
KYSE-140,42642645,0.699404434989545
SK-LU-1,10184653,0.5293731344174952
KO52,6252,-1.3570123270027108
OCI-M1,374536,1.352754792423625
NCI-H2087,3081361,2.6933223687374173
BT 231,1716436,2.0638446522523175
PL-21,49793307,-4.210103561360807
MHH-CALL-4,53232,3.736945887197032
BT-20,2708,5.45036236245344
BICR 31,5282054,4.622453961920413
NCI-H1395,969516,2.7506221381545823
GA-10,JQ-1-navitoclax (2-1 mol-mol),-1.1454356635958804
KO52,135999136,3.8823895578085743
RT-4,24901704,2.5115033957059776
EJM,44202524,0.907560202578118
KO52,11178236,-1.9034207953273736
SK-MES-1,135398516,1.606734353888825
NCI-N87,3825829,3.9513849877108207
SW1353,73707398,1.600430045495041
HMCB,JQ-1-carboplatin (1-1 mol-mol),2.516859123575671
Calu-1,9956119,4.912497464696011
LP-1,45279963,2.186289793797456
GA-10,46174525,3.3805365221193133
NCI-H2087,227681,3.412386851503108
K-562,16722836,1.308803334400655
EJM,5470400,-0.5536603917301139
T84,11214940,0.9897742071939424
SK-HEP-1,11485656,3.3898088020096324
KYSE-140,12001922,1.7474021837860103
SK-MES-1,tanespimycin-gemcitabine (1-1 mol-mol),-2.0504278006261805
HuNS1,6438330,1.3253688019195191
SCC-9,135875424,4.9754653396039314
LS411N,49793307,-3.1894754739686455
HCC1833,216345,4.494275173252598
RCM-1 [Human rectal adenocarcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.1552329187196393
MHH-CALL-4,16725315,3.258420970726196
SK-LU-1,49836020,-1.7403396635124715
Mino,327653,2.450086744090126
SW1353,11214940,1.687778080681149
BT-20,72193861,3.4149247025467635
LP-1,24797083,-0.711293193356186
NMC-G1,11404337,-0.1784694384642232
KHM-1B,46398810,2.0305727625963756
NCI-H2171,44589607,1.1207968177639505
SK-MES-1,4259181,0.518582282255732
T84,JQ-1-MK-0752 (1-1 mol-mol),2.5443638278697485
SK-HEP-1,71304818,1.6350171624170464
MHH-CALL-4,375860,-0.3474081343117626
PE/CA-PJ15,25227462,0.6142202816013134
YD-8,tanespimycin-gemcitabine (1-1 mol-mol),-0.3043825539609709
PL-21,selumetinib-PLX-4032 (8-1 mol-mol),-0.8161543435917286
KHM-1B,135999136,4.388497598108013
BT 416,11640390,0.6570323709296152
BT 231,5280436,2.9983755916706225
L3.3,375860,0.2158630030269858
HCC1833,4917,2.9932601930041973
BT 416,2949965,2.657136576973805
LP-1,135984461,3.5540732743417665
BT 416,5329102,1.823591674329712
NCI-H1395,16741245,6.143335067349052
HMCB,409805,5.980176460908731
GA-10,9911830,0.6286737251156136
ECC10,5351362,0.8587554982799872
K-562,44486219,4.057183894108205
IST-Mes1,126941,-2.6873860553959754
NCI-H2087,57519531,1.2848342782849749
SK-LU-1,ISOX-bortezomib (250-1 mol-mol),0.9857250596861096
SW1353,5311,0.9619727401091288
YD-8,2841722,4.733958021687277
PE/CA-PJ15,25262965,-2.0925054008893285
HD-MY-Z,56949517,6.083020116675627
ECC10,73707438,5.1810993969991
KYSE-140,11455910,1.0441153824583205
Calu-1,crizotinib-PLX-4032 (2-1 mol-mol),3.0210538014483914
NCI-N87,6610216,4.734758596227503
ECC10,3543504,4.096709868389306
SW1353,409805,3.732446628282932
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784
OCI-M1,49766530,0.2650302716544968
YH-13,3552672,4.052352129280503
MHH-ES-1,135440466,0.9124436275678324
Calu-1,9911463,4.35367590047306
MHH-CALL-4,JQ-1-vorinostat (2-1 mol-mol),-0.5039477703864683
NCI-H929,46174525,3.514748643502036
L3.3,65628,4.284850303510067
ECC10,122327,5.316805632769619
IST-Mes1,24753719,4.106786270688489
NCI-N87,1239801,5.115918121174403
SK-MES-1,6438330,3.041939612597124
Mino,54619267,2.854011246875485
TCCSUP,135398516,1.0514197344839231
YH-13,6852167,1.959387815211575
HuNS1,6917907,-5.780593611083224
SCC-9,60750,4.9910553033212866
NCI-H2087,9444,3.929044806320414
TCCSUP,44241473,5.1111150240253975
LP-1,400769,-1.581413247783275
HD-MY-Z,16013152,4.01310052191103
REC-1,6450551,3.361583238713797
Calu-1,71751553,5.536345694277309
GA-10,10302451,1.250963043335676
BT 416,57519531,0.3951445099518623
SCLC-21H,439501,-2.4331226834497612
YH-13,24964624,2.65969154668954
YD-8,16038120,0.5633322906687026
T84,387447,-4.62773918346918
ALL-SIL,71304818,1.8469641946240791
EJM,4788,5.350018534970788
KMS-12-BM,49836020,4.363885927749537
OCI-M1,216345,4.427389182629618
HMCB,4261,2.182520846929022
GP2d,5311,0.9221003604832606
MHH-CALL-4,46215462,1.5743209421285942
SNU-119,135421197,4.049091304293704
REC-1,selumetinib-UNC0638 (4-1 mol-mol),5.204842830109013
BT 416,387447,-4.305201856785441
LP-1,44607531,1.1034483593816269
REC-1,3136844,3.938412595022709
KHM-1B,44489675,3.585809473125015
SK-MES-1,3689413,0.2897315368024132
HuNS1,selumetinib-GDC-0941 (4-1 mol-mol),2.547850957341402
BT 416,637858,2.044208431747075
TCCSUP,decitabine-navitoclax (2-1 mol-mol),3.3142403079225073
T84,SNX-2112-bortezomib (250-1 mol-mol),-2.811794655909118
BICR 31,24856436,1.9770307243044476
GA-10,2871966,-2.4245013516656
HD-MY-Z,6852167,3.895273061647595
BT 416,10385095,0.9416016414331604
NCI-H1395,36462,4.192459813965937
NCI-H929,2828334,5.894238913273239
ECC10,44819697,2.8327193808012385
KYSE-30,9907093,4.316185767868911
KYSE-30,25183872,-1.5143234723926031
NCI-H2122,49793307,-4.1862989673916715
NCI-H929,654092,-1.4076135504033414
YD-8,227681,3.132944737961843
SW1116,navitoclax-pluripotin (1-1 mol-mol),0.3202561225019927
SK-HEP-1,23725625,4.972795252846745
BT 416,216239,2.8005368597842515
YH-13,selumetinib-JQ-1 (4-1 mol-mol),2.881387318518872
RCM-1 [Human rectal adenocarcinoma],2858523,3.3395777905719872
BT 231,54143018,-0.1728200859819445
T84,445643,3.4342837620802724
SK-MES-1,168312962,3.783923765931004
IST-Mes1,54618164,4.8538718291352945
PL-21,9926054,1.453737550570679
SNU-119,2828334,5.778213563087879
YD-8,5351362,1.6415350348808246
SK-LU-1,6918328,1.5606912271550055
EJM,54613361,-0.1468563757258991
SCC-9,44137675,3.491154886377157
SK-HEP-1,9926054,1.934364320328667
REC-1,3503,1.8711858712785363
RCM-1 [Human rectal adenocarcinoma],4521392,4.2393817604075705
NUGC-4,16725315,4.798941433539762
GP2d,navitoclax-birinapant (1-1 mol-mol),-2.4866149946831584
REC-1,9935249,3.294492382049569
NCI-H2087,selumetinib-piperlongumine (8-1 mol-mol),-2.7541222362664426
K-562,9826308,0.1842141800186153
BT-20,navitoclax-sorafenib (1-1 mol-mol),1.4772717436803695
KYSE-30,72376,-1.1561614581775066
KYSE-140,11964036,1.450770065347422
KYSE-140,46907787,2.8487460555393453
HD-MY-Z,24753719,4.079912472521239
IST-Mes1,11364421,-1.7965673619245748
SW1116,9915743,-1.8123899004443464
PE/CA-PJ15,3825829,4.163765164448535
RT-4,44607530,3.804226542421099
NCI-H2087,54143018,-0.2546118333533532
RT-4,55283,3.030224345806742
HMCB,46907787,2.4282883374132256
ECC10,2746,0.8272304201141983
YD-8,16219061,3.09744286971822
GA-10,44632017,0.2088114722180037
NCI-H929,navitoclax-gemcitabine (1-1 mol-mol),-2.8250972812481714
RCM-1 [Human rectal adenocarcinoma],71466380,4.350719813683452
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256
RT-4,445455,5.670983982398453
KO52,56963564,-1.0767290882933307
SKM-1,327653,2.256314826375049
NCI-N87,1641662,2.907963520285112
BT 231,4788,4.836465163715281
RD-ES,25262965,-2.201288484798722
ALL-SIL,100016,4.099229681419155
NCI-H2171,46191454,1.782184086758524
T84,piperlongumine-MST-312 (1-1 mol-mol),1.515516446942885
TCCSUP,carboplatin-UNC0638 (2-1 mol-mol),3.7591677104919334
BT-20,44185566,2.9850470435926546
PANC-1,5746,2.6271251936671387
BICR 31,4096211,1.2121831781068038
ECC10,4917,2.5419022867624954
LP-1,vorinostat-navitoclax (4-1 mol-mol),0.6445164573935491
OCI-M1,11717001,4.526238049524744
SCC-9,4521392,4.43257578464979
GA-10,5281321,-5.157165293760458
CFPAC-1,65064,5.2927235316616885
KYSE-30,9444,5.563295893581009
HMCB,44486219,4.542033268900389
KHM-1B,9911463,3.1729521589558125
SKM-1,3385,1.1892530781163966
MHH-ES-1,3854666,0.6560806360047275
ALL-SIL,46224516,1.508509192124363
NMC-G1,5311,2.830090829715794
ALL-SIL,60700,-4.240130526526249
BT 231,5329102,1.8966299328740657
TCCSUP,9952709,2.608000071984436
SKM-1,66577038,3.0728529943968153
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363
YH-13,6918736,-3.6084117176459913
GA-10,25154868,1.9165336108194704
SK-MES-1,49867926,3.943410497929616
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291
TCCSUP,25126798,3.72552014127361
MHH-CALL-4,selumetinib-JQ-1 (4-1 mol-mol),-0.4835284848569625
OCI-M1,vorinostat-navitoclax (4-1 mol-mol),0.514309599169468
BT 231,6610216,3.7441566513120863
GA-10,44197249,1.2039962980914516
KYSE-30,46199207,3.5759774775264517
L3.3,135398516,2.485669059846241
YH-13,67156097,-1.843734712267085
NCI-H1395,45279963,4.172255756410215
SNU-119,3689413,-2.887862499697321
SKM-1,49850262,2.605889729576421
BT-20,262093,3.15256529620894
LS411N,10127622,0.4126946340819594
KP-N-YN,89928392,0.3391501278594932
YH-13,44137675,2.4918035822396973
SKM-1,9929138,6.747336348801134
ALL-SIL,5329102,0.5818325089631969
T84,6914657,-2.6340454472474435
GP2d,46398810,3.5267516987931624
GA-10,3634881,1.104055640327513
KMS-12-BM,71466578,1.9338301399273083
Hs 936.T,20959075,-0.8772768212588558
KMS-12-BM,445455,3.345017046406881
HD-MY-Z,1566236,1.7825991347956482
MHH-ES-1,46398810,2.23235107834415
GA-10,9823820,1.3707821130218345
KYSE-140,SNX-2112-bortezomib (250-1 mol-mol),-2.0539589726781275
PE/CA-PJ15,5566,3.0835355928329395
KYSE-30,BRD-K55473186,3.9036641146327686
SK-LU-1,568763,0.3139288745456563
KP-N-YN,5311037,3.970144766377015
SKM-1,11719255,2.1127493004030655
BT-20,tanespimycin-bortezomib (250-1 mol-mol),2.8367182462251788
CFPAC-1,46224516,2.9808420041454986
LP-1,135440466,-0.1586468003234718
RT-4,navitoclax-pluripotin (1-1 mol-mol),-1.5234215141375285
KMS-12-BM,3854666,-0.1079800642722917
EJM,6918328,-1.265460040313133
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187
SK-MES-1,16013152,3.696018232946635
ECC10,5291,3.2345796279050187
EJM,11656518,1.6048868934870253
SNU-119,26596,2.579410873890194
Mino,252682,5.80936574948766
YD-8,6918328,0.3268020780062931
SK-MES-1,375860,-0.2426900588796581
SKM-1,8515,1.7539525603020008
HCC1833,216239,2.0593364765091775
NCI-H2122,2858523,3.204751959284372
PE/CA-PJ15,650361,5.890408316913619
NCI-H929,60750,-4.1339317564443965
NCI-H2171,67156097,-2.093355563734418
Mino,135423438,1.6490290727182615
Hs 936.T,JQ-1-carboplatin (1-1 mol-mol),2.819300005463285
HD-MY-Z,11647372,1.9451157049456225
SK-MES-1,568763,1.595795662477684
HCC1833,613753,3.027145513043554
L3.3,6252,0.2429415263286948
NCI-H2087,2828334,5.933458989498525
PL-21,17755052,-1.010415000113381
YH-13,25102847,2.4303848050744747
REC-1,16722836,1.7227474141732009
BICR 31,5329102,1.5123342757929257
LS411N,9935249,3.5378716054356927
EJM,100016,6.634092198961092
SKM-1,452548,-4.875448432121974
HMCB,9903786,3.962700823971229
HuNS1,54678924,0.9476437269332546
NCI-H2122,11609586,3.7048170231847046
BT 231,24753719,4.299852690221636
BT 231,11497983,1.445602899433163
Mino,BRD-A02303741-navitoclax (2-1 mol-mol),-2.5532061684657283
SK-MES-1,44607531,1.3412072630133105
K-562,9887053,4.062685534067952
BICR 31,17755052,0.616652074058669
MHH-CALL-4,44486219,4.107087668273291
HMCB,73707398,1.3368186639169768
BT 231,9866186,2.37208042417243
HCC1833,135999136,4.219025793158123
SK-LU-1,9926054,2.124586219371247
KMS-12-BM,sirolimus-bortezomib (250-1 mol-mol),-0.0125868994295277
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698
T84,54454,3.355815472922681
GA-10,156422,1.7592852662658676
K-562,168313016,4.482960220744853
SW1353,44259,0.3098781264989188
PL-21,135984461,4.312224560924431
NCI-H2122,selumetinib-MK-2206 (8-1 mol-mol),2.312801750614668
SK-MES-1,421610,1.6643892104460023
NCI-H2087,19582717,3.261878473436096
NCI-H929,56963564,-0.3004346894334608
SW1116,60700,0.7157233850635775
ECC10,53325874,4.395938924507053
L3.3,selumetinib-BRD-A02303741 (4-1 mol-mol),5.501199697080603
TCCSUP,3676137,3.9595379052816857
SKM-1,9926054,1.2950133266657913
BT-20,45100481,4.2693689997358275
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446
RT-4,53392493,2.7443643173433454
EJM,637858,1.0127573104049012
KYSE-140,107970,2.5158058197499384
SK-MES-1,44185566,2.3253319519791487
KMS-12-BM,24748573,1.031059985436439
NCI-H2087,3025986,-1.8922365272965511
BT-20,2858523,3.127245876993206
HuNS1,126941,-4.393849223432959
NCI-H1395,5351362,2.8626857880223757
NCI-H2122,54143018,-0.9411268560069778
K-562,6852167,3.2696177089982807
BT 416,2828334,6.084190313733949
NCI-N87,selumetinib-BRD-A02303741 (4-1 mol-mol),3.924319992587928
SW1353,JQ-1-vorinostat (2-1 mol-mol),0.9657635901176712
GA-10,11955716,-5.235847533693612
PL-21,409805,3.3512475851853067
KMS-12-BM,613753,2.6976812863702277
BT 416,5284373,1.591812806518491
HMCB,252682,6.031465547355209
KMS-12-BM,9915743,-0.3780298011492129
ECC10,selumetinib-PLX-4032 (8-1 mol-mol),3.327695061309175
RCM-1 [Human rectal adenocarcinoma],9936388,1.970083737001912
NCI-H2087,25105715,2.577394010897449
K-562,25102847,1.0686863962440132
PE/CA-PJ15,25183872,-1.443697759883257
HMCB,JQ-1-navitoclax (2-1 mol-mol),1.0061070373244176
SKM-1,71466445,1.6319589215508703
EJM,10113978,3.070208700221595
NCI-H1395,1242560,3.324194967981579
NCI-H2087,5280436,2.968936610889587
KHM-1B,3689413,-2.4012228391908783
LS411N,3543504,6.407278726964401
ECC10,5278396,3.2504825185894775
EJM,selumetinib-BRD-A02303741 (4-1 mol-mol),6.6447092258899625
SNU-119,44819697,-0.6073475651500764
HMCB,54143018,0.6781529714604165
MHH-ES-1,6438330,3.3043516542943516
SKM-1,374536,2.026505336627946
RT-4,439501,-1.136247834932354
SK-MES-1,10302451,2.5491443779150273
YD-8,219104,3.5957332803631323
SCC-9,676352,2.0394457592349093
HuNS1,15953870,3.4393359169701845
KMS-12-BM,crizotinib-PLX-4032 (2-1 mol-mol),1.6093595565016696
ALL-SIL,126941,-2.455728969669062
KHM-1B,16038120,-2.393017359341735
EJM,3854666,0.5770225844187807
Mino,135928012,3.1712921803995164
KYSE-30,45279963,4.107571877501361
IST-Mes1,44202524,3.78616908386864
HD-MY-Z,71304818,2.4724796206878996
HD-MY-Z,5287969,-2.2961411891713523
ECC10,135984461,4.0726729521120975
SK-MES-1,10231331,1.6852843396336314
YD-8,docetaxel-tanespimycin (2-1 mol-mol),-1.5629664362824751
SK-MES-1,36462,0.91416353270613
RT-4,23725625,5.6003160205481874
PE/CA-PJ15,67156097,-1.715044152720716
KMS-12-BM,10302451,3.4855488172991924
REC-1,5335621,5.583215213785345
KMS-12-BM,5284616,2.1225566255949047
NCI-N87,9903786,2.403456427338335
BT 231,4917,2.073926714601451
NCI-H2122,57330099,4.448680182072782
SCC-9,72376,-1.0275629780171365
KMS-12-BM,11964036,-0.4657573927084836
NCI-H2171,11222830,1.3474519729527985
REC-1,613000,4.883255539354151
NUGC-4,49850262,2.9606280974976995
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267
PE/CA-PJ15,24951314,2.5074808192251252
BT 416,44185566,1.00909544072231
NCI-H1395,56946209,-3.045135926894346
OCI-M1,11404337,-0.1677571096937809
RCM-1 [Human rectal adenocarcinoma],6184667,3.2761425368749477
EJM,3136844,3.6340399610084537
OCI-M1,11455910,0.9199836560966144
SK-OV-3,387447,-3.0618968905277164
YH-13,9935249,4.648604322917456
PL-21,44607530,1.7589858906312672
EJM,60750,-5.8267895844580515
Mino,doxorubicin-navitoclax (2-1 mol-mol),-4.161121173584363
RT-4,10385095,2.2650869360881742
BT 416,navitoclax-pluripotin (1-1 mol-mol),-2.5329012099295047
BT 231,5287969,-1.6363137435441206
NCI-H2122,60700,1.639825549144002
NCI-H929,6918878,1.2577940998028925
HD-MY-Z,65064,5.230169536001075
NMC-G1,104842,-0.0211828842087816
NUGC-4,tanespimycin-gemcitabine (1-1 mol-mol),-0.9293227274068456
L3.3,19582717,4.421931624871946
BT-20,1566236,3.9435008592905247
HCC1833,46191454,2.2534957756072433
KHM-1B,176870,4.52912328100578
HMCB,11507802,1.157749348598854
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765
HCC1833,selumetinib-vorinostat (8-1 mol-mol),2.3317673316592753
RT-4,135411,2.3178037837243166
BT 231,24772860,-2.67844720532028
BT-20,2126,3.813223892738038
KO52,2729026,2.182339538385487
KHM-1B,54626689,4.681502909310955
SNU-119,675434,5.343032629204847
MHH-ES-1,2945648,0.3681987273714012
BT 416,5328940,1.6151722415913126
GP2d,5287620,-2.550851044344389
LP-1,5329102,1.484371286130317
KHM-1B,44607531,1.2480469496992657
SW1116,2742550,3.2977805707201675
MHH-CALL-4,71466445,1.6335508440746371
HCC1833,5566,2.9534749673753504
HCC1833,24753719,5.582495333758276
KP-N-YN,25195348,3.751890571562456
SK-LU-1,11640390,4.067551966397707
EJM,44607530,2.5070049311277423
ECC10,31703,-3.435096890177879
SKM-1,9936388,-5.746280121163761
NCI-H2171,5287969,-2.1635291246577286
HD-MY-Z,10113978,3.1518981538795448
KHM-1B,navitoclax-piperlongumine (1-1 mol-mol),1.2579870657882444
SW1353,4261,0.7936571762578607
PE/CA-PJ15,2729026,3.0133380592288073
GP2d,11494412,0.0345645894259447
BT 231,72376,-2.3772293781913345
RCM-1 [Human rectal adenocarcinoma],54619267,4.6297481177667725
EJM,2742550,4.0665181922374805
EJM,107985,-4.84255557894517
YH-13,123631,3.7042761573264023
Hs 936.T,54143018,1.3371004072408088
RCM-1 [Human rectal adenocarcinoma],46174525,4.230350619821445
T84,11494412,-0.7217837675976604
NUGC-4,vorinostat-carboplatin (1-1 mol-mol),1.044337439131521
MHH-CALL-4,119607,5.366659461838487
KHM-1B,11404337,0.2779693874185021
Calu-1,serdemetan-SCH-529074 (1-1 mol-mol),2.64564894053932
SK-MES-1,selumetinib-decitabine (4-1 mol-mol),2.662505031887132
SK-MES-1,24856436,-1.8716626645024144
SCC-9,11455910,1.869884665357408
NMC-G1,19582717,4.87352686985601
YD-8,676352,2.488164336749702
KYSE-30,5287620,-1.263072661506909
BT-20,carboplatin-etoposide (40-17 mol-mol),3.700043880887856
KHM-1B,44202524,1.0053468169161075
K-562,24771867,1.7261535062160185
YD-8,2949965,3.0609642629133083
HMCB,24753719,4.311459213197197
TCCSUP,219104,4.0410651584060435
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265
L3.3,31703,-1.9667249709147607
SW1353,crizotinib-PLX-4032 (2-1 mol-mol),1.97749084724726
BT 416,1566236,1.637828038025737
K-562,25105715,3.3934107563871088
TCCSUP,5328940,1.4303575035748048
NCI-H929,16736978,-1.8944362557879229
YD-8,46907787,3.160935680087681
ECC10,53481919,3.386404128952187
BT 231,9444,4.577261476802596
NUGC-4,6918328,-2.084134047447286
KMS-12-BM,42611257,2.4160280183147913
LS411N,16038120,1.458068935835204
CFPAC-1,5470400,-2.5427434970103153
ALL-SIL,54454,2.130103786841792
T84,613000,1.3569843746884054
NMC-G1,135421197,2.4402756951086477
SK-HEP-1,46398810,3.2056962377986333
SK-LU-1,65064,5.179624163681176
SK-MES-1,15983966,1.443038422247867
KMS-12-BM,6610216,3.741234433073347
SNU-119,60700,-0.1085854321234963
PL-21,9936388,-7.198492921849207
SK-HEP-1,4917,3.764636353681369
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188
L3.3,23582824,1.1997888978910711
PE/CA-PJ15,4521392,3.3811867857617575
OCI-M1,JQ-1-UNC0638 (2-1 mol-mol),0.2446293289587729
LP-1,24951314,0.8435237170493114
BT 231,5287620,-4.392060219454981
L3.3,11364421,-3.724172704719069
KHM-1B,984333,-0.473471772340059
L3.3,44489675,4.5650706631267175
CFPAC-1,6918837,-1.7130795548192534
SCC-9,445091,4.9115801471194365
KP-N-YN,409805,3.805476541257568
HCC1833,969516,3.1567317550786744
SK-OV-3,6623618,3.404966669354166
KMS-12-BM,9926054,1.301975129823355
SNU-119,72376,-2.5899020632208742
KO52,10302451,3.962918157421803
KMS-12-BM,5287620,-2.183306507553873
GA-10,16065773,1.6013458481329164
T84,6918328,-0.3197275482809464
KYSE-140,2708,5.479342492589101
YD-8,5280436,4.27125727704808
EJM,25062766,1.6809786410493317
MHH-CALL-4,2729026,2.223040922218365
NMC-G1,4259181,1.051938223963876
EJM,JQ-1-vorinostat (2-1 mol-mol),-0.3009892531248522
SW1353,135398516,2.1500416907401014
KMS-12-BM,navitoclax-pluripotin (1-1 mol-mol),-1.9896147371140072
RT-4,16725315,3.7919214509937977
BT-20,24775005,3.4699611694501264
K-562,16659841,3.212428083743772
NCI-H2122,5311,1.4577503382151662
NCI-H2171,67291369,-0.2342814323553679
PANC-1,3634881,3.4431787977401855
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777
YD-8,2842253,4.968157953189597
OCI-M1,JQ-1-MK-0752 (1-1 mol-mol),0.5861943942758187
KHM-1B,24748573,1.6722296150954905
YD-8,51039095,-0.2899532723267104
IST-Mes1,44819697,0.965138597180618
NCI-H929,5280436,3.412366721606299
YD-8,644241,2.56753139102049
BICR 31,25062766,2.0025728701089904
ECC10,2828334,5.535619433524195
HMCB,ISOX-bortezomib (250-1 mol-mol),0.174785181826403
KHM-1B,24753719,3.787412928700261
BICR 31,15547703,3.2095649219178006
EJM,6610216,4.116260512201503
GP2d,navitoclax-gemcitabine (1-1 mol-mol),-1.7978528727588208
KMS-12-BM,11625818,2.552202137572075
KMS-12-BM,ISOX-bortezomib (250-1 mol-mol),-0.4496875645415525
Mino,9967941,3.0523252398881207
SNU-119,9444,4.392660959332783
SCC-9,23635314,-1.650613607792241
RCM-1 [Human rectal adenocarcinoma],613753,3.402609507762531
PL-21,2858523,2.450848603641957
MHH-CALL-4,11612883,1.8374604725897057
EJM,12003241,0.5402616975347148
RT-4,637858,2.2211102524324717
KYSE-30,salermide-PLX-4032 (12-1 mol-mol),4.189904278193996
Hs 936.T,53232,4.453408696400832
REC-1,6610216,3.8618283441811054
NMC-G1,168313047,2.910913104839514
BT 416,73707398,1.2000065788427186
MHH-CALL-4,53392493,1.358192728922499
HuNS1,54618305,4.275761416742284
NUGC-4,8515,3.8971798863642615
SCC-9,44491742,4.764074483400304
TCCSUP,24978538,1.7362039378241625
PL-21,23582824,0.6302430809246646
PE/CA-PJ15,6505803,-4.077813218319251
HCC1833,10184653,2.0020455461096587
BICR 31,5278396,4.450921628721945
PL-21,72199292,0.8840770097967156
RCM-1 [Human rectal adenocarcinoma],702558,5.773616649362023
ALL-SIL,375860,-1.552794194023853
KP-N-YN,135928012,3.4778289270548233
K-562,11167602,1.4540526159902811
KYSE-30,1714884,3.559826613357598
KYSE-140,9549297,3.7782006127039742
KO52,11707110,-6.904897916995384
HMCB,selumetinib-MK-2206 (8-1 mol-mol),3.305781399088849
KYSE-30,5291,3.754875979175039
BICR 31,6610216,4.499990209090508
SK-HEP-1,176870,5.630942733934813
KYSE-30,5284616,2.979237294374913
KO52,5287620,-2.460280488193722
PL-21,135398744,6.318867550173511
OCI-M1,salermide-PLX-4032 (12-1 mol-mol),5.247906176233847
SK-LU-1,66577038,2.94913951082825
KYSE-30,73707438,4.088230739190161
EJM,24180719,3.679957283710777
ECC10,UNC0638-navitoclax (1-1 mol-mol),-3.3170539937927876
TCCSUP,11228183,2.2108434625291937
GA-10,44462760,1.3514201573984144
BICR 31,10231331,3.776464743887352
EJM,9911463,3.809334952263978
BT 231,54618771,0.7922646437361874
NCI-H2087,107970,0.9807530000225162
SK-MES-1,25105715,1.9972031488998936
NCI-H2122,ISOX-bortezomib (250-1 mol-mol),1.5568360712262648
NCI-H1395,6852167,3.4323108551980748
LP-1,7326481,1.934943170466434
KHM-1B,675434,3.385795736646719
HMCB,24856436,0.4140973737290317
KYSE-140,54454,2.298493074296882
NCI-H1395,67156097,2.84144563210516
OCI-M1,4705,3.4843889260435215
HD-MY-Z,107970,2.364477587314304
SK-OV-3,5278396,4.0115131897954175
SCC-9,3081361,1.719146178558617
NCI-H2171,57519531,1.5586354952126105
NCI-N87,selumetinib-PLX-4032 (8-1 mol-mol),3.8712321401270406
HD-MY-Z,1474550,4.47836514924332
KYSE-140,44607531,0.9644287941407328
GP2d,25126798,3.813707221089916
BT-20,11175137,3.171964987945302
SNU-119,216239,2.5472186615534893
BT 416,44566777,1.0276057961723035
PE/CA-PJ15,navitoclax-MST-312 (1-1 mol-mol),0.989983857271209
K-562,16013152,3.768503882504226
BICR 31,448949,3.395825088667814
ECC10,67156097,-3.1008012843579427
PANC-1,24821094,3.9441178012081934
Mino,71466445,1.235748115046604
PE/CA-PJ15,3081361,0.74058948354625
SKM-1,24180719,1.95578575443114
SK-LU-1,46398810,2.0018200742054932
EJM,alisertib-navitoclax (2-1 mol-mol),1.7794919006305252
NUGC-4,446155,2.5463125242515514
PL-21,53245473,3.771915843050049
PE/CA-PJ15,sirolimus-bortezomib (250-1 mol-mol),0.416438105686926
BT 416,9911463,2.4624621217887457
KYSE-30,6436223,-5.524108382637954
SNU-119,46398810,2.4146356603703527
LS411N,44507138,1.8249335905604152
SKM-1,36314,2.437591695433872
Mino,71466578,1.5916084235024313
KYSE-30,66577038,2.996497160697704
MHH-CALL-4,11719255,1.4430192615873203
NCI-H1395,5287620,-5.195854195125387
SK-HEP-1,54619267,4.307302877095537
MHH-CALL-4,3815108,2.38024137093579
Calu-1,119607,6.082125313535212
SK-MES-1,24978538,3.1187012098525786
Mino,448949,-0.9045161656585446
TCCSUP,54618771,0.6448534643306117
GP2d,42642645,-0.7579191426845988
SNU-119,387447,-4.116955767451351
NCI-H2171,3384730,2.17478810564445
BICR 31,89928392,2.942196417475874
BT 416,16722836,0.9751434529543616
MHH-ES-1,24753719,3.7932935338290954
PL-21,322968,3.301663766180845
LP-1,2749,1.4884112526237945
NUGC-4,20959075,-3.604151563914914
NUGC-4,24856436,-0.7983513564445418
KYSE-30,156422,3.946801273047478
YD-8,49793307,-2.0913800226876704
HuNS1,25262965,-4.284155425036137
Hs 936.T,25183872,0.2544842203841536
RT-4,11152667,0.7569607325973031
KO52,136227924,2.4006650771153923
NCI-H929,5284329,5.087247954769154
KHM-1B,selumetinib-JQ-1 (4-1 mol-mol),-1.6661106827496956
CFPAC-1,24753719,4.623602158880275
PE/CA-PJ15,24748573,2.17566183871997
KO52,5328940,1.2036469066601834
NCI-H2087,4788,5.3674993248381515
SKM-1,23582824,1.1838260126790126
NCI-N87,6184667,4.346047693042568
GA-10,BRD-A02303741-navitoclax (2-1 mol-mol),3.0327117183675676
EJM,53392493,1.8417186959189336
Mino,carboplatin-UNC0638 (2-1 mol-mol),3.2007380668801564
SNU-119,44589607,2.031679026028789
SKM-1,9956119,3.002044970915889
SW1353,5329102,2.2506504918888393
KP-N-YN,650361,3.8016345293446743
KO52,5329102,1.292288709166054
NCI-H2087,46191454,1.0544466525208391
KO52,JQ-1-navitoclax (2-1 mol-mol),-2.7248025297093825
BT-20,9825149,3.6230112341338496
KYSE-30,9866186,1.7216231724950437
GP2d,10296883,2.4344246529088163
KHM-1B,6917907,-6.365498814306295
BT-20,10113978,4.678908782630864
SK-HEP-1,148198,-3.434194259121147
PL-21,11717001,3.8315829216971498
KO52,5351362,0.8431188891689549
Calu-1,49793307,-1.6701033872217004
HD-MY-Z,9935249,2.519302012591236
NCI-H929,6610355,3.3413826828309983
NCI-H2087,55508,2.6675689453998985
NCI-H2087,23725625,3.946434421916632
BICR 31,25195348,4.130650271984148
EJM,26596,-3.57565028157041
NUGC-4,11222830,1.8068583087600911
NMC-G1,25102847,2.203623863297804
HD-MY-Z,alisertib-navitoclax (2-1 mol-mol),0.1199596106864027
PE/CA-PJ15,42611257,3.846620621313575
SK-MES-1,156422,4.318322826584335
Calu-1,navitoclax-gemcitabine (1-1 mol-mol),1.9744819442733277
HD-MY-Z,3552672,1.8214155151534708
KYSE-30,54649381,3.8376199137118223
KMS-12-BM,4915,4.427523198943996
KYSE-30,637858,2.0597026776790544
RCM-1 [Human rectal adenocarcinoma],374536,0.8021830219773941
CFPAC-1,3385,5.739346889187181
SK-LU-1,216345,4.757502551239203
BT 416,2746,4.178903855653317
YD-8,6505803,-0.4521993512764767
NCI-H929,4261,0.6477410637199463
OCI-M1,241158,3.69055500632508
BT-20,10410894,3.3412139081173766
OCI-M1,89183176,2.7167817923094586
TCCSUP,72376,-1.3114530344547206
ECC10,24785538,-1.7960822430835837
L3.3,637858,2.497804094781357
PL-21,3011155,-0.7997038826343562
NUGC-4,navitoclax-MST-312 (1-1 mol-mol),1.242055260272028
KHM-1B,navitoclax-gemcitabine (1-1 mol-mol),-2.36446973278894
PE/CA-PJ15,262093,3.193957949465754
SW1353,3689413,-1.8577928934605696
K-562,11955716,-2.44804051648688
MHH-CALL-4,19582717,2.891608003501736
SW1353,10231331,4.64823511583987
T84,72734382,4.597823557174909
HD-MY-Z,2708,3.182258749778764
HMCB,1641662,3.3637139334178343
SW1353,71466445,3.3058354165580712
GP2d,10385095,1.144770275016541
BT 416,44543605,3.2738095476053144
BT-20,1239801,4.673827716263797
BT 231,5282054,2.940849229089784
PANC-1,285033,-2.2180155616154895
EJM,46224516,1.5336479152215143
BT 416,4259181,-0.2167278617462421
PE/CA-PJ15,7251185,3.2473108983237164
LS411N,53232,4.5193815700089655
GA-10,5280436,-0.044271429066784
BT 231,49793307,-2.782131370462149
NCI-N87,selumetinib-tretinoin (2-1 mol-mol),6.374104250530425
KYSE-30,10302451,4.500697624442922
ALL-SIL,6450551,-1.4599471288533186
KHM-1B,11640390,-1.4659593094548573
SKM-1,54649381,3.9349803004412496
HD-MY-Z,11178236,-4.727807769166241
ECC10,navitoclax-MST-312 (1-1 mol-mol),-2.7444666684648795
SK-MES-1,54454,2.9646039445300314
KYSE-30,7251185,2.6674298913244425
NCI-N87,6918878,2.817621762559668
Calu-1,2945648,2.763041963844817
Mino,57519531,0.8811473119395662
Mino,SNX-2112-bortezomib (250-1 mol-mol),-3.943063699233405
TCCSUP,piperlongumine-MST-312 (1-1 mol-mol),1.4987709869908574
HMCB,11625818,4.609137962647994
SW1353,selumetinib-GDC-0941 (4-1 mol-mol),2.4649613007554185
ECC10,navitoclax-piperlongumine (1-1 mol-mol),-3.249679628366687
L3.3,60750,-5.123801682120219
SCC-9,JQ-1-UNC0638 (2-1 mol-mol),1.0836659373023885
KHM-1B,72734382,4.262414843982703
HuNS1,54454,3.173342511212095
ALL-SIL,439501,-2.349752310116714
SK-OV-3,135440466,2.5162908691834405
EJM,46907787,1.3360205419537388
BT 416,3081361,1.640393970788559
ECC10,3503,2.325869113159625
NUGC-4,54613361,-1.2635453217764343
TCCSUP,122327,4.306454567710715
SKM-1,24772860,-3.5610280198331705
Mino,126941,-4.417965625987865
KP-N-YN,2871966,2.041865052957591
NCI-N87,6918837,-4.459129390963203
Calu-1,327653,2.6340275004388856
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705
MHH-CALL-4,400769,-0.8552551147126066
GP2d,24821094,-0.5028463239614391
NMC-G1,24180125,3.2827632569676433
PL-21,24785538,-2.0521195829616334
CFPAC-1,6623618,2.38568703194058
SK-LU-1,2708,4.169228034592907
HCC1833,6623618,4.328189985935015
NUGC-4,123631,-2.7939181700881757
Mino,11640390,2.9754145364619493
NCI-H2087,3689413,-1.4883160931257695
HD-MY-Z,JQ-1-vorinostat (2-1 mol-mol),1.0074647541407349
LP-1,44241473,4.281218782455272
KP-N-YN,60750,0.6407873148302402
PL-21,448949,2.1287086651315463
SK-LU-1,6505803,-1.477995420791017
RCM-1 [Human rectal adenocarcinoma],16065773,2.083422102332506
IST-Mes1,448949,2.0697752718967677
ECC10,11485656,1.639857171829123
NUGC-4,638278,3.5791564059903527
BT 231,3136844,3.641211375202356
NCI-H929,51039095,0.5625919712885992
SCC-9,54639665,4.512228528266098
SCC-9,119607,6.006958395758143
KMS-12-BM,10385095,1.107401404691538
NUGC-4,71304818,2.293773050056326
LP-1,11222830,1.1055639352737865
YD-8,53232,1.7923845474925033
KMS-12-BM,25154868,4.096426210892481
Mino,2742550,2.804646277870024
T84,docetaxel-tanespimycin (2-1 mol-mol),-2.4050856456698595
BT 416,6610216,3.4319544702554405
RCM-1 [Human rectal adenocarcinoma],135398516,4.64558268257279
NCI-H2171,3825829,3.727904622873516
HD-MY-Z,navitoclax-PLX-4032 (1-1 mol-mol),2.7653209653654183
BT-20,445643,4.406164165044468
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428
YD-8,navitoclax-pluripotin (1-1 mol-mol),-0.5711065804436923
MHH-ES-1,1750826,-3.805155941611628
Calu-1,54678924,2.4531155799492588
HMCB,navitoclax-pluripotin (1-1 mol-mol),-1.6437751572745434
NCI-H2171,15983966,-6.379176066325201
ALL-SIL,71680916,4.0231197218666015
T84,2949965,2.225745156859595
NCI-H1395,25262965,-4.1064506045953095
SK-MES-1,9866186,0.2674876166834913
NUGC-4,54143018,-0.8532658154022662
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236
SK-OV-3,25150857,2.8200349544845045
LS411N,44632017,5.0127460000138
BT-20,11455910,1.5364398716433951
ECC10,1566236,1.6584200154088518
SK-HEP-1,6610216,4.694225049802747
SK-LU-1,25062766,2.0281557148940834
NCI-H1395,119182,1.588983658397695
LS411N,6918289,4.168112514533401
SK-LU-1,10231331,3.230997250694965
MHH-ES-1,2749,1.4016265444010714
BT 231,285033,-2.1752872094301923
TCCSUP,452548,0.1947021614919304
HMCB,11964036,1.8216984030595027
MHH-ES-1,54686904,4.515771344448279
NUGC-4,46398810,2.3247403854081505
REC-1,1716436,3.388391652618184
GA-10,11964036,0.2136370800634017
NCI-H929,10302451,2.7551907478934465
BICR 31,11625818,3.9395546041344858
KO52,156422,3.399553477356099
SK-MES-1,2949965,2.174069128701999
SCLC-21H,11955716,2.5417219346903197
BT 416,216345,2.4450796355070055
BICR 31,10302451,2.0763164615496232
BICR 31,53392493,3.0187901836288824
GA-10,selumetinib-GDC-0941 (4-1 mol-mol),0.5759337231249475
ECC10,52912189,0.7337590922134614
SKM-1,2946601,6.482572504848425
YH-13,JQ-1-UNC0638 (2-1 mol-mol),2.8302570708443757
Mino,107970,1.374067690004091
LP-1,445455,4.279536719360507
YD-8,23725625,6.782116953404122
KYSE-30,15953870,3.608839098975031
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845
KP-N-YN,6450551,2.7889379092848943
NCI-N87,1716436,1.6921610156965474
KYSE-140,crizotinib-PLX-4032 (2-1 mol-mol),2.4944173401747807
SK-HEP-1,5291,4.1108608913621545
SKM-1,168313016,3.949913306453134
BT 416,SNX-2112-bortezomib (250-1 mol-mol),-2.894790691146893
MHH-CALL-4,24978538,-1.6089202292412337
ALL-SIL,675434,4.0400251875066715
MHH-CALL-4,carboplatin-UNC0638 (2-1 mol-mol),1.3623986471970229
SK-HEP-1,4477,0.3599343153867445
KMS-12-BM,9935249,1.0143045497874623
YD-8,16722836,1.043469744130907
BT-20,9911463,4.1322446502045285
GP2d,selumetinib-JQ-1 (4-1 mol-mol),-0.6768305872482345
T84,selumetinib-decitabine (4-1 mol-mol),1.8161384248449337
TCCSUP,SNX-2112-bortezomib (250-1 mol-mol),-2.4004107919331967
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557
YD-8,216239,2.8857236357634655
NCI-H929,44507138,1.4351733932332458
SCC-9,5287620,-3.0509576220001953
NCI-H1395,5978,1.0563157186154253
ALL-SIL,568763,-1.7129740739789223
SNU-119,2126,3.7232553571891143
RT-4,49850262,5.649428604777749
NCI-H929,89183176,-3.1165008066026085
Calu-1,54626689,4.5858763156654065
KYSE-30,60700,1.7238249840086863
T84,984333,1.3284934083884192
SCC-9,9956119,4.352516606884389
KP-N-YN,2113511,3.834753705554555
NCI-H1395,19582717,5.560683797956257
NCI-H929,3081361,2.990825939445924
KYSE-30,53393127,4.650274912562827
KMS-12-BM,selumetinib-MK-2206 (8-1 mol-mol),1.5718969310043658
GP2d,54618771,1.3284936518837778
SK-HEP-1,5351362,3.433378240202124
NCI-H929,168313016,5.007996140484685
LP-1,4917,1.943173579146007
KYSE-30,25154868,4.607885522460028
NMC-G1,3062316,1.204351511337659
RCM-1 [Human rectal adenocarcinoma],11455910,0.3019920512168372
KMS-12-BM,1566236,0.5726482736694104
SKM-1,crizotinib-PLX-4032 (2-1 mol-mol),0.9277132426054632
NCI-H2171,89183176,2.3651641452605747
GP2d,SNX-2112-bortezomib (250-1 mol-mol),-2.900224684446106
GP2d,1242560,3.576045973359989
HuNS1,navitoclax-PLX-4032 (1-1 mol-mol),1.3358528861307375
L3.3,9903786,3.5860218860878263
NCI-H1395,2945648,2.6727068131011285
NCI-H2087,JQ-1-UNC0638 (2-1 mol-mol),0.6551767293331621
Hs 936.T,piperlongumine-MST-312 (1-1 mol-mol),2.6505347838415143
Mino,36462,-1.1921094192987896
ALL-SIL,44819697,-2.9345943950607136
KYSE-140,3025944,4.183403998207803
SK-MES-1,5328940,0.5893925283787428
NCI-N87,104842,-4.261750557946528
ALL-SIL,9903786,1.532435199339551
IST-Mes1,15547703,3.097349866450655
SKM-1,selumetinib-decitabine (4-1 mol-mol),-0.7515820525024105
SW1116,9911830,1.7664188791377746
GP2d,44632017,0.7801652573309042
EJM,135398516,2.3604347567100965
TCCSUP,navitoclax-birinapant (1-1 mol-mol),2.81500851801963
SW1353,9825149,2.2921736669195196
YD-8,11977753,-2.68445470248679
BT 416,25154868,3.6572136221061537
TCCSUP,46191454,2.343192904170071
SCC-9,9549297,5.273243325738832
SKM-1,208908,3.3298351666258763
NCI-H929,2708,3.7525965920977007
GA-10,6184667,1.6550271423411964
MHH-CALL-4,selumetinib-piperlongumine (8-1 mol-mol),1.6440053582558132
SK-MES-1,11507802,1.0091437168486206
NCI-N87,262093,3.0008468279122607
SK-OV-3,9903786,2.611217845094376
BT 231,5291,3.599194681323513
EJM,11609586,2.8527211576187925
YH-13,navitoclax-piperlongumine (1-1 mol-mol),2.7253521934801217
NUGC-4,5291,3.932528228074852
YH-13,637858,2.290172126875016
NCI-H1395,219104,2.9305329834901768
YD-8,11625818,4.711571191575779
MHH-ES-1,36462,-0.1756976495711807
CFPAC-1,carboplatin-UNC0638 (2-1 mol-mol),3.717483139879215
Calu-1,5479543,3.869312504138698
LS411N,54649381,4.0879656113234315
KYSE-30,12001922,1.8673769959819408
NCI-H1395,5281321,-3.249479550606142
SCC-9,alisertib-navitoclax (2-1 mol-mol),1.3350821103573205
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624
IST-Mes1,24180719,3.838804357743771
KO52,462382,0.1087271140115314
BT 416,60700,-4.141087342592999
EJM,56946209,-6.334554937515429
RCM-1 [Human rectal adenocarcinoma],2708,5.228043564409416
SK-OV-3,11626560,2.736987670099794
GA-10,208908,1.3431879769657995
YH-13,alisertib-navitoclax (2-1 mol-mol),-1.4191269033717964
MHH-ES-1,navitoclax-gemcitabine (1-1 mol-mol),-3.76546230160433
YD-8,24771867,2.3430098767377263
SW1116,selumetinib-navitoclax (8-1 mol-mol),2.0727315273172016
KO52,25154868,5.228534318622467
GP2d,36462,0.7877061806446254
NCI-H1395,4477,0.6354024043517065
RT-4,5311,2.127982619731648
KYSE-30,24856436,1.4790372868712185
MHH-CALL-4,46199207,3.7954061228347022
ECC10,65628,3.692288785501721
Calu-1,SNX-2112-bortezomib (250-1 mol-mol),0.3775484633280685
MHH-CALL-4,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2869255563318425
NCI-H1395,3503,1.633865651752571
GP2d,25150857,3.5581544314066105
HCC1833,5351362,1.121276214994555
HMCB,71680916,4.934494068760343
YD-8,9967941,3.7717076559680702
KYSE-140,676352,2.739016656839905
MHH-CALL-4,6252,-2.227301377311202
SNU-119,452548,0.641037029070195
SCC-9,5278396,3.934746070394729
CFPAC-1,3025944,4.538554467399444
TCCSUP,42611257,3.7923980265844417
BICR 31,11175137,2.7548462189262817
HMCB,327653,2.816846205013027
KMS-12-BM,60700,-3.455544016540571
SCC-9,5470400,0.9401931564199802
GA-10,31703,-3.9922516783569657
KO52,44137675,4.99436004315741
CFPAC-1,16722836,2.0694043191519778
RT-4,56946209,-3.9033190222100824
K-562,9911830,-1.954559593888618
Mino,6505803,-0.2823157410063563
NCI-H2087,168313200,1.7599184921468192
KYSE-140,alisertib-navitoclax (2-1 mol-mol),1.688478891551993
Hs 936.T,docetaxel-tanespimycin (2-1 mol-mol),-0.6014920887309735
T84,tretinoin-carboplatin (2-1 mol-mol),4.235324546763504
HCC1833,19582717,2.373356154356548
T84,BRD-A02303741-navitoclax (2-1 mol-mol),4.404017652531584
L3.3,54454,4.824648171697031
NCI-H929,12003241,-1.2414676879861424
SCC-9,49793307,-2.052824266331224
EJM,selumetinib-navitoclax (8-1 mol-mol),3.474694147708575
MHH-CALL-4,448949,0.6523422163479776
SK-LU-1,11404337,-0.1113986286493255
MHH-CALL-4,241158,1.661305159450415
KP-N-YN,17755052,4.1946401268959495
GP2d,selumetinib-piperlongumine (8-1 mol-mol),-1.230276061461676
HuNS1,1716436,2.3756145775517377
NCI-H1395,44819697,2.3149017923532607
TCCSUP,3025986,0.0984647564914155
LP-1,327653,2.8727954788037575
KO52,11213558,1.2433594255309357
SNU-119,6918328,1.4012338898143128
KMS-12-BM,navitoclax-sorafenib (1-1 mol-mol),-0.3529677445590104
T84,36314,-4.01457782468792
NCI-H2122,375860,-0.2915668084843835
RCM-1 [Human rectal adenocarcinoma],67156097,4.4289502620646415
PE/CA-PJ15,11427553,3.0001109261894983
NCI-H929,5284616,-3.61642631777644
NCI-H1395,10127622,5.295029189605721
L3.3,56649450,3.0657913461458564
Calu-1,322968,3.384372976898534
SNU-119,9956119,2.9397923190583866
SKM-1,JQ-1-vorinostat (2-1 mol-mol),-0.4999254314738021
BT-20,6852167,1.899729475222497
NCI-H2122,168313200,3.523081981483709
Calu-1,49867930,4.501633858577474
GA-10,9927531,2.891443375149746
HD-MY-Z,3025986,-1.5853832517207322
ECC10,1317464,3.674173600959183
NUGC-4,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.9739376787395078
SK-HEP-1,3825829,4.395950359013269
NUGC-4,107985,-2.8695226927077604
L3.3,135411,0.9568641453583406
GA-10,11222830,-0.5498241611293921
KO52,285033,-3.0760712671003896
BICR 31,123631,1.818021308876907
NCI-H2122,159324,3.624644935210345
L3.3,452548,-0.800912327932342
PE/CA-PJ15,89183176,5.853169928784385
NMC-G1,selumetinib-piperlongumine (8-1 mol-mol),5.79077007550293
NCI-H929,11964036,-1.4756093749186814
HMCB,753704,4.465795196553446
HD-MY-Z,5460769,0.4985347726770217
MHH-CALL-4,11640390,3.1219729753418495
KHM-1B,36314,1.0802720035135625
SKM-1,16725315,3.1863557694530495
K-562,5328940,0.7651330448756731
HuNS1,25227462,-4.340890799085803
BICR 31,9911830,2.2138272662609064
OCI-M1,9823820,4.171084774352814
K-562,23725625,5.2530061405843975
SNU-119,54618305,4.480526935824261
CFPAC-1,72376,-1.6186584876404144
HMCB,24951314,2.2278273113758083
KYSE-30,6918328,0.3823636922463773
PL-21,JQ-1-vorinostat (2-1 mol-mol),-0.0065522197928831
EJM,16065773,1.9015047473462103
NUGC-4,44507138,0.7558724103722942
T84,5470400,-3.4968933186221665
YH-13,6918328,0.5686815123232866
KO52,6610216,4.150836928578526
KYSE-30,11485656,2.6374732663532794
SCC-9,2828334,6.128266495621781
MHH-CALL-4,124202324,0.2696769767665354
SK-LU-1,10385095,2.41706615965267
PE/CA-PJ15,navitoclax-pluripotin (1-1 mol-mol),-1.160938191480762
KYSE-140,5278396,3.6117605554297256
TCCSUP,9967941,4.9073920600623415
Mino,52947716,-7.975452562141386
GA-10,56963564,-0.4545268242460231
Mino,5460769,1.2525165030578538
ECC10,46907787,-0.2077218323322306
NCI-H2087,66577038,2.476769182425381
HMCB,53232,1.5068869536074645
HuNS1,9935249,0.4549731816761326
SW1116,73707398,1.201154114814001
MHH-ES-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.342682354223777
SK-OV-3,6918837,-1.7709381590236568
BT 231,selumetinib-navitoclax (8-1 mol-mol),1.1755303317094543
NCI-H929,16720766,0.2039883469088212
TCCSUP,148198,-2.229154528716237
ECC10,60750,0.7743486034849092
NCI-H1395,46199207,3.5912826317512136
SCC-9,9915743,1.0040050158500469
OCI-M1,2742550,3.075796712533082
PE/CA-PJ15,6918638,0.9363103788474072
OCI-M1,25126798,-1.2833419763710416
NMC-G1,4378219,4.65762217703462
GP2d,6918878,0.9016706015977336
KYSE-30,613753,3.384944175390391
ECC10,44486219,4.330481270106341
Calu-1,11364421,2.709772881373546
HuNS1,52912189,-1.049338431747539
KO52,JQ-1-vorinostat (2-1 mol-mol),-1.1971582258759
NCI-H2087,216239,0.8549311293278048
ECC10,11609586,2.8054955743231185
EJM,piperlongumine-MST-312 (1-1 mol-mol),0.9890593099361664
KO52,262093,1.2878327274871448
KMS-12-BM,2749,1.1667301765067617
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729
GP2d,2729026,3.232429489761131
HuNS1,25150857,1.2529696553972338
PL-21,159324,0.5268160005724882
HD-MY-Z,6450551,2.872544030844523
KYSE-30,5746,2.79853572945112
SNU-119,11964036,1.0686978114131611
SW1353,44241473,4.4186959651454565
KO52,52947716,2.706684159725711
SW1116,6184667,2.8854186783997755
PL-21,54678924,0.9835605989277932
MHH-ES-1,374536,-4.581990796437391
RCM-1 [Human rectal adenocarcinoma],5287969,-2.1782985548113336
SK-MES-1,25126798,3.8218257647573872
BICR 31,3689413,0.760898743899782
MHH-ES-1,25195348,1.4219716869209031
BT 416,1641662,2.5772952331763097
GA-10,5702613,3.0633290480016138
GA-10,1317464,3.5189722960112846
KP-N-YN,5394,4.20091863501501
REC-1,3062316,3.031590043339633
HMCB,24785538,2.1780409626739177
YH-13,44202524,1.4196385072137423
SNU-119,5282054,3.91901589659366
KHM-1B,24775005,4.409922848852168
NCI-H929,126941,-0.648952926168031
LS411N,638278,3.5631537252490917
HCC1833,2858523,2.5878952226199416
KHM-1B,11964036,-0.558883521071404
OCI-M1,3689413,0.2396810105329112
OCI-M1,54454,5.046313143240091
NUGC-4,119182,-0.0900548950385471
NCI-H1395,11656518,2.2687803518385365
ECC10,navitoclax-pluripotin (1-1 mol-mol),-3.907070407389252
KP-N-YN,44819697,5.727320689022014
RT-4,135440466,1.5975390058414984
YD-8,9825149,2.435749778516473
OCI-M1,8515,3.8522238482171263
RCM-1 [Human rectal adenocarcinoma],11626560,1.948909455015208
L3.3,3081361,5.558675862138055
Mino,tretinoin-carboplatin (2-1 mol-mol),2.2016982485522094
SK-LU-1,3503,3.0037661604554984
KMS-12-BM,11213558,1.176856532865763
IST-Mes1,216345,3.619183672475448
SW1116,selumetinib-PLX-4032 (8-1 mol-mol),0.4271602580748421
ECC10,46843906,2.2049812910395215
GP2d,6918736,-2.4255549928169873
SK-OV-3,11364421,-1.984047807336832
RD-ES,decitabine-navitoclax (2-1 mol-mol),1.2163283937451477
KO52,10385095,0.862604455305029
KYSE-30,387447,-5.111361944966211
SW1353,23725625,6.26925743036576
YD-8,alisertib-navitoclax (2-1 mol-mol),2.5230617442547163
GA-10,46943432,0.1410018979279226
L3.3,71466380,3.127104498422419
RCM-1 [Human rectal adenocarcinoma],6914657,-2.702554466691394
SK-MES-1,10184653,0.8320245673966353
SK-MES-1,11178236,-2.5467986145998287
SNU-119,19582717,4.915003831541955
Calu-1,56946209,-3.3614115021956077
IST-Mes1,4917,3.386112443694605
TCCSUP,11964036,1.9073082077869936
SKM-1,44589607,2.983642754360158
HCC1833,BRD-A02303741-navitoclax (2-1 mol-mol),0.7195005715665461
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257
MHH-CALL-4,decitabine-carboplatin (1-1 mol-mol),0.8839399208105623
SK-LU-1,54626689,6.771949064483641
Mino,salermide-PLX-4032 (12-1 mol-mol),4.6699024952141
SK-OV-3,10184653,1.9718742380811307
LP-1,637858,1.1984002374597165
MHH-CALL-4,navitoclax-piperlongumine (1-1 mol-mol),-1.4303234967061236
RCM-1 [Human rectal adenocarcinoma],24856436,1.4266113819026696
SW1353,1750826,-2.359682327197152
PE/CA-PJ15,11707110,3.5465395571368994
KO52,322968,2.621400804192603
LP-1,54618305,3.83678249468376
T84,6505803,-1.9695494266623712
NCI-H1395,5738263,4.098342920501159
SNU-119,10026128,4.4148318530797885
NCI-H2087,57330099,4.692778958535206
GA-10,49766530,-5.511762261884949
LP-1,7251185,1.0580476359027884
BT 231,6918736,-3.5534251513743245
NCI-H2087,9956119,3.4695373075601323
REC-1,42642645,2.0902609204351537
SCC-9,11955716,-2.333323067647372
PE/CA-PJ15,445643,4.027920596276799
KHM-1B,11364421,-5.203168306963344
HD-MY-Z,135421197,1.63491304477545
HuNS1,702558,5.168542971106935
RT-4,387447,-3.0484703414890744
SK-MES-1,25227462,-1.3207803346820737
NMC-G1,24180719,4.260476623253757
KHM-1B,44259,0.3168726025779862
NCI-H1395,44589607,3.310256586301432
KHM-1B,409805,3.6418621708763945
SK-MES-1,31703,-2.424862391173753
SK-LU-1,5278396,5.716381056710151
K-562,9803433,4.389269041756261
LP-1,119182,0.1396862557821738
NCI-H1395,6610216,4.652818435628847
NUGC-4,11612883,2.303916950132114
SCC-9,doxorubicin-navitoclax (2-1 mol-mol),-1.5026968555435367
HMCB,JQ-1-vorinostat (2-1 mol-mol),1.2235343393627285
MHH-ES-1,568763,0.3016942758898196
YH-13,135875424,4.585935280505426
EJM,9444,4.350025057986223
SCC-9,24772860,-2.0717241396099473
SK-MES-1,24821094,1.071514249291419
GA-10,11234052,3.273398721958912
NCI-N87,16736978,0.698711777805788
HuNS1,36462,-2.348831996229756
RT-4,23635314,-1.9773718066539765
SKM-1,24901704,2.156402770369734
EJM,123631,3.178477510788884
BICR 31,5311281,1.899563489561116
LS411N,9887053,4.348393626170801
PL-21,9907093,3.005830417877172
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215
SKM-1,10231331,-2.5704839701228117
SK-OV-3,5329102,2.1848030817162427
KHM-1B,46224516,1.9552041904833992
LP-1,56963564,0.421428699323652
HCC1833,44589607,2.9618728739957367
SK-OV-3,216345,4.761928129554225
MHH-CALL-4,9915743,0.0855702351312573
GA-10,7251185,0.2264482657231984
SK-MES-1,2874250,4.2529125521194695
SK-MES-1,49766530,1.8908947653330492
KYSE-30,54454,3.438027565382523
CFPAC-1,446155,4.034040949632405
SKM-1,10184653,1.0746342455202622
BICR 31,31703,-0.4867862372580436
KP-N-YN,24771867,4.285082318015032
MHH-ES-1,JQ-1-UNC0638 (2-1 mol-mol),0.7408680741377575
K-562,568763,0.3044566284292496
EJM,71751553,6.47545049455161
PL-21,3552672,1.8830744000385244
NCI-H929,71466380,3.795978498823376
ALL-SIL,44490293,5.541636788423512
SK-HEP-1,24797083,1.0035545042427043
OCI-M1,9911463,3.27082780782835
MHH-CALL-4,9935249,3.1368744392379555
SK-MES-1,JQ-1-carboplatin (1-1 mol-mol),2.3477622395388495
BICR 31,119607,5.814089022953436
BT 416,322968,4.6755532161606785
PL-21,6918837,-4.0654696388961895
LS411N,984333,1.2324204412799928
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952
GA-10,216345,2.561762358205053
GA-10,4096211,0.3873440100336342
BT-20,12001922,2.386959845886897
ECC10,20959075,-3.5327256518549515
MHH-ES-1,10127622,5.683725343814701
SNU-119,54454,1.8992360561821908
MHH-ES-1,124202324,1.5748338770735049
KHM-1B,16722836,0.0780331724282444
NCI-H929,57519531,1.5644006725496582
SCC-9,322968,4.6886309532040435
KHM-1B,9907093,3.851614847193926
KHM-1B,15547703,2.9789166957763045
SNU-119,11222830,0.2284603651401007
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784
NCI-H929,3062316,1.7563437367831485
EJM,11427553,2.2799246122967674
NCI-H2122,51039095,2.859114215122068
NCI-H2122,67156097,-1.4657713808786557
YH-13,5746,2.3705459380305256
KO52,168313016,6.361073320142098
HD-MY-Z,45279963,3.475870555778974
HMCB,71466380,3.936881687634452
SW1116,4705,0.6661703449380979
YD-8,5311281,1.1979218299648091
HuNS1,46224516,1.524021297779193
BT 416,3384730,0.522246032271141
SNU-119,44202524,1.6419079750813077
IST-Mes1,JQ-1-MK-0752 (1-1 mol-mol),2.655505520266403
HD-MY-Z,24775005,3.692856779723642
LP-1,selumetinib-GDC-0941 (4-1 mol-mol),0.6666027580739052
SK-MES-1,219104,4.134012585128855
L3.3,72193861,1.4096427828350668
SK-OV-3,5311,1.582209129738937
KP-N-YN,44491742,4.254136072994776
KHM-1B,89928392,-0.1592315561663482
SK-HEP-1,31703,0.3185055118054912
MHH-ES-1,9911463,3.923380979166965
LP-1,107985,-4.335772464221896
HCC1833,24785538,1.3501047699214817
SK-MES-1,135423438,2.7133393164015027
NCI-H2087,alisertib-navitoclax (2-1 mol-mol),0.0143180307456591
BICR 31,168313016,4.3680397842259095
NCI-H929,6918289,2.8956061350920796
NCI-H929,5951923,6.150668957534198
MHH-CALL-4,49836020,-0.2445846673370129
PE/CA-PJ15,53325874,4.420861887362008
GA-10,122327,3.738658782875115
SNU-119,selumetinib-UNC0638 (4-1 mol-mol),3.591039220835182
OCI-M1,24978538,1.1674887828078435
MHH-ES-1,2841722,4.606938878200454
SW1353,6610216,4.8642492591567175
RT-4,219104,3.5116723720438636
HuNS1,54626689,4.810315002739711
T84,10074640,2.326993213877941
NCI-H2171,2945648,2.4840683519833835
ECC10,51037431,1.556314413061526
SW1353,9936388,-5.283221475424073
KYSE-30,135411,0.5399611674911847
L3.3,10127622,6.808802938866309
PL-21,168312962,1.717192870329579
T84,selumetinib-vorinostat (8-1 mol-mol),0.4047942108328854
NCI-H2171,702558,3.801125308495619
BT 416,3854666,-0.8392418796175438
MHH-CALL-4,656346,1.1471887215377563
HD-MY-Z,219104,3.8611270593209968
BICR 31,262093,3.397835562493394
BT 416,tretinoin-navitoclax (4-1 mol-mol),0.5297591746376416
GP2d,25154868,2.5676356669512863
NMC-G1,44589607,4.400916629195003
HCC1833,16725315,4.645083854470245
HCC1833,44185566,2.277485776304897
HD-MY-Z,3634881,3.15805754209679
PE/CA-PJ15,5479543,3.83954766911358
YD-8,446155,1.4211540199964532
IST-Mes1,JQ-1-UNC0638 (2-1 mol-mol),0.9628638270224468
BT-20,46843906,4.2498682653830215
TCCSUP,24785538,1.2023292009410418
SK-MES-1,4705,1.78363684998227
EJM,650361,3.796410138993618
KMS-12-BM,44607530,1.8742389530579
BT-20,46191454,1.9523962309464176
YD-8,2113511,5.249485368051986
SKM-1,52912189,-0.3265905862540428
Calu-1,72376,-1.479410196134551
KMS-12-BM,9887053,-0.448618862637891
RT-4,4259181,0.4956946540898031
MHH-CALL-4,23635314,-2.292665574227079
ECC10,44137675,2.4549822664560357
GA-10,24785538,0.468704580009897
MHH-CALL-4,11396600,2.799931622192491
Calu-1,selumetinib-JQ-1 (4-1 mol-mol),6.8446491124721085
BT-20,9927531,4.105614320548644
GA-10,444795,3.886732538639244
KYSE-140,15953870,3.2653213178091725
BICR 31,5426,4.483861121335425
HD-MY-Z,5566,3.0608138230025195
RT-4,322968,4.646430873835076
NMC-G1,1750826,-5.856204132098948
MHH-ES-1,selumetinib-vorinostat (8-1 mol-mol),2.4304170716272813
EJM,16038120,0.4172376538699918
NMC-G1,11317348,4.22738873605946
ALL-SIL,9927531,4.600523700119875
HD-MY-Z,5282054,2.5149472411972904
LP-1,3503,1.1113232863093836
NCI-H929,11717001,3.5813087305608575
NCI-H1395,613753,3.1434817827730126
BT 416,10410894,2.5812856315054535
MHH-CALL-4,135440466,1.0497711456833223
EJM,71466380,4.304951400979373
KYSE-30,selumetinib-GDC-0941 (4-1 mol-mol),-0.4989491730222611
GA-10,400769,-4.449150229090682
RT-4,123631,3.0084600892391875
HMCB,3634881,3.192903309408832
BICR 31,4378219,2.049792351388142
BICR 31,3503,3.4488620791118993
KYSE-30,2729026,3.090986240428151
KHM-1B,135398738,4.5070735955788255
HD-MY-Z,5351362,1.0430182615760306
L3.3,6918328,0.6582944097969459
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592
SKM-1,11717001,-3.556230910849805
KMS-12-BM,10296883,2.976049270226853
SK-HEP-1,9840324,5.848573782723059
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095
OCI-M1,285033,-3.665388132152773
LP-1,24901704,2.612569091279868
HMCB,9936388,-4.997946026418023
NCI-H929,52912189,-1.2648597734935654
OCI-M1,5328940,1.6217025243447876
NUGC-4,carboplatin-etoposide (40-17 mol-mol),4.146527297178118
GP2d,12003241,-2.636823152177336
PE/CA-PJ15,23725625,6.336602626198082
ECC10,637858,1.1085550148233343
NCI-H1395,216239,1.7586314171989954
L3.3,25183872,0.3957917888669793
NCI-H2087,10322450,3.569680650808545
NCI-H2171,1566236,1.862945078393334
GA-10,44202524,0.934689168342098
NCI-H2087,24951314,0.9035509849412338
NCI-H1395,15547703,3.241893522159582
GP2d,252682,5.9851298560950985
BICR 31,44566777,1.4466588952743178
K-562,71466380,4.109476883218819
GP2d,6918328,-1.6113370244277687
BT 231,5470400,1.511774854898776
EJM,9936388,-8.624056137584708
L3.3,56963564,0.8777502284965835
OCI-M1,16741245,5.331104002739498
BICR 31,11955716,-3.162575487986667
Calu-1,9866186,2.9947102830528047
SNU-119,carboplatin-etoposide (40-17 mol-mol),4.59312893478617
MHH-CALL-4,9840324,6.294233040903878
RT-4,selumetinib-GDC-0941 (4-1 mol-mol),2.7541316564382856
ALL-SIL,16722836,0.4684239096852854
NCI-H929,54619267,3.6660361188352306
REC-1,3634881,1.64098323028159
BT 231,3503,0.9797586267103968
SCC-9,53232,2.1606412524830017
SCC-9,5978,-3.875351555062552
SK-MES-1,1716436,1.7524592082452732
SK-MES-1,16659841,3.691085080663924
NCI-H2171,71466445,1.378191899492029
MHH-ES-1,168312962,-0.2859723707796943
NMC-G1,42642645,1.1047489593795097
NCI-H929,5278396,3.025125883131511
ALL-SIL,67156097,-2.3407546390754037
NUGC-4,docetaxel-tanespimycin (2-1 mol-mol),-5.541448697690424
NCI-H1395,25102847,3.3934069433864953
GA-10,11427553,-0.0781212065151305
GA-10,3025986,-4.371367450732099
YD-8,3025944,4.131674769368578
Mino,8515,3.2979107224105406
BT 231,11222830,1.6058632892311393
BT 416,vorinostat-carboplatin (1-1 mol-mol),2.762420817472584
T84,11717001,2.9594901638256226
OCI-M1,3634881,3.364393443024394
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404
NCI-H929,9884685,-3.111418876103824
BT-20,89928392,3.388875506086706
NCI-H1395,9866186,2.8046320736833894
SNU-119,crizotinib-PLX-4032 (2-1 mol-mol),2.378023446596204
HD-MY-Z,3825829,3.737933206647403
HuNS1,24856436,-1.4349802519228263
LP-1,17755052,-0.3678078378430159
KYSE-140,54143018,-0.5730791495695653
MHH-CALL-4,44819697,-2.9697860709537003
NMC-G1,57519531,2.920854985510066
NCI-N87,10410894,1.83413876253328
SKM-1,5291,3.5671310197846267
BT 231,5746,3.025901776181892
BT 416,selumetinib-piperlongumine (8-1 mol-mol),2.6666337454070623
KMS-12-BM,24856436,-0.1996093117488152
SK-MES-1,salermide-PLX-4032 (12-1 mol-mol),5.300817254281253
KO52,10127622,0.9080853553527672
KYSE-140,44589607,1.602873721256903
KO52,25062766,2.019050283662434
SNU-119,638278,4.6940839403885555
NCI-H1395,2871966,-1.8514751727384056
YD-8,24901704,3.1814238875583585
PL-21,9911830,2.7327137399498302
HD-MY-Z,71576739,6.380603310515708
L3.3,135421197,2.5730452840447415
BT 231,753704,3.5842016877882945
MHH-CALL-4,24785538,1.0805835982856549
NCI-H2171,3503,1.152076889590999
NCI-H1395,selumetinib-MK-2206 (8-1 mol-mol),2.294517762393479
ECC10,6184667,0.9109455072052562
REC-1,135411,0.3102978372083019
RT-4,tanespimycin-gemcitabine (1-1 mol-mol),-3.611548867798562
SK-MES-1,selumetinib-navitoclax (8-1 mol-mol),2.357697513779426
NCI-H2122,54618164,4.161455181946263
SW1353,54613361,0.0469603694090625
SCC-9,3136844,4.895725881728452
KP-N-YN,46907787,4.256466884181242
LP-1,46174525,3.595474658225571
Hs 936.T,decitabine-navitoclax (2-1 mol-mol),5.266782414239764
EJM,46199207,3.0615007754696095
L3.3,1641662,3.117391597616944
K-562,2729026,2.90327889883348
HD-MY-Z,selumetinib-UNC0638 (4-1 mol-mol),2.3629816942253936
BT 416,selumetinib-vorinostat (8-1 mol-mol),2.2892282073971737
BICR 31,11964036,0.7129684858082154
PL-21,135398516,1.2885024658088218
PL-21,24821094,3.176448664941527
BT 231,6436223,-5.476432215723778
ECC10,3854666,0.7424887644114392
YD-8,44589607,2.9595252781326784
KYSE-140,selumetinib-navitoclax (8-1 mol-mol),2.8969546565549393
Hs 936.T,135411,1.402977023446485
HCC1833,5470400,0.4492475857546014
SCC-9,104842,-1.437225086828998
NCI-N87,navitoclax-gemcitabine (1-1 mol-mol),-3.6490042770502815
NCI-H2171,71304818,1.9125624841179896
ECC10,42642645,-0.069366061650994
LS411N,2828334,6.327786282136184
BICR 31,11167602,4.451308398956488
SKM-1,135440466,0.5492238324239911
K-562,11404337,1.5978316825317844
YH-13,23725625,5.130607279174726
T84,5311281,1.0101759845658
KP-N-YN,73707398,1.440636079440376
YH-13,72193861,0.945446843514748
PE/CA-PJ15,135875424,3.5762101924458585
MHH-CALL-4,JQ-1-UNC0638 (2-1 mol-mol),0.030742461546213
BICR 31,51037431,4.633533363663127
HD-MY-Z,5284329,1.7863131223898725
NCI-N87,navitoclax-PLX-4032 (1-1 mol-mol),1.558715689605079
SW1353,23635314,-1.5374648835365063
YH-13,72734382,5.819140658588148
MHH-CALL-4,16720766,-1.0064133343173167
PL-21,46224516,1.9222542521636092
SK-MES-1,11497983,5.281357685203491
YH-13,6505803,-0.6394660445903715
NCI-N87,16038120,-0.0105690503285029
KMS-12-BM,49766530,-2.33896572420352
T84,400769,-0.7932552759829344
KYSE-30,53325874,4.440916408166355
LP-1,46191454,-0.7719291654750454
SNU-119,16219061,3.5319077719330885
PE/CA-PJ15,24978538,3.991703826733128
IST-Mes1,4261,1.7623274186426838
GP2d,148124,-6.606459612747149
TCCSUP,6852167,2.775293027732918
SCC-9,49766530,0.4117706354329887
TCCSUP,5746,1.7637111796176403
BT 416,448949,-0.0612372208643479
SK-MES-1,100016,6.467052003541006
PE/CA-PJ15,65064,5.660757119379924
KP-N-YN,11626560,3.500620006667072
HMCB,19582717,4.963972584535481
K-562,16065773,1.923835638804153
HCC1833,vorinostat-carboplatin (1-1 mol-mol),2.8199338876528173
NCI-H2087,2949965,1.7868429025911388
YH-13,6918837,-2.973076414332095
KMS-12-BM,44589607,1.1628348529963377
EJM,24748573,1.377291094457539
HD-MY-Z,tretinoin-carboplatin (2-1 mol-mol),6.822782648726273
ECC10,JQ-1-carboplatin (1-1 mol-mol),0.0523843610498873
SCC-9,9866186,1.319539660579235
IST-Mes1,51037431,5.172794571797409
RCM-1 [Human rectal adenocarcinoma],119607,5.94570045924447
SK-OV-3,124202324,3.0713957973247186
BT 416,9549297,0.4104374226563262
REC-1,selumetinib-MK-2206 (8-1 mol-mol),4.739772098068011
NCI-H2087,322968,3.1630947034620025
NCI-H929,selumetinib-GDC-0941 (4-1 mol-mol),-0.5028542892584752
SK-HEP-1,16013152,4.2454363352103925
T84,1641662,3.03706302885615
KYSE-30,327653,3.5492828171510937
Mino,23939,5.8661621140675795
NCI-H1395,16038120,3.027555805242751
Calu-1,25105715,4.030391636665495
SK-HEP-1,439501,-2.4482777943885856
KMS-12-BM,9884685,-1.5036404450716507
NCI-H2171,24856436,-0.4096039036242957
SK-HEP-1,16725315,5.326615386804391
LP-1,tretinoin-navitoclax (4-1 mol-mol),4.406814132342561
GA-10,2842253,3.5781982485046897
KHM-1B,decitabine-navitoclax (2-1 mol-mol),0.777035437815577
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052
RT-4,docetaxel-tanespimycin (2-1 mol-mol),-2.3839682334999823
SKM-1,6918328,-1.5551778635865745
KP-N-YN,25102847,3.8492537923123313
KYSE-30,25062766,1.8679497478709757
NMC-G1,44607531,2.5080941589447674
SK-MES-1,156414,0.4265793069571684
YD-8,56946209,-4.261193272731818
SK-OV-3,24964624,2.562140083880341
REC-1,crizotinib-PLX-4032 (2-1 mol-mol),3.524411495353615
HD-MY-Z,24901704,3.9172679812065208
NUGC-4,2742550,4.776949321673274
RCM-1 [Human rectal adenocarcinoma],54454,4.0573540170920355
HuNS1,10385095,0.4099305568454984
KMS-12-BM,decitabine-navitoclax (2-1 mol-mol),-4.759135600180924
SKM-1,44543605,3.543477995326012
BT 231,6438330,0.5385307594180988
EJM,52912189,-1.0770989556153556
HCC1833,135984461,4.342714287426043
LP-1,25126798,4.0066590852410835
REC-1,445455,4.440589550189474
ALL-SIL,49793307,-3.5976005593324607
HD-MY-Z,262093,3.0364164526237807
BT-20,23725625,5.291362835527745
RT-4,135999136,6.151607962032574
GP2d,72376,-2.745932873015718
LP-1,24856436,-0.3432782320306308
T84,151289,1.2633487720507646
BT-20,11178236,-5.892925817280717
TCCSUP,2708,4.555473359535819
GA-10,10427712,2.55886393175063
PE/CA-PJ15,49867926,3.939583945337153
MHH-ES-1,24951314,-0.0639633899818705
GA-10,9887053,-0.6474807816546203
SK-LU-1,426756,4.3629956416196825
LS411N,4917,3.429074291339912
MHH-CALL-4,11485656,2.372182753461333
GA-10,56946209,-6.348710606640538
PL-21,119182,-4.99853521902161
NCI-H2171,11494412,-0.1110474347644453
KO52,9926054,1.7676529122170044
SKM-1,16722836,0.5905694358336332
SW1116,6623618,1.8559748528141653
RCM-1 [Human rectal adenocarcinoma],45279963,4.209581344916876
YH-13,135421197,2.4430977346174165
BT 231,3062316,2.541779191079674
LP-1,9933475,2.001150068800928
SK-HEP-1,51039095,3.60670356936783
Calu-1,navitoclax-piperlongumine (1-1 mol-mol),1.5494737959798537
MHH-CALL-4,44607530,1.9421755305344228
RT-4,3025986,-0.629141422701896
BT 416,135999136,1.7385922508955245
HD-MY-Z,3062316,2.195955511453349
PL-21,16725315,3.1959872414680444
BT-20,5329102,3.689962874846776
GA-10,53481919,2.979442116605351
NCI-H2171,navitoclax-PLX-4032 (1-1 mol-mol),-0.7537972454626107
KMS-12-BM,6918328,-3.473135115653443
KYSE-140,122327,5.483557489127441
PE/CA-PJ15,1641662,3.2691272545520884
GP2d,66577038,3.6312637060087383
NCI-H2122,1716436,3.623036492667551
EJM,439501,-2.5591027297640565
BT-20,637858,1.5317212374288376
OCI-M1,15547703,3.141872596751403
ECC10,2945648,2.9315890552130224
HCC1833,11626560,1.659289303724281
CFPAC-1,76446078,4.3199096836628685
K-562,12003241,-5.632155645383806
Mino,6918878,-0.6688566059846761
GA-10,11175137,0.9542499893353898
SNU-119,104842,-1.1389094996160742
SK-MES-1,46215462,0.9945925799964696
KMS-12-BM,55508,1.5916377605400036
Hs 936.T,24951314,1.112983132525777
Mino,46943432,-0.4971400671027619
KYSE-140,navitoclax-pluripotin (1-1 mol-mol),-0.6467454789733307
MHH-CALL-4,vorinostat-carboplatin (1-1 mol-mol),1.8150714015130471
RCM-1 [Human rectal adenocarcinoma],2945648,2.1413236480438544
RT-4,3062316,1.5013745922534365
T84,5291,3.333682299790063
KHM-1B,9826308,0.2290503887290589
ALL-SIL,2949965,1.286096946783907
HuNS1,31703,-4.278807679590824
BICR 31,5311,2.2783252682939876
HD-MY-Z,11167602,1.6882998388727035
TCCSUP,2828334,6.2469193029566235
NUGC-4,67156097,-1.3817046690320285
PL-21,568763,-0.6529819882505294
SW1116,selumetinib-piperlongumine (8-1 mol-mol),0.4966657503942199
HMCB,23635314,-3.4339046991489743
MHH-CALL-4,46843906,1.1508066983335754
LS411N,71304818,3.0616651991102697
MHH-ES-1,3384730,-0.6207746450397544
KHM-1B,446155,3.672634684818232
HMCB,387447,-4.760692258076148
SCC-9,107970,3.0149180037966095
NCI-H2122,24901704,6.1617315531670185
NCI-H929,10184653,1.0865277300085363
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888
HD-MY-Z,15983966,-1.5257212979744452
TCCSUP,135999136,4.392620213932673
K-562,9866186,0.7861847855254385
NCI-H2087,441298,0.9473172276565824
IST-Mes1,6917907,-4.257425330675956
YD-8,selumetinib-decitabine (4-1 mol-mol),5.345294149747968
NCI-H1395,25062766,3.463916813883382
YH-13,sirolimus-bortezomib (250-1 mol-mol),0.2727627020521754
HD-MY-Z,5702613,3.0168280751925804
YD-8,56649450,2.606046956482712
SKM-1,71680916,4.070179784204398
BT-20,119607,5.085610841266581
HMCB,11717001,6.037652275918416
EJM,135999136,1.6782155584907743
SCC-9,135411,1.0456929507985402
OCI-M1,1566236,1.1491839821612235
Mino,5287969,-2.5376508899436647
SNU-119,46224516,3.0258187740166083
RCM-1 [Human rectal adenocarcinoma],107970,2.147130016699997
NCI-H2122,2749,2.0261857420592784
EJM,54618164,3.6862835131456455
T84,2746,3.6506002682923926
NCI-H2122,36314,2.365041235123564
LP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.125273728110295
SK-MES-1,9911830,2.0090126357404334
YD-8,9936388,2.2646667902608724
NCI-N87,8515,4.286102801865053
NCI-H2087,7326481,2.511403885241106
GP2d,23582824,-1.4180257942971464
TCCSUP,82146,3.724750281671297
KMS-12-BM,2828334,4.379653513423718
PE/CA-PJ15,16219061,3.234867207662873
IST-Mes1,119182,0.8525106306178227
NCI-H2122,9929138,6.815327786842329
BICR 31,71466578,6.11729815776394
RT-4,46199207,3.146589071997412
HMCB,2113511,5.752921913122264
SW1116,3025944,3.934159905684231
BT-20,4788,5.141361715745134
SK-HEP-1,11404337,1.0852289139958715
SK-LU-1,6918837,-0.3011037043403155
NCI-N87,navitoclax-birinapant (1-1 mol-mol),2.0087616801931953
PE/CA-PJ15,15983966,-4.408426759241299
BT-20,11612883,3.4119376143601463
GA-10,613000,1.5926197662334218
NCI-H2171,JQ-1-carboplatin (1-1 mol-mol),1.7298129528217236
KYSE-140,72193861,1.2603624614836186
PE/CA-PJ15,613753,3.2873816903354083
Mino,135984461,1.4657661855370687
KYSE-30,ISOX-bortezomib (250-1 mol-mol),0.5080153743805289
OCI-M1,5738263,3.711899559349346
PE/CA-PJ15,208908,0.9831396466916148
HD-MY-Z,676352,1.6174495741463533
NCI-H2087,16720766,0.631241892066406
NCI-H2087,44487872,5.468068577588152
Mino,445643,3.4726395175320612
KHM-1B,54618164,3.3281109403552795
NCI-H1395,11427553,4.002864688694153
YH-13,241158,3.687700430080618
BT-20,5394,4.295975156717868
IST-Mes1,135411,1.0362911335756892
KP-N-YN,54618771,4.352699986589353
SKM-1,carboplatin-etoposide (40-17 mol-mol),-0.1005652278487919
KHM-1B,54686904,3.578603716754377
KO52,119182,-4.453173140639883
SK-OV-3,17755052,2.097752569372091
TCCSUP,3634881,3.232096710476599
SK-MES-1,9823820,4.608258378545017
NCI-N87,44137675,2.149558923433186
RCM-1 [Human rectal adenocarcinoma],2828334,6.287208595728056
HMCB,56963564,0.3861475037431977
HD-MY-Z,285033,-2.8250683700564374
NCI-H929,3825829,4.289333234926349
BT-20,135440466,3.0186786814270388
NCI-H2087,49846579,1.7501102551033103
MHH-ES-1,5470400,-3.5366477270176944
YD-8,17755052,1.5678870901115745
NUGC-4,100016,6.130178573368833
YH-13,568763,0.2718115041974417
OCI-M1,carboplatin-etoposide (40-17 mol-mol),1.225876763043248
Mino,444795,1.9878842537418735
IST-Mes1,216239,2.2087908746431517
GA-10,25126798,2.094998104378153
KP-N-YN,25154868,4.788621990913417
RCM-1 [Human rectal adenocarcinoma],52912189,1.6859492587685891
SW1353,4259181,0.2746350901066433
NMC-G1,10090485,5.548404510288884
TCCSUP,42642645,1.035198778312657
OCI-M1,10074640,3.7308591023202218
SNU-119,44607531,1.0035867478806315
SK-MES-1,148198,-4.042000221520934
HCC1833,89928392,1.098931509447168
BT 416,15547703,2.7550703641707934
SCC-9,11609586,3.4579622750703902
PE/CA-PJ15,11364421,-5.742721831490082
SK-MES-1,168313016,3.674631178203009
GP2d,5281321,-4.7592076844232984
PE/CA-PJ15,57330099,4.4384780408522815
ALL-SIL,16725315,3.2612856597636064
SK-MES-1,54619267,3.759844760251414
ECC10,568763,0.630027878086737
HMCB,46215462,2.3614914052536062
NCI-H2087,44589607,2.3117233085993742
PANC-1,72193861,1.9586688781502752
KYSE-30,crizotinib-PLX-4032 (2-1 mol-mol),2.5966134284670614
HD-MY-Z,119182,-0.8346437702336673
HD-MY-Z,3689413,-2.31640912661536
PE/CA-PJ15,57519531,3.7236545137960073
SCLC-21H,25227462,-0.2448487152738173
BT-20,10385095,0.9284855433615824
NCI-H929,2858523,2.982891394222708
MHH-ES-1,tanespimycin-bortezomib (250-1 mol-mol),-0.6292839894036704
RT-4,11609586,3.0565970282052475
MHH-CALL-4,1750826,-2.5253622683526076
KHM-1B,448949,2.2712398362063575
NUGC-4,25062766,3.0378381458591397
RCM-1 [Human rectal adenocarcinoma],24771867,4.508296832673209
OCI-M1,24856436,-0.9873271152340236
RT-4,65628,4.4679434201664945
LP-1,23635314,-3.87402898320376
MHH-ES-1,doxorubicin-navitoclax (2-1 mol-mol),-2.660881377247826
IST-Mes1,12001922,2.6228240364869113
SK-LU-1,60700,-0.6890248809230339
KO52,25161177,1.7926893873102905
SCC-9,24821094,2.906183993814488
Mino,11178236,-4.576642678682091
NCI-H929,969516,1.5005590932517423
ALL-SIL,72376,-2.2514410459425043
NCI-H2122,25150857,3.2045438398387023
TCCSUP,16219061,3.6706292867258945
REC-1,46199207,3.314311267175405
LP-1,46943432,-0.1218139199537091
KYSE-30,10385095,1.4963223193065267
CFPAC-1,16736978,2.15871900403134
YD-8,36462,2.7241354710815
Mino,25150857,1.4207276079060136
SK-MES-1,25102847,1.828930312710661
RCM-1 [Human rectal adenocarcinoma],227681,1.7640901700531322
Calu-1,2949965,3.24951222865022
NUGC-4,JQ-1-UNC0638 (2-1 mol-mol),-0.7976422990378336
KO52,25227462,1.3400451170529613
T84,46191454,2.3144303863481404
YD-8,6184667,3.1421858236064235
SK-OV-3,176870,3.5610869734905255
REC-1,JQ-1-MK-0752 (1-1 mol-mol),3.97873368586236
YH-13,46907787,2.497821160225489
HMCB,11404337,-1.2429546984634874
NCI-H2087,24180719,3.2246777209202553
NCI-H2171,984333,-0.9596445260901963
RT-4,JQ-1-vorinostat (2-1 mol-mol),2.118819013371158
SNU-119,24964624,2.885020861025008
HMCB,54678924,1.6823171066105604
GP2d,11364421,-5.641043573399117
YH-13,selumetinib-tretinoin (2-1 mol-mol),4.993849877011519
YD-8,selumetinib-PLX-4032 (8-1 mol-mol),2.7404084947043077
NCI-H1395,25195348,3.618629950214112
KMS-12-BM,285033,-4.098643381088682
NCI-H1395,637858,2.3715473340173774
ALL-SIL,9826308,-0.8056632694679019
CFPAC-1,6610355,5.947919278921459
GP2d,448949,1.6859327447820691
Calu-1,6918638,2.4930739459862936
Hs 936.T,49793307,-1.6382410213541378
IST-Mes1,46907787,2.643041583848796
ECC10,JQ-1-navitoclax (2-1 mol-mol),-2.54657136416281
OCI-M1,SNX-2112-bortezomib (250-1 mol-mol),-2.4702084132619464
ALL-SIL,9911830,-2.857836139869332
NCI-N87,44202524,1.5092428544055756
SKM-1,2945648,2.351982295686625
SCC-9,44185566,3.0958673753547785
TCCSUP,156422,3.9310929272005466
GP2d,71466445,4.352014639159245
MHH-CALL-4,46174525,2.7750542873724875
NCI-H2122,9825149,2.3981789100700466
NCI-H2122,docetaxel-tanespimycin (2-1 mol-mol),0.3420358530593154
BT 416,100016,4.165407662771479
REC-1,445091,3.552814815749705
CFPAC-1,71304818,2.836133226037853
NCI-H1395,285033,-0.7222597352874329
SK-LU-1,navitoclax-gemcitabine (1-1 mol-mol),-3.9420416668018823
REC-1,selumetinib-vorinostat (8-1 mol-mol),5.79386517083513
LP-1,6918837,-5.626038365028848
IST-Mes1,25227462,1.492895446731939
ALL-SIL,11964036,0.9057184864624424
BT 416,navitoclax-piperlongumine (1-1 mol-mol),-0.9261149548732752
NCI-H1395,4261,3.7287687859459377
LS411N,25154868,4.929077040033465
KYSE-140,71304818,2.425637291715007
OCI-M1,navitoclax-pluripotin (1-1 mol-mol),0.0992502230439679
CFPAC-1,252682,6.539945765477037
MHH-CALL-4,6918837,-5.69719504435029
Mino,11364421,-5.761283261417625
RT-4,3543504,4.339418344926718
SK-OV-3,36462,2.5052417836250496
MHH-CALL-4,5351362,0.8634946226880985
IST-Mes1,carboplatin-UNC0638 (2-1 mol-mol),3.3529895985097675
SK-OV-3,11427553,3.3243369937323877
KYSE-30,89928392,2.5029448655473474
NCI-H1395,11640390,4.861591383833504
SK-MES-1,89183176,4.516172533147641
PL-21,44819697,-0.211205585896067
YD-8,285033,-1.8984148294735084
KP-N-YN,168313200,3.2829506752497415
L3.3,5460769,1.7814582708772182
K-562,5351362,1.2059406782397044
SK-LU-1,3081361,2.0812071927714224
GA-10,56649450,0.9895095416625234
NCI-H2087,4521392,3.983202939961211
GA-10,25161177,3.317822863859713
OCI-M1,6505803,0.7665872263269772
SCLC-21H,67156097,-0.2611056182258284
BT 416,3025944,4.5673329859622545
LP-1,11612883,2.31078108862899
K-562,9927531,3.3022164605184763
Calu-1,4378219,2.1615496659266396
NMC-G1,crizotinib-PLX-4032 (2-1 mol-mol),1.382772696223706
TCCSUP,6914657,-4.082102009024434
NMC-G1,11152667,1.2131729378595566
BT 231,9952709,2.221808237226659
NCI-H2087,24180125,3.4986995074600356
SCC-9,11427553,3.060791645335887
NCI-H2087,136227924,2.807670387816286
OCI-M1,navitoclax-piperlongumine (1-1 mol-mol),0.9088919910628585
NUGC-4,5329102,2.374457911061478
SNU-119,219104,2.9063855496873416
KP-N-YN,1750826,-2.9913994592309865
EJM,445643,4.021541307883637
KMS-12-BM,44491742,3.489197811217823
KHM-1B,5281672,4.060074282228128
PE/CA-PJ15,135999136,4.2175976064097265
GP2d,11427553,1.208249012770262
RCM-1 [Human rectal adenocarcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),4.856399530140112
BT 416,168313200,1.511876706612717
RT-4,24951314,2.159360193185554
HD-MY-Z,135875424,4.008559842592383
IST-Mes1,9866186,0.9671533169607398
SNU-119,1750826,-5.069173879827324
GA-10,11719255,0.8933587204659038
REC-1,24180719,5.326289522106428
TCCSUP,11175137,3.3484208163516587
RCM-1 [Human rectal adenocarcinoma],JQ-1-vorinostat (2-1 mol-mol),0.912398125341492
NCI-H2087,168313047,1.682028745912712
SCC-9,5460769,4.655053652221148
BT-20,11222830,1.6348917255089364
HD-MY-Z,44607531,1.583966876784299
PE/CA-PJ15,10427712,4.366561552625221
IST-Mes1,49867926,4.44564652397053
IST-Mes1,3062316,-4.79181247277669
BT-20,156414,1.6027842834064494
PL-21,10385095,1.1291915165256132
KHM-1B,5351362,0.671182618644872
NCI-N87,148198,-3.7864178683693774
MHH-ES-1,2828334,5.833724394341639
SW1353,3815108,2.6898468007627714
SK-HEP-1,5566,3.210365271342881
BICR 31,11213558,1.307666782243681
BT 416,3552672,1.9962381779699805
SW1116,56946209,-4.718429275744117
HD-MY-Z,5113032,4.988271552898249
PL-21,44185566,1.2858787660588562
T84,24856436,-0.5340561811270637
NCI-H929,135999136,4.255812797167961
OCI-M1,5351362,1.123653484933997
BT 231,148124,-6.361454610291721
LP-1,4788,3.4410201739225057
L3.3,126941,-2.2408794553514735
SNU-119,44185566,1.946638032582097
GP2d,3062316,-2.4101668989053175
NCI-H2087,54618305,4.263137730985128
KMS-12-BM,445643,2.943383383902934
NUGC-4,3503,2.2389970655278337
SKM-1,6917907,-8.026488311304904
SCC-9,25154868,5.2906536290113975
T84,2742550,3.5016652738458456
GP2d,375860,-0.4187362187145614
REC-1,123631,3.5036781589715296
HD-MY-Z,5284616,2.981238788670534
Hs 936.T,9825149,2.3392575702195013
NCI-H2122,44607530,2.975774009792971
EJM,216345,3.6507207430679616
MHH-ES-1,44607531,1.3476786039515165
PL-21,2708,4.165678032261031
KMS-12-BM,42642645,-0.399689528391991
HD-MY-Z,26596,0.1075810605234112
MHH-ES-1,5287620,-2.139170409844356
NCI-H2087,24748573,1.2384853879814886
KHM-1B,2130404,2.712460002003977
HuNS1,9933475,1.551879327280454
NCI-N87,44486093,4.414725106733636
NCI-H2171,400769,-1.2297634018381476
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977
KMS-12-BM,5280436,2.8744585986860236
SKM-1,3854666,-0.271294085602593
REC-1,2708,6.648601387442783
HCC1833,9935249,3.7916141061990305
SW1353,12003241,-1.0641088251163675
NCI-H1395,89928392,1.518159514357362
EJM,11497983,5.0496561241094895
OCI-M1,54626689,4.522261035968461
T84,1750826,-2.4536520047157384
KMS-12-BM,4705,2.431122737655679
OCI-M1,11234052,4.238298626310231
Hs 936.T,1750826,0.9469357663479944
Hs 936.T,44137675,5.160581447890313
NCI-H2087,984333,0.5802050625689186
KYSE-140,675434,4.138735839126751
NCI-H2087,72193861,1.3860295052912548
CFPAC-1,navitoclax-birinapant (1-1 mol-mol),3.871897548622426
HuNS1,selumetinib-MK-2206 (8-1 mol-mol),2.914253649220685
SCLC-21H,25262965,0.6319161488662877
L3.3,11497983,4.314112910656769
SKM-1,9444,4.064416967836726
SNU-119,46191454,1.5208499646959712
YH-13,151289,0.8746416780528874
ECC10,19582717,2.114216095306597
KP-N-YN,JQ-1-navitoclax (2-1 mol-mol),1.2178523556386232
KO52,selumetinib-PLX-4032 (8-1 mol-mol),-1.2002620728634303
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022
NCI-H2171,119182,5.854927706564024
ECC10,16725315,3.2954911616997946
OCI-M1,UNC0638-navitoclax (1-1 mol-mol),1.3490882330999483
T84,23725625,5.570127029311934
IST-Mes1,3503,2.9550990055374413
SKM-1,148198,-3.315233928127138
GP2d,65064,5.328408003342937
PE/CA-PJ15,tretinoin-navitoclax (4-1 mol-mol),4.408695223285738
KMS-12-BM,2733487,6.235161466652842
EJM,44543605,3.7217729651907825
GA-10,49793307,-4.909648889139862
GA-10,42611257,2.225488701803114
HMCB,241158,3.538321708116031
ALL-SIL,54618305,4.365324809283883
SW1353,BRD-K03911514,2.3757156311941348
NCI-H1395,24901704,3.973165668688871
BT 231,322968,2.4744910053308096
L3.3,176870,2.4076894274707947
K-562,54619267,3.679496217482672
HMCB,11427553,2.900768435371354
SK-HEP-1,54596558,4.485352352092043
NCI-H929,9866186,0.2477340085292711
Hs 936.T,11485656,2.4154558200874803
T84,24771867,-3.1514285711428487
BT 416,9926054,1.8827513028201357
EJM,10302451,3.688285722224437
RCM-1 [Human rectal adenocarcinoma],9926054,2.0094388483046757
Mino,25062766,0.2957039446768776
SW1116,sirolimus-bortezomib (250-1 mol-mol),0.982406512308436
SW1353,20959075,-2.953470460099728
HCC1833,107970,2.3243441845600517
HuNS1,5281321,-2.0497817628559374
SNU-119,2841722,2.795149248179567
ALL-SIL,10302451,-1.1728976190372558
GP2d,navitoclax-piperlongumine (1-1 mol-mol),-3.632657997147868
HCC1833,selumetinib-BRD-A02303741 (4-1 mol-mol),6.847446627412621
PE/CA-PJ15,5281672,6.160455651983477
SNU-119,selumetinib-JQ-1 (4-1 mol-mol),2.003564395289463
PL-21,vorinostat-carboplatin (1-1 mol-mol),2.2966363163848413
NUGC-4,11485656,2.4536140227741776
HMCB,246676,5.779204987667754
KYSE-140,24964624,2.6138091786309117
RT-4,135984461,3.767018649492271
EJM,23635314,-4.518162794650304
NCI-H929,135440466,-1.839012232533784
TCCSUP,23725625,5.945522035236543
SK-MES-1,2729026,1.974378492879576
K-562,25161177,2.405708421255354
L3.3,51037431,2.2305263064792396
HMCB,24964624,3.0929732847658613
NUGC-4,11609586,1.2918797525756485
HuNS1,44589607,1.238552608095058
BT 231,11977753,-1.6609283077108818
RT-4,31703,-0.972901161484085
HCC1833,6918878,2.6315946463231277
KYSE-140,5282054,3.127753095728618
BT-20,11707110,3.945859365415114
SK-LU-1,126941,-2.136254917360733
MHH-CALL-4,11497983,-3.9590441728113297
NCI-H2087,400769,-2.4829693906683605
MHH-CALL-4,135999136,4.260034737485126
NCI-H929,104842,-3.822816655471148
SW1116,5470400,-2.8803761043427656
SW1353,119607,5.899055541342629
K-562,11234052,2.2960989815513013
NMC-G1,5329102,1.7222942214726968
SKM-1,16038120,-0.2538482343739291
HCC1833,89183176,5.4452055552766545
NCI-H2087,selumetinib-UNC0638 (4-1 mol-mol),-2.4172736874156455
KO52,selumetinib-GDC-0941 (4-1 mol-mol),-0.8937445174658034
RCM-1 [Human rectal adenocarcinoma],54618305,4.342158128597338
BT 231,135440466,2.185903365184472
MHH-ES-1,piperlongumine-MST-312 (1-1 mol-mol),1.8697496829744815
BT 416,JQ-1-navitoclax (2-1 mol-mol),-2.5388911118482933
NCI-H2171,135421197,2.0026019926205185
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553
BICR 31,24901704,3.914024172074534
L3.3,67156097,-1.9530361511710264
MHH-CALL-4,44632017,1.2490679680930217
HD-MY-Z,9823820,4.151323824004303
PANC-1,241158,4.756219321498369
SNU-119,54649381,3.4431248050255636
HMCB,123631,3.130302719689839
SKM-1,676352,2.3445946302797984
SK-MES-1,71304818,2.2853348998335092
NCI-H2087,5281672,3.97758974129148
GA-10,3025944,3.423327414050511
GA-10,2126,3.0884056808081555
Mino,10410894,1.3441982081715471
KYSE-30,44566777,0.9605065806339524
KO52,135875424,3.01966044425059
SKM-1,151289,-0.219296204228563
SK-LU-1,387447,-2.872984091497821
T84,11178236,-2.337743106761184
EJM,322968,2.5237519299290687
KMS-12-BM,107970,1.2280769647153718
BT-20,613000,3.359905085481973
KHM-1B,6438330,0.7214920302496746
SKM-1,2746,1.6032420730880204
YD-8,16065773,3.197824930494566
KYSE-140,2945648,3.1209992671460767
SW1116,11404337,-1.048062477762995
HuNS1,5278396,3.3980623327606683
KO52,15953870,3.5562610214324653
SW1353,168313047,2.341625514967763
PL-21,2729026,1.8760846479647657
RCM-1 [Human rectal adenocarcinoma],104842,-3.5875650629821942
L3.3,11964036,1.0452508880612652
ECC10,5566,2.732539744204358
GA-10,135875424,2.5269087035880844
YH-13,vorinostat-navitoclax (4-1 mol-mol),1.848157138564096
KO52,9927531,4.721929704585103
K-562,11964036,1.6077176524784418
L3.3,26596,-0.871586326159775
Hs 936.T,SNX-2112-bortezomib (250-1 mol-mol),1.8257530470777708
KP-N-YN,11640390,3.6159868983165624
SW1353,168313016,6.218366310793427
Mino,5281321,0.7265625378388493
Mino,56946209,-6.321322671061657
OCI-M1,25195348,3.658032733941317
SKM-1,216468,0.4318372825903644
MHH-CALL-4,23582824,0.78167067480379
SW1353,637858,2.400898572711613
SCC-9,selumetinib-tretinoin (2-1 mol-mol),3.7791942672746974
NCI-H1395,11396600,4.124168749082167
NCI-H929,44486219,3.7960191523770135
GP2d,9933475,1.5702761107895076
KHM-1B,49766530,-2.233986045015649
TCCSUP,135411,0.4235399042489139
MHH-ES-1,15547703,2.497308608247884
HD-MY-Z,4578,4.1957339154132205
KMS-12-BM,9956119,2.7211618813495257
NUGC-4,2858523,2.3168357114485474
YD-8,241158,4.108189803137544
ECC10,SNX-2112-bortezomib (250-1 mol-mol),-0.1825961970556119
SKM-1,656346,0.2148623299853773
NCI-H2087,24901704,2.607985477522521
ECC10,4521392,4.289230907560516
KYSE-30,selumetinib-PLX-4032 (8-1 mol-mol),5.170866903797644
NCI-N87,selumetinib-GDC-0941 (4-1 mol-mol),-0.1269197084307303
Mino,1641662,2.553654686023489
NMC-G1,26596,5.43387943202461
REC-1,6184667,4.234456857670769
GA-10,decitabine-navitoclax (2-1 mol-mol),-4.619225210661929
KYSE-30,11427553,3.4979403664400115
TCCSUP,vorinostat-carboplatin (1-1 mol-mol),2.1894231074754185
LS411N,25126798,4.124739072985443
SK-OV-3,9956119,5.08600620496794
LS411N,969516,3.2917111714105647
NCI-H2171,carboplatin-UNC0638 (2-1 mol-mol),3.641096967492651
LS411N,9915743,2.8294092926119028
SW1353,24180125,2.9527880744197708
KHM-1B,2733526,2.638104564736822
HD-MY-Z,8515,3.657206097253692
BT-20,374536,-1.1960194426953608
PE/CA-PJ15,11955716,-2.713956440083192
HCC1833,135440466,1.9717575622635708
NCI-H929,SNX-2112-bortezomib (250-1 mol-mol),-3.169119515826122
NUGC-4,4788,5.992912489435113
KMS-12-BM,10231331,5.965261420703939
MHH-CALL-4,10113978,3.539458038955694
BICR 31,8515,4.104799625743522
Mino,tretinoin-navitoclax (4-1 mol-mol),-3.6288399741987374
KP-N-YN,2874250,5.690222132807717
KO52,25262965,-1.468267644417411
BT 416,3825829,4.074757546233149
NCI-H2087,72199292,3.781024975346955
SNU-119,4788,5.600954059003079
BT 416,6436223,-5.664260928921251
BT-20,156422,4.489690872692788
SK-LU-1,5311281,4.099328597066096
Hs 936.T,637858,2.404158263720436
REC-1,89183176,6.320609171745764
BT-20,42611257,3.2120508477296132
NCI-N87,676352,1.7095816234371617
SNU-119,25183872,-0.5002243893820045
NUGC-4,5281321,-1.9520497533974273
REC-1,5280436,6.299859839186282
KYSE-30,1716436,3.547929455379654
KO52,1242560,3.1925977163120267
NMC-G1,9936388,2.483063894359811
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012
RT-4,9911830,1.893497559140728
NCI-H929,46907787,-2.2229329095691495
YH-13,44241473,5.475816552188209
SK-OV-3,54618164,4.236989567252486
BT 231,24951314,0.1132807035510326
BT 416,421610,2.593513880397723
KHM-1B,71304818,1.1498757447247578
HD-MY-Z,462382,0.0349469416305801
Mino,374536,1.2898948128821337
NUGC-4,3689413,0.1501840734639977
KMS-12-BM,327653,2.270237785805321
PL-21,3815108,3.3544867308557973
NCI-H2087,168312962,3.354622103471914
KHM-1B,439501,-2.4289183886287535
BT 416,36462,1.1914496621950696
KYSE-140,46191454,1.7613995130875306
IST-Mes1,decitabine-navitoclax (2-1 mol-mol),4.382542969117623
PE/CA-PJ15,11485656,1.9220584297940355
SCC-9,5329102,2.2394800798474677
KO52,168313200,1.5421636413024
MHH-ES-1,400769,-1.0600670415445956
RCM-1 [Human rectal adenocarcinoma],24964624,3.1300744088166312
EJM,navitoclax-pluripotin (1-1 mol-mol),0.1382872848010396
K-562,24772860,-2.920105669473321
TCCSUP,2945648,3.149020866253819
YH-13,10410894,5.153853208310613
OCI-M1,10127622,4.826612611852515
BT 416,441298,2.7344787362492147
KYSE-140,16722836,1.553863117641073
ALL-SIL,5351362,0.9273092220520184
BT 231,9825149,1.737111458062006
HMCB,10427712,4.183996317253481
BT 416,168312962,2.0962029303712924
K-562,46907787,1.0881737362577
SKM-1,5282054,2.595149696397153
EJM,2858523,3.0050440424582554
OCI-M1,11178236,-2.2141288414633187
BT 416,3062316,-3.3080158576448864
KYSE-140,176870,-0.1940081997587029
ECC10,46191454,0.4434687845056448
NCI-H929,52947716,-4.644393709847638
GA-10,44489675,3.4950840085979142
BT-20,15547703,4.841812947906481
TCCSUP,17759555,3.887278594694756
KP-N-YN,19582717,5.677891572751624
SK-OV-3,3689413,0.6002437290843657
PE/CA-PJ15,44566777,-0.036067971292337
RT-4,selumetinib-vorinostat (8-1 mol-mol),2.4962461169474084
NCI-H1395,52912189,3.2257776206607205
BT 416,11955716,-1.7820386123300953
REC-1,219104,3.576061161986938
YD-8,54619267,4.1728433428246365
PE/CA-PJ15,54618771,-1.2856394778285385
LS411N,262093,3.2594677855419456
YD-8,216345,4.535987762651242
IST-Mes1,51039095,1.641675506171098
YD-8,44819697,-2.7739089583765684
TCCSUP,16736978,1.6866417014298338
BT 416,71466578,4.168431688364057
ECC10,JQ-1-vorinostat (2-1 mol-mol),-0.6964208453069293
SW1353,11152667,0.6062945809493967
RCM-1 [Human rectal adenocarcinoma],135875424,4.234717543087367
PL-21,439501,-2.414753232425099
NUGC-4,168312962,1.1823200954562194
OCI-M1,JQ-1-vorinostat (2-1 mol-mol),0.233888680996392
TCCSUP,168313016,5.913828803978875
HD-MY-Z,644241,1.5083011664495825
LP-1,tanespimycin-gemcitabine (1-1 mol-mol),0.155614547038447
KMS-12-BM,5335621,3.708216955119463
NCI-H929,1242560,2.1865471387936513
KMS-12-BM,89928392,-0.4987831925576881
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139
SW1353,11175137,0.8859911435903006
GA-10,19582717,1.868495224596564
YH-13,46199207,3.8574280996782337
Hs 936.T,11609586,2.8425177628844662
KYSE-30,tretinoin-carboplatin (2-1 mol-mol),4.889482322281075
MHH-ES-1,676352,1.714920712350109
YH-13,71304818,3.292650030763082
Calu-1,1750826,-4.136758079328303
IST-Mes1,6852167,3.791716512628995
NCI-H1395,54618164,4.0783729987601225
KHM-1B,71466380,4.706065807266485
TCCSUP,9911463,4.056352676279941
NCI-N87,46199207,2.9512504868324565
REC-1,31703,-0.2190696100824472
RCM-1 [Human rectal adenocarcinoma],4261,0.3806474761357037
HCC1833,2945648,2.7937654052206033
HCC1833,selumetinib-MK-2206 (8-1 mol-mol),1.5500230748299342
PE/CA-PJ15,71680916,4.353383537079945
L3.3,23725625,5.56548732943537
GA-10,tretinoin-navitoclax (4-1 mol-mol),2.853669100000912
KYSE-30,navitoclax-MST-312 (1-1 mol-mol),1.2710148870500753
EJM,3825829,3.923583211439946
MHH-ES-1,452548,-2.0664457284822997
MHH-ES-1,25150857,2.105881860487344
NCI-H2122,11612883,2.4264364608693674
NCI-H2087,tretinoin-navitoclax (4-1 mol-mol),0.6358587348730419
BT 231,2126,3.800576280626504
KO52,tretinoin-navitoclax (4-1 mol-mol),-2.9404392116104767
KYSE-30,5494449,3.110329138286974
NUGC-4,5460769,4.378159421113783
K-562,25195348,2.6278567451650394
NUGC-4,2126,6.715871302797295
PE/CA-PJ15,3025944,4.079329167671241
NCI-H2171,10074640,2.5219754676966435
GP2d,54613361,-2.703454115126651
HuNS1,5328940,1.3926240440515034
SNU-119,25105715,3.2927005530338933
HMCB,5351362,3.123131663123805
KYSE-30,3136844,4.38425468524212
RCM-1 [Human rectal adenocarcinoma],216468,3.6601371592015273
KHM-1B,322968,1.990474592363433
YD-8,4259181,0.3383272267042485
SK-OV-3,44507138,1.930427516054787
HuNS1,10410894,1.9215764984758592
RCM-1 [Human rectal adenocarcinoma],selumetinib-GDC-0941 (4-1 mol-mol),1.7782951057156742
KP-N-YN,UNC0638-navitoclax (1-1 mol-mol),0.0470016406930417
MHH-CALL-4,3385,3.1852476611202043
NCI-H2122,6505803,-2.4477843500675207
ECC10,11238147,-0.0786526525624239
KYSE-140,JQ-1-vorinostat (2-1 mol-mol),1.5817870869761113
YH-13,16720766,0.962389750080769
ALL-SIL,19582717,3.9660864037028793
T84,12003241,-0.2889439900128532
GA-10,16219061,1.125006839578196
MHH-CALL-4,168312962,-0.531776818694699
T84,46224516,2.3504475673282244
BICR 31,49836020,4.313223650735915
MHH-CALL-4,637858,0.6402103133022878
HMCB,11175137,3.661072098195176
SCC-9,24785538,2.4612574042553432
GA-10,60750,-9.08581040279166
SW1353,3825829,4.392940799001886
SW1353,tanespimycin-bortezomib (250-1 mol-mol),-0.2663421154423994
SW1353,16736978,4.524585881975195
YH-13,navitoclax-pluripotin (1-1 mol-mol),0.1454276161313981
KYSE-30,135421197,1.7734254693963984
HD-MY-Z,10074640,3.3401649346570808
KYSE-140,navitoclax-piperlongumine (1-1 mol-mol),2.7987090403268526
PL-21,5278396,2.968610981157125
NCI-H929,9956119,1.818516846968062
NCI-H929,3503,1.25684257431255
BT-20,400769,-0.4348770456350514
SCC-9,409805,5.497565328609373
LP-1,11214940,3.0684079747174264
KP-N-YN,11494412,3.870145712967313
KO52,7326481,2.795216556097651
NCI-H2171,selumetinib-GDC-0941 (4-1 mol-mol),2.15287144597935
RCM-1 [Human rectal adenocarcinoma],135999136,4.538916733621322
LP-1,6918328,-2.08093149199636
MHH-CALL-4,73707386,0.2000268022047914
KMS-12-BM,5311,-0.4045600227605066
BT 416,11214940,4.20138811482423
NCI-H2087,JQ-1-navitoclax (2-1 mol-mol),-0.8509099715184558
SCC-9,selumetinib-BRD-A02303741 (4-1 mol-mol),5.354085868822434
BT 231,67156097,-1.2142947199039105
EJM,107970,2.184437882167209
K-562,9903786,3.6050720376028105
HD-MY-Z,selumetinib-JQ-1 (4-1 mol-mol),0.9792895483914368
BT 416,65064,4.602041655583533
K-562,6505803,-1.797722788015983
KO52,tanespimycin-gemcitabine (1-1 mol-mol),-1.9669297663564216
NCI-N87,25102847,3.5806366762623645
HuNS1,25183872,-1.7095560192532355
NCI-H1395,JQ-1-MK-0752 (1-1 mol-mol),2.3863379692228976
KMS-12-BM,55283,1.3656241179048696
Mino,51037431,3.4405759009251953
CFPAC-1,73707398,2.9085605361845213
SNU-119,9935249,3.2348685245924726
CFPAC-1,387447,-4.14278988535647
GP2d,11455910,0.6533370320075141
L3.3,9936388,-5.444309252993802
HD-MY-Z,BRD-A02303741-navitoclax (2-1 mol-mol),3.474656161306879
L3.3,54619267,4.657132666629917
RCM-1 [Human rectal adenocarcinoma],1566236,2.0083001744148596
NCI-H2087,10296883,3.767340744960793
NCI-N87,2828334,6.0279909292271165
KYSE-140,637858,2.3149924463818534
SNU-119,11626560,1.6667374543655389
Hs 936.T,10296883,3.997542153042743
IST-Mes1,409805,5.880779442140838
PE/CA-PJ15,docetaxel-tanespimycin (2-1 mol-mol),-7.588791932673522
NCI-H2122,12003241,-0.1228144224546952
SKM-1,67156097,-2.558709086141829
LP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.242971676361593
NCI-H2087,3384730,2.353478346936067
CFPAC-1,46943432,3.316693908453427
NCI-H2122,navitoclax-pluripotin (1-1 mol-mol),-0.0855214246229275
NUGC-4,135984461,2.7361037757189184
KHM-1B,654092,-1.7753167598635085
KHM-1B,vorinostat-carboplatin (1-1 mol-mol),1.1385799517319026
SK-MES-1,9935249,2.2482629589570804
KO52,53232,4.022283845582505
BT 416,9826308,-1.736692568240451
SKM-1,984333,0.5121971220732339
KMS-12-BM,tanespimycin-gemcitabine (1-1 mol-mol),-2.331991876675554
KYSE-140,168312962,2.220447453888649
Mino,3689413,-3.624730843514525
L3.3,702558,3.3585745644546474
SK-LU-1,9956119,4.745695885453493
BT 231,637858,1.9874949933256931
SCC-9,44486219,3.972056382599232
NCI-H929,49850262,3.128406990217982
SCC-9,selumetinib-piperlongumine (8-1 mol-mol),4.590174164336879
TCCSUP,246676,4.500819346374967
Hs 936.T,10113978,3.558466478476465
LS411N,445643,4.311506480272609
KO52,4578,4.496766222375734
KMS-12-BM,9868037,1.5063019992906226
Mino,25262965,-3.440473877593767
NCI-H929,5281321,-2.264984865592431
MHH-CALL-4,4096211,3.1328620260731945
SNU-119,5311,3.0436313599319673
SK-OV-3,73707398,1.4890038437616029
NCI-H2087,24821094,3.033514708352242
MHH-CALL-4,67156097,-3.243957774326181
SK-HEP-1,216345,4.108495190728752
LP-1,168313200,2.9786417938497807
BT 416,5280436,3.2351245109604365
KMS-12-BM,44202524,0.8101877803602248
K-562,9967941,4.015535149970178
SNU-119,10385095,1.2447707748514782
T84,selumetinib-MK-2206 (8-1 mol-mol),0.7128448713027771
REC-1,8515,2.9172768808189096
OCI-M1,568763,1.3889256171645852
EJM,11396600,3.800195279839431
MHH-CALL-4,24753719,3.3862640639647457
NCI-H1395,12001922,2.192187193874862
SK-HEP-1,9933475,2.440596541444364
KYSE-30,400769,-1.1172722104114907
NCI-H929,135984461,1.9075332391524664
IST-Mes1,969516,2.6899901133592103
KHM-1B,44185566,1.2108718099020337
MHH-CALL-4,12001922,2.60292711517169
MHH-ES-1,54618164,3.950702257104535
BT-20,285033,-1.1817964263250509
HD-MY-Z,1750826,-2.9471708614278693
YD-8,44491742,4.162245932134171
KO52,25126798,3.67676175110437
SKM-1,9911463,3.5328203832136276
OCI-M1,JQ-1-navitoclax (2-1 mol-mol),0.0104175536452699
L3.3,11178236,-1.5128667899079982
LP-1,4261,1.0165712640274651
HMCB,3081361,2.917485308140701
SCC-9,3552672,2.2159119862051355
NCI-N87,12001922,1.750767235665954
BT-20,11964036,2.1392362133647675
RCM-1 [Human rectal adenocarcinoma],11178236,-3.001745406812045
REC-1,4096211,5.082492134853834
HCC1833,119607,5.294359973784007
GP2d,168313200,3.749157716830288
KO52,serdemetan-SCH-529074 (1-1 mol-mol),2.372423406417755
BT-20,selumetinib-BRD-A02303741 (4-1 mol-mol),5.414807859072554
SK-MES-1,12003241,-1.463616091527542
EJM,JQ-1-navitoclax (2-1 mol-mol),0.2111319026515788
HMCB,9866186,-0.3805378738701598
NCI-N87,219104,3.2437824126869415
SNU-119,6918837,-0.1720170696149332
PE/CA-PJ15,alisertib-navitoclax (2-1 mol-mol),0.3645623597579537
NCI-H929,409805,3.661820790042666
MHH-ES-1,navitoclax-sorafenib (1-1 mol-mol),2.6931592640104864
NCI-H2122,16725315,5.257494737262997
REC-1,446155,6.051384547880599
OCI-M1,11152667,-1.18912794450191
RCM-1 [Human rectal adenocarcinoma],15983966,2.238460019878405
PE/CA-PJ15,46224516,3.629361812570019
L3.3,11625818,4.38532777510286
PL-21,24797083,1.1254206566400924
T84,421610,2.1610542569160125
GA-10,46215462,0.96546653854445
KYSE-30,16038120,1.2151511044670331
Calu-1,selumetinib-MK-2206 (8-1 mol-mol),4.975744071316263
L3.3,448949,2.9670184834605244
KMS-12-BM,2130404,3.4441142127860696
BICR 31,56649450,1.7574149169243078
PL-21,11238147,2.764428173679623
GP2d,44607531,1.367850627658915
T84,374536,1.231955264187491
T84,9927531,3.2336753080400933
HD-MY-Z,675434,4.666609354477646
LS411N,3038522,4.360410119835835
EJM,208908,2.014256342304326
SK-MES-1,54765302,3.6474017293200696
GA-10,23582824,-0.6213968555542161
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275
CFPAC-1,53232,5.6008083321410655
MHH-ES-1,42642645,-1.0578856293193435
HuNS1,3038522,2.3384297166034593
RT-4,25262965,-0.987005470802566
SK-LU-1,11485656,3.4042769893477023
YH-13,25183872,-1.6197416035202905
MHH-CALL-4,JQ-1-navitoclax (2-1 mol-mol),0.2589057241792026
YD-8,11213558,0.4605208185550022
SNU-119,969516,3.8713828709310256
BT 231,selumetinib-PLX-4032 (8-1 mol-mol),4.624189309726486
HMCB,322968,4.304190812139685
YH-13,8515,4.054803825976401
HMCB,7251185,3.03450552612139
NCI-H2122,71466578,5.048347107298388
KHM-1B,135984461,4.335909278526869
YD-8,54618771,-1.0700457769979232
IST-Mes1,676352,1.6027795070012942
HCC1833,6610216,4.331535803824163
T84,10184653,1.4568104752553752
MHH-ES-1,702558,2.9193210282638185
YH-13,44607531,1.7046203795980872
SCC-9,16722836,2.261290441734353
PL-21,124202324,1.2604691388605709
RCM-1 [Human rectal adenocarcinoma],676352,2.484571523504373
KMS-12-BM,168313047,1.7734190846374434
K-562,44462760,3.6560426907742896
EJM,25102847,3.2089639074549123
BICR 31,285033,-1.6333817403557132
SK-LU-1,5351362,1.865018673399555
ECC10,71304818,1.1176975251469572
PL-21,10127622,-2.4792049761741133
GP2d,44589607,2.646247436271379
HCC1833,49793307,-1.1910579397928416
GP2d,24785538,-0.1207853940501678
NCI-H1395,9927531,4.9557176619227015
HMCB,selumetinib-JQ-1 (4-1 mol-mol),1.6185777798994516
SNU-119,31703,-1.023889627752851
HMCB,25126798,4.221661983457504
EJM,11152667,-2.5425383772209393
HD-MY-Z,11507802,0.6581544150608399
NCI-H1395,5281672,6.220750867773061
ECC10,387447,-5.050381669967023
Mino,11234052,1.8502095178714597
Mino,25195348,1.65866400673103
SCC-9,2742550,4.1692460597635135
KMS-12-BM,16741245,2.1137703099951537
OCI-M1,676352,2.469865991246693
Mino,tanespimycin-bortezomib (250-1 mol-mol),-0.3113346740290634
KYSE-140,11152667,-1.9920193440846787
MHH-ES-1,67291369,1.5411503148317995
KYSE-30,11214940,1.389593176433802
L3.3,675434,4.909949648038981
KP-N-YN,alisertib-navitoclax (2-1 mol-mol),0.9560891018527204
RCM-1 [Human rectal adenocarcinoma],11175137,3.6620571654650846
SK-MES-1,5287969,-2.241618079633723
SW1116,selumetinib-UNC0638 (4-1 mol-mol),1.3177227542227
BICR 31,54618164,5.999146696375086
K-562,10074640,1.329135681779355
SKM-1,JQ-1-navitoclax (2-1 mol-mol),-0.3773904973177986
LP-1,44819697,-0.3225719880484693
LP-1,52947716,-5.663786247051261
K-562,4096211,1.5585244853649294
Mino,1242560,2.508321818330107
KYSE-30,6184667,2.645196031113754
KYSE-140,doxorubicin-navitoclax (2-1 mol-mol),0.3554206777859654
NCI-H2087,446155,3.3798180264290347
HD-MY-Z,44486219,3.986672282615431
L3.3,4788,5.85214112282752
NCI-N87,23725625,5.7035859672182125
IST-Mes1,4521392,4.383284740471391
GA-10,5746,-1.179284411121872
PL-21,51039095,1.6306911398800912
NCI-H2171,44607531,0.7654225162387793
BT-20,5328940,2.3421880975149847
EJM,11238147,1.5865276508772588
BT-20,216468,4.379753928035757
BT 231,54596558,3.986857373058861
SW1353,67156097,-1.1160940632422092
SNU-119,16725315,4.275634814543551
YD-8,322968,3.497203303162591
SW1116,9866186,2.478350921258821
REC-1,637858,3.5079007609087527
SW1116,55508,3.840658535629498
MHH-ES-1,100016,6.165620846351705
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213
BT-20,49867926,4.725822674106094
KO52,11964036,1.6912487507512317
YD-8,navitoclax-gemcitabine (1-1 mol-mol),1.3225182449197073
NCI-N87,10231331,4.183605147658756
KMS-12-BM,445091,3.61459918682191
BT-20,11640390,3.242873274782458
KMS-12-BM,navitoclax-birinapant (1-1 mol-mol),-0.785030684423409
CFPAC-1,11626560,2.1092805247032023
SK-LU-1,6438330,2.799070579262559
T84,54618795,3.1826742038766684
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532
BT-20,44462760,4.14254751526145
T84,60700,-0.3345632602841024
LS411N,107985,-2.091782559178726
NCI-H2087,3465537,1.2179436522568818
K-562,4578,4.401657334703153
KP-N-YN,11222830,1.9257342960628043
RT-4,selumetinib-navitoclax (8-1 mol-mol),2.485762476290879
MHH-ES-1,446155,1.9620506019964012
BT 416,46926350,-4.365459454867529
HD-MY-Z,444795,4.361137066373933
SK-HEP-1,11152667,2.375581084403437
SCC-9,387447,-4.584813930042193
LP-1,675434,3.836205340349151
Mino,1317464,3.739113340319872
KHM-1B,2749,0.8754642075989242
YH-13,17755052,1.8478012162745872
SKM-1,10296883,3.074274434558128
SK-LU-1,25183872,-0.961168082495074
SKM-1,6852167,1.599440768743568
PE/CA-PJ15,16659841,4.664105426478433
NCI-N87,31703,-2.5850470675010175
GA-10,53495165,-3.3156551925034625
PE/CA-PJ15,637858,2.2671736383658985
Calu-1,2729026,3.1806773344369454
KHM-1B,4261,0.5935590694863259
GA-10,219104,1.4418640861719692
KP-N-YN,3384730,5.4215551264469966
T84,2828334,5.9249585406278555
BT 231,71680916,5.057074088100034
SW1116,135984461,2.388083333366143
NCI-H1395,10113978,4.152681883448846
KP-N-YN,67156097,4.564758957305894
RCM-1 [Human rectal adenocarcinoma],vorinostat-carboplatin (1-1 mol-mol),3.4124582914647026
NCI-N87,5479543,3.770784511292927
RT-4,9840324,5.695184545393867
HCC1833,25126798,4.004868661279059
T84,5566,2.3420322367029702
GA-10,salermide-PLX-4032 (12-1 mol-mol),4.821673789969655
NCI-H1395,11977753,-2.444387577547746
T84,46926350,-3.687733796852173
KHM-1B,4477,-0.1092447779535195
NCI-H2122,4261,1.8573840857652124
LP-1,5287969,-2.482966528801792
BT 416,104842,-6.19633956497533
Calu-1,6918837,0.1341443332323005
RCM-1 [Human rectal adenocarcinoma],71466445,2.906568419759945
ALL-SIL,4477,0.1906678465210559
BT-20,135999136,4.456503311518702
SW1353,25262965,-0.9203060382306252
SW1353,17755052,3.137972420553509
SK-HEP-1,10302451,4.165168773877425
YD-8,72376,-1.7625580612803151
HMCB,11640390,3.771072765277519
SNU-119,216345,3.614862183808471
YD-8,53495165,0.9440837926278288
TCCSUP,sirolimus-bortezomib (250-1 mol-mol),0.3356822516851041
NCI-H1395,462382,1.900499609260616
SW1116,156414,1.6393126370911288
YD-8,9911463,3.690343271752708
NCI-H929,9903786,1.9183912305018265
KMS-12-BM,3676137,3.133967205799227
ALL-SIL,6505803,0.7073572306495796
HD-MY-Z,3854666,0.9362531303701136
L3.3,3825829,3.356100526361819
PL-21,15547703,2.3185705489177577
ECC10,44493528,3.789717888225728
YD-8,24180125,3.6955333195671938
BT 416,126941,-2.0595047975880676
GA-10,9866186,-0.5763361620704219
BT 231,ISOX-bortezomib (250-1 mol-mol),-0.1116554240716208
NMC-G1,12003241,-0.7597442114064075
YH-13,5329102,1.6719454710321933
GP2d,6450551,1.298037230241124
PE/CA-PJ15,46398810,3.170934794920483
RCM-1 [Human rectal adenocarcinoma],65064,5.283352652805609
HCC1833,10127622,1.7526167797864896
YD-8,65064,4.498532470774199
PL-21,23725625,5.69492238540234
RCM-1 [Human rectal adenocarcinoma],6918837,-4.6352405483445525
KO52,docetaxel-tanespimycin (2-1 mol-mol),-5.1615589988724215
SW1353,46191454,1.7171645016755352
HD-MY-Z,984333,-0.184115285263688
LP-1,23725625,4.559457442772426
YH-13,969516,2.628286868310954
HuNS1,5460769,0.1719707153677664
HCC1833,3136844,5.079214485702816
RT-4,36462,2.6630323769700013
SKM-1,60750,-2.55232212647046
K-562,54454,3.689215856042272
PL-21,10074640,2.916924015240851
SK-HEP-1,46199207,3.772137058295689
NCI-N87,49793307,-2.95740399691262
RCM-1 [Human rectal adenocarcinoma],24753719,5.1478478816318685
TCCSUP,650361,4.871702860557827
LP-1,6252,1.896555363983277
SNU-119,5284373,1.050197910759818
GP2d,9915743,-1.6456174019811347
NCI-H2122,9935249,3.63066345559963
HuNS1,selumetinib-decitabine (4-1 mol-mol),3.8348395467017538
T84,44607530,1.1827367735747547
SK-LU-1,16722836,1.1461946744373794
GA-10,2949965,2.1722689539698736
SK-MES-1,24771867,3.6484623093531066
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907
GP2d,446155,-0.6431743718983025
SW1116,44819697,-0.1581245709222752
ECC10,44185566,1.0306118590598905
RT-4,25126798,3.4225327599877096
MHH-CALL-4,tretinoin-navitoclax (4-1 mol-mol),0.1772474520490496
KYSE-140,25126798,3.9153135629506104
KMS-12-BM,BRD-A02303741-carboplatin (1-1 mol-mol),5.576574018385502
YD-8,24748573,2.6006584758291735
Mino,JQ-1-MK-0752 (1-1 mol-mol),-0.8090660778541161
L3.3,11175137,3.713617877823204
NCI-H2087,11964036,0.8060178626955179
GA-10,selumetinib-tretinoin (2-1 mol-mol),3.668193288080753
MHH-CALL-4,135421197,1.0493029833886585
PL-21,5311281,1.4018594096055264
SKM-1,2749,1.349204961084549
L3.3,11626560,2.44177024695359
NCI-H929,702558,5.133204411961539
BT 416,49846579,1.4848380559775147
HuNS1,navitoclax-birinapant (1-1 mol-mol),1.2554531577538897
SCC-9,10127622,7.404435857651999
NCI-H2087,637858,1.5556640998503009
SK-LU-1,12003241,-2.6616586719339725
HD-MY-Z,44202524,2.8415703403715113
Mino,BRD-K55473186,3.89998753141564
SK-LU-1,73707398,2.0384137453818316
NCI-N87,2733487,6.3981873446173285
NUGC-4,15983966,-3.5893216665480594
L3.3,656346,0.8770519202421161
EJM,JQ-1-UNC0638 (2-1 mol-mol),-0.7989999630217455
HCC1833,4259181,-0.2637882544292723
NCI-H929,selumetinib-navitoclax (8-1 mol-mol),2.7472624638867766
MHH-CALL-4,11238147,4.030791520522143
BT 416,49793307,-3.476071523819802
SW1116,24901704,3.5037025312133556
ECC10,tretinoin-navitoclax (4-1 mol-mol),-3.1297803675559757
HCC1833,16722836,1.307342015536399
NCI-N87,docetaxel-tanespimycin (2-1 mol-mol),-6.128008635109833
HD-MY-Z,9825149,2.703984837402777
KMS-12-BM,5738263,2.600440253298569
KO52,2945648,2.667880655920765
ECC10,53232,2.494928921174981
BT-20,36314,-6.324447855686247
SK-MES-1,9933475,1.3152122839962752
SK-OV-3,24180719,3.148638094054939
PE/CA-PJ15,9952709,3.102814524192607
T84,9826308,0.019005047329911
KMS-12-BM,3384730,0.2737397742242424
KMS-12-BM,16725315,3.09098323700468
NCI-H2122,5287620,-2.189195964420022
ECC10,23635314,-2.229540767758827
SK-MES-1,5470400,-0.9012678711058232
Calu-1,navitoclax-sorafenib (1-1 mol-mol),2.008561186970766
ECC10,15547703,1.958798832425731
YH-13,25227462,0.7870312069105344
NCI-H929,56946209,-4.927465594530247
LP-1,25154868,2.9637769526614277
HMCB,100016,6.123582467992384
T84,11977753,-2.108574247583264
BT 416,3689413,-0.9545304181237728
GP2d,119607,3.888397948180277
EJM,navitoclax-gemcitabine (1-1 mol-mol),-5.027748230090614
Mino,navitoclax-PLX-4032 (1-1 mol-mol),-3.680255642878147
OCI-M1,2733526,4.349464991305354
BT-20,1716436,2.9903345522321065
NCI-H2087,11497983,4.716156132739146
HMCB,24797083,1.265825872563084
TCCSUP,navitoclax-PLX-4032 (1-1 mol-mol),2.317230132678856
HCC1833,49836020,-1.119955366422227
CFPAC-1,168313047,4.899775491361795
RCM-1 [Human rectal adenocarcinoma],71680916,4.48717515696629
NCI-N87,6252,-1.400414082532842
CFPAC-1,15953870,3.265940435383662
KO52,65064,5.236519181387881
NCI-H2122,66577038,3.1583851379997165
IST-Mes1,11640390,3.2581579646920966
BT-20,5311,2.380429313624445
MHH-CALL-4,227681,1.6931640287124523
K-562,9935249,0.8993678101188762
KHM-1B,107970,1.817903354032074
YH-13,4259181,0.5149162893859401
RT-4,5566,2.9903378984967546
SKM-1,135411,-0.1897153244847568
BT 231,44202524,1.029981904128022
KP-N-YN,JQ-1-MK-0752 (1-1 mol-mol),3.8697188446629887
HD-MY-Z,11612883,2.9701971233907907
KHM-1B,56946209,-4.323127458316883
K-562,5278396,3.2143611477277325
ECC10,5738263,2.674135001692005
YD-8,57330099,4.8709299916964905
IST-Mes1,16722836,0.916062842065302
T84,25062766,2.121621772574291
L3.3,71304818,3.108733273598676
PE/CA-PJ15,54618164,4.606818581386584
RT-4,10184653,0.8000143447696744
MHH-ES-1,4788,4.701713785413964
KMS-12-BM,168312962,0.4292683974856141
SCC-9,selumetinib-vorinostat (8-1 mol-mol),3.604672449855193
KMS-12-BM,11647372,-0.2688616751164015
HMCB,135999136,1.9344485879492248
NCI-H929,387447,-6.464991803110621
NMC-G1,6914657,-3.6553833551599406
YH-13,10184653,1.670229317933307
CFPAC-1,2749,2.5046708468350065
NCI-H2171,5479543,3.509510962528721
KYSE-30,selumetinib-MK-2206 (8-1 mol-mol),1.5845629061319633
IST-Mes1,3689413,0.9013533734229402
SNU-119,1716436,3.1005632385597237
HuNS1,3025944,3.905798149020651
HMCB,5978,-3.0634075828231757
ECC10,753704,6.011363133623213
YD-8,5566,3.0799845846164047
KO52,10231331,-1.770944789563704
SK-MES-1,9444,4.21667692919347
NCI-H2087,6918289,2.1631959281709396
Calu-1,445091,4.298882577265647
GA-10,10113978,1.1686886170121615
NCI-H1395,11238147,4.343547830393109
BT-20,9549297,3.1562113364608515
GP2d,89928392,0.7750225848079928
SW1116,53232,4.123252621024031
REC-1,15983966,3.4749561975260237
T84,10127622,0.8865637162723905
Mino,5280436,0.8101119000946707
KYSE-140,11364421,0.0883507181704555
OCI-M1,46174525,1.7261413775672034
LP-1,54618164,3.411691931198772
BICR 31,25262965,-3.4333038857773093
BT-20,9444,4.779272842423912
ALL-SIL,452548,-3.3771532504793194
PE/CA-PJ15,1750826,2.974208117628124
SK-LU-1,6623618,2.2897331665673977
NCI-H929,vorinostat-navitoclax (4-1 mol-mol),1.516172419894528
SW1116,107970,1.8262752967373983
NCI-H929,452548,-1.297254287564457
SK-LU-1,107985,-3.118655364766745
REC-1,54618305,4.3771111696641185
MHH-ES-1,4259181,-2.005736185062781
Hs 936.T,2828334,6.406801353000258
Mino,16219061,1.1508668062940444
SK-MES-1,25062766,1.379914880891141
CFPAC-1,44185566,3.5266009796820814
RCM-1 [Human rectal adenocarcinoma],54618164,4.275813843135039
MHH-ES-1,10184653,0.8323473139854688
ECC10,7326481,2.2671651800298287
SK-MES-1,3081361,1.551594817618588
KYSE-30,23582824,0.6789778445181319
Hs 936.T,44632017,1.7652145798607677
SNU-119,66577038,3.3366072908443756
SKM-1,tretinoin-carboplatin (2-1 mol-mol),1.0065568323561174
SKM-1,15983966,-6.231443096361553
T84,vorinostat-carboplatin (1-1 mol-mol),2.172248367623146
SK-LU-1,11427553,2.8669468954815405
T84,56649450,0.7901881529239119
BICR 31,135411,1.1842135795155395
KP-N-YN,15547703,4.748162549466405
HMCB,135411,0.3409472589453896
NCI-N87,6918736,-4.217256713101777
GP2d,6610355,4.609987482568483
L3.3,24771867,2.302026780280536
SKM-1,44507138,-0.8724707362135841
REC-1,2742550,3.767979931246989
RT-4,452548,0.6609517448162834
HD-MY-Z,4788,5.103889452387665
LP-1,10322450,2.4863509324995827
NCI-H2171,151289,1.4157771037164255
HMCB,46926350,-4.187449030083668
KMS-12-BM,132971,2.9129705347041495
PE/CA-PJ15,6918328,0.6587015663992094
OCI-M1,3503,2.2009403958574016
CFPAC-1,10184653,5.260233951008423
HD-MY-Z,25262965,-2.4175906414339043
MHH-ES-1,11612883,1.819177163857139
SK-OV-3,5281321,-0.7098099698865428
NCI-H2087,71466445,4.206842460124275
SK-MES-1,11640390,2.737419707806134
NCI-H1395,44486219,4.094426397743146
OCI-M1,168313200,2.930152484546089
RCM-1 [Human rectal adenocarcinoma],24951314,1.1143156240073944
REC-1,11626560,3.077771804962775
MHH-ES-1,448949,1.9695100395073728
L3.3,46398810,3.0103098250539846
BT 231,57519531,3.827063167603516
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424
LP-1,15983966,-6.172256826954221
GA-10,68056272,2.631331565953115
GP2d,1641662,2.411486469913387
NUGC-4,54454,2.358842505079948
OCI-M1,10113978,3.911445567363817
PE/CA-PJ15,navitoclax-sorafenib (1-1 mol-mol),3.0607110817671885
LS411N,6918837,-3.511331359252859
TCCSUP,selumetinib-GDC-0941 (4-1 mol-mol),1.9950465927761605
NCI-H929,11213558,0.6823472924014866
LP-1,5566,2.477579634357161
K-562,44185566,1.8580861510177096
TCCSUP,11640390,3.766989584853525
ALL-SIL,46199207,2.4207183231317826
RCM-1 [Human rectal adenocarcinoma],3634881,3.579575013653745
Hs 936.T,16720766,0.4223978733026219
PL-21,46398810,2.0056326769686064
SK-OV-3,107985,-2.353051363092625
NCI-N87,11683005,3.6426598339920297
SW1353,72193861,0.581986237918242
ECC10,10127622,2.9830262684381306
SCC-9,56963564,0.633234370730304
CFPAC-1,15547703,3.981609188608015
SW1353,49850262,3.553378017195041
OCI-M1,9952709,2.6362477163629463
ECC10,11647372,0.5926837972200864
RCM-1 [Human rectal adenocarcinoma],17755052,4.178055403408082
PE/CA-PJ15,12003241,-2.2005242909151668
HD-MY-Z,3503,2.00831024254013
GA-10,4477,0.1340980811984037
K-562,168312962,1.3008721680360658
NCI-H1395,36314,2.584917869739777
SNU-119,50905018,4.442332120900816
NCI-N87,selumetinib-MK-2206 (8-1 mol-mol),0.3550893984048577
HuNS1,462382,1.311714057233463
L3.3,navitoclax-piperlongumine (1-1 mol-mol),3.3771859534422703
MHH-CALL-4,9866186,1.7393522850949918
ECC10,9935249,2.455654324483876
REC-1,613753,5.013136988520993
PE/CA-PJ15,3136844,3.987949830303945
NCI-H2122,3689413,3.5396747143031497
HCC1833,104842,-1.5788408099329163
NCI-H2087,135999136,4.85845906429525
YH-13,107985,-2.561016282380613
T84,9936388,-5.402148456291863
BICR 31,9907093,4.585915925811977
GA-10,44137675,0.8453491724509868
KMS-12-BM,vorinostat-carboplatin (1-1 mol-mol),0.7008192168713556
MHH-ES-1,3062316,2.401791380403149
PE/CA-PJ15,44819697,0.4241094034222136
NCI-N87,46191454,1.700307220457573
KO52,400769,-1.2212933891917823
ECC10,9866186,1.9482588818675393
NCI-N87,375860,-0.928197184659684
ECC10,selumetinib-GDC-0941 (4-1 mol-mol),1.2320886517075502
KYSE-140,1750826,-0.7857652195434837
NCI-H2171,10427712,3.6918148562663937
ALL-SIL,11175137,2.2895463411974597
GP2d,60700,-0.6883169969337792
NCI-H1395,445643,4.969337372862375
OCI-M1,docetaxel-tanespimycin (2-1 mol-mol),-4.241886779863389
CFPAC-1,6610216,4.540388472392638
PL-21,52912189,-0.1700629664007233
MHH-CALL-4,216468,0.9466915943933264
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238
SK-LU-1,24951314,2.448443948318189
KYSE-140,5287620,-1.452929232168318
NCI-H929,11175137,1.2036169120329363
KYSE-140,72734382,6.476405569989238
Calu-1,57330099,4.4521933438115004
RT-4,serdemetan-SCH-529074 (1-1 mol-mol),2.3514467892397852
TCCSUP,11485656,2.4858219651419966
RT-4,sirolimus-bortezomib (250-1 mol-mol),0.9499468705615456
SNU-119,676352,1.897114472435228
RCM-1 [Human rectal adenocarcinoma],36462,2.9964453818745924
BICR 31,12003241,-1.4237270953299652
GA-10,26596,-3.772659675473913
RCM-1 [Human rectal adenocarcinoma],216345,4.578948480850923
Hs 936.T,53392493,3.24574554515573
GP2d,4788,4.021469327474248
T84,3689413,-1.5299599275494418
SK-OV-3,5351362,2.7626479495985765
GP2d,decitabine-navitoclax (2-1 mol-mol),-2.063284646439393
HD-MY-Z,2828334,6.040708634806872
BICR 31,2828334,6.263113325647995
K-562,49836020,4.414855158615189
L3.3,25195348,5.818157346447802
SCC-9,10302451,2.205114392498864
KO52,241158,3.6727095918533
EJM,carboplatin-UNC0638 (2-1 mol-mol),3.206648557272409
NCI-N87,SNX-2112-bortezomib (250-1 mol-mol),-4.305728707352715
HD-MY-Z,72734382,4.7092061989643765
BICR 31,11497983,4.106423080888053
IST-Mes1,42642645,0.3467837133172653
KYSE-140,159324,2.642529178463094
OCI-M1,613753,3.176926739433859
HD-MY-Z,selumetinib-decitabine (4-1 mol-mol),2.592975654277937
TCCSUP,46199207,2.7417054506008967
ECC10,23725625,3.7259554302875952
BT 231,15983966,-4.704937406433679
ECC10,54613361,-1.734486107381894
LS411N,6918328,-0.170211770014818
NCI-H929,44632017,1.43603243468148
KO52,9952709,3.149976936491048
KHM-1B,10113978,2.248565849983048
L3.3,5311281,4.47128753759965
KP-N-YN,637858,1.0855268631392891
SK-MES-1,5284373,0.3681874752966407
ALL-SIL,9549297,0.2429486516660708
PE/CA-PJ15,5951923,6.390550874412015
BT-20,9956119,3.9851417227010546
KYSE-30,216239,2.041639282463107
EJM,9929138,6.263891211273599
HuNS1,navitoclax-sorafenib (1-1 mol-mol),2.119059062474118
BT-20,44498493,4.427046206906442
YD-8,carboplatin-UNC0638 (2-1 mol-mol),3.392730087781214
Mino,9803433,4.282514646270307
KO52,72734382,3.7619867854642663
BT-20,16741245,4.545534120679877
LS411N,656346,4.206497662771029
KP-N-YN,446155,5.508306142174024
MHH-ES-1,8515,3.021519312968192
REC-1,72193861,3.839467453811461
GA-10,5479543,1.1511426249208312
SK-MES-1,3136844,4.0902197826019995
HCC1833,11404337,0.2409381121234374
BICR 31,45279963,4.353781648061694
KO52,1641662,2.14069731624562
NMC-G1,136227924,2.469359539544405
KO52,6852167,2.1234945146220645
LS411N,11612883,3.0472980958623705
NUGC-4,navitoclax-gemcitabine (1-1 mol-mol),0.0717070064899554
BICR 31,55283,4.60336009153674
BT-20,4261,2.5616297350133004
IST-Mes1,9903786,2.7623614356082458
PL-21,1566236,1.5934473154308642
LP-1,JQ-1-UNC0638 (2-1 mol-mol),-1.7651848226430418
MHH-ES-1,JQ-1-MK-0752 (1-1 mol-mol),0.7190290476837716
KMS-12-BM,119182,-2.8670798945659617
ECC10,5335621,4.177830924303476
IST-Mes1,10385095,2.3784865098232255
MHH-CALL-4,6610355,4.817673986207659
KYSE-140,9911830,2.9872527631338324
Hs 936.T,11238147,3.4436779581141175
HD-MY-Z,9866186,-0.1784243221554363
NCI-N87,4259181,-0.3128226187706996
TCCSUP,2130404,3.221967733361771
RD-ES,36462,-0.4809008818897318
NCI-N87,10074640,2.8038201142488504
BT-20,11485656,1.799713509383809
ALL-SIL,6438330,0.5772640537372373
KYSE-30,56649450,3.557479455531029
NCI-H2087,navitoclax-sorafenib (1-1 mol-mol),0.4342645369592831
LS411N,54618771,1.0517408544895162
EJM,9826308,-0.8928202360474983
HD-MY-Z,9903786,3.5223384929798187
MHH-ES-1,104842,-6.302536791501777
NCI-N87,5311281,2.449994968111211
LP-1,5291,2.253998547337269
KMS-12-BM,49867926,3.4280203306526524
NCI-H929,135411,0.3622558435964065
BT-20,4096211,2.095127476353052
GP2d,44185566,2.6416623020205767
SK-HEP-1,1716436,3.791424957504218
EJM,5335621,4.269621462989024
OCI-M1,23635314,-4.483533817242398
MHH-CALL-4,42642645,0.2381641586834445
NMC-G1,JQ-1-vorinostat (2-1 mol-mol),2.8721932831937727
KO52,tretinoin-carboplatin (2-1 mol-mol),3.6636707238793624
SW1353,5291,3.5261396277983144
LS411N,1641662,3.6634193785306337
NCI-N87,60700,-1.3451868063168757
SK-LU-1,56946209,-3.9431027814524
T84,9825149,1.2612982154014536
YD-8,11964036,1.157152109498934
YD-8,3543504,4.346865658912418
EJM,135659046,3.4058346184663693
PE/CA-PJ15,16736978,1.610051692476406
GA-10,439501,-3.812594537001909
HD-MY-Z,42642645,0.9582143168219108
ECC10,44491742,3.5514188140431644
L3.3,54613361,-0.6336215633441857
HD-MY-Z,136227331,3.950603619388181
NCI-H929,3025944,3.918293488310436
ECC10,2949965,2.8574646728978093
SCC-9,9823820,5.247901285797655
K-562,71751553,5.367911183247371
RT-4,piperlongumine-MST-312 (1-1 mol-mol),2.794941054913251
NCI-H2087,5460769,-1.5102005910697154
SK-LU-1,11612883,4.445797006500659
EJM,54596558,4.61440332017562
NCI-H1395,25183872,0.7237859951347151
SNU-119,BRD-A02303741-navitoclax (2-1 mol-mol),3.084106743145068
BT 231,selumetinib-UNC0638 (4-1 mol-mol),3.6405987072594064
YD-8,11656518,3.459144048405474
Hs 936.T,54618305,4.362446334432475
KYSE-140,selumetinib-PLX-4032 (8-1 mol-mol),2.9518740036377475
Calu-1,5311281,1.6105109382718037
SW1353,ISOX-bortezomib (250-1 mol-mol),0.6127651806414284
ALL-SIL,12001922,1.676377280214729
HMCB,44620216,3.75907635673166
LS411N,11427553,2.839596649209722
L3.3,5328940,2.2327140114261597
RT-4,3825829,3.4258833117884064
EJM,53495165,-2.1869464879132963
OCI-M1,409805,6.068123689034305
BICR 31,52912189,2.5113420173615464
SK-OV-3,12001922,2.3689117655248197
REC-1,9907093,4.061850457187021
KO52,11396600,3.051627581840025
YH-13,selumetinib-piperlongumine (8-1 mol-mol),4.547014115194958
SW1353,11640390,4.224966787369633
TCCSUP,3503,2.528239452217975
LP-1,216345,3.6878490905842782
NUGC-4,375860,-0.1996539544596114
SK-LU-1,1566236,3.629821638142186
KP-N-YN,135440466,3.570111699935219
NCI-H2087,15983966,-2.4195651270312553
SK-MES-1,10113978,3.1537712970808407
SKM-1,24753719,3.966974937988049
NCI-H929,25102847,2.528780215609897
KMS-12-BM,227681,1.85871490335109
HD-MY-Z,3038522,2.827532250303149
IST-Mes1,375860,0.4088289358172842
ECC10,46215462,1.3870913202570485
BT-20,11234052,4.237730834937647
Hs 936.T,46199207,3.670949605486352
PL-21,25183872,-1.2702699158750224
IST-Mes1,107985,-3.865584471784785
MHH-CALL-4,46191454,-0.4557602226357556
SW1353,322968,4.414793076802715
REC-1,5284616,3.779450255031602
ECC10,10302451,3.62041349864807
HMCB,tanespimycin-gemcitabine (1-1 mol-mol),0.8879400812338334
SK-HEP-1,262093,3.158620019748703
ECC10,9884685,-0.6725691061854394
GA-10,23939,3.8055573319507214
SCC-9,15983966,-4.042628093805887
HMCB,crizotinib-PLX-4032 (2-1 mol-mol),2.393956445339111
KO52,445643,3.829050066229971
KYSE-140,9936388,1.9603983153875792
KMS-12-BM,16736978,-0.4930730722396533
SCC-9,navitoclax-birinapant (1-1 mol-mol),1.9538462590257963
KMS-12-BM,24180125,1.472923036280714
NMC-G1,72734382,-0.4445235363893036
KYSE-30,53232,1.574322890506623
T84,11955716,-2.529643466430461
NCI-H2087,decitabine-navitoclax (2-1 mol-mol),2.1374616931302324
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284
SK-OV-3,65064,5.055886881526936
KMS-12-BM,5284373,1.9120963986235795
NMC-G1,216239,3.560905783370073
SK-MES-1,44589607,2.933184591977697
SW1353,11626560,1.945887027440842
OCI-M1,56946209,-4.5336491977449995
Hs 936.T,49850262,4.110654188972971
OCI-M1,71466578,2.600544521492335
BT 231,BRD-K55473186,1.86151309583958
SK-OV-3,25022340,0.9085118587340768
ALL-SIL,9884685,1.523019065964201
BT 416,ISOX-bortezomib (250-1 mol-mol),-0.0170336487300608
IST-Mes1,439501,-2.4971864822052767
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004
PE/CA-PJ15,doxorubicin-navitoclax (2-1 mol-mol),-2.601929873995627
YH-13,10385095,0.585484965582367
BT 416,60750,-1.909220477568992
TCCSUP,24748573,1.7257440496514025
KO52,5284329,4.405190261988607
OCI-M1,navitoclax-gemcitabine (1-1 mol-mol),-3.487140113888963
BT 231,11455910,0.2900866749520439
SK-OV-3,31703,-0.6007067740148971
GA-10,tanespimycin-bortezomib (250-1 mol-mol),-0.5876436517522915
NCI-H2087,4917,2.4523991015416313
RT-4,vorinostat-carboplatin (1-1 mol-mol),3.924557304364806
KO52,969516,2.728197317619067
TCCSUP,12003241,-0.9458347981681208
NCI-H2087,selumetinib-JQ-1 (4-1 mol-mol),-5.600268685370347
ALL-SIL,10427712,3.5706749567785625
T84,11656518,1.2899389568782835
NCI-H929,10074640,2.9963817325731807
YD-8,11175137,2.9389718766102906
SCC-9,11625818,5.698343618019975
SK-MES-1,36314,-4.376796906860549
L3.3,168313047,3.843757543685879
Calu-1,ISOX-bortezomib (250-1 mol-mol),1.2385612088871711
LS411N,11609586,3.7769222068832384
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256
OCI-M1,2749,1.7498958402886906
NMC-G1,124202324,3.5561633651011237
NCI-H2171,5282054,2.409902559914623
BT 231,219104,3.245050885185789
RD-ES,JQ-1-navitoclax (2-1 mol-mol),0.2470246492884772
BT 231,2729026,1.6518737008758786
KO52,46224516,1.1439524692050589
K-562,56649450,4.352548214039191
KO52,65628,3.991598666523216
REC-1,25150857,4.137412786869543
NCI-H929,10113978,2.6674788600772597
NCI-H2171,6918837,-5.273009588122425
HMCB,vorinostat-carboplatin (1-1 mol-mol),3.689100478232481
BT 231,3634881,1.5000447182815708
SK-LU-1,5566,3.030649513499838
ECC10,44607530,0.8965006826879965
HD-MY-Z,3676137,3.8651399341474817
SK-LU-1,31703,-1.6876879012783903
SCC-9,11152667,-0.1233430086603879
YH-13,3081361,3.4000588476390963
KHM-1B,73707440,5.196065246508486
NCI-H2122,11977753,-1.613554214501102
MHH-ES-1,12001922,1.634757567044827
HCC1833,100016,6.427561679501585
YD-8,72734382,4.785719030428051
PANC-1,5738263,2.394583977737206
MHH-CALL-4,216345,1.5761457642508243
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467
PE/CA-PJ15,11977753,-2.687864175369831
KMS-12-BM,9936388,-7.442749057312851
NCI-N87,5978,-2.9043455823279185
MHH-CALL-4,12003241,-1.7117307202040182
OCI-M1,sirolimus-bortezomib (250-1 mol-mol),0.0784730767185344
GP2d,52912189,4.56464481849365
SK-MES-1,637858,1.374960774456644
KO52,36462,1.66960340133658
NCI-H2122,11626560,2.019746186504272
Hs 936.T,119607,5.675258674275019
SCC-9,navitoclax-MST-312 (1-1 mol-mol),0.9061907565004998
NUGC-4,16722836,0.7053586924113402
L3.3,44507138,2.7873723049829544
PE/CA-PJ15,148198,-2.65559177778782
Calu-1,23582824,1.960898171838655
LP-1,4578,4.277677864677143
CFPAC-1,selumetinib-GDC-0941 (4-1 mol-mol),3.108186987901354
KYSE-140,9903786,2.4605743135261653
KYSE-30,3854666,4.258040109077401
BT-20,5281321,-2.5475683190961727
LS411N,446155,3.6642844723827266
ALL-SIL,4369359,5.632204520937589
SK-MES-1,53392493,1.498846173056942
SKM-1,53392493,1.9339863901276448
KMS-12-BM,9866186,1.4538422549800163
OCI-M1,4917,3.694148646625616
GA-10,56949517,2.2553997114161852
NCI-H929,44137675,0.5857297222034469
Mino,navitoclax-piperlongumine (1-1 mol-mol),-4.020329741894284
SCC-9,56946209,-4.978704692275232
KYSE-30,123631,2.2798821665338793
BT-20,409805,3.857390251652358
HMCB,2858523,3.340163049950989
NCI-H2122,9936388,-2.3512808318812555
MHH-CALL-4,52947716,-7.312894581281093
KHM-1B,5282054,1.6499895899015693
NCI-H929,107985,-4.785949324647598
SK-LU-1,216239,1.7131460102086349
KYSE-30,409805,5.989157547538198
NMC-G1,9887053,4.251932400181619
KO52,3854666,-0.4105607896605044
SK-OV-3,46398810,2.6339706660379205
SCC-9,10427712,3.976850957625781
SK-OV-3,60750,-4.210978436614257
ECC10,54143018,-1.3278581329617392
BT 416,71729975,3.4448990537881876
YD-8,5311,1.737118017629579
NUGC-4,135398516,4.001287438872159
NCI-N87,JQ-1-vorinostat (2-1 mol-mol),-1.1800761907808068
MHH-ES-1,carboplatin-UNC0638 (2-1 mol-mol),2.9184279566214273
KMS-12-BM,doxorubicin-navitoclax (2-1 mol-mol),-2.1380196151601845
PE/CA-PJ15,11656518,0.2985068958700391
LP-1,piperlongumine-MST-312 (1-1 mol-mol),1.2668663387778956
T84,16722836,1.4578695554234813
TCCSUP,568763,0.1575730969992337
BICR 31,409805,3.7719372874267982
GA-10,984333,-2.8102395168114462
LS411N,654092,0.6196619744838121
NCI-H929,10385095,0.7754305798230204
MHH-ES-1,16038120,-1.1254463102423389
HuNS1,4261,-0.1376060559269122
NUGC-4,216345,2.0504393334844195
Calu-1,15547703,4.302254576623021
KP-N-YN,selumetinib-tretinoin (2-1 mol-mol),5.083574745416403
SK-HEP-1,24964624,3.121305411780932
MHH-CALL-4,erlotinib-PLX-4032 (2-1 mol-mol),3.41801394259042
NCI-H929,4788,5.842901865932074
KHM-1B,11214940,1.6917073338671202
RCM-1 [Human rectal adenocarcinoma],16038120,1.1652003457864657
HMCB,44566777,1.6890977945598695
GA-10,3385,2.3265815049326486
BT 231,24901704,2.428348103447541
SW1353,31703,-1.2534397431393514
YD-8,2708,5.154021841255303
NCI-H1395,11707110,3.0530004675688964
K-562,11626560,-0.7477726232652755
MHH-CALL-4,UNC0638-navitoclax (1-1 mol-mol),-1.5087642797213563
ECC10,5284373,2.079444207494568
EJM,36462,0.7713020046102423
HD-MY-Z,56946209,-4.901804079523323
NCI-H2087,9935249,2.1855057709444092
HD-MY-Z,9840324,5.458146117036662
NCI-N87,151289,0.0450530603050232
YH-13,168313016,4.37029301578321
GA-10,2874250,4.150672876814761
REC-1,4788,5.882204624871407
KO52,11364421,-5.790016441966964
GA-10,9549297,1.0414436423034976
KP-N-YN,5329102,1.861884951969256
BT 416,11396600,2.2118594965797147
PE/CA-PJ15,44493528,4.269836707696998
PANC-1,56973724,4.36812704495413
NUGC-4,11455910,2.097041344071872
SCC-9,selumetinib-GDC-0941 (4-1 mol-mol),0.7797361148156482
Mino,3038522,2.4167515752748145
GA-10,selumetinib-vorinostat (8-1 mol-mol),1.5334838453135928
SKM-1,16741245,1.8575385373814357
Mino,122327,5.625532204627329
GA-10,462382,-0.0659816191882385
BT-20,selumetinib-GDC-0941 (4-1 mol-mol),1.9366034216750805
SK-MES-1,71466380,4.281273671532061
ECC10,168313016,3.3239878993756684
HMCB,serdemetan-SCH-529074 (1-1 mol-mol),2.4925748009554938
OCI-M1,5746,1.0585593796830943
K-562,42642645,-0.9952706094252596
SCC-9,57519531,3.918058558817349
T84,216345,2.7852139135475453
SCC-9,54143018,0.8755026739061308
ECC10,5328940,2.4411153185999734
SKM-1,285033,-2.3553922545886796
HuNS1,JQ-1-navitoclax (2-1 mol-mol),-0.6134045850580996
L3.3,100016,6.042484334243821
OCI-M1,24821094,3.7828892118776536
CFPAC-1,10302451,2.7378299397254366
TCCSUP,tretinoin-carboplatin (2-1 mol-mol),6.838469471858124
TCCSUP,9927531,4.77726983491798
NCI-H2087,31703,-3.1868170955131805
T84,44185566,0.9391053357635772
BICR 31,439501,-2.4499261286992007
GA-10,451668,-6.1053278324460205
GA-10,navitoclax-piperlongumine (1-1 mol-mol),0.4479958544246797
Mino,6918328,-3.2797037405532987
NCI-H929,17755052,-1.864844387301065
BT 416,tretinoin-carboplatin (2-1 mol-mol),4.943718364542161
KYSE-140,4261,2.7559601926663775
HuNS1,426756,3.939841201891996
KYSE-30,2126,4.397145301531095
BT 231,135398516,1.9379766729159449
KYSE-30,9933475,2.410859276855484
MHH-CALL-4,BRD-A02303741-navitoclax (2-1 mol-mol),0.6304377594090925
BT 416,53325874,6.214859444286573
YD-8,selumetinib-tretinoin (2-1 mol-mol),6.635581773153188
BICR 31,400769,0.3553213589698107
LS411N,2729026,2.9791300415919646
SNU-119,10231331,4.363406465804169
GA-10,136227924,1.4612725021832749
K-562,11178236,-5.937287665657859
MHH-CALL-4,25183872,-1.0930954285687713
ECC10,4788,4.020581878515748
GA-10,24775005,2.842265334762146
BT 416,tanespimycin-bortezomib (250-1 mol-mol),-2.7176161537390837
REC-1,5566,3.0953320771208275
ECC10,decitabine-carboplatin (1-1 mol-mol),3.990077878668341
T84,5282054,3.20581646822901
YD-8,20959075,0.9850613920765108
NCI-H2087,49793307,-2.561873855841841
SK-MES-1,9884685,-0.7643025392616056
T84,57519531,2.422566491818773
BT 416,241158,3.719071622577502
MHH-CALL-4,9903786,1.9013313990407976
SW1353,4788,5.9620984724999415
NCI-H1395,crizotinib-PLX-4032 (2-1 mol-mol),2.536780809037994
MHH-ES-1,ISOX-bortezomib (250-1 mol-mol),0.1753730510619311
GP2d,6252,1.1142426597702098
PE/CA-PJ15,2749,1.3392553924109478
MHH-CALL-4,753704,3.500329018890042
BT 231,56649450,2.3701716466817127
NCI-H2122,1750826,2.902014880515386
HCC1833,241158,3.043564904971582
EJM,9935249,2.9209217117855903
NCI-H929,JQ-1-vorinostat (2-1 mol-mol),-1.9493300173988888
Mino,4096211,1.2252655187490238
MHH-ES-1,SNX-2112-bortezomib (250-1 mol-mol),-3.1852510123217948
NCI-H929,5978,-3.149795005815329
Mino,3025944,3.883461647541772
LP-1,5470400,0.4843152507059578
Calu-1,441298,3.407652733343724
SK-LU-1,168312962,-1.6277290892098688
GP2d,9911463,3.4287638364332333
EJM,9907093,4.11164993118498
TCCSUP,216239,2.7641054306818265
BICR 31,44185566,3.0664042381745946
TCCSUP,753704,5.368261344163991
KP-N-YN,216345,4.505126340141369
MHH-ES-1,89183176,3.164997857767062
BT 416,135411,-0.0921802672256165
MHH-CALL-4,decitabine-navitoclax (2-1 mol-mol),-2.0572744769431077
OCI-M1,selumetinib-piperlongumine (8-1 mol-mol),3.1900841158423416
SW1353,10385095,1.4015944143459336
NCI-H929,613753,3.174052302519367
PE/CA-PJ15,44491742,3.9025986426144934
GP2d,54143018,0.9661192216720148
EJM,1750826,-2.1256322025072323
BT-20,6610355,4.911738393458072
PE/CA-PJ15,2945648,3.047957601160832
SK-LU-1,11497983,5.841616323405361
SK-OV-3,9887053,4.42879128381072
KP-N-YN,serdemetan-SCH-529074 (1-1 mol-mol),2.336976103101352
BT 416,46199207,1.7103511401822575
TCCSUP,9825149,2.319100468711196
SKM-1,5281321,-0.4705948424838158
L3.3,9444,4.344069420298931
Mino,6917907,-5.79053360764326
REC-1,25105715,4.2910669876148875
TCCSUP,44819697,-0.8958892266160017
MHH-CALL-4,969516,1.7507893887576411
BT-20,5291,4.44172477757951
ECC10,5282054,1.6505040606795556
KMS-12-BM,56963564,-1.528308653494457
TCCSUP,168313047,2.4299018394791507
SCC-9,53495165,0.7472636588137463
SK-MES-1,selumetinib-PLX-4032 (8-1 mol-mol),2.548906555556659
SW1353,navitoclax-pluripotin (1-1 mol-mol),-0.5821276177104706
BT-20,5282054,3.970682126654945
T84,135398516,1.8150151150959204
GA-10,17755052,-0.9509619033995962
SK-MES-1,444795,5.062530202812243
NCI-H2122,navitoclax-MST-312 (1-1 mol-mol),2.1574754665694185
NCI-N87,89928392,0.9456157368763274
BT-20,9887053,4.223418717862435
RCM-1 [Human rectal adenocarcinoma],12001922,1.85954377189608
YH-13,6918638,0.7209706519949683
KMS-12-BM,72193861,-0.3059555505997974
SW1353,654092,0.01790145307113
LS411N,72193861,2.8187845663214848
KYSE-30,alisertib-navitoclax (2-1 mol-mol),2.4671996280044057
SKM-1,44185566,1.2087289104491263
HD-MY-Z,122327,4.0208449568470215
Calu-1,45279963,4.221149859079129
YD-8,1641662,3.7116044926087146
RCM-1 [Human rectal adenocarcinoma],44607531,1.8642852142992712
YD-8,2858523,3.2041590177045665
SK-MES-1,tanespimycin-bortezomib (250-1 mol-mol),-2.706649698692507
NCI-H2122,11455910,1.0821419204732732
LP-1,11404337,-1.552804364872206
KP-N-YN,11404337,1.502474208515668
NCI-H2122,44137675,3.802561400221864
Hs 936.T,23582824,3.7258222765729454
HCC1833,9825149,2.5864642612830564
NCI-N87,15547703,1.070685995489879
OCI-M1,36314,-2.1956344647299137
GA-10,241158,1.1347612436603682
HuNS1,6918736,-3.5274943272244847
RT-4,ISOX-bortezomib (250-1 mol-mol),1.1242037732608314
HMCB,16065773,1.8456110367577696
KYSE-140,6852167,2.934032084850076
EJM,25227462,-4.274317957574103
NCI-H1395,24964624,3.1015144047697367
ALL-SIL,44489675,3.868517697091687
YD-8,54143018,4.014642236255498
BT 416,5566,2.7940398160296813
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565
MHH-CALL-4,72193861,1.1425740638809945
HMCB,5287620,-2.490214484592024
KO52,23635314,-5.1824728926411945
MHH-ES-1,216345,3.994681575439313
SK-LU-1,3815108,3.2616265579045702
BT 416,11228183,-0.5281351984392108
T84,3552672,2.2249186631483826
HD-MY-Z,36462,0.9002235780520323
BT 416,25062766,1.7046497291811478
MHH-CALL-4,17755052,0.2696588931106342
RT-4,44202524,1.5489412364823092
REC-1,1242560,4.120560836413046
BT-20,25195348,3.9538437013694
NCI-H929,5287620,-2.9527713293437734
Mino,6610355,3.477910494331319
RT-4,12001922,1.7739058895208752
Hs 936.T,4259181,0.7907782963904789
SK-MES-1,1242560,3.5327665012224663
TCCSUP,60700,-0.1040459377874521
GP2d,56649450,-1.9257996730776956
PL-21,400769,-1.8716590801051
PE/CA-PJ15,vorinostat-navitoclax (4-1 mol-mol),2.4853954630897053
ALL-SIL,9444,2.1167841583667277
BT 231,16736978,1.784155706767899
K-562,135421197,2.032823128578147
PL-21,219104,2.621073553136223
HMCB,2874250,-4.802730295191432
HCC1833,3825829,4.543250520424916
PL-21,16722836,0.6734750585605728
NCI-H1395,5282054,4.370285426965396
KO52,119607,5.619128288871563
NCI-H2171,11228183,-0.0614644470988351
HuNS1,9907093,4.19416792690849
HuNS1,216345,1.9473498513652987
YH-13,11612883,3.2122521691176975
YH-13,16722836,2.280757149111382
PL-21,2746,1.912238920638634
KYSE-30,4705,4.659105063071051
KMS-12-BM,tretinoin-carboplatin (2-1 mol-mol),1.5291573634197104
GA-10,51037431,2.3510394501039173
NCI-H2122,637858,2.372515616710106
SNU-119,124202324,4.249664634956003
PE/CA-PJ15,3854666,0.5733431717297748
BT 231,5278396,3.366305854308052
SNU-119,11647372,1.96438955117864
KMS-12-BM,176870,2.4229038104943457
HCC1833,25183872,1.5847147980545246
IST-Mes1,9936388,2.2275468363886763
NCI-H1395,49766530,-2.8850236043305792
SW1353,24772860,-0.9669202709751876
K-562,53392493,1.9280012389180945
SKM-1,446155,3.079957129001659
BT-20,44607531,1.4516300480459003
NCI-H929,3038522,2.7996723936558943
BT 416,45279963,3.465202049192015
SK-LU-1,5311,2.5600115935477787
HCC1833,65628,4.511213018881878
HMCB,25227462,1.4267273911688456
SK-LU-1,36462,1.0548894968192253
BT-20,24748573,1.2954519950471566
ALL-SIL,219104,1.1543769867483644
OCI-M1,42642645,1.7044851255097004
CFPAC-1,23725625,5.729714444939111
GP2d,11175137,2.6822093019335354
MHH-ES-1,49850262,2.8417930598183645
KO52,9911830,0.3090306906252232
KYSE-30,3038522,2.040358986950868
K-562,11222830,1.892206265748428
Calu-1,navitoclax-MST-312 (1-1 mol-mol),1.1450034235954567
YD-8,54678924,2.5377672134217435
NCI-H2171,24771867,-2.6220866978549444
HMCB,4477,0.1906220265974898
EJM,tanespimycin-bortezomib (250-1 mol-mol),-0.1920922307802734
NCI-H2087,46215462,1.4251588207428108
GP2d,2858523,2.4423978342069805
RCM-1 [Human rectal adenocarcinoma],11404337,-0.1256073852846617
CFPAC-1,navitoclax-piperlongumine (1-1 mol-mol),3.452418544509062
GA-10,3062316,-4.169753072672148
KO52,44486219,3.943229748737328
KO52,navitoclax-pluripotin (1-1 mol-mol),-1.853817353117152
T84,5311,1.0263802595342448
YH-13,148198,-2.7695139562786526
Calu-1,17755052,4.365987360570635
Calu-1,54649381,3.1839946229098777
ALL-SIL,11167602,0.1759872916057691
HCC1833,72376,-1.996603086834844
KHM-1B,selumetinib-PLX-4032 (8-1 mol-mol),4.453771782553302
SK-LU-1,49793307,-2.041632837909902
KYSE-140,6505803,1.6434747535859726
ECC10,11625818,4.252068548498996
T84,4096211,1.1511328300120167
Calu-1,11222830,2.0340596383589733
PL-21,10184653,1.195801168130885
BT 416,16725315,3.245139153213775
Mino,44489675,3.4027989138594426
PE/CA-PJ15,53392493,2.944433696457154
MHH-CALL-4,20959075,-2.827490989917312
NCI-H2122,73707398,2.514369766982023
KYSE-30,25161177,5.60138766772949
IST-Mes1,serdemetan-SCH-529074 (1-1 mol-mol),2.635765253356215
NCI-H2171,25195348,2.4042641753284872
SCC-9,11640390,4.170413196512925
REC-1,10184653,3.8754614074646407
KHM-1B,135421197,0.982032972009238
SK-OV-3,44137675,2.687297746540291
KP-N-YN,168312962,1.7427533732932377
NCI-H2087,1716436,1.4600390567088413
GP2d,119182,-0.8545817878864771
GP2d,56946209,-4.5730216708176865
NCI-H2087,docetaxel-tanespimycin (2-1 mol-mol),1.1979389650313694
KHM-1B,11178236,-5.183518181224002
RCM-1 [Human rectal adenocarcinoma],carboplatin-etoposide (40-17 mol-mol),3.7784194640429822
SK-OV-3,10385095,3.0219456492917485
KMS-12-BM,2945648,2.2840305648054833
NCI-H2087,25183872,-1.5757014354805876
L3.3,5566,3.1406901276995094
KYSE-30,42642645,1.5481968016239538
SK-HEP-1,5287620,-1.0463187584720948
KMS-12-BM,53232,3.5585540988187176
YD-8,44507138,1.814494867453689
OCI-M1,5311,0.7612880765729189
YD-8,1750826,-3.2226271071481123
RCM-1 [Human rectal adenocarcinoma],1750826,-0.1499809417024857
KO52,3136844,3.587765010729267
PL-21,46215462,1.1322172973164697
SW1353,638278,3.622514291658039
KO52,UNC0638-navitoclax (1-1 mol-mol),-2.0411974213550965
SCC-9,16659841,4.917362195715636
RT-4,54618164,3.1267558882512803
NCI-H929,54639665,4.443848049019438
KHM-1B,25150857,0.9778770077521932
HCC1833,46907787,1.8265768936236628
MHH-CALL-4,11214940,2.055181704405491
T84,44607531,1.15410240858558
EJM,navitoclax-piperlongumine (1-1 mol-mol),0.8895676752169835
KYSE-30,702558,5.304254208785751
SNU-119,9823820,3.989816323435888
NUGC-4,25195348,2.4163542852679627
SK-LU-1,11175137,3.4005743318448505
L3.3,52947716,-5.849313058865459
ECC10,71466380,3.102337810860152
HCC1833,navitoclax-piperlongumine (1-1 mol-mol),-1.243387595200138
NCI-H2171,3689413,-2.7117222930063867
BT 416,327653,3.217588277124403
KYSE-30,25126798,4.108886282415501
KO52,54613361,-1.011400617715983
EJM,252682,5.970760325898544
CFPAC-1,9903786,2.8562781406669653
NUGC-4,3384730,5.191546490040968
ECC10,BRD-A02303741-navitoclax (2-1 mol-mol),-1.476976659663081
KYSE-140,16741245,4.523769759341886
CFPAC-1,5566,3.187771404144167
KHM-1B,9840324,5.635096396232016
ALL-SIL,11152667,-2.075218964097288
CFPAC-1,navitoclax-pluripotin (1-1 mol-mol),-0.2248940086536964
MHH-ES-1,docetaxel-tanespimycin (2-1 mol-mol),-7.91882107766102
L3.3,16725315,5.215482090576187
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589
NCI-H929,selumetinib-MK-2206 (8-1 mol-mol),-0.3553721950271566
NCI-H2087,5287620,-1.8390285468902192
BT 416,252682,7.265562385795986
KO52,49766530,-2.9689315906411413
SNU-119,9866186,2.2038278212817652
HD-MY-Z,16736978,1.52186678045542
RCM-1 [Human rectal adenocarcinoma],5328940,2.0329581384082944
Mino,1716436,1.8287087640560211
EJM,72193861,-0.1961911914583163
IST-Mes1,sirolimus-bortezomib (250-1 mol-mol),2.2264590257726704
K-562,4477,-0.1635303329058878
HCC1833,73707398,0.9424461947301042
BT 231,387447,-4.897581630448022
BT 231,4096211,0.5779460379075206
REC-1,119607,3.5916178398125065
BT 231,navitoclax-pluripotin (1-1 mol-mol),-1.1237359287095805
LS411N,46191454,1.665967132338862
NCI-H2122,11404337,0.2982247321371532
TCCSUP,5566,3.1120135973832386
Calu-1,53232,0.6964675179781098
EJM,navitoclax-sorafenib (1-1 mol-mol),1.3600415783658448
TCCSUP,alisertib-navitoclax (2-1 mol-mol),-0.001751015596035
SCC-9,100016,6.423023301160456
TCCSUP,439501,-2.3382973857263893
NCI-H2087,56963564,0.923231167959068
SW1116,5281321,-0.8565872780521203
KYSE-30,3543504,4.7477636754283195
RCM-1 [Human rectal adenocarcinoma],135398738,5.665186147666449
RT-4,24180719,5.152911409441223
YD-8,6610216,4.600166157453743
SNU-119,5479543,5.507463423789633
T84,11222830,1.47223603941253
GP2d,49793307,-2.268582178324036
YD-8,decitabine-navitoclax (2-1 mol-mol),3.994685595112437
HD-MY-Z,421610,3.681784635747525
BT-20,serdemetan-SCH-529074 (1-1 mol-mol),2.974659887947634
LP-1,JQ-1-navitoclax (2-1 mol-mol),-1.7452336232878392
SK-LU-1,3552672,4.237005613143791
SKM-1,4477,0.924139002455618
BT 416,24901704,2.6065092647107817
LP-1,11396600,4.222971690174634
SW1353,46224516,3.6109228657214576
Calu-1,262093,2.8993991941012704
Calu-1,9823820,6.28527903751675
HD-MY-Z,vorinostat-navitoclax (4-1 mol-mol),0.981473170149335
RCM-1 [Human rectal adenocarcinoma],46843906,3.578406808206158
KHM-1B,5311281,2.058534783362704
Calu-1,11167602,2.6874692075040816
BT 416,9929138,7.415658440710529
NCI-H2171,19582717,3.772812394316534
SW1353,24753719,5.958124958528096
NMC-G1,53232,3.926738303476471
MHH-CALL-4,16736978,1.9553583037238351
NCI-H2122,17755052,1.779448574610522
PL-21,JQ-1-navitoclax (2-1 mol-mol),0.023163990374476
IST-Mes1,vorinostat-carboplatin (1-1 mol-mol),3.785712345618982
YH-13,66577038,3.5409561648626293
BT-20,decitabine-navitoclax (2-1 mol-mol),3.5060527216071997
SCC-9,148198,-2.735497552895971
MHH-CALL-4,327653,2.3339923757908028
KYSE-140,4917,3.137904679918754
NCI-H2087,navitoclax-gemcitabine (1-1 mol-mol),-3.182155221646003
BT 231,246676,5.655367787950382
HMCB,44589607,2.914653389177592
NCI-H929,3634881,1.384558879628874
BT-20,122327,4.227839142294907
GA-10,53301938,3.6520495291012742
RCM-1 [Human rectal adenocarcinoma],3854666,3.226193389725711
RT-4,selumetinib-UNC0638 (4-1 mol-mol),3.4689576164003664
KYSE-30,5351362,1.0039779133714108
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424
HD-MY-Z,23725625,3.126238160654845
BT 416,JQ-1-carboplatin (1-1 mol-mol),0.4698269492624847
T84,31703,0.0903923805840869
GP2d,10113978,2.0889156085813134
TCCSUP,24771867,2.435510206237169
IST-Mes1,16736978,2.528104664048346
KMS-12-BM,3025986,-1.3403296282767831
MHH-ES-1,11178236,-5.175056089374598
KHM-1B,3384730,0.7492899060268451
T84,135875424,3.2008335504024963
BT 231,7251185,1.587898220909823
TCCSUP,53481919,3.87542192202802
SK-OV-3,54618771,2.5849230632376923
NCI-H2087,3038522,2.60371249468015
LS411N,168313047,3.2811764574410893
L3.3,5351362,1.6156165657787482
Mino,45279963,2.5079787628894095
Mino,selumetinib-UNC0638 (4-1 mol-mol),3.4058404706720844
NCI-H2122,11507802,2.226427960261829
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456
SK-MES-1,JQ-1-navitoclax (2-1 mol-mol),1.2191460374401153
LP-1,67291369,1.7400492546958437
SK-HEP-1,11494412,3.332434654266433
SKM-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.830110061350853
SW1353,3101542,4.402736775889611
YD-8,9952709,3.080336399855263
IST-Mes1,1566236,1.9315527075511711
Hs 936.T,46843906,3.318589545634005
IST-Mes1,selumetinib-piperlongumine (8-1 mol-mol),4.502033014563436
BT 416,9933475,1.6205456078526836
MHH-CALL-4,sirolimus-bortezomib (250-1 mol-mol),0.7403590273968818
PL-21,selumetinib-GDC-0941 (4-1 mol-mol),-0.6617204641483091
SNU-119,4917,2.930723431336195
GA-10,2746,0.7729221646050856
GA-10,1239801,1.5398465202798377
BT 416,3543504,3.4553880004726403
BT-20,4521392,4.543976111320099
SNU-119,208908,1.7146109385017043
ECC10,72734382,2.241944719655817
RCM-1 [Human rectal adenocarcinoma],11396600,4.9998303274937115
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776
NCI-H2087,navitoclax-PLX-4032 (1-1 mol-mol),2.2567362219764493
GA-10,9929138,4.091985168387067
OCI-M1,9887053,4.165081662028765
HD-MY-Z,25183872,-1.7793500590131532
TCCSUP,2729026,2.469162640243315
BT 416,3634881,0.3297641828259731
HCC1833,6852167,3.1486831435900164
KYSE-30,135999136,4.4123994381842415
SK-MES-1,JQ-1-vorinostat (2-1 mol-mol),0.5044165020935187
KYSE-30,107970,2.3754255446432935
T84,448949,1.658889589965805
RT-4,44632017,1.2730155033067565
TCCSUP,5287620,-1.0602115166818715
MHH-ES-1,135398738,2.7768094519124227
SW1116,6438330,2.8803790171028996
SNU-119,6917907,-5.873983095672985
KYSE-140,10127622,3.4153277269451547
ECC10,24753719,4.390592261959423
NCI-H929,5746,0.47536469132715
IST-Mes1,119607,5.839609606963759
Mino,42642645,-0.9713328397694244
GA-10,11612883,1.5633956339057955
KHM-1B,25126798,3.5572512627861053
HuNS1,19582717,3.685057579245595
Hs 936.T,44185566,3.0518971481058808
RCM-1 [Human rectal adenocarcinoma],tretinoin-navitoclax (4-1 mol-mol),-2.5028847208859637
L3.3,25126798,4.136340325033448
SK-HEP-1,135440466,3.4774178685499324
SK-HEP-1,123631,3.617013696107864
PE/CA-PJ15,11152667,-0.7034244137409247
NCI-H2122,11238147,3.9928344459086023
TCCSUP,2733487,6.902368396257458
Hs 936.T,navitoclax-pluripotin (1-1 mol-mol),1.236795538799037
L3.3,9956119,3.8207787288773063
HCC1833,23635314,2.928134882513868
EJM,60700,-2.1593175727596856
KYSE-140,selumetinib-MK-2206 (8-1 mol-mol),2.896831418888764
SK-HEP-1,6852167,5.53454213252302
EJM,16659841,3.8654950259269056
BT-20,navitoclax-piperlongumine (1-1 mol-mol),2.0184591020328786
BT 416,135398516,2.763388121155061
SK-LU-1,tanespimycin-bortezomib (250-1 mol-mol),1.5987534653894475
RCM-1 [Human rectal adenocarcinoma],11494412,4.241721696176272
ALL-SIL,42642645,-2.33031271995146
KYSE-30,2842253,6.137174329438131
NCI-H2087,crizotinib-PLX-4032 (2-1 mol-mol),1.521255189386394
Mino,168313016,3.695449207711372
MHH-ES-1,119607,4.978182328627944
SCC-9,44566777,0.4714703461280546
MHH-CALL-4,3384730,1.5222719075455695
KYSE-140,66577038,3.6009367398198906
K-562,6914657,-3.91828110768511
NCI-H929,5470400,-1.7946579824155076
BT-20,1750826,-4.511014172182052
HuNS1,44632017,0.6075813626152662
HD-MY-Z,BRD-K55473186,4.414282184814065
PANC-1,53495165,-0.3514680394492745
BICR 31,16065773,3.973194001978765
NCI-H929,crizotinib-PLX-4032 (2-1 mol-mol),1.1143694059459794
EJM,375860,-0.4454409247993169
REC-1,24771867,5.565042494395041
KYSE-140,docetaxel-tanespimycin (2-1 mol-mol),1.7130185974037202
BICR 31,11427553,1.8414471938085448
KHM-1B,25195348,3.649934480073114
SK-MES-1,10296883,3.8789679823498178
EJM,6918837,-5.817810388992218
L3.3,3385,2.739789505554014
ECC10,65064,5.060312611621768
NCI-H1395,11228183,4.844045820829891
YH-13,11152667,0.725065654418547
BT 231,24821094,1.227994651739791
NMC-G1,11222830,3.0570111131602573
ALL-SIL,3815108,1.81429533281988
BT 231,11152667,1.8482025461380396
BT 231,navitoclax-MST-312 (1-1 mol-mol),0.961597338682918
Hs 936.T,71304818,2.8583076383201247
BT 416,11257553,0.2550979597596211
SKM-1,56946209,-5.085207204294124
ECC10,JQ-1-UNC0638 (2-1 mol-mol),0.3935002825867998
BT 416,54143018,-1.2974031637375136
HMCB,57519531,4.328338374820244
BT-20,31703,0.2519913088470299
KP-N-YN,44607531,1.491994031486724
CFPAC-1,107985,-2.993539279710045
SW1116,4259181,0.852960615063059
BT 231,46199207,1.5189461629253225
T84,4917,2.265997493418996
ECC10,24180719,2.258488342196553
MHH-ES-1,3825829,3.024649062845587
ECC10,25183872,-1.2814923187653804
LS411N,11626560,1.8283516183370416
NUGC-4,6852167,2.041234695282504
ALL-SIL,56946209,-4.755076906810128
BT 231,135421197,1.0763175924586934
PE/CA-PJ15,327653,3.705959138945344
YD-8,3634881,3.215634292733124
BT 416,11657048,4.384440738652228
NCI-N87,400769,-1.2757727144105298
Hs 936.T,1242560,4.616869641739925
SKM-1,10385095,0.5930890296191716
PL-21,15953870,2.570096406228743
SW1116,46174525,4.7134586112168
KYSE-140,9967941,3.8872933830485183
NCI-H1395,387447,-2.916256020115362
GA-10,46224516,0.9928042950512632
CFPAC-1,46398810,2.571677117704187
KHM-1B,241158,2.5921165995346565
L3.3,selumetinib-piperlongumine (8-1 mol-mol),4.6860683758170145
SK-OV-3,6610355,6.222226160480143
K-562,44489675,3.6585617881709585
KHM-1B,selumetinib-GDC-0941 (4-1 mol-mol),-0.3982194737494156
KMS-12-BM,15983966,-6.367162129369465
KHM-1B,9866186,-0.1943937509034402
KO52,327653,2.901066573817011
NCI-N87,702558,5.013224249903468
NCI-N87,24772860,-4.531203546207334
Calu-1,11612883,3.767165022642054
T84,23635314,-2.5908952264810012
T84,3081361,1.3201511351081645
SK-MES-1,44566777,0.9018703552695456
NCI-H929,44185566,1.267263970973427
Hs 936.T,4261,1.9122484606144865
YH-13,12001922,2.42245560318508
LP-1,25150857,1.2202961462080766
PE/CA-PJ15,4788,5.865158053674836
MHH-ES-1,219104,3.5100690273741377
ECC10,54649381,3.5357027767335616
ALL-SIL,44589607,0.5481515481681011
SK-MES-1,51039095,1.8869338171299388
NCI-H2171,5281321,-4.274427204887198
NCI-H929,11152667,-0.508669926836867
RT-4,5287620,-2.3596459820452376
Mino,3552672,3.474584960640692
ECC10,56946209,-5.124252025083172
NCI-H2087,72734382,3.5931106239496544
Hs 936.T,2746,2.6919045473185284
SK-MES-1,24748573,1.8548465143185875
RT-4,51039095,3.6513947715077135
KYSE-140,5113032,5.221505491332799
L3.3,66577038,3.645952100238679
SCLC-21H,46926350,-4.457827394922709
MHH-CALL-4,6918736,-1.6730980021902548
NCI-H1395,selumetinib-BRD-A02303741 (4-1 mol-mol),5.369939363502549
YD-8,vorinostat-carboplatin (1-1 mol-mol),3.421403122872885
HCC1833,6610355,4.659381362710915
CFPAC-1,3854666,3.9218760682690545
BT 231,5335621,4.988733991945575
IST-Mes1,135440466,1.140650487435685
Mino,3136844,3.4566917217945163
KO52,71576739,5.251943964885362
BT-20,16013152,4.180428329825768
NUGC-4,9903786,1.3800210436357438
SNU-119,439501,-2.3303537311085143
SW1353,JQ-1-MK-0752 (1-1 mol-mol),1.5140865441275937
TCCSUP,11647372,0.3076356003247925
SK-HEP-1,219104,4.349330089087446
NCI-H2122,136227924,3.797810316623325
NCI-H2122,71304818,3.109005245074252
SW1116,JQ-1-carboplatin (1-1 mol-mol),-0.0144510957041741
T84,208908,1.686566699284744
EJM,crizotinib-PLX-4032 (2-1 mol-mol),1.5260381375566714
CFPAC-1,3825829,4.805499515472961
SKM-1,439501,-2.678240610691138
YH-13,409805,5.8043407056117395
NCI-H2087,60750,-3.040361684562255
PE/CA-PJ15,11497983,5.527040483901927
KMS-12-BM,24180719,3.687281269749717
RT-4,10427712,4.289155491450476
OCI-M1,3025986,1.084905074875324
SK-LU-1,54649381,4.2563598308568285
GA-10,426756,2.525129245445353
SK-LU-1,2858523,3.1336813925975333
NUGC-4,alisertib-navitoclax (2-1 mol-mol),-1.3804805518108856
SK-OV-3,23582824,0.9299959314677436
GP2d,BRD-A02303741-navitoclax (2-1 mol-mol),-1.697407946696108
CFPAC-1,6918328,1.8295469168914251
LS411N,25183872,0.0970121311419586
RT-4,9956119,3.103226813532622
MHH-CALL-4,67291369,-0.0654909371665785
OCI-M1,navitoclax-MST-312 (1-1 mol-mol),0.8894292054909885
K-562,1716436,3.607306146681396
NCI-H2122,53232,3.139264153576602
EJM,675434,4.21924619538193
OCI-M1,10184653,1.704903735514341
LS411N,44607531,1.9881484499388475
NUGC-4,ISOX-bortezomib (250-1 mol-mol),-0.7972823034465618
SK-LU-1,1716436,2.837995818679175
KMS-12-BM,tretinoin-navitoclax (4-1 mol-mol),-1.130622835397235
SW1353,9926054,2.273911586274605
Mino,5287620,-1.644304692772357
SK-HEP-1,2746,4.04921422913523
ECC10,crizotinib-PLX-4032 (2-1 mol-mol),2.0662207118247267
MHH-CALL-4,navitoclax-gemcitabine (1-1 mol-mol),-5.710044400444586
T84,9823820,3.571639511837854
L3.3,4259181,-1.5745308976200183
IST-Mes1,4477,0.8135431021107292
SKM-1,3503,1.2893215840676688
BT 416,219104,3.4522586169673732
REC-1,25102847,2.749185219775311
KO52,4917,3.71660896485238
HMCB,2871966,0.8621861028027487
T84,135999136,4.269750359734968
HCC1833,15547703,1.746479245305281
SNU-119,vorinostat-carboplatin (1-1 mol-mol),4.187778089555317
PL-21,11612883,1.475637296729497
Mino,crizotinib-PLX-4032 (2-1 mol-mol),0.5449253612491881
ALL-SIL,1641662,2.105441320822025
ECC10,5280436,2.687154631407107
HMCB,262093,2.6900614407313355
SK-LU-1,JQ-1-carboplatin (1-1 mol-mol),2.4628830674055933
HuNS1,2113511,5.798232076901374
KO52,89928392,0.7106504990592801
LP-1,selumetinib-MK-2206 (8-1 mol-mol),1.166880524291129
LS411N,11175137,2.6624545374598
KYSE-30,JQ-1-navitoclax (2-1 mol-mol),3.0942512739983075
REC-1,25154868,4.640862968305209
T84,42611257,3.273170358147939
NCI-H1395,100016,6.569605836811141
T84,5329102,1.7772760283968396
NCI-H2087,10172275,3.646616070607715
SNU-119,23635314,-0.7073360701887041
KYSE-140,11485656,2.138414918607982
Mino,9952709,2.0285527321317787
KMS-12-BM,54649381,3.2424778032361186
KMS-12-BM,1317464,5.551631719777859
SNU-119,11609586,3.0973958164397013
KYSE-140,11427553,3.4871012359964246
YH-13,49793307,-1.1961754726416267
HMCB,67156097,-0.9353963085848984
NCI-H2087,2708,4.08112740143676
MHH-ES-1,4096211,0.7969488792862363
BT-20,46215462,2.6540326443304227
TCCSUP,10127622,5.496019179334474
HMCB,piperlongumine-MST-312 (1-1 mol-mol),1.358280026891677
HCC1833,11396600,5.135041940263416
T84,9868037,2.575833887310964
TCCSUP,2742550,3.882646249663198
HuNS1,66577038,2.762840038277969
KO52,4259181,-1.031664922111082
HD-MY-Z,100016,6.5820470291511555
NCI-N87,65628,4.009039012864223
NCI-H2122,3385,0.8929689122505158
NCI-H2171,136227924,2.167829841056951
SK-HEP-1,5470400,0.5577708849126581
K-562,6918837,-4.262812875828109
KMS-12-BM,BRD-A02303741-navitoclax (2-1 mol-mol),1.0941472093440388
SK-MES-1,5738263,2.7320724449331135
KYSE-30,24775005,4.18237064419158
CFPAC-1,10074640,2.9685612383110027
ALL-SIL,124202324,0.3755400921280209
YH-13,54618771,3.881155680896358
HuNS1,135398738,4.537175919177802
SKM-1,107970,2.3266449159028735
SNU-119,9840324,5.792176147063417
KMS-12-BM,5479543,3.250022203761556
SW1353,613753,4.1194502062698035
HMCB,6918736,-3.5722803082985064
GA-10,135984461,1.4208058611129633
Mino,46199207,2.059032191745762
PL-21,151289,0.4265213506561994
KYSE-30,16720766,-0.661471894862819
Hs 936.T,3011155,6.159332802897177
BT-20,51039095,3.742292656381169
OCI-M1,9967941,4.112605002198731
NCI-H2087,11152667,-1.020172453854182
BT 416,4261,2.359841858704966
NCI-H1395,9903786,3.8864807174358984
KMS-12-BM,23725625,4.892779562300822
SCC-9,2871966,2.1501352130214695
HD-MY-Z,448949,1.4690011383627
KP-N-YN,25161177,5.564243504890285
SK-HEP-1,5282054,5.2464488654660935
LS411N,24964624,2.837560916730962
SW1116,44493952,3.6651965103953175
SKM-1,57519531,1.204378273950668
NCI-N87,71466578,5.1108247117444865
BICR 31,637858,2.611871003184785
GA-10,46199207,1.836689947067024
YH-13,31703,-0.371701474811386
SCC-9,252682,6.244434841835944
SK-MES-1,9840324,7.102658728800513
KYSE-30,262093,2.7328983938102693
KO52,JQ-1-carboplatin (1-1 mol-mol),0.6520623811208981
BT 416,4705,1.1449833696295684
NCI-H1395,60700,0.9119898603788574
ECC10,51039095,0.7205250238384695
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944
NCI-H2171,navitoclax-piperlongumine (1-1 mol-mol),-0.1756857272470243
KP-N-YN,selumetinib-JQ-1 (4-1 mol-mol),4.653792080901046
KYSE-140,16736978,2.1763754897707948
NCI-H2122,selumetinib-GDC-0941 (4-1 mol-mol),2.3163159551655177
K-562,3854666,0.2872946014041473
PL-21,5746,1.9217174362285017
BT 231,BRD9876-MK-1775 (4-1 mol-mol),1.5153004262805043
NUGC-4,crizotinib-PLX-4032 (2-1 mol-mol),2.5455694224788235
HD-MY-Z,57519531,1.3061635973910235
Mino,400769,-3.7996984437734858
NCI-N87,448949,2.160730221150561
HD-MY-Z,navitoclax-gemcitabine (1-1 mol-mol),-4.35818801997287
KYSE-30,9936388,2.2895828136918785
Calu-1,9825149,3.1231289414125674
Calu-1,navitoclax-pluripotin (1-1 mol-mol),-0.1409584104782747
Mino,vorinostat-navitoclax (4-1 mol-mol),-3.5102193934911066
LS411N,31703,0.7183186901084707
LP-1,10427712,5.075637271535112
SCC-9,selumetinib-MK-2206 (8-1 mol-mol),2.3963375706124967
SK-OV-3,24797083,1.6169926593639932
GA-10,73707398,-0.3686666371597158
HD-MY-Z,54678924,1.49847513410549
NMC-G1,9952709,4.293654089959455
HuNS1,12003241,-0.810335190638815
NCI-N87,123631,-0.3933912143385343
KYSE-30,65628,6.48911885956441
KYSE-30,10074640,3.250354574556748
SW1353,5351362,1.1918603462651254
NCI-H2087,327653,2.6573092193564665
KYSE-140,5738263,3.046094413131976
OCI-M1,7251185,2.0083665320638615
SK-MES-1,11222830,1.6526635703216108
KMS-12-BM,2842253,3.641564107870781
KHM-1B,sirolimus-bortezomib (250-1 mol-mol),0.0402110157809841
SK-LU-1,10127622,4.503880955417533
SCC-9,5281321,1.285660121438517
GP2d,374536,-4.260499281053746
Hs 936.T,53495165,2.2442261716204626
HMCB,12001922,1.7530973363803413
NMC-G1,JQ-1-UNC0638 (2-1 mol-mol),2.869330384712891
L3.3,16722836,1.76831050763334
SK-LU-1,439501,-0.3728808637534341
PE/CA-PJ15,SNX-2112-bortezomib (250-1 mol-mol),-4.513784898683675
L3.3,16736978,2.121770338408602
LS411N,46199207,3.2917214979820506
KYSE-140,9929138,7.103811482735402
K-562,3081361,1.217245739162405
SK-OV-3,52912189,0.2062426244094619
CFPAC-1,11214940,1.8692111831900036
EJM,1641662,2.9948072583311567
NCI-H2087,11717001,2.25855533830727
GP2d,alisertib-navitoclax (2-1 mol-mol),-4.56666611807368
KMS-12-BM,5329102,1.2155421851150237
PL-21,6918736,-3.0441083085870906
NCI-H2171,135411,0.036573209368321
PANC-1,4705,3.930019058376023
SNU-119,11612883,2.57942029058091
SK-MES-1,25195348,3.2661293421813284
PANC-1,11214940,1.547872972010167
NCI-N87,navitoclax-MST-312 (1-1 mol-mol),0.8705289738440536
TCCSUP,73707398,0.9718071298936178
MHH-ES-1,6917907,-5.9680991761196385
Calu-1,135440466,3.0410869342334323
OCI-M1,44632017,0.925789355273566
NUGC-4,9907093,4.188508984285991
SCC-9,122327,5.629849115039079
KYSE-140,241158,3.465086029728998
KHM-1B,452548,-2.125621480774164
PL-21,3825829,3.2055348919547013
KHM-1B,6918878,3.029851495909813
SCC-9,24771867,5.065268858490301
MHH-CALL-4,54454,3.4877057430208445
PE/CA-PJ15,104842,-3.638454647557915
BT-20,4477,0.0033942253279343
Calu-1,10410894,2.4567989334427893
KMS-12-BM,1239801,3.0053615870296753
BT-20,36462,2.88431470758021
HuNS1,11964036,1.156631491823157
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609
GA-10,23725625,3.067561407276476
SK-HEP-1,1566236,1.7725788045776691
NCI-H2087,BRD-K27188169-navitoclax (2-1 mol-mol),2.996002246582284
REC-1,54618771,4.304155025574206
HuNS1,10074640,3.1290676418063463
EJM,54618771,0.5366367501744294
SW1116,54618164,3.73631090457485
NMC-G1,4477,2.107061176825984
PL-21,1716436,2.4873747277093625
NCI-N87,selumetinib-piperlongumine (8-1 mol-mol),3.3316492796689112
NCI-H2171,71466380,3.3392440967630797
REC-1,11625818,5.343350600184494
Hs 936.T,navitoclax-piperlongumine (1-1 mol-mol),3.0603763402881183
YD-8,4917,3.030228999243137
Calu-1,7251185,1.778501404150549
LP-1,89183176,3.7043248510771094
KYSE-30,5282054,4.002334252076739
KMS-12-BM,444795,2.0247311602920415
GA-10,49836020,3.868484173874789
LP-1,227681,1.8153333384208528
HD-MY-Z,25154868,4.524711016046434
ECC10,9956119,3.663338106346823
ECC10,10385095,1.0735709305574426
EJM,135875424,3.8151689174566665
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127
SK-HEP-1,66577038,3.45712203265648
SK-MES-1,11238147,2.742463875479474
T84,135440466,1.5143239825459482
SK-MES-1,JQ-1-UNC0638 (2-1 mol-mol),0.4518091140046482
T84,1566236,1.6536979341568203
KYSE-140,136227924,3.3753020930843065
SK-OV-3,1716436,3.636442167288748
MHH-ES-1,44487061,4.641945635218892
HCC1833,53245473,3.7321256171004977
SNU-119,10322450,3.771322180088625
GA-10,12001922,1.1091305368788935
Mino,9866186,-1.1603525203531226
K-562,6450551,-0.0734681627771844
HuNS1,44137675,3.505602181641379
CFPAC-1,25262965,-1.2217784611201217
HD-MY-Z,5291,3.807982262852603
KP-N-YN,55508,1.879684304428932
MHH-ES-1,crizotinib-PLX-4032 (2-1 mol-mol),1.014983763755841
NCI-H2171,sirolimus-bortezomib (250-1 mol-mol),0.0870413029192065
MHH-CALL-4,246676,1.7310022839692016
BT-20,2742550,3.667982838644888
CFPAC-1,25183872,-0.6626899547334446
KHM-1B,1242560,-1.3628719812202528
EJM,4705,3.167336091742425
OCI-M1,984333,-0.2349308912523499
SK-MES-1,135875424,4.094460625120135
NCI-H2122,46174525,5.185593028622521
YD-8,208908,2.493595047729409
SKM-1,135875424,3.1648969740603095
L3.3,53495165,2.194695518305113
BT-20,54596490,5.325824832549944
KHM-1B,25154868,3.944420162324233
HCC1833,637858,1.485454068401974
NCI-H2087,navitoclax-birinapant (1-1 mol-mol),2.29709394708139
SK-OV-3,3503,3.0304882575129497
KYSE-140,216345,4.049198379726989
HD-MY-Z,2126,4.1342901161268735
KYSE-30,piperlongumine-MST-312 (1-1 mol-mol),2.141798214488037
BICR 31,1566236,4.637821170940002
EJM,selumetinib-tretinoin (2-1 mol-mol),5.075808196107974
NCI-H2087,49836020,4.38375865979883
K-562,5287969,-0.8630520858269013
BICR 31,6917907,-2.0849244140580683
BT 416,148124,-5.33137477776155
NCI-H929,docetaxel-tanespimycin (2-1 mol-mol),-5.802184770793407
ECC10,9936388,-3.931527167718931
YH-13,24797083,1.5819702777514613
NCI-N87,15953870,2.623738434863841
IST-Mes1,31703,-0.6384703159849433
RCM-1 [Human rectal adenocarcinoma],6450551,4.167380741941181
NCI-H1395,168313016,6.368341181188219
SNU-119,6610355,4.422886164754199
EJM,219104,2.2100971150413264
NCI-N87,176870,1.1060804163410003
T84,613753,2.628283712526202
PL-21,10296883,3.1495852903666623
BT 231,11234052,3.9481879292065143
RT-4,444795,5.14749831666829
K-562,3025944,3.938999685525622
NCI-H2087,44507138,1.5136875847969675
NCI-H2122,3854666,2.0598225653016424
RCM-1 [Human rectal adenocarcinoma],10410894,5.33973414369723
SNU-119,24951314,2.332589086371041
RT-4,navitoclax-sorafenib (1-1 mol-mol),1.0712554861689316
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555
Mino,5284616,-4.806590873776145
NCI-H1395,25161177,5.627463134287728
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434
NCI-H2087,11647372,0.3372259437443828
GA-10,135999136,3.782942361648187
HD-MY-Z,9911463,3.453159994393753
ECC10,71680916,3.9791491844348426
TCCSUP,446155,1.4238340154074924
MHH-ES-1,11964036,0.210018877887797
NCI-H1395,24771867,4.164021178387528
Calu-1,decitabine-navitoclax (2-1 mol-mol),2.4404461247177354
BT-20,387447,-3.8237379342261018
PANC-1,11507802,1.1832214916072272
SNU-119,vorinostat-navitoclax (4-1 mol-mol),2.3396657030551684
KP-N-YN,navitoclax-piperlongumine (1-1 mol-mol),0.681945942048365
MHH-CALL-4,23725625,1.8543776619356969
IST-Mes1,46215462,2.5624084058363676
T84,446155,1.923376613513834
SNU-119,9911463,2.8532899111041385
KMS-12-BM,24797083,1.2365117165456094
GA-10,6438330,0.1630046366944086
RCM-1 [Human rectal adenocarcinoma],24901704,4.114962911798603
NCI-H929,66577038,3.051859645281257
GP2d,selumetinib-BRD-A02303741 (4-1 mol-mol),-0.0828698318616823
IST-Mes1,46843906,1.738626305357275
Mino,119607,3.8332759469198248
Mino,selumetinib-decitabine (4-1 mol-mol),-0.4110450400232648
K-562,57330099,5.557476297558147
NUGC-4,969516,3.4391937339019067
SK-MES-1,262093,3.241171035364572
MHH-CALL-4,135398516,1.9207641599358891
BT-20,selumetinib-JQ-1 (4-1 mol-mol),4.7209808702572
MHH-ES-1,52947716,-4.672293364144294
HuNS1,tanespimycin-gemcitabine (1-1 mol-mol),-4.877832535131223
K-562,107970,1.9304513771469212
SK-MES-1,navitoclax-gemcitabine (1-1 mol-mol),-4.253259821770174
SK-MES-1,72734382,4.43746428917745
KO52,25102847,1.7246116477249929
SK-HEP-1,45279963,4.052806603396004
MHH-CALL-4,11717001,5.4063802043279425
ALL-SIL,4259181,-1.3200126273341632
HMCB,4259181,-1.3658440890199388
KYSE-140,9911463,3.6059267318888817
SW1353,6505803,0.3759495055091644
HMCB,10296883,4.337758420607625
SKM-1,24821094,1.9211007905225637
K-562,11317348,0.8853213314815674
PL-21,11214940,3.808129382949849
YH-13,10113978,4.558059650015548
NCI-H2087,5702613,2.9937660422427625
SW1116,5282054,3.6747840983488143
NCI-H929,9907093,2.342525327576932
OCI-M1,148124,-5.179396495011338
BT 416,135421197,2.461654603646364
EJM,285033,-3.245893351127227
NCI-H929,12001922,1.6200785055416655
ECC10,72193861,-0.1870462533605398
NCI-H2171,44202524,1.9759332673432517
RT-4,11427553,3.5858806335596483
KYSE-30,6917907,-8.298008793420593
GP2d,613753,3.096410178772738
HCC1833,676352,2.1839703055749347
MHH-ES-1,5738263,2.950604694605738
Calu-1,54454,2.6765198253795988
NCI-H2122,3825829,3.800201671004512
NMC-G1,10127622,5.908625386269528
TCCSUP,9936388,1.8313124822353004
RT-4,135928012,3.02526945611553
KMS-12-BM,2742550,3.02175924738708
ECC10,24964624,1.4251286334973416
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804
SCC-9,71751553,4.89059631642312
PL-21,54613361,-1.4002992751840675
KP-N-YN,selumetinib-PLX-4032 (8-1 mol-mol),4.663241098107434
TCCSUP,11234052,4.361103658415106
YH-13,54143018,0.7752211198324802
BT 231,9933475,1.574194986358974
MHH-CALL-4,441298,4.422901817483269
HMCB,16736978,1.7637750571409103
LP-1,19582717,2.7038748878741883
KYSE-30,3689413,-2.4041486305877497
NCI-H929,3384730,2.4908246089676385
KMS-12-BM,9823820,3.407131386822144
LP-1,11497983,3.8813874298045103
GA-10,10127622,5.164536017571027
LP-1,262093,1.1866363383040155
HD-MY-Z,60750,-4.237972819693724
TCCSUP,6918328,-0.4251652651497192
LS411N,36462,3.380504085081747
REC-1,11238147,6.148625364557363
SCC-9,5287969,-2.1272191034883874
PL-21,10113978,2.943320108374954
LS411N,10074640,3.3220574057236876
PE/CA-PJ15,1716436,3.7079819536891554
CFPAC-1,15983966,0.9754927696795276
Hs 936.T,10302451,3.751378963953563
BT-20,10184653,1.801032005065934
PL-21,9929138,5.81570058531176
SK-OV-3,42642645,1.640931292575566
HCC1833,262093,2.988096800875125
K-562,17755052,3.8994339695870326
NCI-H2087,23582824,0.1178919889770711
SW1353,44202524,1.4836033309704788
NCI-H1395,148124,3.756905797674181
SK-MES-1,2113511,7.634209304454373
HCC1833,11364421,0.4065258184514193
NMC-G1,9444,4.482367294957566
NCI-N87,2749,1.4538564926114168
KYSE-30,11175137,2.6632433593524807
PL-21,9866186,0.3070712131756914
LP-1,11609586,2.2863883054682455
OCI-M1,selumetinib-JQ-1 (4-1 mol-mol),-0.1559464569185333
TCCSUP,44185566,2.4741695937363506
EJM,71466578,1.4924180595408962
ECC10,53392493,1.1077776401623702
OCI-M1,56649450,4.377361178815417
BICR 31,46843906,2.802485697538939
KO52,5978,-3.230844863320846
EJM,9866186,0.2932895588367603
SNU-119,73707398,0.7345911888158907
MHH-CALL-4,176870,3.1265641019875017
SKM-1,selumetinib-navitoclax (8-1 mol-mol),-0.63098338976802
MHH-CALL-4,9911830,3.172534584054814
GP2d,24771867,-2.9334511642290906
PE/CA-PJ15,5329102,2.2036522902454454
REC-1,53392493,3.37260858409881
PE/CA-PJ15,10322450,4.3579745096101075
SK-HEP-1,11214940,1.8009666315936252
BT 416,374536,3.9740957780448474
SK-MES-1,45279963,3.691661981161022
REC-1,9866186,2.788920837091142
L3.3,9926054,1.9335911906728165
BT-20,11977753,-0.3700593634160474
T84,6917907,-7.676756739661601
YD-8,crizotinib-PLX-4032 (2-1 mol-mol),1.7734837444184717
L3.3,54143018,0.1799627669965377
HMCB,4096211,2.0391547918713626
KO52,9884685,2.8647583667584553
NMC-G1,51039095,2.8675268354192034
PL-21,decitabine-carboplatin (1-1 mol-mol),2.2769583510283766
NCI-N87,2841722,4.410495760007658
SKM-1,2858523,3.0530773935068836
SNU-119,9884685,1.7075636021097025
BICR 31,23725625,6.004496967521932
KO52,56973724,2.0714628306435507
Mino,11228183,-4.3465114919290455
EJM,3038522,1.9147262325597951
SCC-9,4788,5.928282303581182
BICR 31,11647372,2.8607835505972035
NCI-H929,JQ-1-navitoclax (2-1 mol-mol),-1.7995914527242012
YD-8,9915743,1.4308611377432014
T84,3038522,2.388935278881086
HD-MY-Z,46215462,1.652257308567236
OCI-M1,5978,-3.115681059781749
Mino,24180719,3.160868152372625
NCI-H2171,BRD-A02303741-navitoclax (2-1 mol-mol),-0.1592201049133759
PL-21,11626560,0.5650731916807197
SKM-1,46224516,2.679988010860087
NCI-H2087,656346,0.9019460322092954
NCI-N87,5470400,-1.6354434063399317
YD-8,JQ-1-UNC0638 (2-1 mol-mol),2.771778742465765
Calu-1,49766530,-2.4151861357185056
GP2d,19582717,3.6894844245255625
GP2d,11964036,0.6027881479397249
EJM,71466445,3.872070794685453
T84,11609586,2.3226025543366893
Mino,9907093,3.3998483837898323
BT-20,10074640,3.7988980994885018
KMS-12-BM,5351362,1.0681546231333583
BT-20,5460769,5.85454688440853
HMCB,216345,4.536008903536929
BT-20,126941,-4.14245284448656
NCI-H2122,168312962,3.275266313560697
YH-13,702558,5.825874792265712
BT-20,46907787,4.606441667420873
SK-LU-1,44491742,5.866940990531296
SK-MES-1,448949,1.5073704862606438
BT 231,31703,-0.5942880064496666
HD-MY-Z,54626689,4.2520115750124345
YD-8,24889392,3.1391484247952777
MHH-ES-1,decitabine-navitoclax (2-1 mol-mol),0.3840284416361282
MHH-ES-1,6914657,-7.413019962986384
KHM-1B,216468,0.1436700661739532
GA-10,alisertib-navitoclax (2-1 mol-mol),-2.6187240497600612
LP-1,16013152,3.391607745925794
SNU-119,56946209,-3.841507017590091
SK-HEP-1,5278396,4.037206436677834
Hs 936.T,selumetinib-JQ-1 (4-1 mol-mol),1.8156081078118131
EJM,erlotinib-PLX-4032 (2-1 mol-mol),3.5502108693148973
YH-13,36462,2.0221735206643743
MHH-ES-1,5746,-2.309579664404326
ECC10,selumetinib-vorinostat (8-1 mol-mol),1.623685100455314
K-562,4705,3.481256778033869
OCI-M1,4096211,1.679277366992696
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658
NUGC-4,73707398,1.4695211141371651
CFPAC-1,31703,0.0404071328923643
YD-8,9911830,1.9962756690281929
NCI-H1395,11612883,3.2235820919891256
T84,25227462,-0.2167636031889614
SK-MES-1,65064,3.0537577796694557
NCI-H1395,6918328,1.6549046673815768
SKM-1,6438330,1.742877849242422
Mino,12003241,-3.278689335869641
L3.3,135875424,3.974579804692541
YH-13,5281321,-2.463748915985143
ECC10,vorinostat-carboplatin (1-1 mol-mol),1.1782057622716309
KMS-12-BM,16722836,0.1078471440950463
CFPAC-1,12001922,1.889915230102209
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078
LP-1,25102847,1.522080291124844
KYSE-140,10302451,0.062632955772706
T84,3062316,0.2914539988972143
GA-10,tanespimycin-gemcitabine (1-1 mol-mol),-4.877538896744229
KO52,9803433,5.79600278203547
YD-8,selumetinib-UNC0638 (4-1 mol-mol),2.6843150773739453
NCI-N87,11455910,1.6652699053284308
ECC10,6852167,1.422945191083627
OCI-M1,262093,1.0880796533665364
HD-MY-Z,9956119,3.802330177889949
GP2d,4705,2.380546540309972
SW1353,10113978,2.9377138337183117
T84,89928392,0.6196899459253532
SK-LU-1,9911830,2.3624970438658144
OCI-M1,3062316,2.093911861880763
OCI-M1,6918328,-0.9975741150767292
NCI-H1395,6450551,6.187307607667542
SK-MES-1,42611257,3.5010761493856863
Calu-1,sirolimus-bortezomib (250-1 mol-mol),1.450698493515476
K-562,12001922,1.1213264373636214
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053
NCI-H2087,89183176,4.0521764184690925
L3.3,44632017,1.809753180552785
KHM-1B,selumetinib-UNC0638 (4-1 mol-mol),2.050672890925013
Calu-1,44589607,3.4237796729931658
RCM-1 [Human rectal adenocarcinoma],4788,6.143393528563881
LP-1,SNX-2112-bortezomib (250-1 mol-mol),-2.2494135547577923
CFPAC-1,49793307,-2.0584035538508947
SW1353,5978,-1.6024908854671944
PL-21,11647372,-0.7935257644567679
KHM-1B,5566,2.2801989314066637
L3.3,984333,-1.3131333034824293
SNU-119,445091,4.135214962682557
EJM,1566236,1.0332712944799087
BT-20,168313307,4.416530392456532
HMCB,4788,5.563501322279771
HD-MY-Z,salermide-PLX-4032 (12-1 mol-mol),5.199311330975796
SK-LU-1,7326481,2.380871716185953
PL-21,637858,1.6083768268340104
SK-OV-3,11178236,-2.424602318267421
HMCB,613753,3.1872639599039188
NUGC-4,10184653,-3.64577572293382
PL-21,6252,-5.813775569035407
ECC10,3384730,0.8163000934908424
LP-1,216239,1.3305282587818508
PL-21,3854666,0.4528352950899395
KP-N-YN,6918837,3.656852965324674
IST-Mes1,11222830,1.7720886037954378
GA-10,148198,-7.740276698759935
HD-MY-Z,53392493,1.9067521803202752
NCI-N87,11485656,1.873926788766734
ALL-SIL,421610,2.937759224643201
PL-21,11152667,-4.55142163084927
LP-1,11175137,1.52075961335128
Calu-1,285033,-0.8607593882513652
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901
LP-1,285033,-3.2890191969978675
NCI-H2122,124202324,4.4352590383146735
PL-21,navitoclax-pluripotin (1-1 mol-mol),-0.7359784746962519
PE/CA-PJ15,241158,3.6544935074881586
BICR 31,25102847,2.842271629600241
HD-MY-Z,4378219,1.959213460816033
PL-21,9884685,-0.9848433807049898
T84,11238147,3.2040065699592564
RT-4,44486219,4.156179916043431
HD-MY-Z,5738263,2.637711870901627
ALL-SIL,11507802,-0.6218585688390301
GA-10,52912189,-0.9604170078419596
Calu-1,46215462,3.630453221666685
SK-MES-1,3062316,0.0520245061614421
L3.3,25150857,3.2841029560324246
SCC-9,5311,1.75647433259966
Hs 936.T,16038120,2.841885460792345
HuNS1,5287969,-2.2248931874534703
NCI-H1395,53495165,1.995718788623105
SCC-9,6914657,-2.6898440352771704
SKM-1,46191454,-1.3563386144764775
Mino,3543504,3.083969513905799
TCCSUP,11238147,3.457873265179278
KHM-1B,BRD-A02303741-navitoclax (2-1 mol-mol),3.1307381995393153
SW1353,56963564,0.2034877901731586
SW1116,2130404,3.3720651468665253
ECC10,11404337,0.1866316876880306
SK-MES-1,crizotinib-PLX-4032 (2-1 mol-mol),1.250071388483906
Mino,168312962,1.3879343762134344
KMS-12-BM,11609586,2.2614384485200625
EJM,44137675,3.342808530148661
IST-Mes1,11427553,1.720147340773497
L3.3,374536,1.2868097755844614
L3.3,2828334,6.9353242086196225
KYSE-140,selumetinib-UNC0638 (4-1 mol-mol),3.578182553170603
ECC10,136227924,2.5549710603978366
NCI-H2087,2733526,2.4372944070920317
SKM-1,135398738,0.0508084825394364
YH-13,selumetinib-PLX-4032 (8-1 mol-mol),4.578081619399974
NCI-H2122,2113511,6.250009309777055
PE/CA-PJ15,15547703,2.735293811596617
K-562,100016,4.034095210213227
L3.3,168313016,5.4672449278411595
KP-N-YN,11364421,3.432565965387532
BT 231,1242560,1.9176620778179092
NCI-H1395,10302451,4.201114377039751
PL-21,54619267,2.7728090672389287
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084
KMS-12-BM,656346,0.20048229693813
GA-10,11657048,4.338325572666049
HD-MY-Z,10302451,3.8671846767021663
KMS-12-BM,23635314,-2.3782143441311954
KYSE-140,10385095,1.6004896195430536
HD-MY-Z,24748573,1.7265483009446096
Calu-1,11656518,5.1677855530035615
NUGC-4,SNX-2112-bortezomib (250-1 mol-mol),-3.2946876604251436
LP-1,374536,1.8164607644288473
LP-1,44491742,3.686326414227543
MHH-CALL-4,5287620,-1.9564924153182184
GA-10,57330099,4.392099047088525
HD-MY-Z,44589607,1.819658130141466
HD-MY-Z,387447,-5.134052723603236
NCI-H2171,9903786,1.7901794952315444
NCI-H2087,23635314,-2.1525138968132813
ECC10,135398516,0.2833083722307675
EJM,7326481,2.7208134108803503
NCI-H1395,3136844,4.616978313876093
NMC-G1,46199207,3.4916585804286413
PL-21,8515,3.0959710718642044
SK-MES-1,6917907,-5.279221144976365
BT 231,sirolimus-bortezomib (250-1 mol-mol),0.2590844427623678
CFPAC-1,984333,1.7609005876893955
Hs 936.T,3503,2.910014668686026
KYSE-140,54618305,4.517279868327929
KO52,12001922,1.5749423624462988
BT 231,11404337,-1.7001463923522222
SK-LU-1,57519531,2.6602975931502924
SK-MES-1,JQ-1-MK-0752 (1-1 mol-mol),0.906075863647398
SNU-119,2858523,2.542556177546106
LS411N,676352,3.0047981548436873
KHM-1B,44495899,-1.7944693078792426
K-562,6918736,-3.666344542032524
T84,25183872,-1.3981925333848149
PE/CA-PJ15,selumetinib-PLX-4032 (8-1 mol-mol),3.579969697697414
KMS-12-BM,448949,1.575561913547924
SK-LU-1,53495165,0.0920659995947192
KMS-12-BM,5282054,2.7090393270562796
RCM-1 [Human rectal adenocarcinoma],23582824,0.8636405428481416
SCC-9,JQ-1-vorinostat (2-1 mol-mol),0.3641375851810363
SK-LU-1,241158,4.950718472920296
GP2d,4578,4.66948855384402
NUGC-4,5470400,-0.639733653144846
LP-1,2746,1.409450400710279
KMS-12-BM,9927531,3.2870919606414963
SW1116,25183872,-0.1808563202107506
RCM-1 [Human rectal adenocarcinoma],6505803,-0.0377469333531859
NCI-H2171,49793307,-5.547674326636965
MHH-ES-1,vorinostat-carboplatin (1-1 mol-mol),1.9772098623076144
EJM,BRD-A02303741-navitoclax (2-1 mol-mol),2.6594376626213614
HMCB,navitoclax-piperlongumine (1-1 mol-mol),1.137064859390896
ALL-SIL,168313047,1.973173862571291
HCC1833,71466445,4.001049080223579
BT 416,5281321,-2.2889946709092475
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671
KHM-1B,25262965,-2.736326683370708
ALL-SIL,5738263,2.854339564213428
HCC1833,409805,5.961157606825395
Mino,JQ-1-vorinostat (2-1 mol-mol),-2.134819462233736
RT-4,2858523,3.0846585781360782
NMC-G1,126941,-1.550620530790649
HuNS1,44185566,1.1542464216417472
T84,107985,-5.262211423380302
OCI-M1,9907093,4.53024110147271
NMC-G1,navitoclax-MST-312 (1-1 mol-mol),1.925455353240355
BT 231,10427712,3.904289947290795
SKM-1,6918878,-0.8378415751208989
BT 416,3503,0.9425501929257484
TCCSUP,5351362,1.0787076559340512
ECC10,6610216,4.114118365396388
NCI-H2087,1317464,5.716036347209886
IST-Mes1,11964036,1.5284066254046933
KO52,5479543,3.70628144154809
ALL-SIL,44202524,-0.4119558263455749
YD-8,24951314,1.71060998865463
BT 416,5291,3.132030409125134
Calu-1,73707438,3.977421197507922
Hs 936.T,navitoclax-MST-312 (1-1 mol-mol),2.915938147169646
SCC-9,9935249,4.690276947265519
SK-LU-1,16720766,0.7001374348489302
CFPAC-1,54618771,0.7086931491389132
LP-1,11647372,0.3298987645422678
Hs 936.T,6610216,4.507566402989384
Mino,11238147,1.72457905436784
KYSE-30,navitoclax-pluripotin (1-1 mol-mol),0.1567444841614214
MHH-CALL-4,11656518,-1.1712955781095884
IST-Mes1,151289,3.762568892374828
SK-LU-1,4261,3.4246779198715336
NCI-H2087,6610216,3.791496413970123
GP2d,168313016,5.68534337088213
BT-20,44491742,4.162819949257598
RT-4,10113978,3.079983585040923
YD-8,4378219,2.399532986422255
Mino,375860,-0.5060371680285715
NCI-N87,54454,3.669804409798402
NCI-H2087,9840324,6.148237298935839
BICR 31,3825829,4.543850483279072
PE/CA-PJ15,5280436,2.1166954192920677
EJM,11719255,2.3281018448944195
KYSE-30,44185566,2.929833316946886
PL-21,2841722,6.818863197490328
CFPAC-1,piperlongumine-MST-312 (1-1 mol-mol),2.6689012056269776
Calu-1,24951314,2.384581246684641
SKM-1,400769,-3.7567993571091063
BICR 31,984333,1.688597902845401
PL-21,387447,-4.452583454516552
ECC10,54678924,1.0722304725744034
Calu-1,216239,2.1135581970605872
YH-13,11178236,-3.430618404279131
K-562,5329102,1.5928854941533903
LP-1,5738263,2.180898139815135
KMS-12-BM,409805,3.008136654369979
IST-Mes1,446155,1.803889787209672
PL-21,5566,2.9739762599368036
NCI-N87,11228183,1.1576925814137384
NCI-H2122,6918878,3.1347759203186127
ECC10,82146,3.01971463984994
PL-21,JQ-1-MK-0752 (1-1 mol-mol),0.8513970156357211
MHH-CALL-4,44202524,1.3642091880480285
SK-OV-3,613753,3.56222269809742
Calu-1,44137675,6.04640754301181
KYSE-140,24856436,0.3087813759539541
BT-20,BRD-A02303741-navitoclax (2-1 mol-mol),3.511460387740053
KO52,11640390,3.55946469667695
SK-OV-3,9911463,4.2249846626647125
OCI-M1,4788,4.198966746624767
PE/CA-PJ15,53495165,-0.1488380586894688
GA-10,11656518,-0.6791088022338929
SW1353,25154868,5.657651447670206
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502
HMCB,23725625,4.742834994685236
LS411N,6610216,4.962940577428159
KHM-1B,9915743,0.5787442773030028
RD-ES,navitoclax-pluripotin (1-1 mol-mol),-2.170563616101317
LP-1,3634881,3.0615145317222443
KHM-1B,11152667,-2.085888250346346
KMS-12-BM,25150857,1.6071345823937382
NCI-H2122,51037431,3.150280884486201
NCI-H1395,25227462,2.331405873777041
EJM,51037431,2.8000590273437274
ECC10,3552672,1.5719104164106283
SW1353,doxorubicin-navitoclax (2-1 mol-mol),-1.1224912814389136
YD-8,25262965,-1.542928389011739
SK-MES-1,53495165,1.3295734430301336
SNU-119,9915743,-0.9461018440857424
GA-10,tretinoin-carboplatin (2-1 mol-mol),2.5424407358324292
IST-Mes1,6610216,4.781215155625892
NCI-H2171,6917907,-6.363958938419671
MHH-CALL-4,9825149,1.7382679296577397
MHH-CALL-4,56963564,0.7829174017307481
KHM-1B,57519531,1.9307254851504612
NCI-H1395,16725315,5.329149992697811
BT 231,salermide-PLX-4032 (12-1 mol-mol),3.076250146625534
KYSE-30,31703,0.2479085148368351
NCI-N87,ISOX-bortezomib (250-1 mol-mol),-0.226060851576525
NCI-H2087,5284616,2.553138626404206
KYSE-30,24772860,-2.3560533584421104
ECC10,11719255,1.0610832150287484
GA-10,54619267,3.265841884292194
SCC-9,51037431,5.108150298111964
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627
Calu-1,selumetinib-UNC0638 (4-1 mol-mol),5.943247256653739
L3.3,16720766,-1.973453330210062
K-562,11717001,4.3318290739670555
HMCB,sirolimus-bortezomib (250-1 mol-mol),0.2910880989689153
LP-1,753704,4.125531625528972
SCC-9,151289,2.789872420286255
BT-20,15953870,3.8375641504894342
KYSE-30,25227462,1.9529926893308245
SK-MES-1,462382,0.3908214341456548
GA-10,45279963,2.1224844381195127
KMS-12-BM,65064,2.717641893492065
K-562,72193861,0.1570904811456113
BT-20,navitoclax-MST-312 (1-1 mol-mol),0.9303235201278528
SK-OV-3,6610216,4.5015440272840275
NCI-N87,17759555,3.435080423112301
GA-10,6917907,-6.55386047304114
NCI-H2087,24775005,4.491412203535691
SCC-9,3503,2.580691900576731
BT 231,24856436,0.2940047595538051
T84,16736978,-0.0728826524501043
OCI-M1,24785538,2.4510531601052183
KHM-1B,6914657,-6.231607767095075
REC-1,2113511,4.615761097345554
K-562,9444,4.095192274458736
L3.3,navitoclax-MST-312 (1-1 mol-mol),2.4950782279808656
YH-13,16038120,1.3752099545726146
KYSE-140,9935249,3.7147808884364473
T84,54618771,0.5762306711501146
OCI-M1,44819697,-1.7568362097376509
BT-20,71680916,4.41337025840458
HuNS1,11640390,3.2495149814606585
KHM-1B,selumetinib-MK-2206 (8-1 mol-mol),-1.0193788552435303
BT 231,119607,4.054018136262302
K-562,969516,2.7986550178028216
HMCB,5113032,4.37953106967478
MHH-ES-1,selumetinib-UNC0638 (4-1 mol-mol),4.090943680919855
BT 416,25102847,2.7691408202295547
GP2d,25262965,2.211864349774893
NCI-H2087,44202524,2.4888178133158516
ECC10,5284329,2.339486772535131
RT-4,49793307,-1.8490869702405208
KP-N-YN,16741245,4.061843061754539
Hs 936.T,9926054,1.615791858991988
OCI-M1,6918878,-0.1368972853141914
SK-LU-1,navitoclax-sorafenib (1-1 mol-mol),2.0102798317929302
EJM,327653,3.072072044008088
BICR 31,9927531,5.661036072082279
NCI-N87,44486219,4.180509732108111
KO52,16720766,0.6419660963639499
KYSE-140,5291,4.241475820532419
Mino,10127622,4.688317768254317
KYSE-30,24964624,3.0210292246927155
KYSE-30,doxorubicin-navitoclax (2-1 mol-mol),-0.0286601538789438
SK-MES-1,2126,5.731037141703568
BT-20,16219061,3.526925528883131
SCC-9,44607531,1.3853072214617428
T84,45279963,3.771852865039894
NCI-N87,25183872,-2.1426120555107824
NUGC-4,656346,0.8340222747206181
BICR 31,3854666,2.26793763186435
KP-N-YN,2749,2.7463951965311284
NCI-H2087,JQ-1-MK-0752 (1-1 mol-mol),-0.6091959091317923
BT 231,9935249,0.8788796020104754
OCI-M1,selumetinib-decitabine (4-1 mol-mol),-0.0362216832369579
HMCB,navitoclax-sorafenib (1-1 mol-mol),1.4210675529122485
KMS-12-BM,44493952,5.238647579582932
MHH-ES-1,15953870,2.7845064920938123
RT-4,46843906,5.20167725568056
BT 416,71466445,4.968371844164254
SK-OV-3,16038120,1.745962946040546
SK-MES-1,16736978,1.1803409089199923
Calu-1,3062316,3.344865018801714
NCI-H2087,11396600,3.1581134421925
KYSE-140,53232,3.082873326892014
GA-10,49867926,3.2716664217262283
REC-1,4259181,2.258839706285654
REC-1,11964036,2.2027300169841957
REC-1,448949,3.078603121406269
NCI-H2087,135423438,1.5480624083633234
TCCSUP,65064,5.167716602731698
HCC1833,ISOX-bortezomib (250-1 mol-mol),1.0666816456218993
TCCSUP,9935249,4.183000192911627
BICR 31,11214940,4.966543096658616
KHM-1B,6918736,-1.6456969223035287
SK-LU-1,9840324,6.121654982569381
BT 416,46174525,2.867824932867276
SNU-119,57519531,5.7777697645171795
SKM-1,9915743,-0.8868720134451151
KHM-1B,73707398,-0.6689954941559422
KHM-1B,11612883,4.120699306463628
SCC-9,9903786,2.6448761987997917
KMS-12-BM,2746,1.2802142564618226
BICR 31,53325874,4.467091056736401
NCI-H929,49793307,-4.29401842302784
GA-10,24797083,0.1704088042824074
SK-HEP-1,16065773,3.000790971898234
PANC-1,11485656,2.097269968494983
MHH-ES-1,136227924,2.293763722118734
NCI-H2122,65064,5.338427883089129
T84,navitoclax-MST-312 (1-1 mol-mol),1.3357978355972064
TCCSUP,54626689,3.911629715273472
Calu-1,vorinostat-navitoclax (4-1 mol-mol),1.1171576300209622
LS411N,448949,2.5849168666236273
IST-Mes1,crizotinib-PLX-4032 (2-1 mol-mol),1.4798286107475835
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158
LS411N,89183176,4.7846004508379085
YD-8,31703,-0.6418507819689356
REC-1,5291,2.78520070098662
LP-1,969516,1.925666147547227
MHH-ES-1,9907093,3.946191355039042
YD-8,11719255,2.4151031872867397
K-562,3552672,6.190745251508109
ALL-SIL,1750826,-2.8707446972397483
NCI-H2087,73707398,0.8336025649851103
PL-21,36462,0.4732785028115152
SK-HEP-1,5978,1.689065603838291
KHM-1B,135875424,3.3101852288443276
NCI-H1395,46926350,-3.2144597586965515
SK-MES-1,11960529,4.815723958373509
BT 416,6917907,-5.88987647241959
KHM-1B,piperlongumine-MST-312 (1-1 mol-mol),1.4082068245453034
LP-1,11178236,-5.188581542059312
NUGC-4,11626560,1.388670932460034
KHM-1B,15983966,1.6900305517060583
SW1116,11167602,2.496759203352098
OCI-M1,46843906,1.3733367993974843
Mino,decitabine-navitoclax (2-1 mol-mol),-3.7664399124443326
OCI-M1,135440466,0.950117351960973
YD-8,452548,0.7666794967881028
BT 231,136227924,3.1954768658582378
SK-LU-1,16725315,3.241338013300658
BT 231,53392493,1.6468096436822095
LP-1,11626560,0.6935578000461913
NMC-G1,5738263,4.58161718250598
BT 416,54678924,1.5372622920504908
NCI-N87,322968,2.9452063604799417
ALL-SIL,984333,-1.3370961884574026
BICR 31,5287969,-2.0848564793948423
K-562,11707110,1.6681367726124623
CFPAC-1,5278396,3.739569542023512
BT 231,crizotinib-PLX-4032 (2-1 mol-mol),1.983526229856042
SK-MES-1,5281672,3.851228939139255
GA-10,216468,-1.080010654114425
Mino,3465537,1.332066458036503
K-562,5113032,4.649240406472478
T84,168312962,1.9829759139512977
SK-MES-1,4917,1.8508520977254737
BT 416,11213558,0.3598797194594364
HuNS1,6252,-1.3831320906710272
T84,25161177,4.62712483420274
Hs 936.T,5281321,1.236363085543662
KO52,25105715,3.69197677171084
YH-13,44185566,3.169017423167434
MHH-CALL-4,11364421,-6.216481160519788
Mino,10302451,2.7399249984312863
KMS-12-BM,salermide-PLX-4032 (12-1 mol-mol),4.711885987308765
Mino,5328940,0.2661217011017847
NMC-G1,107970,2.528467571568031
T84,3634881,3.2968914612245936
NCI-H1395,11152667,2.8212920431399597
OCI-M1,66577038,3.3805050698232724
LS411N,136227924,3.1900427132689724
EJM,374536,1.880245992175634
Calu-1,216345,4.5623371719818815
MHH-CALL-4,219104,1.660774323849114
SW1353,107985,-2.47114721264714
K-562,11485656,1.7795111963017332
T84,decitabine-navitoclax (2-1 mol-mol),1.849034288711343
OCI-M1,71751553,4.386393852068909
HCC1833,68056272,5.017986121860751
RT-4,285033,-2.016111545796812
IST-Mes1,52912189,1.1075207421426316
KYSE-30,selumetinib-piperlongumine (8-1 mol-mol),2.229929709105198
KHM-1B,44487061,4.467153172059052
KMS-12-BM,400769,-2.0250605176070864
KO52,44589607,1.6213501013448446
Hs 936.T,15983966,1.7288341504975784
SW1116,31703,0.9899689024056206
BT 231,135999136,1.241486028701245
PE/CA-PJ15,135659046,3.5653102065107176
PL-21,9826308,-0.4407299767494929
PE/CA-PJ15,46215462,1.5654927399329872
NCI-H2122,107970,2.8025359770355047
T84,25262965,-3.235960371234552
KHM-1B,400769,-0.7563953043015217
SNU-119,3081361,1.3460457927796947
KMS-12-BM,tanespimycin-bortezomib (250-1 mol-mol),-0.6230177375781689
KHM-1B,3025944,3.5975685819410503
KO52,6184667,1.650378416289273
OCI-M1,9903786,1.4970236133945398
MHH-ES-1,5113032,4.58868655542252
Mino,44566777,-1.2832302862660665
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653
SKM-1,54619267,4.249968374064052
HCC1833,3025944,4.5794124600984825
SCC-9,17755052,1.3521912896367647
Calu-1,selumetinib-PLX-4032 (8-1 mol-mol),4.770757405669591
KHM-1B,51039095,0.918931317329286
SK-HEP-1,56946209,-4.57873882670014
KYSE-140,3634881,3.591288155548458
BT 416,23635314,-3.5886708346134504
BT-20,54626689,4.5259843221506655
NUGC-4,51037431,3.614696493425903
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078
L3.3,navitoclax-pluripotin (1-1 mol-mol),0.1565483194262438
SW1353,11427553,2.8120317318626107
LP-1,6918736,-1.725239825829704
HD-MY-Z,82146,3.660253020834776
RT-4,448949,1.759750827005002
LS411N,24772860,-2.6286287692739587
HMCB,60700,1.0606608504131512
KYSE-30,56946209,-4.587144692791201
NCI-H2122,54613361,0.4442721091400867
KMS-12-BM,82146,2.660947076146562
HuNS1,tanespimycin-bortezomib (250-1 mol-mol),-0.352087837441777
NCI-H2087,148198,-2.1193068046896255
KYSE-140,selumetinib-decitabine (4-1 mol-mol),3.032076419472077
KMS-12-BM,241158,1.5195082823857844
ECC10,6438330,1.18301511468355
HMCB,9907093,4.430209797884857
YH-13,piperlongumine-MST-312 (1-1 mol-mol),1.341145556901202
NCI-H1395,9936388,2.8582059793440964
NCI-N87,erlotinib-PLX-4032 (2-1 mol-mol),3.0192784761472
IST-Mes1,54454,3.4404607016766264
SK-OV-3,219104,6.736269406359778
KP-N-YN,44589607,3.0237240548240627
NCI-N87,17755052,-1.4521000328048816
KHM-1B,12003241,-0.9345261470540068
EJM,10296883,2.9448984253361057
KYSE-140,25062766,3.2411438994980792
NCI-H2122,107985,-2.1476502559508828
HD-MY-Z,9927531,4.2813620085195625
HD-MY-Z,9911830,2.287012187948462
MHH-ES-1,67156097,-2.2395325460199813
NCI-H929,46199207,3.0580701159443766
RCM-1 [Human rectal adenocarcinoma],25126798,4.131561769072402
K-562,5291,-1.1872539047134878
YD-8,3689413,-2.153430400522153
SNU-119,6918289,2.523909001846346
SK-LU-1,46191454,1.8208789695045011
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331
ALL-SIL,11427553,-0.6859128537837271
MHH-CALL-4,3025986,-1.484851683369407
KO52,46215462,1.4911343495601384
LP-1,3038522,1.5041318755479802
EJM,10127622,6.4367680304352675
BICR 31,11612883,2.9886930364048387
MHH-CALL-4,54618164,3.885057071185027
GP2d,71466578,4.340488775547865
SK-MES-1,11152667,-3.0245097367815172
Mino,11955716,-2.6826182707421653
NCI-H929,24951314,0.3525234026902946
HCC1833,327653,2.396591228489624
TCCSUP,135440466,1.783942290366752
GA-10,11455910,-1.5757849465302998
SK-MES-1,42642645,1.0695406416711744
SK-LU-1,3062316,-2.062292005329787
KYSE-140,5311281,2.7898895940271022
TCCSUP,4259181,1.0116551093848198
NCI-H2122,9911463,3.941857850856705
NCI-H2087,11175137,2.571895011042483
KO52,71466445,2.839981960673523
SKM-1,5328940,0.3112400146687634
YH-13,51039095,2.0739005868490983
MHH-ES-1,selumetinib-GDC-0941 (4-1 mol-mol),1.820294732010153
HCC1833,49766530,-1.3796186102265957
EJM,16722836,1.936156340232378
BT-20,3503,2.7520727884096545
NCI-H2087,6852167,3.953337173011455
KO52,2708,3.123821220671842
BT 416,119607,3.8457243548969537
K-562,5746,1.9738407973257048
IST-Mes1,1242560,3.612096070768593
BT 231,2858523,2.7852446227054375
YD-8,24964624,2.5606551305717455
BT 416,6610355,3.477155791629683
SKM-1,51039095,1.6344221890369603
NCI-H1395,5460769,5.87662281780079
Mino,25126798,3.3820284274411767
EJM,25105715,3.7124435653326984
KYSE-140,navitoclax-gemcitabine (1-1 mol-mol),2.9822873947148425
KO52,26596,-3.758446698642679
LP-1,11455910,0.2365094775897044
NCI-H2171,676352,1.591250217642193
KMS-12-BM,9911463,2.0749809508981256
RT-4,9915743,2.2914033994891847
SNU-119,10427712,3.870149394322131
L3.3,654092,0.3260809528195456
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581
RT-4,erlotinib-PLX-4032 (2-1 mol-mol),3.2445039768018624
GP2d,5280436,4.056596768191373
KYSE-30,65064,5.630579167022311
SK-LU-1,5287620,-1.9872725293991136
RT-4,11178236,-1.895969264263487
PE/CA-PJ15,135421197,1.0415253026449975
GA-10,9907093,3.298636136128675
SKM-1,568763,-0.8159483316937144
RCM-1 [Human rectal adenocarcinoma],56649450,3.837346847556256
SK-LU-1,16741245,2.299228496484796
SK-OV-3,9936388,2.038842599711319
Mino,44620216,3.636708432484359
Calu-1,123631,3.640091697641548
OCI-M1,462382,-0.0367256720899532
PL-21,656346,0.4859232356104526
GP2d,5282054,2.2866711744172497
Mino,55508,2.217062239877633
GP2d,6438330,1.2288892894710792
RT-4,15547703,3.010002143922484
REC-1,9967941,4.301773121348624
ECC10,BRD-K27188169-navitoclax (2-1 mol-mol),-2.5242626143168234
ALL-SIL,44607531,0.7892287314343482
Mino,11213558,1.5378531509771507
NCI-H1395,675434,4.314501346602578
NCI-H929,3025986,-2.370688030167058
NMC-G1,176870,4.281867556883536
IST-Mes1,53232,2.11135293708232
K-562,54613361,-1.429503199294265
MHH-ES-1,navitoclax-pluripotin (1-1 mol-mol),-1.161790613987537
HCC1833,31703,-0.007733940630614
NUGC-4,25154868,3.057958889278692
SCC-9,ISOX-bortezomib (250-1 mol-mol),0.3127664498221564
KMS-12-BM,52912189,-1.6763978674189333
SW1353,71466578,4.099665805630875
K-562,10385095,0.5975872383647969
NUGC-4,65064,4.846140945272845
HMCB,126941,-4.47992491137788
GA-10,135423438,1.5263864558122735
ALL-SIL,44491742,3.700418914769662
Calu-1,135999136,4.366294064672552
NCI-N87,24753719,4.36387060101307
BT 231,89183176,6.185556760142526
PE/CA-PJ15,piperlongumine-MST-312 (1-1 mol-mol),1.379887967820859
Calu-1,3081361,3.734773993675202
GP2d,216239,1.8041467725381477
NUGC-4,17755052,0.0433702500229821
SKM-1,9840324,5.371011979568873
KYSE-140,46398810,2.569005803357439
NCI-N87,19582717,3.5520999296373437
KP-N-YN,2708,5.375360692617648
BT-20,6917907,-5.747669482313855
KMS-12-BM,216345,3.047571531104052
BT 416,44241473,4.372636562751848
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312
KMS-12-BM,56946209,-5.052101721159677
NCI-H2171,10184653,0.99528741531969
K-562,637858,1.3097643671251342
BT 416,9444,3.80542207264471
HCC1833,54649381,3.732114486371366
BICR 31,73707398,2.635299985295534
NUGC-4,49793307,-3.1478249779550715
BT-20,216239,2.9685629446819233
SW1353,54618305,5.761463956285616
RCM-1 [Human rectal adenocarcinoma],5280436,3.538296903160907
NCI-H1395,11485656,1.9214345391656065
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395
KYSE-140,44486219,4.914968084571605
PL-21,25262965,-2.359588886516522
PL-21,ISOX-bortezomib (250-1 mol-mol),0.6213099519071712
NCI-H2087,9927531,4.212541441573842
NMC-G1,3825829,5.0747615717694154
HuNS1,SNX-2112-bortezomib (250-1 mol-mol),-4.0987599011490365
SCC-9,46215462,2.815249887965138
NCI-H1395,44607531,1.6381567273877196
SCC-9,12003241,-1.125345709331217
RCM-1 [Human rectal adenocarcinoma],387447,-5.081876711684109
PE/CA-PJ15,568763,0.8807153121588625
NCI-H929,67291369,2.695813932699893
Mino,71466380,3.1164895629530753
K-562,5978,-3.1400031562505393
KMS-12-BM,54454,3.3056700898570277
SNU-119,12001922,1.855369676663499
BICR 31,9908783,4.390198834476992
NCI-N87,60750,-4.457686499395666
ECC10,4378219,1.4134664456324193
NCI-H2087,387447,-4.957755773164931
SNU-119,126941,-2.8871019003996574
GA-10,9903786,1.0626395044563215
HCC1833,11625818,6.214788584296636
NCI-H2087,445091,3.7774679409762815
SNU-119,1242560,2.269349854429625
KYSE-140,262093,3.0131352463234906
SCC-9,208908,2.838235608451249
SK-LU-1,11609586,2.9776867697459704
HD-MY-Z,16725315,3.260596549029092
SK-OV-3,9926054,2.1800400954819716
YD-8,6918289,3.053778903951025
ALL-SIL,6918736,-2.784980550106597
BT 416,54618771,0.7344198776151593
KYSE-140,11626560,1.7950151320637706
OCI-M1,123631,3.717399343326929
LS411N,23725625,5.218761480016774
Calu-1,selumetinib-vorinostat (8-1 mol-mol),3.8564467382040304
KHM-1B,46191454,-0.9954887816979984
YD-8,5738263,3.505877458565359
GA-10,5351362,0.3553668450868501
BICR 31,16038120,0.7865824758597759
SK-MES-1,11717001,4.164777593482417
BT 231,JQ-1-carboplatin (1-1 mol-mol),2.3175217406535156
TCCSUP,16720766,3.8833621535211074
BT-20,6450551,2.863822185029378
T84,crizotinib-PLX-4032 (2-1 mol-mol),1.637489876470356
T84,9915743,0.6360721322539938
KO52,151289,-0.2495262689960944
MHH-ES-1,10302451,2.7656001788565283
YD-8,49766530,-2.0839194852213976
SCC-9,docetaxel-tanespimycin (2-1 mol-mol),-3.608220129301709
SW1353,10302451,4.375388652736272
KYSE-30,9911830,3.463728225083358
GP2d,7326481,2.0527625967983423
Hs 936.T,36462,2.938435716058904
BT-20,sirolimus-bortezomib (250-1 mol-mol),0.9050670682088444
NCI-N87,72734382,4.464771871646434
YH-13,3503,1.9021555788410789
NCI-H929,54686904,2.5438684398285996
LP-1,16741245,3.535006996680232
Mino,tanespimycin-gemcitabine (1-1 mol-mol),-5.004027944412501
BT 231,11640390,3.090982905572894
HD-MY-Z,7251185,1.7059761818830372
HD-MY-Z,3136844,3.914350724657188
SCC-9,11175137,3.431057653368815
LS411N,1750826,2.0365622567800985
KHM-1B,4917,2.355684811244976
KMS-12-BM,51039095,1.746743438142051
KMS-12-BM,44493528,3.477782404349953
SK-LU-1,452548,-0.9242285589958992
GA-10,9926054,1.7130115486469382
BT 416,9956119,1.7302745861428512
PL-21,54454,2.854132058335336
KHM-1B,168312962,-1.6342091010648556
LP-1,49867930,4.22193365548988
REC-1,17755052,3.936834362379093
NCI-H2087,5566,2.790978172964132
REC-1,2749,2.457349954560022
T84,6450551,3.0234528631913795
L3.3,10184653,0.0220617179423389
RT-4,54613361,0.2615829847949534
HuNS1,navitoclax-pluripotin (1-1 mol-mol),-0.8105034028397787
SNU-119,5278396,2.5454097325647904
LP-1,4705,3.1959395550133247
GP2d,11719255,3.5702199097123435
BT 416,568763,0.4744840778942942
BT 416,16038120,-0.531142408993897
CFPAC-1,JQ-1-vorinostat (2-1 mol-mol),1.5144589002078035
PANC-1,11175137,3.1282411644718833
SW1353,387447,-4.17811329227342
KO52,10184653,1.4838473316294571
Mino,25161177,3.7618528243559712
KHM-1B,16736978,0.8941116844537789
HD-MY-Z,51039095,2.8538664218414187
EJM,753704,3.6448847004253055
CFPAC-1,702558,5.695360545970538
EJM,9823820,4.691178108469771
IST-Mes1,7251185,3.206804970970884
GA-10,54143018,-0.3519099317855343
MHH-CALL-4,24964624,0.1090236933593203
Mino,10385095,0.494040271373144
KP-N-YN,241158,4.193334687339578
HCC1833,alisertib-navitoclax (2-1 mol-mol),-0.622457000502575
NCI-N87,444795,4.906796024963376
KO52,selumetinib-navitoclax (8-1 mol-mol),-1.982956418902813
NCI-N87,5278396,3.196450874168962
IST-Mes1,5281321,-0.504099135222913
SW1116,9936388,1.5004696743438164
NUGC-4,46174525,3.5845584722489696
GP2d,15547703,3.2123747817329846
Hs 936.T,5978,-1.9352842224238924
NCI-H2171,7251185,0.8673768610035957
GP2d,11485656,0.5695398212792343
SKM-1,46398810,2.0273283297042712
K-562,135398516,2.1877631842117315
IST-Mes1,462382,1.0027449292382402
BICR 31,148124,2.7085675831815292
SK-HEP-1,387447,-3.995016034956776
GA-10,42642645,-0.7001416286986243
GP2d,6852167,0.7851862344848514
OCI-M1,11485656,1.896897846334656
K-562,445643,4.07029800941494
IST-Mes1,11178236,-2.2337214332221023
REC-1,44491742,3.8136752597353953
T84,5351362,0.2619919370242125
Calu-1,9936388,2.4202012833379016
T84,44620216,3.4325901001695605
YD-8,tanespimycin-bortezomib (250-1 mol-mol),-0.6090982455977105
LS411N,6918878,3.507421995092854
TCCSUP,123631,2.272054627361115
PE/CA-PJ15,1242560,3.1315569486629315
NUGC-4,3854666,3.7030088458950914
NCI-H1395,66577038,3.726458763342507
ECC10,135440466,0.5416977335225992
SW1353,6610355,5.24277370831806
GP2d,675434,4.359756762497025
NCI-H2087,UNC0638-navitoclax (1-1 mol-mol),2.07313942878803
NUGC-4,tretinoin-navitoclax (4-1 mol-mol),0.6936865632205451
NCI-H2171,44819697,-4.1780638649943675
PL-21,65064,3.690520283045156
K-562,25227462,-1.535473545694956
REC-1,216239,2.4300236285527177
TCCSUP,selumetinib-tretinoin (2-1 mol-mol),7.288595889127544
KO52,72376,-3.1710971417333726
NCI-H2122,216468,4.494830056348621
EJM,9840324,5.73899517118649
GA-10,46843906,1.0285718262384662
L3.3,11152667,-1.6552573738209355
GA-10,9840324,5.406756620420617
L3.3,36462,1.8942720792997911
NCI-H1395,3025986,0.7160390395986832
NMC-G1,60700,2.1507994953761154
LP-1,9915743,0.8947745693738212
PL-21,135875424,3.3109880797567595
SW1353,54454,4.098399948115215
NCI-H2087,10127622,-1.5771098974983928
NUGC-4,16038120,1.378509713283364
OCI-M1,446155,2.9317475660477164
HMCB,10385095,1.0131649772543003
MHH-ES-1,5280436,3.701521013365009
ALL-SIL,176870,2.444675771693443
BT 416,26596,-1.7367305778393065
Calu-1,54619267,4.52263302080944
BT 416,4917,2.646168069464792
NUGC-4,9868037,2.67095726720747
SNU-119,44486219,4.148857305108833
ECC10,25062766,2.210099046424368
SCC-9,3825829,4.24505295528646
HMCB,375860,-0.2087542288186852
MHH-CALL-4,9907093,3.7627107305027394
EJM,168312962,1.0850962961178168
HCC1833,2708,5.543444793516199
MHH-ES-1,72734382,4.576562100927282
MHH-CALL-4,168313016,3.901082293744531
HuNS1,25126798,3.417726251719692
TCCSUP,5470400,0.0875702939988733
NCI-H2122,piperlongumine-MST-312 (1-1 mol-mol),2.8327906884112046
NUGC-4,11656518,1.4794713550351724
SK-LU-1,JQ-1-vorinostat (2-1 mol-mol),2.1100999346045213
SCC-9,9884685,0.522968392230544
NCI-H929,400769,-1.5124256482167764
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401
RCM-1 [Human rectal adenocarcinoma],44185566,2.9642149554045
NMC-G1,613753,5.394475298509844
MHH-CALL-4,73707438,4.268370156641683
GP2d,156414,-1.495990520647441
KYSE-140,135440466,1.1528263998384944
MHH-CALL-4,49850262,1.7146288739893654
NCI-H2122,3503,2.8466330593559275
HD-MY-Z,72199292,1.6399648528776631
SK-HEP-1,15953870,5.227718988850451
MHH-ES-1,3038522,2.880741154877155
KO52,decitabine-navitoclax (2-1 mol-mol),-1.7889510477453996
PE/CA-PJ15,9915743,-1.4704662389348668
T84,11507802,1.1507961968825102
OCI-M1,5291,4.027043472019751
NCI-H2087,5951923,5.865203070109288
HMCB,46398810,3.6730747784920226
HD-MY-Z,3465537,2.9850007343449003
NCI-H929,25150857,1.5927885501879306
PE/CA-PJ15,10410894,3.434134302968134
KYSE-30,8515,5.061057481415257
LS411N,5287620,-2.7795044954925423
LP-1,72734382,3.8496634348483383
Calu-1,53393127,6.32858334699818
NMC-G1,54686904,4.414049770805853
KYSE-140,654092,-0.1825739700951138
MHH-ES-1,44259,0.9365993758948372
ECC10,322968,2.466297326789295
KO52,2749,1.7174149313892582
SCC-9,46398810,2.8303032541075455
ECC10,60700,-3.614604351002563
HD-MY-Z,navitoclax-MST-312 (1-1 mol-mol),0.8155990051120232
OCI-M1,135411,0.469490466947555
NCI-H929,6918736,-2.069198249683734
SNU-119,1641662,3.269862503326484
TCCSUP,navitoclax-sorafenib (1-1 mol-mol),3.067250196506974
KHM-1B,17755052,-0.5225933092645372
SK-MES-1,55508,3.396317623323121
GP2d,24951314,0.7048277809046599
SK-LU-1,selumetinib-tretinoin (2-1 mol-mol),2.8661622989310587
IST-Mes1,1641662,3.7606227939030528
Mino,5311,-0.1516234540317863
NUGC-4,selumetinib-MK-2206 (8-1 mol-mol),-1.8374961032226955
BICR 31,156414,0.5699919561712937
NCI-H2087,selumetinib-MK-2206 (8-1 mol-mol),-3.262317596966715
YH-13,10074640,3.684344080158783
SK-LU-1,72193861,3.856531910436518
SK-LU-1,56649450,4.887022705560705
NCI-H1395,49793307,-1.2890393548834251
KYSE-30,57330099,4.382033774793468
K-562,2742550,1.8061055262772656
Mino,24180125,1.2507747465119918
MHH-ES-1,5282054,3.4163889514708004
PE/CA-PJ15,54143018,0.7108830901806709
BT 416,135659046,3.716005987498819
NCI-H2087,44491742,3.6695473170739583
NCI-H2122,selumetinib-UNC0638 (4-1 mol-mol),2.728098073177844
NCI-N87,54686904,4.2918164398278815
SK-OV-3,16725315,5.283554915030345
MHH-CALL-4,24180125,2.4020121607744653
OCI-M1,24753719,3.8441601097778015
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717
SK-LU-1,11364421,-1.2493126328106792
KYSE-140,216239,2.3173533099878183
HMCB,135423438,4.419625220654583
NCI-N87,54618771,0.8863121899707505
Calu-1,11396600,3.740782908411944
Mino,24785538,-0.2127371350611869
NCI-H1395,10322450,2.951434286433811
SKM-1,126941,-2.265408392302096
PE/CA-PJ15,6917907,-5.814677187736003
YD-8,44137675,3.4700993938772324
LS411N,9866186,0.9541786681011424
GP2d,1566236,1.660029832907994
ECC10,159324,-0.9362506976016994
HCC1833,navitoclax-MST-312 (1-1 mol-mol),-0.2838753036623474
MHH-ES-1,5978,-2.8079962029840866
LP-1,2871966,-1.0128999400548846
OCI-M1,11238147,2.9106173900040058
KMS-12-BM,2126,3.610569458867974
RCM-1 [Human rectal adenocarcinoma],82146,3.3691200384154456
NCI-H929,53232,1.3774173243264964
KO52,6918328,-1.4981845438810923
YD-8,9868037,3.0733964994503244
BT 231,11494412,-1.440888792525865
PL-21,969516,2.5807249687022664
BT-20,9936388,-7.739336729410493
KYSE-30,11964036,2.893603418094798
YH-13,4096211,1.7553390235947497
ALL-SIL,216345,2.7239648031314108
NCI-H1395,71304818,2.2994001148699414
MHH-ES-1,375860,-0.6305847513048299
Mino,24771867,-3.235629712313572
KYSE-30,16013152,4.94293089584889
HD-MY-Z,2733526,4.14332066306466
OCI-M1,tanespimycin-bortezomib (250-1 mol-mol),0.2831250626591589
KO52,148198,-6.726627358418003
PE/CA-PJ15,54618305,4.31153259720802
HMCB,2708,5.151962818613397
KHM-1B,JQ-1-MK-0752 (1-1 mol-mol),-0.8214903492404299
YH-13,selumetinib-MK-2206 (8-1 mol-mol),3.53074146528381
SK-MES-1,11167602,2.859403378030726
LP-1,11955716,-2.740810355151359
K-562,11497983,3.839483588328175
MHH-CALL-4,52912189,-0.3158444085986885
OCI-M1,11228183,1.0757396823682752
K-562,24856436,0.0017034666231649
BT 416,9868037,3.6297803130488377
BT-20,3689413,-3.3374276278199972
SCC-9,4917,3.683292695011318
L3.3,5280436,4.8128342001361
KMS-12-BM,31703,-3.250328951463323
BT-20,613753,3.78963091227962
SCC-9,23725625,6.300420686237622
HCC1833,159324,2.7242134281125883
KHM-1B,637858,1.18497480261582
RT-4,12003241,-1.8542714118634884
YD-8,637858,2.173572899934862
GA-10,409805,3.0075509696192397
BT 416,44607530,0.9831302557907352
EJM,24753719,3.944145631978448
NCI-H2122,56946209,-4.372642698446231
KO52,11977753,-0.926133463520109
KMS-12-BM,3062316,1.283927819580485
LP-1,4477,-0.0240291839643015
HCC1833,5311,0.9449721633180788
SCC-9,67156097,-0.5297515363076177
GA-10,71680916,2.1133589399064143
BT 416,doxorubicin-navitoclax (2-1 mol-mol),-1.7047527487566958
KHM-1B,20959075,-3.335325508403103
PE/CA-PJ15,6918736,-2.1464031856297443
KO52,6914657,-6.464336066123526
NCI-H929,17759555,3.669029016892366
K-562,46224516,3.0237589268452396
BT 231,5566,2.2220572851516605
T84,5287969,-1.6510483915291672
HD-MY-Z,9933475,2.248081579621366
BT-20,969516,3.392908616441558
KMS-12-BM,6450551,2.204544668217096
NCI-H2122,26596,-0.3703174924227287
RCM-1 [Human rectal adenocarcinoma],vorinostat-navitoclax (4-1 mol-mol),2.52102368660606
K-562,10184653,1.719293175029272
T84,262093,2.390395114942932
NCI-H2171,2746,1.1013983502046127
IST-Mes1,613753,3.190229377917506
BICR 31,49766530,2.6564815829329236
NCI-H2087,4259181,-0.0076353302505686
PL-21,24856436,-1.1057756427347476
IST-Mes1,67156097,2.0129233452386095
GA-10,6914657,-9.106032039949524
RT-4,54649381,5.182810489152522
YD-8,1242560,3.4576125136726805
HMCB,11364421,-5.583776675584482
ECC10,168312962,-1.3433914471980206
SW1116,159324,1.6231393918689625
HD-MY-Z,71466445,5.190152829485737
NMC-G1,4917,2.9745770240138785
KMS-12-BM,24901704,2.3878689097063424
BT 231,216239,1.7435663351679715
Calu-1,15953870,5.3238181569878655
Calu-1,6610355,5.851211468429444
BT-20,tretinoin-carboplatin (2-1 mol-mol),5.243702598647878
HuNS1,54596558,4.147874821574218
SCC-9,51039095,3.242385267473305
BT-20,9908783,4.395136847641339
HMCB,5311,2.1964407346203627
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083
BT-20,54619267,4.430270639515803
HMCB,637858,1.3431818902192771
Calu-1,44185566,3.1396206382141583
BICR 31,11455910,2.0785566961581186
BT 231,3385,6.58392061343833
SK-OV-3,53232,3.610813443380856
MHH-CALL-4,tretinoin-carboplatin (2-1 mol-mol),3.13120171512941
BICR 31,374536,2.383890315264743
SKM-1,100016,4.336407790429152
HD-MY-Z,navitoclax-pluripotin (1-1 mol-mol),-1.0608230517161834
LP-1,176870,4.843302806725258
L3.3,11238147,4.461700161811432
NCI-H929,tretinoin-carboplatin (2-1 mol-mol),0.1432218131901559
HD-MY-Z,11396600,3.2182854001324768
PE/CA-PJ15,11222830,1.5034258070513389
MHH-CALL-4,1716436,2.8366370912133565
Calu-1,doxorubicin-navitoclax (2-1 mol-mol),0.1402462528802404
RT-4,60750,-4.938890545189148
LS411N,44202524,4.412838675121289
EJM,10410894,1.930744280371102
ECC10,2113511,3.933975042495113
YD-8,15953870,3.5713699030166186
Mino,24772860,-3.581741223453769
OCI-M1,5335621,5.011957601379178
KMS-12-BM,SNX-2112-bortezomib (250-1 mol-mol),-3.02097095985075
Mino,5278396,2.8139792481200887
GP2d,676352,2.0133645997182423
PE/CA-PJ15,45279963,3.892578403317123
LS411N,16741245,4.421981695824733
SNU-119,tretinoin-navitoclax (4-1 mol-mol),1.7834789734876322
Calu-1,36462,2.444973660840076
NCI-H2171,selumetinib-BRD-A02303741 (4-1 mol-mol),6.130541879028699
REC-1,11222830,3.69502429393256
KMS-12-BM,56649450,0.982928705692675
KMS-12-BM,637858,0.99115660334439
GA-10,441298,2.7814533966013864
HMCB,3062316,2.903029383335688
YH-13,53495165,2.0012799986886822
HD-MY-Z,11609586,3.194563541817793
OCI-M1,6918837,-5.248034805849478
HCC1833,navitoclax-PLX-4032 (1-1 mol-mol),-0.8260006816071501
ALL-SIL,10184653,0.3156525087572682
T84,52912189,3.5875129547726075
SNU-119,262093,2.598697839644185
SCC-9,sirolimus-bortezomib (250-1 mol-mol),0.9662100185478
NCI-H2122,11717001,5.885447966559419
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745
NCI-H2087,54454,2.025862636143525
PANC-1,46907787,0.0989885994051276
NCI-N87,9936388,-5.070095106907016
CFPAC-1,25062766,1.9149690434058944
NCI-H1395,9803433,5.44811246769085
KYSE-140,135411,0.5977785665444979
TCCSUP,56946209,-3.1340499895794487
YD-8,15547703,3.876361457328563
GP2d,46926350,-4.393153997744706
BT-20,9967941,2.8267803113216696
CFPAC-1,5282054,5.018119390497045
SW1116,285033,0.2696990604329895
BT 416,decitabine-navitoclax (2-1 mol-mol),-1.0946984961198327
KYSE-30,49793307,-3.105071137975557
KO52,568763,0.0919093108671874
KP-N-YN,decitabine-navitoclax (2-1 mol-mol),1.5820926504424375
SK-LU-1,4521392,4.294893273360184
EJM,44566777,-0.1727976349601711
EJM,2871966,-0.3879200189788208
SKM-1,2828334,5.763127700268427
TCCSUP,52912189,5.693268432248509
SK-MES-1,9903786,1.5074557756101594
ECC10,5746,1.603838843612377
SK-OV-3,400769,-0.3757443057400228
TCCSUP,5282054,3.8186779909070094
KYSE-140,17755052,1.652587435791082
GP2d,208908,4.083900259292246
NCI-H2171,46224516,1.006764214935909
NCI-H2087,16013152,3.311573331362872
HD-MY-Z,49793307,-4.9510389739389336
SK-MES-1,148124,-3.591423335334301
TCCSUP,5329102,2.310933732009281
HuNS1,9884685,1.7669935378589272
BT-20,54596558,4.521245671752113
Mino,selumetinib-JQ-1 (4-1 mol-mol),-0.0896875125298877
NCI-N87,44607531,-2.3963447234482196
MHH-CALL-4,44607531,1.616505066539873
YD-8,erlotinib-PLX-4032 (2-1 mol-mol),2.8218609512009603
EJM,65064,5.323795448913802
KMS-12-BM,10077130,2.5047652451380857
SW1353,10074640,2.848095098485291
LP-1,71751553,3.851521724606858
LS411N,6505803,-0.6536233604701492
NCI-H929,3689413,-2.331613234092956
PANC-1,4477,1.1851294236735146
SNU-119,54618771,1.6343524810724477
HCC1833,tretinoin-navitoclax (4-1 mol-mol),0.6053054305973946
YH-13,26596,-1.6020780091570677
OCI-M1,4261,0.9336066764728363
YD-8,448949,1.587735779011906
KHM-1B,10322450,2.734741066135324
SK-HEP-1,168313200,3.8713243832650335
HCC1833,9911830,3.390320046455881
SCC-9,2729026,3.0647326637868573
TCCSUP,ISOX-bortezomib (250-1 mol-mol),0.0880640354872425
BT 416,44607531,1.370060656500881
OCI-M1,71304818,2.448284582916836
T84,9933475,1.51243022068564
NUGC-4,208908,-1.3852573120678664
KYSE-140,219104,4.041454503734818
SK-LU-1,409805,5.4476736017437135
GA-10,54596558,3.8904655464079214
GP2d,439501,-1.2526235353612607
MHH-CALL-4,51039095,2.965929063211584
KYSE-140,439501,-2.2036133964389446
SCC-9,262093,3.396257832039873
HD-MY-Z,46907787,2.2677015455494187
LS411N,409805,5.900990799691521
NCI-H2122,168313047,3.4035718856106594
BT 416,6252,3.156655213429649
Mino,10074640,3.0447839707381577
YH-13,JQ-1-vorinostat (2-1 mol-mol),1.6666990115178115
NCI-H2122,71466445,3.71055721858648
HCC1833,51039095,3.1109594100421165
ALL-SIL,9967941,3.4348481015027628
KYSE-140,4259181,-1.5506571157207716
KO52,24753719,3.780928273062828
RCM-1 [Human rectal adenocarcinoma],44589607,3.248085405337134
NMC-G1,4096211,3.457822888928463
GP2d,44607530,1.1078337066935298
NMC-G1,4369359,4.209653768438191
YD-8,10231331,5.266552071230695
NCI-H2122,46843906,3.262241217326747
T84,53392493,1.722389789849051
T84,56973724,2.202677251716597
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538
KO52,11228183,-4.013409516363687
KO52,11455910,0.9067852842316652
Hs 936.T,241158,4.073902447809716
L3.3,44486219,4.220339607908531
NCI-H2087,4261,0.961491540302613
SKM-1,sirolimus-bortezomib (250-1 mol-mol),0.3833247137434921
MHH-ES-1,9903786,1.586022951185602
T84,676352,0.9535277414738228
IST-Mes1,135875424,5.039969018342982
K-562,65628,4.517417686157834
PE/CA-PJ15,3062316,-1.476141456362071
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507
MHH-CALL-4,3136844,3.580762905250605
TCCSUP,676352,1.7918855242955138
GP2d,sirolimus-bortezomib (250-1 mol-mol),1.47869263930016
NCI-H929,54143018,-0.1441434705872438
KYSE-30,1242560,3.6555370944311054
BT-20,44241473,4.955734709190799
LP-1,10113978,1.3292791954855825
NCI-H2122,10302451,3.7465874333262654
HD-MY-Z,73707371,4.880777210281508
Calu-1,5329102,3.0805902647134977
EJM,9967941,2.872620425548139
ECC10,426756,4.639063650532838
SCC-9,navitoclax-piperlongumine (1-1 mol-mol),2.9839395541067515
HMCB,5738263,2.6270115747347993
MHH-ES-1,JQ-1-vorinostat (2-1 mol-mol),0.2884232519418347
HuNS1,53232,2.1458684056634114
LS411N,51039095,3.380080993968732
BT 231,3543504,4.192158652157851
KMS-12-BM,654092,-2.2721779873504224
MHH-CALL-4,71680916,4.339831638862171
K-562,25150857,2.2256112733235978
EJM,135411,0.4460244130907568
KHM-1B,26596,-2.1296194509234576
NCI-N87,5351362,0.9196567139345124
Hs 936.T,3025986,-0.4502588085403909
HD-MY-Z,57330099,5.524896778586044
HMCB,16659841,4.044533184021594
Hs 936.T,446155,4.0718218224930975
SW1116,serdemetan-SCH-529074 (1-1 mol-mol),2.082066333820028
BT-20,3385,6.679464251962196
SKM-1,15547703,2.340856724788066
KYSE-140,56946209,-3.364672626272534
NCI-H2087,10077130,6.353638527955233
SK-LU-1,107970,2.349132829745335
BT 416,54454,-1.3487590074225788
SK-MES-1,5329102,1.301067202793318
KP-N-YN,676352,1.9035859107276871
LS411N,11238147,4.220683195687341
SKM-1,5566,3.0901148412654877
NCI-H2171,56963564,-0.0417490265139498
SK-OV-3,4261,3.2658157069367615
ALL-SIL,327653,2.0915878780614623
HuNS1,151289,0.4174144499948718
BT-20,16725315,3.3091237825765307
KP-N-YN,5460769,4.0809724038992705
HuNS1,11977753,-3.4047449622103354
OCI-M1,25102847,3.6786264643546462
K-562,11656518,1.1460195934444493
Mino,54678924,1.078833350632611
LP-1,613753,3.067914036099391
ECC10,navitoclax-sorafenib (1-1 mol-mol),-2.438081921111202
NCI-H2122,10184653,1.7831572753338232
BT 416,409805,6.33771322760139
T84,11964036,0.3959683641341698
YD-8,16736978,2.484760794127255
ECC10,73707398,0.3199143694659382
BT 231,9915743,1.2683297871302317
BICR 31,613753,3.1747241586791772
HuNS1,5291,3.678960058980664
K-562,71466445,2.3693775657442373
GA-10,16741245,3.917076127236771
T84,44202524,2.9348734299097172
MHH-CALL-4,25102847,3.29432016935911
NUGC-4,12001922,1.7013116164726718
HuNS1,2858523,3.1312765388666723
NCI-H2171,tanespimycin-gemcitabine (1-1 mol-mol),-2.6967474652224745
HD-MY-Z,46174525,4.904183059636927
SK-LU-1,54618771,0.3237862890103595
BT 416,11317348,1.591537095354147
HMCB,selumetinib-vorinostat (8-1 mol-mol),3.744114804484371
SK-MES-1,10385095,1.1316059221084596
Calu-1,5284616,3.255611412308511
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848
KHM-1B,73707438,4.044668520699287
L3.3,24951314,1.4054712073944002
PE/CA-PJ15,107985,-2.5858433218961108
CFPAC-1,1716436,3.681270165505168
PL-21,44493952,4.265181453263251
ALL-SIL,54619267,3.6744484896003713
NUGC-4,4917,3.005836319242386
OCI-M1,445455,3.932155775713188
KHM-1B,445455,4.826586800965752
SW1353,carboplatin-etoposide (40-17 mol-mol),5.720421590838591
PL-21,24771867,2.814856917473943
YH-13,426756,4.439847465268924
